0001558370-21-013911.txt : 20211101 0001558370-21-013911.hdr.sgml : 20211101 20211101160859 ACCESSION NUMBER: 0001558370-21-013911 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 83 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211101 DATE AS OF CHANGE: 20211101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 211367222 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 10-Q 1 tdoc-20210930x10q.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-37477

TELADOC HEALTH, INC.

(Exact name of registrant as specified in its charter)

Delaware		04-3705970
(State of incorporation)		(I.R.S. Employer Identification No.)

2 Manhattanville Road, Suite 203
Purchase, New York		10577
(Address of principal executive office)		(Zip code)

(203) 635-2002

(Registrant’s telephone number including area

code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	TDOC	The New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧ No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ⌧ No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:


Large accelerated filer	⌧	Accelerated filer	◻	Non-accelerated filer	◻	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes ☐ No ⌧

As of October 27, 2021, the Registrant had 160,086,661 shares of Common Stock outstanding.

Table of Contents

TELADOC HEALTH, INC.

QUARTERLY REPORT ON FORM 10-Q

For the period ended September 30, 2021

TABLE OF CONTENTS

		Page Number

PART I	Financial Information	2
Item 1.	Financial Statements	2
	Consolidated Balance Sheets as of September 30, 2021 (unaudited) and December 31, 2020	2
	Consolidated Statements of Operations and Comprehensive Loss (unaudited) for the quarters and nine months ended September 30, 2021 and 2020	3
	Consolidated Statements of Stockholders’ Equity (unaudited) for the quarters and nine months ended September 30, 2021 and 2020	4
	Consolidated Statements of Cash Flows (unaudited) for the nine months ended September 30, 2021 and 2020	5
	Notes to Unaudited Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	35
Item 4.	Controls and Procedures	35
PART II	Other Information	37
Item 1.	Legal Proceedings	37
Item 1A.	Risk Factors	37
Item 6.	Exhibits	38
Exhibit Index		38
Signatures		40

Table of Contents

PART I

FINANCIAL INFORMATION

ITEM 1. Financial Statements

TELADOC HEALTH, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data, unaudited)


	September 30,		December 31,
	2021		2020

Assets
Current assets:
Cash and cash equivalents	$	823,828	$	733,324
Short-term investments		2,538		53,245
Accounts receivable, net of allowance of $11,277 and $6,412, respectively		178,072		169,281
Inventories		56,937		56,498
Prepaid expenses and other current assets		95,941		47,259
Total current assets		1,157,316		1,059,607
Property and equipment, net		27,027		28,551
Goodwill		14,470,399		14,581,255
Intangible assets, net		1,932,012		2,020,864
Operating lease - right-of-use assets		47,935		46,647
Other assets		17,890		18,357
Total assets	$	17,652,579	$	17,755,281
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	34,655	$	46,030
Accrued expenses and other current liabilities		106,252		83,657
Accrued compensation		75,891		94,593
Deferred revenue-current		72,865		52,356
Advances from financing companies		12,442		13,453
Current portion of long-term debt		0		42,560
Total current liabilities		302,105		332,649
Other liabilities		1,328		1,616
Operating lease liabilities, net of current portion		42,729		43,142
Deferred revenue, net of current portion		4,075		2,449
Advances from financing companies, net of current portion		9,561		9,926
Deferred taxes		93,824		102,103
Convertible senior notes, net		1,211,375		1,379,592
Commitments and contingencies
Stockholders’ equity:
Common stock, $0.001 par value; 300,000,000 shares authorized as of September 30, 2021 and December 31, 2020; 160,013,751 shares and 150,281,099 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively		160		150
Additional paid-in capital		17,399,023		16,857,797
Accumulated deficit		(1,410,469)		(992,661)
Accumulated other comprehensive (loss) gain		(1,132)		18,518
Total stockholders’ equity		15,987,582		15,883,804
Total liabilities and stockholders’ equity	$	17,652,579	$	17,755,281

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

TELADOC HEALTH, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except share and per share data, unaudited)


	Quarter Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Revenue	$	521,658	$	288,812	$	1,478,472	$	710,641
Expenses:
Cost of revenue (exclusive of depreciation and amortization, which is shown separately below)		169,041		104,725		475,273		267,887
Operating expenses:
Advertising and marketing		111,078		52,302		303,738		132,395
Sales		62,602		23,483		191,251		60,110
Technology and development		80,250		29,958		239,017		72,244
Acquisition, integration and transformation costs		4,340		25,395		22,084		30,686
General and administrative		103,016		59,742		319,404		162,699
Depreciation and amortization		51,907		12,932		151,907		32,535
Total expenses		582,234		308,537		1,702,674		758,556
Loss from operations		(60,576)		(19,725)		(224,202)		(47,915)
Loss on extinguishment of debt		850		1,227		43,728		8,978
Other expense (income), net		376		252		(5,493)		827
Interest expense, net		18,895		16,970		61,493		38,849
Net loss before taxes		(80,697)		(38,174)		(323,930)		(96,569)
Income tax expense (benefit)		3,643		(2,290)		93,878		(5,400)
Net loss		(84,340)		(35,884)		(417,808)		(91,169)
Other comprehensive (loss) gain, net of tax:
Cumulative translation adjustment		(13,423)		16,285		(19,650)		11,610
Comprehensive loss	$	(97,763)	$	(19,599)	$	(437,458)	$	(79,559)

Net loss per share, basic and diluted	$	(0.53)	$	(0.43)	$	(2.68)	$	(1.17)

Weighted-average shares used to compute basic and diluted net loss per share		159,435,165		83,607,902		155,926,680		77,821,073

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

TELADOC HEALTH, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except share data, unaudited)


								Accumulated
				Additional				Other		Total
	Common Stock			Paid-In		Accumulated		Comprehensive		Stockholders’
	Shares	Amount		Capital		Deficit		Gain (Loss)		Equity
Balance as of June 30, 2021	159,462,978	$	159	$	17,314,749	$	(1,326,129)	$	12,291	$	16,001,070
Exercise of stock options	216,882		1		5,174		0		0		5,175
Issuance of common stock upon vesting of restricted stock units	235,674		0		(0)		0		0		0
Issuance of common stock for conversion/exchange of 2025 Notes	98,217		0		14,868		0		0		14,868
Equity portion of extinguishment of 2025 Notes	0		0		(10,079)		0		0		(10,079)
Stock-based compensation	0		0		74,311		0		0		74,311
Other comprehensive loss, net of tax	0		0		0		0		(13,423)		(13,423)
Net loss	0		0		0		(84,340)		0		(84,340)
Balance as of September 30, 2021	160,013,751	$	160	$	17,399,023	$	(1,410,469)	$	(1,132)	$	15,987,582

Balance as of December 31, 2020	150,281,099	$	150	$	16,857,797	$	(992,661)	$	18,518	$	15,883,804
Exercise of stock options, net	2,123,935		3		22,953		0		0		22,956
Issuance of common stock upon vesting of restricted stock units	1,490,879		1		(1)		0		0		0
ESPP	82,088		0		10,539		0		0		10,539
Issuance of common stock for 2022 Convertible Notes	1,058,373		1		270,111		0		0		270,112
Issuance of common stock for 2025 Notes	5,182,656		5		920,514		0		0		920,519
Recovery of excess common stock issued for acquisition (see Note 4)	(205,279)		(0)		(40,329)		0		0		(40,329)
Equity portion of extinguishment of 2025 Notes	0		0		(668,507)		0		0		(668,507)
Equity portion of extinguishment of 2022 Notes	0		0		(224,081)		0		0		(224,081)
Stock-based compensation	0		0		250,027		0		0		250,027
Other comprehensive loss, net of tax	0		0		0		0		(19,650)		(19,650)
Net loss	0		(0)		0		(417,808)		0		(417,808)
Balance as of September 30, 2021	160,013,751	$	160	$	17,399,023	$	(1,410,469)	$	(1,132)	$	15,987,582

Balance as of June 30, 2020	79,099,433	$	79	$	1,879,573	$	(562,810)	$	(21,913)	$	1,294,929
Exercise of stock options	400,555		0		7,113		0		0		7,113
Issuance of common stock upon vesting of restricted stock units	49,396		0		(0)		0		0		0
Issuance of common stock for conversion/redemption of 2022 Notes	950		0		187		0		0		187
Equity portion of extinguishment of 2022 Notes	0		0		(44)		0		0		(44)
Issuance of common stock for conversion/exchange of 2025 Notes	187,346		0		37,780		0		0		37,780
Equity portion of extinguishment of 2025 Notes	0		0		(29,326)		0		0		(29,326)
Issuance of common stock in acquisition	4,620,665		5		918,813		0		0		918,818
Stock-based compensation	0		0		21,178		0		0		21,178
Other comprehensive gain, net of tax	0		0		0		0		16,285		16,285
Net loss	0		0		0		(35,884)		0		(35,884)
Balance as of September 30, 2020	84,358,345	$	84	$	2,835,274	$	(598,694)	$	(5,628)	$	2,231,036

Balance as of December 31, 2019	72,761,941	$	73	$	1,538,716	$	(507,525)	$	(17,239)	$	1,014,025
Exercise of stock options, net	1,999,518		1		40,625		0		0		40,626
Issuance of common stock upon vesting of restricted stock units	801,575		1		(1)		0		0		0
ESPP	35,901		0		2,473		0		0		2,473
Issuance of common stock for 2022 Convertible Notes	3,951,399		4		694,047		0		0		694,051
Issuance of common stock for 2025 Notes	187,346		0		37,780		0		0		37,780
Issuance of common stock in acquisition	4,620,665		5		918,813		0		0		918,818
Equity portion of extinguishment of 2022 Notes	0		0		(715,195)		0		0		(715,195)
Equity portion of extinguishment of 2025 Notes	0		0		(29,326)		0		0		(29,326)
Equity component of 2027 Notes, net of issuance costs	0		0		285,601		0		0		285,601
Stock-based compensation	0		0		61,741		0		0		61,741
Other comprehensive gain, net of tax	0		0		0		0		11,611		11,611
Net loss	0		0		0		(91,169)		0		(91,169)
Balance as of September 30, 2020	84,358,345	$	84	$	2,835,274	$	(598,694)	$	(5,628)	$	2,231,036

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

TELADOC HEALTH, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)


	Nine Months Ended September 30,
	2021		2020
Cash flows provided by operating activities:
Net loss	$	(417,808)	$	(91,169)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		151,907		32,535
Depreciation of rental equipment		2,500		851
Amortization of right-of-use assets		8,185		4,643
Allowance for doubtful accounts		11,353		2,320
Stock-based compensation		240,971		61,151
Deferred income taxes		91,414		(4,096)
Accretion of interest		46,843		29,459
Loss on extinguishment of debt		40,631		8,978
Gain on sale of investment		(5,901)		0
Other, net		38		216
Changes in operating assets and liabilities:
Accounts receivable		(19,407)		(16,450)
Prepaid expenses and other current assets		(34,566)		(5,906)
Inventory		(2,661)		(2,392)
Other assets		(3,432)		140
Accounts payable		(11,115)		6,584
Accrued expenses and other current liabilities		15,880		17,269
Accrued compensation		(17,352)		9,329
Deferred revenue		20,002		15,348
Operating lease liabilities		(8,202)		(4,360)
Other liabilities		1,502		(3,025)
Net cash provided by operating activities		110,782		61,425
Cash flows used in investing activities:
Capital expenditures		(5,611)		(2,872)
Capitalized software development costs		(35,402)		(14,515)
Proceeds from marketable securities		50,000		0
Proceeds from the sale of investment		10,901		0
Acquisitions of business, net of cash acquired		(75,944)		(159,663)
Other, net		3,150		0
Net cash used in investing activities		(52,906)		(177,050)
Cash flows provided by financing activities:
Net proceeds from the exercise of stock options		22,956		40,627
Proceeds from issuance of 2027 Notes		0		1,000,000
Payment of issuance costs of 2027 Notes		0		(24,070)
Repurchase of 2022 Notes		(139)		(228,153)
Proceeds from advances from financing companies		10,677		1,924
Payment against advances from financing companies		(12,053)		(4,427)
Proceeds from employee stock purchase plan		13,996		2,473
Cash received for withholding taxes on stock-based compensation, net		3,109		326
Other, net		(4,224)		0
Net cash provided by financing activities		34,322		788,700
Net increase in cash and cash equivalents		92,198		673,075
Foreign exchange difference		(1,694)		(129)
Cash and cash equivalents at beginning of the period		733,324		514,353
Cash and cash equivalents at end of the period	$	823,828	$	1,187,299

Income taxes paid	$	3,114	$	786

Interest paid	$	7,973	$	5,612

See accompanying notes to unaudited consolidated financial statements.

Table of Contents

Note 1. Organization and Description of Business

Teladoc, Inc. was incorporated in the State of Texas in June 2002 and changed its state of incorporation to the State of Delaware in October 2008. Effective August 10, 2018, Teladoc, Inc. changed its corporate name to Teladoc Health, Inc. Unless the context otherwise requires, Teladoc Health, Inc., together with its subsidiaries, is referred to herein as “Teladoc Health” or the “Company”. The Company’s principal executive office is located in Purchase, New York. Teladoc Health is a global leader in providing virtual healthcare services with a focus on high quality, lower costs, and improved outcomes around the world.

On January 4, 2021, the Company completed the acquisition of the UK-based telemedicine provider Consultant Connect Limited (“Consultant Connect”). Consultant Connect provides a platform that specializes in facilitating healthcare professional-to-professional advice and guidance in the United Kingdom.

On October 30, 2020, the Company completed the merger with Livongo Health, Inc. (“Livongo”), a transformational opportunity to improve the delivery, access and experience of healthcare for consumers around the world. Livongo is pioneering a new category in healthcare, called Applied Health Signals, which is transforming the management of chronic conditions.

On July 1, 2020, the Company completed the acquisition of InTouch Technologies, Inc. (“InTouch”), a leading provider of enterprise telehealth solutions for hospitals and health systems.

Note 2. Basis of Presentation and Principles of Consolidation

The accompanying unaudited consolidated financial statements for the three and nine months ended September 30, 2021 and 2020, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of Teladoc Health for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended December 31, 2020, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.

These financial statements include the results of Teladoc Health, as well as three professional associations and thirteen professional corporations (collectively, the “Association”). All intercompany transactions and balances have been eliminated. Certain prior year amounts have been reclassified to conform to the current year presentation.

Teladoc Health Medical Group, P.A., formerly Teladoc Physicians, P.A. is party to several Services Agreements by and among it and the professional associations and professional corporations pursuant to which each professional association and professional corporation provides services to Teladoc Health Medical Group, P.A. Each professional association and professional corporation is established pursuant to the requirements of its respective domestic jurisdiction governing the corporate practice of medicine.

The Company holds a variable interest in the Association which contracts with physicians and other health professionals in order to provide services to the Company. The Association is considered a variable interest entity (“VIE”) since it does not have sufficient equity to finance its activities without additional subordinated financial support. An enterprise having a controlling financial interest in a VIE must consolidate the VIE if it has both power and benefits—that is, it has (1) the power to direct the activities of a VIE that most significantly impacts the VIE’s economic performance (power) and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE (benefits). The Company has the power and rights to control all activities of the Association and funds and absorbs all losses of the VIE and appropriately consolidates the Association.

Total revenue and net income (loss) for the VIE were $56.2 million and $0.1 million, and $48.9 million and $(0.7) million, for the quarters ended September 30, 2021 and 2020, respectively. Total revenue and net income (loss)

Table of Contents

for the VIE were $161.9 million and $(3.0) million, and $149.1 million and $0.1 million, for the nine months ended September 30, 2021 and 2020, respectively. The VIE’s total assets, all of which were current, were $31.0 million and $28.7 million at September 30, 2021 and December 31, 2020, respectively. Total liabilities, all of which were current for the VIE, were $71.0 million and $65.8 million at September 30, 2021 and December 31, 2020, respectively. The VIE’s total stockholders’ deficit was $40.1 million and $37.1 million at September 30, 2021 and December 31, 2020, respectively.

Business Combinations

The Company accounts for its business combinations using the acquisition method of accounting. The purchase price is attributed to the fair value of the assets acquired and liabilities assumed. Transaction costs directly attributable to the acquisition are expensed as incurred. Identifiable assets and liabilities acquired or assumed are measured separately at their fair values as of the acquisition date. The excess of the purchase price of acquisition over the fair value of the identifiable net assets of the acquiree is recorded as goodwill. The results of businesses acquired in a business combination are included in the Company’s consolidated financial statements from the date of acquisition.

When the Company issues stock-based or cash awards to an acquired company’s stockholders, the Company evaluates whether the awards are consideration or compensation for post-acquisition services. The evaluation includes, among other things, whether the vesting of the awards is contingent on the continued employment of the acquired company’s stockholders beyond the acquisition date. If continued employment is required for vesting, the awards are treated as compensation for post-acquisition services and recognized as expense over the requisite service period.

Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates, including the selection of valuation methodologies, estimates of future revenue and cash flows, discount rates and selection of comparable companies. The estimates and assumptions used to determine the fair values and useful lives of identified intangible assets could change due to numerous factors, including market conditions, technological developments, economic conditions and competition. In connection with determination of fair values, the Company may engage a third-party valuation specialist to assist with the valuation of intangible and certain tangible assets acquired and certain assumed obligations. Acquisition-related transaction costs incurred by the Company are not included as a component of consideration transferred but are accounted for as an operating expense in the period in which the costs are incurred.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates on historical experience, current business factors, and various other assumptions that the Company believes are necessary to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment evolves. The Company believes that estimates used in the preparation of these consolidated financial statements are reasonable; however, actual results could differ materially from these estimates.

Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.

Significant estimates and assumptions by management affect areas including the allowance for doubtful accounts, the carrying value of long-lived assets (including goodwill and intangible assets), capitalization and amortization of software development costs, the finalization of purchase accounting adjustments, Client performance guarantees, the calculation of a contingent liability in connection with an acquisition earn-out, the provision for income taxes and related deferred tax accounts, revenue recognition, contingencies, and other items as described in the Summary of Significant Accounting policies in this Quarterly Report and in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Form 10-K”).

Table of Contents

Recently Issued Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-06—"Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.” ASU 2020-06 simplifies the accounting for convertible instruments by eliminating the conversion option separation model for convertible debt that can be settled in cash and by eliminating the measurement model for beneficial conversion features. Convertible instruments that continue to be subject to separation models are (1) those with conversion options that are required to be accounted for as bifurcated derivatives and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. This ASU also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. This standard becomes effective for the Company on January 1, 2022 and may be early adopted during an interim period of 2021. The Company will adopt the standard on January 1, 2022 and is currently evaluating the impact of ASU 2020-06 on its consolidated financial statements.

Summary of Significant Accounting Policies

The following sections reflect updates to the summary of significant accounting policies described in the 2020 Form 10-K. In addition, on an ongoing basis, the Company will continue to closely monitor for any significant impact to its estimates and assumptions as a result of the COVID-19 pandemic, especially on the allowance for doubtful accounts.

Acquisition, Integration and Transformation Costs

Acquisition, integration and transformation costs include investment banking, financing, legal, accounting, consultancy, integration, fair value changes related to contingent consideration and certain other transaction costs related to mergers and acquisitions. It also includes costs related to certain business transformation initiatives focused on integrating and optimizing various operations and systems, including enhancing our customer relationship management (CRM) and enterprise resource planning (ERP) systems, incurred in connection with our acquisition and integration activities.

General and Administrative Costs

General and Administrative costs consist of all operating expenses not included in the other operating expense categories and now include legal and regulatory costs for all current and historical periods presented.

Other Expense (Income), Net

Other expense (income), net includes the impact of foreign currency remeasurement, realized and unrealized gains on investment securities and all other non-operating items not included in other financial statement lines.

Note 3. Revenue, Deferred Revenue, Deferred Costs and Other

The Company generates access fees from Clients accessing its professional provider network, hosted virtual healthcare platform and chronic care management platforms. Visit fee revenue is generated for general medical, expert medical service and other specialty visits. In addition, other revenue is primarily associated with virtual healthcare device equipment included with its hosted virtual healthcare platform. Access revenue accounted for 87% and 78% of our revenue for the quarters ended September 30, 2021 and 2020. Access revenue accounted for 86% and 77% of our revenue for the nine months ended September 30, 2021 and 2020, respectively.

Table of Contents

The following table presents the Company’s revenues disaggregated by revenue source (in thousands):


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Access Fees Revenue
U.S.	$	413,594	$	194,622	$	1,161,084	$	454,582
International		37,989		31,997		112,699		91,261
Total		451,583		226,619		1,273,783		545,843

Visit Fee Revenue
U.S.		59,863		50,948		173,399		152,944
International		116		96		368		705
Total		59,979		51,044		173,767		153,649

Other
U.S.		9,583		10,299		29,617		10,299
International		513		850		1,305		850
Total		10,096		11,149		30,922		11,149

Total Revenues	$	521,658	$	288,812	$	1,478,472	$	710,641

International revenues primarily reflect the location of the customer, except for direct to consumer activities which primarily reflect the location of operations to service customers.

Deferred Revenue

Deferred revenue represents billed, but unrecognized revenue, and is comprised of fees received in advance of the delivery or completion of the services and amounts received in instances when revenue recognition criteria have not been met. Deferred revenue associated with upfront payments for a device is amortized ratably over the expected Member enrollment period. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as current deferred revenue and the remaining portion is recorded as noncurrent deferred revenue.

For certain services, payment is required for future months before the service is delivered to the Member. The Company records deferred revenue when cash payments are received in advance of the Company’s performance obligation to provide services. Deferred revenue, current plus long-term, was $76.9 million at September 30, 2021 and $51.6 million at September 30, 2020. The net increase of $21.8 million and $36.8 million in the deferred revenue balance for the nine months ended September 30, 2021 and 2020, respectively, is primarily driven by InTouch and Livongo as well as the direct-to-consumer behavioral health product and cash payments received or due in advance of satisfying the Company’s performance obligations, offset by revenue recognized that were included in the deferred revenue balance at the beginning of the period. The Company anticipates that it will satisfy most of its performance obligation associated with the deferred revenue within the prospective fiscal year. Revenue recognized during the quarters ended September 30, 2021 and 2020 that was included in deferred revenue at the beginning of the periods was $47.2 million and $18.9 million, respectively. Revenue recognized during the nine months ended September 30, 2021 and 2020 that was included in deferred revenue at the beginning of the periods was $48.5 million and $10.6 million, respectively.

We expect to recognize $48.5 million and $15.4 million of revenue in 2021 and 2022, respectively, related to future performance obligations that are unsatisfied or partially unsatisfied as of September 30, 2021.

Table of Contents

Deferred Costs and Other

Deferred costs and other, consist of deferred device cost and deferred contract cost, which are classified as a component of Prepaid expenses and other current assets or Other assets depending on term, consist of the following as of September 30, 2021 (in thousands):


	As of		As of
	September 30,		December 31,
	2021		2020
Deferred costs and other, current	$	20,243	$	3,468
Deferred costs and other, noncurrent		7,788		2,179
Total deferred costs and other	$	28,031	$	5,647

Deferred costs and other activity are as follows (in thousands):


	Deferred Costs and Other
Beginning balance as of December 31, 2020	$	5,647
Additions		34,554
Cost of revenue recognized		(12,170)
Ending balance as of September 30, 2021	$	28,031

Note 4. Business Acquisitions

On January 4, 2021, the Company completed the acquisition of the UK-based telemedicine provider Consultant Connect for cash consideration of $56.3 million, net of cash acquired. Consultant Connect provides a platform that specializes in facilitating healthcare professional-to-professional advice and guidance in the United Kingdom. As part of purchase accounting, the Company recognized intangibles related to customer relationships, technology and the brand of $9.8 million, $1.9 million, and $0.6 million, respectively; and goodwill of $47.3 million. The acquisition was considered a stock acquisition for tax purposes and accordingly, the goodwill resulting from this acquisition is not tax deductible.

On October 30, 2020, the Company completed the acquisition of Livongo through a merger in which Livongo became a wholly-owned subsidiary of the Company. Upon completion of the merger, each share of Livongo’s common stock converted into the right to receive 0.5920 shares of Teladoc Health’s common stock and $4.24 in cash, without interest. In addition, in connection with the closing of the merger, Livongo paid a special cash dividend equal to $7.09 per share of Livongo’s common stock to shareholders of Livongo as of a record date of October 29, 2020. The total initial consideration calculated on upon deal closing was $13,938.0 million, consisting of $401.0 million of net cash, $555.4 million related to the conversion feature of the Livongo Notes guaranteed by the Company and 60.4 million shares of Teladoc Health’s common stock valued at approximately $12,981.6 million on October 30, 2020. The acquisition was considered a stock acquisition for tax purposes and accordingly, the goodwill resulting from this acquisition is not tax deductible. The total acquisition related costs were $59.0 million and included transaction costs for investment bankers, other professional fees and income taxes for accelerated grants and were recognized in the Company’s consolidated statement of operations in acquisition, integration and transformation costs.

In the first quarter of 2021, the Company identified 205,279 of additional shares of Teladoc Health common stock that were included as part of the merger consideration (“Excess Shares”) and 85,481 of additional shares of Teladoc Health common stock that were not withheld from the merger consideration for withholding tax purposes (“Withholding Shares”). In addition, the Company identified $5.6 million of merger-related cash payments related to the Excess Shares (“Cash Overpayments”). The Company has recovered and cancelled all 205,279 of the Excess Shares and expects to recover the Cash Overpayments in the form of cash. The Company expects to apply the cash value of the Withholding Shares to offset future employment tax obligations of the Company. As a result, the total adjusted consideration was $13,876.9 million, consisting of $380.2 million of net cash, $555.4 million related to the conversion feature of the Livongo Notes guaranteed by the Company and 60.2 million shares of Teladoc Health’s common stock valued at approximately $12,941.3 million. The Company does not expect to incur any material charges or expenses related to the recovery of the Withholding Shares and the Cash Overpayments. Accordingly, the Company recorded, in the first quarter of fiscal year 2021, an increase to receivables in current other assets of $20.8 million, a decrease to consolidated stockholders’ equity of $40.3 million and a decrease to goodwill of $61.1 million.

Table of Contents

In the first quarter of 2021, the Company recognized a discrete non-cash income tax charge substantially reflecting an additional valuation allowance on excess stock compensation benefits and other state deferred tax assets associated with the Livongo merger which resulted in a $106.5 million measurement period reduction to goodwill.

In the third quarter of 2021, the Company recorded a $5.0 million increase to goodwill reflecting a final adjustment to its measurement date tax valuation allowances and a $6.3 million increase to goodwill to reflect the cost to replace certain devices becoming obsolete due to provider upgrades to telecommunications networks known at the date of the Livongo merger.

On July 1, 2020, the Company completed the acquisition of InTouch through a merger in which InTouch became a wholly-owned subsidiary of the Company. The aggregate merger consideration paid was $1,078.5 million, net of cash acquired of $1.1 million, which was comprised of 4.6 million shares of Teladoc’s common stock valued at $918.8 million on July 1, 2020, and $160.7 million of cash. InTouch is a leading provider of enterprise telehealth solutions for hospitals and health systems. The acquisition was considered a stock acquisition for tax purposes and accordingly, the goodwill resulting from this acquisition is not tax deductible. The total acquisition related costs were $12.5 million and included transaction costs for investment bankers and other professional fees and were recognized in the Company’s consolidated statement of operations in acquisition, integration and transformation costs.

The acquisitions described above were accounted for using the acquisition method of accounting, which requires, among other things, the assets acquired and the liabilities assumed be recognized at their fair values as of the acquisition date. The results of the acquisitions were included within the consolidated financial statements commencing on the aforementioned acquisition dates.

The following table summarizes the fair value estimates of the assets acquired and liabilities assumed for the Livongo and InTouch acquisitions. The Company, with the assistance of a third-party valuation expert, estimated the fair value of the acquired tangible and intangible assets with significant estimates such as revenue projections.

The allocation of the consideration transferred to the assets acquired and the liabilities assumed for the Livongo merger remains preliminary and therefore can be revised as a result of additional information obtained due to the finalization of the valuation inputs and assumptions as well as completing the assessment of the tax attributes of the business combination. As discussed further in Note 15, the Company recognized a non-cash income tax charge during the nine months ended September 30, 2021, substantially reflecting the recording of a valuation allowance on stock compensation benefits associated with the Livongo merger. Additional adjustments that could have a material impact on the Company’s results of operations and financial position may be recorded within the measurement period, which will not exceed one year from the acquisition date.

Table of Contents

Identifiable assets acquired and liabilities assumed (in thousands):


	Livongo		InTouch
Purchase price, net of cash acquired	$	13,876,931	$	1,069,759
Less:
Accounts receivable		80,084		16,986
Short term investment		52,500		0
Inventory		24,299		8,492
Property and equipment, net		8,952		11,366
Right of use assets		15,056		4,965
Other assets		17,337		2,541
Client relationships		1,050,000		164,580
Technology		300,000		29,190
Trademarks		250,000		32,630
Advances from financing companies		0		(26,012)
Accounts payable		(119,302)		(5,589)
Deferred revenue		(997)		(20,729)
Convertible notes		(453,417)		0
Deferred taxes		(37,980)		(30,102)
Lease liabilities		(18,834)		(5,495)
Other liabilities		(46,606)		(13,042)
Goodwill	$	12,755,839	$	899,978

The amount allocated to goodwill reflects the benefits Teladoc Health expects to realize from the growth of the respective acquisitions’ operations, cost savings, and various synergies.

The Company’s pro forma revenue and net loss for the quarters and nine months ended September 30, 2020 below have been prepared as if Livongo and InTouch had been purchased on January 1, 2020. As such, the Company made pro-forma adjustments related to deferred revenue, deferred costs, amortization of intangible assets, interest expense, stock-based compensation, acquisition costs and transaction expenses for the purpose of this presentation.


	Unaudited Pro Forma
	Quarter Ended		Nine Months Ended
	September 30,		September 30,
(in thousands)	2020		2020
Revenue	$	395,519	$	1,026,957
Net loss	$	(93,149)	$	(778,287)

The unaudited pro forma financial information above is not necessarily indicative of what the Company’s consolidated results actually would have been if the acquisitions had been completed at the beginning of the respective periods. In addition, the unaudited pro forma information above does not attempt to project the Company’s future results.

Note 5. Inventories

Inventories consisted of the following (in thousands):


	As of September 30,		As of December 31,
	2021		2020
Raw materials and purchased parts	$	21,836	$	19,591
Work in process		501		1,431
Finished goods		34,600		35,476
Total inventories	$	56,937	$	56,498

Table of Contents

Note 6. Intangible Assets, Net

Intangible assets, net consist of the following (in thousands):


									Weighted
									Average
									Remaining
	Useful			Accumulated		Net Carrying			Useful Life
	Life	Gross Value		Amortization		Value			(Years)
September 30, 2021
Client relationships	2 to 20 years	$	1,467,396	$	(174,523)	$	1,292,873		14.8
Non-compete agreements	1.5 to 5 years		5,008		(5,008)		0
Trademarks	3 to 15 years		326,594		(38,075)		288,519		9.7
Patents	3 years		200		(200)		0
Capitalized software development costs	3 to 5 years		97,779		(35,717)		62,062		2.7
Technology	5 to 7 years		342,039		(53,481)		288,558		5.9
Intangible assets, net		$	2,239,016	$	(307,004)	$	1,932,012		12.3
December 31, 2020
Client relationships	2 to 20 years	$	1,460,648	$	(100,844)	$	1,359,804	`	15.4
Non-compete agreements	1.5 to 5 years		5,097		(4,872)		225		0.4
Trademarks	3 to 15 years		326,786		(15,576)		311,210		10.5
Patents	3 years		200		(200)		0
Capitalized software development costs	3 to 5 years		52,518		(24,771)		27,747		2.8
Technology	5 to 7 years		338,150		(16,272)		321,878		6.6
Intangible assets, net		$	2,183,399	$	(162,535)	$	2,020,864		13.1

Amortization expense for intangible assets net of foreign currency remeasurement for intangible assets was $49.6 million and $11.7 million for the quarters ended September 30, 2021 and 2020, respectively. Amortization expense, net of foreign currency remeasurement for intangible assets was $145.3 million and $29.6 million for the nine months ended September 30, 2021 and 2020, respectively.

Note 7. Goodwill

Goodwill consists of the following (in thousands):


	As of September 30,		As of December 31,
	2021		2020
Beginning balance as of December 31, 2020 and 2019, respectively	$	14,581,255	$	746,079
Additions associated with acquisitions		61,157		13,812,198
Purchase consideration adjustments (see Note 4)		(55,801)		0
Deferred tax adjustments (see Note 4)		(101,536)		0
Cumulative translation adjustment		(14,676)		22,978
Ending balance as of September 30, 2021 and December 31, 2020, respectively	$	14,470,399	$	14,581,255

Table of Contents

Note 8. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):


	As of September 30,		As of December 31,
	2021		2020
Professional fees	$	2,726	$	4,717
Consulting fees/provider fees		16,253		23,167
Client performance guarantees		8,817		7,215
Interest payable		5,811		2,049
Income tax payable		1,385		1,627
Insurance		6,272		3,139
Marketing		5,733		2,815
Operating lease liabilities - current		13,148		11,438
Earnout		0		4,514
Acquisition & Integration		4,212		1,036
Franchise and Sales Taxes		5,802		2,099
Device Replacement Cost		6,263		0
Other		29,831		19,841
Total	$	106,252	$	83,657

Note 9. Fair Value Measurements

The carrying value of the Company’s cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued liabilities approximates fair value due to their short-term nature.

The Company measures its financial assets and liabilities at fair value at each reporting period using a fair value hierarchy that requires it to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value:

Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active

markets.

Level 2—Include other inputs that are directly or indirectly observable in the marketplace.

Level 3—Unobservable inputs that are supported by little or no market activity.

The Company measures its cash equivalents at fair value on a recurring basis. The Company classifies its cash equivalents within Level 1 because they are valued using observable inputs that reflect quoted prices for identical assets in active markets and quoted prices directly in active markets.

The Company’s investments in equity securities without readily determinable fair values are accounted for under the measurement alternative of the FASB ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities, with any changes to fair value recognized within other expense (income), net each reporting period. Under the measurement alternative, equity investments without readily determinable fair values are carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar securities of the same issuer; value is generally determined based on a market approach as of the transaction date.

The Company measures its short-term investments at fair value on a recurring basis and classifies such as Level 2. They are valued using observable inputs that reflect quoted prices directly or indirectly in active markets. The short-term investments amortized cost approximates fair value.

The Company measured its contingent consideration at fair value on a recurring basis and classifies such as Level 3. The Company estimates the fair value of contingent consideration as the present value of the expected contingent payments, determined using the weighted probability of the possible payments.

Table of Contents

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis using the above input categories (in thousands):


	September 30, 2021
	Level 1		Level 2		Level 3		Total
Cash and cash equivalents	$	823,828	$	0	$	0	$	823,828
Short-term investments	$	0	$	2,538	$	0	$	2,538


	December 31, 2020
	Level 1		Level 2		Level 3		Total
Cash and cash equivalents	$	733,324	$	0	$	0	$	733,324
Short-term investments	$	0	$	53,245	$	0	$	53,245
Equity securities without readily determinable fair values	$	0	$	5,000	$	0	$	5,000
Contingent liability	$	0	$	0	$	4,514	$	4,514

There were no transfers between fair value measurement levels during the quarters or nine months ended September 30, 2021 and 2020.

The change in fair value of the Company’s equity securities without readily determinable fair values was as follows:


Fair value and historical cost basis at December 31, 2020	$	5,000
Upward adjustment due to observable price change in identical securities		5,901
Sale of investment		(10,901)
Fair value at September 30, 2021	$	0

The change in fair value of the Company’s contingent liability is recorded in acquisition, integration and transformation costs in the consolidated statements of operations. The contingent liability is based on future revenue and profitability expectations. The following table reconciles the beginning and ending balance of the Company’s Level 3 contingent liability (in thousands):


Fair value at December 31, 2020	$	4,514
Payments		(4,367)
Change in fair value		0
Currency translation adjustment		(147)
Fair value at September 30, 2021	$	0

Note 10. Leasing Operations

The Company has operating leases for facilities, hosting co-location facilities and certain equipment under non-cancelable leases in the United States and various international locations. The leases have remaining lease terms of 1 to 7 years, with options to extend the lease term from 1 to 5 years. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the arrangement covering the right to use property, plant or equipment for a stated period of time. For new and amended leases beginning in 2020 and after, the Company will separately allocate the lease (e.g., fixed lease payments for right-to-use land, building, etc.) and non-lease components (e.g., common area maintenance) for its leases.

Table of Contents

Operating Leases

The Company leases office space under non-cancelable operating leases in the United States and various international locations. As of September 30, 2021, the future minimum lease payments under non-cancelable operating leases were as follows (in thousands):


	As of
Operating Leases:	September 30, 2021
2021	$	14,594
2022		14,872
2023		10,927
2024		7,233
2025		6,028
2026 and thereafter		13,997
Total future minimum payments	$	67,651

The Company rents its systems to certain qualified customers under arrangements that qualify as either sales-type lease or operating lease arrangements. Leases have terms that generally range from two to five years.

Note 11. Convertible Senior Notes

Outstanding Convertible Senior Notes

As of September 30, 2021, the Company had three series of convertible senior notes outstanding. The issuances of such notes originally consisted of (i) $1 billion aggregate principal amount of 1.25% convertible senior notes due 2027 (the “2027 Notes”), issued on May 19, 2020 for net proceeds to the Company of $975.9 million after deducting offering costs of approximately $24.1 million, (ii) $287.5 million aggregate principal amount of 1.375% convertible senior notes due 2025 (the “2025 Notes”), issued on May 8, 2018 for net proceeds to the Company of $279.1 million after deducting offering costs of approximately $8.4 million, and (iii) $550.0 million aggregate principal amount of 0.875% convertible senior notes due 2025 that were issued by Livongo on June 4, 2020 for which the Company has agreed to guarantee Livongo’s obligations (the “Livongo Notes;” and together with the 2027 Notes, the 2025 Notes and the 2022 Notes (as defined below), the “Notes”). On June 27, 2017, the Company issued, at par value, $275 million aggregate principal amount of 3% convertible senior notes due 2022 (the “2022 Notes”), which were redeemed during the quarter ended March 31, 2021 as described below.

The following table presents certain terms of the Notes that were outstanding as of September 30, 2021:



	2027 Notes			2025 Notes			Livongo Notes
Interest Rate Per Year		1.25	%		1.375	%		0.875	%
Fair Value as of September 30, 2021 (in millions)	$	970.5		$	2.1		$	710.6
Maturity Date		June 1, 2027			May 15, 2025			June 1, 2025
Optional Redemption Date		June 5, 2024			May 22, 2022			June 5, 2023
Conversion Date		December 1, 2026			November 15, 2024			March 1, 2025
Conversion Rate Per $1,000 Principal Amount as of September 30, 2021		4.1258			18.6621			13.94
Remaining Contractual Life as of September 30, 2021		5.7 years			3.6 years			3.7 years

All of the Notes are unsecured obligations of the Company and rank senior in right of payment to the Company’s indebtedness that is expressly subordinated in right of payment to such Notes; equal in right of payment to the Company’s liabilities that are not so subordinated; effectively junior in right of payment to any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities incurred by the Company’s subsidiaries.

Table of Contents

Holders may convert all or any portion of their Notes in integral multiples of $1,000 principal amount, at their option, at any time prior to the close of business on the business day immediately preceding the applicable conversion date only under the following circumstances:

●

during any quarter (and only during such quarter), if the last reported sale price of the shares of Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding quarter is greater than or equal to 130% of the conversion price for the applicable Notes on each applicable trading day;

●

during the five business day period after any ten consecutive trading day period (or five consecutive trading day period in the case of the Livongo Notes) in which the trading price was less than 98% of the product of the last reported sale price of Company’s common stock and the conversion rate for the applicable Notes on each such trading day;

●

upon the occurrence of specified corporate events described under the applicable indenture; or

●

if the Company calls the applicable Notes for redemption, at any time until the close of business on the second business day immediately preceding the redemption date.

On or after the applicable conversion date, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of such Notes, regardless of the foregoing circumstances.

The 2027 Notes and the 2025 Notes are convertible into shares of the Company’s common stock at the applicable conversion rate shown in the table above. The Livongo Notes are convertible at the applicable conversion rate shown in the table above into “units of reference property,” each of which is comprised of 0.5920 of a share of the Company’s common stock and $4.24 in cash, without interest. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s common stock (or units of reference property, in the case of the Livongo Notes) or a combination thereof, at the Company’s election. If the Company elects to satisfy the conversion obligation solely in cash or through payment and delivery, as the case may be, of a combination of cash and shares of the Company’s common stock or units of reference property, the amount of cash and shares of the Company’s common stock or units of reference property, if any, due upon conversion will be based on a daily conversion value calculated on a proportionate basis for each trading day in a 25 consecutive trading days observation period (or 40 days in the case of the Livongo Notes).

The Company may redeem for cash all or part of the Notes, at its option, on or after the applicable optional redemption date shown in the table above (and prior to the 41st scheduled trading day immediately preceding the maturity date in the case of the Livongo Notes) if the last reported sale price of its common stock exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading days ending on, and including, the trading day immediately preceding the date on which the Company provides notice of the redemption. The redemption price will be the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any. In addition, calling any 2027 Note or 2025 Note for redemption on or after the applicable optional redemption date will constitute a make-whole fundamental change with respect to that Note, in which case the conversion rate applicable to the conversion of that Note, if it is converted in connection with the redemption, will be increased in certain circumstances as described in the applicable indenture. If Livongo undergoes a fundamental change (as defined in the applicable indenture) at any time prior to the maturity date, holders will have the right, at their option, to require Livongo to repurchase for cash all or any portion of their Livongo Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Livongo Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

In accounting for the issuance of the 2027 Notes, 2025 Notes and the 2022 Notes, the Company separated the Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of a similar liability that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the applicable Notes as a whole. The excess of the principal amount of the liability component over its carrying amount, referred to as the debt discount, is amortized to interest expense from the issuance date to the applicable maturity date. The equity component is not re-measured as long as it continues to meet the conditions for equity classification. The equity component related to the 2027 Notes, 2025 Notes and 2022 Notes was $286 million,

Table of Contents

$91.4 million and $62.4 million, respectively, net of issuance costs which were recorded in additional paid-in capital on the accompanying condensed consolidated balance sheet. The Company carries the liability component of the Livongo Notes at face value less unamortized debt discount on its condensed consolidated balance sheets and provides the fair value for disclosure purposes only. The Company has reserved an aggregate of 8.7 million shares of common stock for the Notes.

In accounting for the transaction costs related to the issuance of the 2027 Notes, 2025 Notes and 2022 Notes, the Company allocated the total costs incurred to the liability and equity components of the Notes based on their relative values. Transaction costs attributable to the liability component are being amortized to interest expense over the seven-year term of the Notes (or five-and-a-half year term in the case of the 2022 Notes), and transaction costs attributable to the equity component are netted with the equity components in stockholders’ equity.

The liability components of the Notes consist of the following (in thousands):


	As of September 30,		As of December 31,
2027 Notes	2021		2020
Principal	$	1,000,000	$	1,000,000
Less: Debt discount, net (1)		(260,324)		(287,916)
Net carrying amount	$	739,676	$	712,084

2025 Notes
Principal	$	882	$	276,788
Less: Debt discount, net (1)		(215)		(65,923)
Net carrying amount	$	667	$	210,865

Livongo Notes
Principal	$	550,000	$	550,000
Less: Debt discount, net (1)		(78,968)		(93,357)
Net carrying amount	$	471,032	$	456,643

2022 Notes
Principal	$	0	$	46,762
Less: Debt discount, net (1)		0		(4,202)
Net carrying amount	$	0	$	42,560

(1)

Included in the accompanying consolidated balance sheet within convertible senior notes and amortized to interest expense over the expected life of the Notes using the effective interest rate method.

The Company estimates the fair value of its Notes utilizing market quotations for debt that have quoted prices in active markets. Since the Notes do not trade on a daily basis in an active market, the fair value estimates are based on market observable inputs based on borrowing rates currently available for debt with similar terms and average maturities.

Table of Contents

The following table sets forth total interest expense recognized related to the Notes (and in the case of the Livongo Notes, subsequent to the acquisition of Livongo) (in thousands):


	Quarters Ended							Nine Months Ended
	September 30,							September 30,
2027 Notes:		2021			2020			2021		2020
Contractual interest expense	$	3,125		$	3,125		$	9,375		$	4,618
Amortization of debt discount		9,370			8,989			27,592			12,911
Total	$	12,495		$	12,114		$	36,967		$	17,529
Effective interest rate of the liability component		3.4	%		3.4	%		3.4	%		3.4	%

	Quarters Ended						Nine Months Ended
	September 30,						September 30,
2025 Notes:		2021			2020			2021		2020
Contractual interest expense	$	10		$	971		$	1,080		$	2,947
Amortization of debt discount		48			3,170			4,546			9,379
Total	$	58		$	4,141		$	5,626		$	12,326
Effective interest rate of the liability component		4.7	%		7.9	%		4.7	%		7.9	%

	Quarters Ended						Nine Months Ended
	September 30,						September 30,
Livongo Notes:	2021							2021
Contractual interest expense	$	1,203					$	3,609
Amortization of debt discount		4,858						14,389
Total	$	6,061					$	17,998
Effective interest rate of the liability component		5.2	%					5.2	%

	Quarters Ended						Nine Months Ended
	September 30,						September 30,
2022 Notes:		2021			2020			2021		2020
Contractual interest expense	$	0		$	351		$	116		$	3,696
Amortization of debt discount		0			650			316			6,940
Total	$	0		$	1,001		$	432		$	10,636
Effective interest rate of the liability component					10.0	%		3.0	%		10.0	%

Exchanges and Conversions of Convertible Senior Notes Due 2025

In August 2021, the Company entered into privately negotiated agreements with certain holders of the 2025 Notes to exchange approximately $5.1 million aggregate principal amount of 2025 Notes for an aggregate of 95,347 shares of the Company’s common stock in private placement transactions pursuant to Section 4(a)(2) of the Securities Act. In addition, certain holders of the 2025 Notes converted their 2025 Notes in exchange for approximately 5.2 million shares of the Company’s common stock during the nine months ended September 30, 2021. As a result of the exchanges and conversions, the Company recorded a charge associated with the loss on extinguishment of debt net of transaction fees of $0.8 million and $40.3 million during the quarter and nine months ended September 30, 2021, respectively.

Redemption and Conversions of Convertible Senior Notes Due 2022

In March 2021, the Company completed a redemption of all of the then outstanding 2022 Notes in exchange for approximately $0.1 million in cash (including accrued and unpaid interest). Prior to that redemption, certain holders of the 2022 Notes converted their 2022 Notes in exchange for 1.1 million shares of the Company’s common stock during the quarter ended March 31, 2021. As a result of the redemption and conversions, the Company recorded a charge associated with the loss on extinguishment of debt of $3.4 million during the quarter ended March 31, 2021.

Table of Contents

Note 12. Advances from Financing Companies

The Company utilizes a third-party financing company to provide certain Clients with a rental option. The principal portion of these up-front payments are reported as advances from financing companies in the accompanying consolidated balance sheet. Interest rates applicable to the outstanding advances as of September 30, 2021 ranged from 3.35% to 9.89%.

Client lease payments to third party financing companies will reduce the advances from financing companies as of September 30, 2021 by year as follows (in thousands):


	As of September 30,
	2021
2021	$	3,763
2022		11,718
2023		5,491
2024		1,031
	$	22,003

Note 13. Legal Matters

From time to time, Teladoc Health is involved in various litigation matters arising in the normal course of business, including the matters described below. The Company consults with legal counsel on those issues related to litigation and seeks input from other experts and advisors with respect to such matters. Estimating the probable losses or a range of probable losses resulting from litigation, government actions and other legal proceedings is inherently difficult and requires an extensive degree of judgment, particularly where the matters involve indeterminate claims for monetary damages, may involve discretionary amounts, present novel legal theories, are in the early stages of the proceedings, or are subject to appeal. Whether any losses, damages or remedies ultimately resulting from such matters could reasonably have a material effect on our business, financial condition, results of operations, or cash flows will depend on a number of variables, including, for example, the timing and amount of such losses or damages (if any) and the structure and type of any such remedies. As of the date of these financial statements, Teladoc Health’s management does not expect any litigation matter to have a material adverse impact on its business, financial condition, results of operations or cash flows.

On May 14, 2018, a purported class action complaint (Thomas v. Best Doctors, Inc.) was filed in the United States District Court for the District of Massachusetts against the Company’s wholly owned subsidiary, Best Doctors, Inc. The complaint alleges that on or about May 16, 2017, Best Doctors violated the U.S. Telephone Consumer Protection Act (the “TCPA”) by sending unsolicited facsimiles to plaintiff and certain other recipients without the recipients’ prior express invitation or permission. The lawsuit seeks statutory damages for each violation, subject to trebling under the TCPA, and injunctive relief. The Company will vigorously defend the lawsuit and any potential loss is currently deemed to be immaterial.

On December 12, 2018, a purported securities class action complaint (Reiner v. Teladoc Health, Inc., et.al.) was filed in the United States District Court for the Southern District of New York (the “SDNY”) against the Company and certain of the Company’s officers and a former officer. The complaint is brought on behalf of a purported class consisting of all persons or entities who purchased or otherwise acquired shares of the Company’s common stock during the period March 3, 2016 through December 5, 2018. The complaint asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegedly false or misleading statements and omissions with respect to, among other things, the alleged misconduct of one of the Company’s previous executive officers. The complaint seeks certification as a class action and unspecified compensatory damages plus interest and attorneys’ fees. On November 30, 2020, the SDNY granted the Company’s motion to dismiss the complaint, but granted the plaintiff the opportunity to refile, which refiling was made on December 30, 2020. The Company subsequently filed a motion to dismiss the lawsuit, which was granted with prejudice by the SDNY on September 29, 2021.

In addition, on June 21, 2019, a stockholder derivative lawsuit (Kreutter v. Gorevic, et al.) was filed in the SDNY against certain current and former directors and officers of the Company. The derivative lawsuit alleges that the named directors and officers breached their fiduciary duties to the Company in connection with factual assertions

Table of Contents

substantially similar to those in the purported securities class action complaint described above. On September 17, 2021, the Company’s motion to dismiss the lawsuit was granted with prejudice by the SDNY.

On August 27, 2021, a purported securities class action complaint (City of Hialeah Employees’ Retirement System v. Teladoc Health, Inc., et.al.) was filed in the Circuit Court of Cook County, Illinois against the Company and certain of the Company’s current and former officers and directors. The complaint is brought on behalf of a purported class consisting of all persons who acquired shares of Teladoc Health common stock issued in the Livongo merger. The complaint asserts violations of Sections 11, 12(a)(2) and 15 of the Securities Act of 1933 based on allegedly false or misleading statements and omissions with respect to the registration statement and prospectus filed in connection with the Livongo merger. The complaint seeks certification as a class action, unspecified compensatory damages plus interest and attorneys’ fees, rescission or a rescissory measure of damages and equitable or other relief. The Company believes that these claims are without merit, and the Company and its named current and former officers and directors intend to defend the Company vigorously.

Note 14. Common Stock and Stockholders’ Equity

Capitalization

Effective October 30, 2020, the authorized number of shares of the Company’s common stock was increased from 150,000,000 to 300,000,000 shares.

Warrants

The Company had no warrants outstanding as of September 30, 2021 or December 31, 2020.

Stock Plans

The Company’s 2015 Incentive Award Plan, 2017 Employment Inducement Incentive Award Plan and Livongo Acquisition Incentive Award Plan (collectively, the “Plans”) provide for the issuance of incentive and non-statutory options and other equity-based awards to its employees and non-employee service providers.

In connection with the closing of the Livongo merger, the Company assumed the Livongo Health, Inc. 2019 Equity Incentive Plan, the Livongo Health, Inc. Amended and Restated 2014 Stock Incentive Plan and the Livongo Health, Inc. Amended and Restated 2008 Stock Incentive Plan (collectively, the “Assumed Plans”). At the effective time of the Livongo merger on October 30, 2020, each outstanding Livongo equity award issued under the Assumed Plans was converted into a corresponding award with respect to the Company’s common stock, with the number of shares underlying such award adjusted based on the “Equity Award Adjustment Ratio” (as defined below), and remained outstanding in accordance with the terms that were applicable to such award prior to the Livongo merger. The exercise price of each outstanding Livongo stock option was also adjusted based on the Equity Award Adjustment Ratio. The “Equity Award Adjustment Ratio” means the quotient determined by dividing (i) the volume weighted average closing price of Livongo common stock on the four trading days ending on October 29, 2020, by (ii) the volume weighted average closing price of the Company’s common stock on the New York Stock Exchange on the four trading days beginning on October 29, 2020.

All stock-based awards to employees are measured based on the grant-date fair value or replacement grant date fair value in relation to the Livongo transaction, and are generally recognized on a straight line basis in the Company’s consolidated statement of operations over the period during which the employee is required to perform services in exchange for the award (generally requiring a four-year vesting period for each stock option and a three-year vesting period for each restricted stock unit (“RSU”)).

Stock Options

Options issued under the Plans are exercisable for periods not to exceed ten years, and vest and contain such other terms and conditions as specified in the applicable award document. Options to buy common stock are issued under the Plans, with exercise prices equal to the closing price of shares of the Company’s common stock on the New York Stock Exchange on the date of award. The Company had 12,574,026 shares available for grant at September 30, 2021.

Table of Contents

Activity under the Plans was as follows (in thousands, except share and per share amounts and years):


				Weighted-
		Weighted-		Average
	Number of	Average		Remaining	Aggregate
	Shares	Exercise		Contractual	Intrinsic
	Outstanding	Price		Life in Years	Value
Balance at December 31, 2020	5,826,685	$	17.19	5.31	$	1,064,944
Stock option grants	35,740	$	162.38	N/A
Stock options exercised	(2,120,943)	$	10.79	N/A	$	(409,182)
Stock options forfeited	(90,583)	$	30.03	N/A
Balance at September 30, 2021	3,650,899	$	21.96	5.57	$	386,390
Vested or expected to vest at September 30, 2021	3,650,899	$	21.96	7.10	$	35,607
Exercisable at September 30, 2021	3,243,849	$	18.84	5.37	$	350,848

The total grant-date fair value of stock options granted during the quarters ended September 30, 2021 and 2020 were $3.0 million and $10.7 million, respectively. The total grant-date fair value of stock options granted during the nine months ended September 30, 2021 and 2020 were $5.8 million and $11.2 million, respectively.

The Company estimates the fair value of stock options granted using the Black Scholes option pricing model.

The assumptions used in the Black-Scholes option-pricing model are determined as follows:

Volatility. The expected volatility was derived from the historical stock volatilities of the Company’s stock volatility over a period equivalent to the expected term of the stock option grants.

Expected Term. The expected term represents the period that the stock-based awards are expected to be outstanding. When establishing the expected term assumption, the Company utilizes historical data.

Risk-Free Interest Rate. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with terms similar to the expected term on the options.

Dividend Yield. The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, it used an expected dividend yield of zero.

Forfeiture rate. The Company recognizes forfeitures as they occur.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions and fair value per share:


	Nine Months Ended September 30,
	2021		2020
Volatility		56.52% - 58.14%		46.1% - 56.0%
Expected term (in years)		4.1		4.1
Risk-free interest rate		0.31% - 0.70%		0.27%-1.64%
Dividend yield		0		0
Weighted-average fair value of underlying stock options	$	72.46	$	49.21

The Company determined that a Monte Carlo valuation model is most suitable for valuation of options for the replaced and replacement awards from the Livongo merger, for the following reasons:

●

Options are deeply in-the-money, as such don’t qualify as “plain-vanilla” options.

●

With the merger, the exercise pattern of the replaced and replacement options might be different from a regular “plain-vanilla” option that assumes the exercise of the option at the end of the option expiration time. A lattice approach can be used to directly model the effect of different expected periods before exercise on the fair-value-based measure of the option, whereas it is assumed under the Black-Scholes-Merton model that exercise occurs at the end of the option’s expected term.

For the quarters ended September 30, 2021 and 2020, the Company recorded compensation expense related to stock options of $23.3 million and $3.4 million, respectively. For the nine months ended September 30, 2021 and 2020,

Table of Contents

the Company recorded compensation expense related to stock options granted of $77.1 million and $11.5 million, respectively.

As of September 30, 2021, the Company had $40.4 million in unrecognized compensation cost related to non-vested stock options, which is expected to be recognized over a weighted-average period of approximately 0.9 years.

Restricted Stock Units

The fair value of RSUs is determined on the date of grant. The Company records compensation expense in the consolidated statement of operations on a straight-line basis over the vesting period for RSUs. The vesting period for employees and members of the Board of Directors ranges from one to four years.

Activity under RSUs was as follows:


		Weighted-Average
		Grant Date
	RSUs	Fair Value Per RSU
Balance at December 31, 2020	3,550,595	$	162.11
Granted	650,335	$	192.86
Vested and issued	(1,222,550)	$	131.65
Forfeited	(681,510)	$	183.98
Balance at September 30, 2021	2,296,870	$	175.60
Vested and unissued at September 30, 2021	13,755	$	50.90
Non-vested at September 30, 2021	2,283,115	$	175.60

The total grant-date fair value of RSUs granted during the quarters ended September 30, 2021 and 2020 were $23.1 million and $11.9 million, respectively. The total grant-date fair value of RSUs granted during the nine months ended September 30, 2021 and 2020 were $125.0 million and $54.9 million, respectively.

For the quarters ended September 30, 2021 and 2020, the Company recorded stock-based compensation expense related to RSUs of $42.8 million and $11.3 million, respectively. For the nine months ended September 30, 2021 and 2020, the Company recorded stock-based compensation expense related to RSUs of $142.6 million and $32.0 million, respectively.

As of September 30, 2021, the Company had $343.6 million in unrecognized compensation cost related to non-vested RSUs, which is expected to be recognized over a weighted-average period of approximately 2.2 years.

Performance Stock Units

Stock-based compensation costs associated with our performance stock units (“PSUs”) are initially determined using the fair market value of the Company's common stock on the date the awards are approved by the Compensation Committee of the Board of Directors (service inception date). The vesting of these PSUs is subject to certain performance conditions and a service requirement ranging from 1-3 years. Until the performance conditions are met, stock compensation costs associated with these PSUs are re-assessed each reporting period based upon the estimated performance attainment on the reporting date. The ultimate number of PSUs that are issued to an employee is the result of the actual performance of the Company at the end of the performance period compared to the performance conditions and can range from 50% to 225% of the initial grant. Stock compensation expense for PSUs is recognized on an accelerated tranche by tranche basis for performance-based awards. Forfeitures are accounted for at the time they occur consistent with Company policy.

Table of Contents

Activity under PSUs was as follows:


		Weighted-Average
		Grant Date
	Shares	Fair Value Per PSU
Balance at December 31, 2020	429,319	$	76.60
Granted	531,309	$	132.66
Vested and issued	(268,201)	$	74.33
Forfeited	(26,730)	$	153.05
Balance at September 30, 2021	665,697	$	119.07
Vested and unissued at September 30, 2021	0	$	0
Non-vested at September 30, 2021	665,697	$	119.07

The total grant-date fair value of PSUs granted during the quarter ended September 30, 2021 was $2.5 million and no PSUs were granted during the quarter ended September 30, 2020. The total grant-date fair value of PSUs granted during the nine months ended September 30, 2021 and 2020 were $70.4 million and $13.1 million, respectively.

For the quarters ended September 30, 2021 and 2020, the Company recorded stock-based compensation expense related to PSUs of $4.2 million and $5.9 million, respectively. For the nine months ended September 30, 2021 and 2020, the Company recorded stock-based compensation expense related to PSUs of $16.7 million and $16.8 million, respectively.

As of September 30, 2021, the Company had $22.5 million in unrecognized compensation cost related to non-vested PSUs, which is expected to be recognized over a weighted-average period of approximately 2.4 years.

Employee Stock Purchase Plan

In July 2015, the Company adopted the 2015 Employee Stock Purchase Plan (“ESPP”) in connection with its initial public offering. A total of 926,109 shares of common stock were reserved for issuance under this plan as of September 30, 2021. The Company’s ESPP permits eligible employees to purchase common stock at a discount through payroll deductions during defined offering periods. Under the ESPP, the Company may specify offerings with durations of not more than 27 months and may specify shorter purchase periods within each offering. Each offering will have one or more purchase dates on which shares of its common stock will be purchased for employees participating in the offering. An offering may be terminated under certain circumstances. The price at which the stock is purchased is equal to the lower of 85% of the fair market value of the common stock at the beginning of an offering period or on the date of purchase.

During the quarters ended September 30, 2021 and 2020, the Company did not issue any shares under the ESPP. During the nine months ended September 30, 2021 and 2020, the Company issued 82,088 shares and 35,901 shares, respectively under the ESPP. As of September 30, 2021, 517,015 shares remained available for issuance.

For the quarters ended September 30, 2021 and 2020, the Company recorded stock-based compensation expense related to the ESPP of $1.4 million and $0.6 million, respectively. For the nine months ended September 30, 2021 and 2020, the Company recorded stock-based compensation expense related to the ESPP of $4.6 million and $1.4 million, respectively.

As of September 30, 2021, the Company had $0.6 million in unrecognized compensation cost related to the ESPP, which is expected to be recognized over a weighted-average period of approximately 0.1 year.

Table of Contents

Total compensation costs for stock-based awards were recorded as follows (in thousands):


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Cost of revenue (exclusive of depreciation and amortization, which is shown separately)	$	2,162	$	128	$	6,310	$	128
Advertising and marketing		5,244		1,644		15,141		4,447
Sales		17,518		3,275		57,638		9,465
Technology and development		22,910		2,622		77,335		7,285
General and administrative		23,867		13,239		84,547		39,826
Total stock-based compensation expense (1)	$	71,701	$	20,908	$	240,971	$	61,151

(1)	Excluding the amount capitalized related to internal software development projects.

Note 15. Income Taxes

As a result of the Company’s history of net operating losses (“NOL”), the Company had historically provided for a full valuation allowance against its deferred tax assets for assets that are not more-likely-than-not to be realized, which was partially released in the quarter ended December 31, 2020. The Company’s income tax expense for the quarter and nine months ended September 30, 2021 was $3.6 million and $93.9 million, respectively.

For the quarter ended September 30, 2021, the Company recognized an additional discrete non-cash income tax charge reflecting an additional valuation allowance on excess stock compensation and other state deferred tax assets associated with the Livongo merger.

For the nine months ended September 30, 2021, the Company recognized a discrete non-cash income tax charge substantially reflecting an additional valuation allowance on excess stock compensation benefits and other state deferred tax assets associated with the Livongo merger. This was recorded in the first quarter, and was partially offset by tax benefits on current period losses.

The Company’s income tax benefit for the quarter and nine months ended September 30, 2020 of $(2.3) million and $(5.4) million, respectively, was primarily related to the release of an uncertain tax provision, amortization of acquired intangibles, and stock compensation deductions.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Special Note Regarding Forward-Looking Statements

Many statements made in this Quarterly Report on Form 10-Q that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies. These statements often include words such as “anticipates,” “believes,” “suggests,” “targets,” “projects,” “plans,” “expects,” “future,” “intends,” “estimates,” “predicts,” “potential,” “may,” “will,” “should,” “could,” “would,” “likely,” “foresee,” “forecast,” “continue” and other similar words or phrases, as well as statements in the future tense to identify these forward-looking statements. These forward-looking statements and projections are contained throughout this Form 10-Q, including the section entitled” “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” We base these forward-looking statements or projections on our current expectations, plans and assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances and at such time. As you read and consider this Form 10-Q, you should understand that these statements are not guarantees of performance or results. The forward-looking statements and projections are subject to and involve risks, uncertainties and assumptions and you should not place undue reliance on these forward-looking statements or projections. Although we believe that these forward-looking statements and projections are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect our actual financial results or results of operations and could cause actual results to differ materially from those expressed in the forward-looking statements and projections. Factors that may materially affect such forward-looking statements and projections include, but are not limited to, the section entitled “Risk Factors” in the 2020 Form 10-K and in our other reports and SEC filings. These cautionary statements should not be construed by you to be exhaustive and are made only as of the date of this Form 10-Q. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should evaluate all forward-looking statements made in this Form 10-Q in the context of these risks and uncertainties.

Overview

Teladoc Health solutions are transforming the access, cost and quality dynamics of healthcare delivery for all of our market participants. Members rely on Teladoc Health to remotely access affordable, on-demand healthcare whenever and wherever they choose. Our Clients on behalf of their employees or beneficiaries as well as direct-to consumer individuals (D2C) purchase our solutions to reduce their healthcare spending and offer convenient, affordable, high-quality healthcare to their employees or beneficiaries. Our network of physicians and other healthcare professionals, or our providers have the ability to generate meaningful income and deliver their services more efficiently with no administrative burden.

COVID-19 Update

We believe that favorable existing macro trends were accelerated by the impacts of the COVID-19 pandemic, driving greater consumer trial and use of virtual care, and increased adoption by employers, health plans, hospitals and health systems, and health care providers. In combination with the expansion of our capabilities, we believe that these trends present significant opportunities for virtual healthcare to address the most pressing, universal healthcare challenges through trusted solutions, such as ours, that deliver convenient, high quality care; empower consumers to manage and improve their health; and enable providers to offer their best care for their patients.

We continue to closely monitor the impact of the COVID-19 pandemic on all aspects of our business. The outbreak of COVID-19 in 2020 increased utilization of our telehealth services, but it is uncertain whether such increase in demand will continue. While the COVID-19 pandemic has not had a material adverse impact on our financial

Table of Contents

condition and results of operations to date, the future impact on our operational and financial performance will depend on certain developments, including the duration and spread of the pandemic, impact on our Clients and Members, impact on our sales cycles, and effect on our vendors, all of which are uncertain and cannot be predicted. Public and private sector policies and initiatives to reduce the transmission of COVID-19 and disruptions to our operations and the operations of our third-party suppliers, along with any related global slowdown in economic activity, may result in decreased revenues, decreased collections, and increased costs. Further, the economic effects of the COVID-19 pandemic have financially constrained some of our prospective and existing Clients’ healthcare spending, which may negatively impact our ability to acquire new Clients and our ability to renew subscriptions with or sell additional solutions to our existing Clients. We also may experience increased Member attrition to the extent our existing Clients reduce their respective workforces in response to economic conditions. In addition, due to our subscription-based business model, the effect of the COVID-19 pandemic may not be fully reflected in our revenue until future periods. It is possible that the COVID-19 pandemic, the measures taken by the governments and businesses affected and any resulting economic impact may materially and adversely affect our business, results of operations, cash flows and financial positions as well as our customers.

We have also taken measures in response to the COVID-19 pandemic, and we may take further actions that alter our business operations as may be required by federal, state, local or foreign authorities or that we determine are in the best interests of our employees, Clients, Members, and stockholders. The effects of these operational modifications are unknown and may not be realized until future reporting periods.

Acquisition History

We have scaled and intend to continue to scale our platform through the pursuit of selective acquisitions. We have completed multiple acquisitions since our inception, which we believe have expanded our distribution capabilities and broadened our service offerings.

On January 4, 2021, we completed the acquisition of the UK-based telemedicine provider Consultant Connect for an aggregate consideration of $56.3 million, net of cash acquired. Consultant Connect provides a platform that specializes in facilitating healthcare professional-to-professional advice and guidance in the United Kingdom.

On October 30, 2020, we completed the merger with Livongo. Upon completion of the merger, each share of Livongo’s common stock converted into the right to receive 0.5920 shares of Teladoc Health’s common stock and $4.24 in cash, without interest. In addition, in connection with the closing of the merger, Livongo paid a special cash dividend equal to $7.09 per share to shareholders of Livongo as of a record date of October 29, 2020. The total consideration was $13,876.9 million consisting of $380.2 million of net cash, $555.4 million related to the conversion feature of the Livongo Notes guaranteed by the Company and 60.2 million shares of Teladoc Health’s common stock valued at approximately $12,941.3 million on October 30, 2020. Livongo is a leading provider to empower people with chronic conditions to live better and healthier lives.

On July 1, 2020, we completed the acquisition of InTouch for aggregate consideration of $1,069.8 million, which was comprised of 4.6 million shares of our common stock valued at $903.3 million on July 1, 2020, and $166.5 million of net cash. InTouch is a leading provider of enterprise telehealth solutions for hospitals and health systems.

Revenue

We have a demonstrated track record of driving growth both organically and through acquisitions. For the quarter ended September 30, 2021, we increased revenue by 81% to $521.7 million, including the impact from acquired businesses. For the nine months ended September 30, 2021 we increased revenue by 108% to $1,478.5 million, including the impact from acquired businesses. Excluding the impact of the acquisitions, revenue increased 32% and 44% for the quarter and nine months ended September 30, 2021, respectively, reflecting the acceleration of the adoption of virtual care stemming from the COVID-19 pandemic and the Company’s broad momentum to transform the healthcare experience.

For the quarter ended September 30, 2021, 87%, 11% and 2% of our revenue was derived from access fees, visit fees and other revenue, respectively, and for the nine months ended September 30, 2021, 86%, 12% and 2% of our revenue was derived from access fees, visit fees, and other revenue, respectively. For the quarter ended September 30, 2020, 78%, 18% and 4% of our revenue was derived from access fees, visit fees and other revenue, respectively,

Table of Contents

and for the nine months ended September 30, 2020, 77%, 22% and 1% of our revenue were derived from access fees, visit fees, and other revenue, respectively. We believe our continued strong access fee revenue is mainly representative of the value proposition we provide the broader healthcare system.

Key Factors Affecting Our Performance

We believe that our future performance will depend on many factors, including the following:

Number of Members. Our revenue growth rate and long-term profitability are affected by our ability to increase our number of Members because we derive a substantial portion of our revenue from access and other fees via Client contracts that provide Members access to our professional provider network primarily in exchange for contractual based periodic fees or access fees derived from our D2C Members. Therefore, we believe that our ability to add new Members is a key indicator of our increasing market adoption, the growth of our business and future revenue potential, and that increasing our Membership is an integral objective that will provide us with the ability to continually innovate our services and support initiatives that will enhance Members’ experiences. U.S. Paid Membership was 52.5 million at September 30, 2021.

Number of Visits. We also recognize revenue in connection with the completion of a general medical visit, expert medical service, and other specialty visits for contracts where the service is not part of access fees. Visit fee revenue is driven primarily by the number of Clients, the number of Members in a Client’s population, Member utilization of our provider network services and the contractually negotiated prices of our services. We believe that increasing our current Member utilization rate and increasing penetration further into existing and new health plan Clients is a key objective in order for our Clients to realize tangible healthcare savings with our service. Visits increased by 37%, or 1.1 million, to approximately 3.9 million for the quarter ended September 30, 2021 compared to the same period in 2020. Visits increased by 39%, or 3.0 million, to approximately 10.6 million for the nine months ended September 30, 2021 compared to the same period in 2020.

Number of Platform-Enabled Sessions. A platform-enabled session is a unique instance in which our licensed software platform has facilitated a virtual voice or video encounter between a care provider and our Client’s patient, or between care providers. We believe platform-enabled sessions are an indicator of the value our Clients derive from the platform they license from us in order to facilitate virtual care. Over time, we expect platform-enabled sessions to outpace overall revenue growth as telehealth becomes a bigger part of our Clients’ care delivery strategy. Our Clients completed 1.0 million and 3.1 million platform-enabled sessions during the quarter and nine months ended September 30, 2021, respectively.

Seasonality. We typically experience the strongest increases in consecutive quarterly revenue during the fourth and first quarters of each year, which coincides with traditional annual benefit enrollment seasons. In particular, as a result of many Clients’ introduction of new services at the very end of the current year, or the start of each year, a high concentration of our new Client contracts has an effective date of January 1. Therefore, while Membership increases, utilization is dampened until service delivery ramps up over the course of the year. Additionally, our business has become more diversified across services, channels, and geographies. We continue to see a diversification of Client start dates, resulting from our health plan expansions, cross sales of new services, international growth, and mid-market employer growth, all of which are not constrained by a calendar year start.

As a result of national seasonal cold and flu trends, we typically experience our highest level of visit fees during the first and fourth quarters of each year. Conversely, the second quarter of the year has historically been the period of lowest utilization of our provider network services relative to the other quarters of the year. However, during the COVID-19 pandemic in 2021 and 2020, we did not experience the typical seasonality associated with national cold and flu outbreaks. See “Risk Factors—Risks Related to Our Business—Our quarterly results may fluctuate significantly, which could adversely impact the value of our common stock” included in our Form 10-K for the year ended December 31, 2020 filed with the SEC.

Table of Contents

Critical Accounting Policies and Estimates

Our discussion and analysis of our results of operations, liquidity and capital resources are based on our consolidated financial statements which have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities.

On an ongoing basis, we evaluate our estimates and judgments, including those related to the allowance for doubtful accounts, the carrying value of long-lived assets (including goodwill and intangible assets), capitalization and amortization of software development costs, the finalization of purchase accounting adjustments, Client performance guarantees, the calculation of a contingent liability in connection with an acquisition earn-out, the provision for income taxes and related deferred tax accounts, revenue recognition, contingencies, and other items. We base our estimates on historical and anticipated results and trends and on various other assumptions that we believe are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. By their nature, estimates are subject to an inherent degree of uncertainty. Actual results may differ from our estimates and could have a significant adverse effect on our results of operations and financial position. For a discussion of our critical accounting policies and estimates see Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Form 10-K for the year ended December 31, 2020 filed with the SEC.

Consolidated Results of Operations

The following table sets forth our consolidated statement of operations data for the quarters and nine months ended September 30, 2021 and 2020 and the dollar and percentage change between the respective periods (in thousands):


	Quarter Ended September 30,								Nine Months Ended September 30,
	2021		2020						2021		2020
	$		$		Variance		%		$		$		Variance		%
Revenue	$	521,658	$	288,812	$	232,846	81	%	$	1,478,472	$	710,641	$	767,831	108	%
Expenses:
Cost of revenue (exclusive of depreciation and amortization, which is shown separately below)		169,041		104,725		64,316	61	%		475,273		267,887		207,386	77	%
Operating expenses:
Advertising and marketing		111,078		52,302		58,776	112	%		303,738		132,395		171,343	129	%
Sales		62,602		23,483		39,119	167	%		191,251		60,110		131,141	218	%
Technology and development		80,250		29,958		50,292	168	%		239,017		72,244		166,773	231	%
Acquisition, integration and transformation costs		4,340		25,395		(21,055)	(83)	%		22,084		30,686		(8,602)	(28)	%
General and administrative		103,016		59,742		43,274	72	%		319,404		162,699		156,705	96	%
Depreciation and amortization		51,907		12,932		38,975	301	%		151,907		32,535		119,372	367	%
Total expenses		582,234		308,537		273,697	89	%		1,702,674		758,556		944,118	124	%
Loss from operations		(60,576)		(19,725)		(40,851)	207	%		(224,202)		(47,915)		(176,287)	368	%
Loss on extinguishment of debt		850		1,227		(377)	(31)	%		43,728		8,978		34,750	387	%
Other expense (income), net		376		252		124	49	%		(5,493)		827		(6,320)	N/M	%
Interest expense, net		18,895		16,970		1,925	11	%		61,493		38,849		22,644	58	%
Net loss before taxes		(80,697)		(38,174)		(42,523)	111	%		(323,930)		(96,569)		(227,361)	235	%
Income tax expense (benefit)		3,643		(2,290)		5,933	(259)	%		93,878		(5,400)		99,278	N/M	%
Net loss	$	(84,340)	$	(35,884)	$	(48,456)	135	%	$	(417,808)	$	(91,169)	$	(326,639)	358	%

Table of Contents

EBITDA and Adjusted EBITDA

The following is a reconciliation of net loss, the most directly comparable U.S. GAAP financial measure, to EBITDA and Adjusted EBITDA for the quarters and nine months ended September 30, 2021 and 2020 (in thousands):


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Net loss	$	(84,340)	$	(35,884)	$	(417,808)	$	(91,169)
Add:
Loss on extinguishment of debt		850		1,227		43,728		8,978
Other expense (income), net		376		252		(5,493)		827
Interest expense, net		18,895		16,970		61,493		38,849
Income tax expense (benefit)		3,643		(2,290)		93,878		(5,400)
Depreciation and amortization		51,907		12,932		151,907		32,535
EBITDA(1)		(8,669)		(6,793)		(72,295)		(15,380)
Stock-based compensation		71,701		20,908		240,971		61,151
Acquisition, integration and transformation costs		4,340		25,395		22,084		30,686
Adjusted EBITDA(1)	$	67,372	$	39,510	$	190,760	$	76,457

(1)	Non-GAAP Financial Measures:

To supplement our financial information presented in accordance with U.S. GAAP, we use EBITDA and Adjusted EBITDA, which are non-U.S. GAAP financial measures, to clarify and enhance an understanding of past performance. We believe that the presentation of these financial measures enhances an investor’s understanding of our financial performance. We further believe that these financial measures are useful financial metrics to assess our operating performance from period-to-period by excluding certain items that we believe are not representative of our core business. We use certain financial measures for business planning purposes and in measuring our performance relative to that of our competitors. We utilize Adjusted EBITDA as the primary measure of our performance.

EBITDA consists of net loss before interest; other expense (income), net, including foreign exchange gain or loss; taxes; depreciation and amortization; and loss on extinguishment of debt. Adjusted EBITDA consists of net loss before interest; other expense (income), net, including foreign exchange gain or loss; taxes; depreciation and amortization; loss on extinguishment of debt; stock-based compensation; and acquisition, integration and transformation costs. We believe that making such adjustments provides investors meaningful information to understand our results of operations and the ability to analyze financial and business trends on a period-to-period basis.

We believe the above financial measures are commonly used by investors to evaluate our performance and that of our competitors. However, our use of the terms EBITDA and Adjusted EBITDA may vary from that of others in our industry. Neither EBITDA nor Adjusted EBITDA should be considered as an alternative to net loss before taxes, net loss, loss per share or any other performance measures derived in accordance with U.S. GAAP.

EBITDA and Adjusted EBITDA have important limitations as analytical tools and you should not consider them in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:

●

EBITDA and Adjusted EBITDA do not reflect the significant interest expense on our debt;

●

EBITDA and Adjusted EBITDA eliminate the impact of income taxes on our results of operations;

●

EBITDA and Adjusted EBITDA do not reflect the loss on extinguishment of debt;

●

EBITDA and Adjusted EBITDA do not reflect other expense (income), net;

●

Adjusted EBITDA does not reflect the significant acquisition, integration and transformation costs. Acquisition, integration and transformation costs include investment banking, financing, legal, accounting, consultancy, integration, fair value changes related to contingent consideration and certain other transaction costs related to mergers and acquisitions. It also includes costs related to certain business transformation

Table of Contents

initiatives focused on integrating and optimizing various operations and systems, including upgrading our customer relationship management (CRM) and enterprise resource planning (ERP) systems. These transformation cost adjustments made to our results do not represent normal, recurring, operating expenses necessary to operate the business but rather, incremental costs incurred in connection with our acquisition and integration activities;

●

Adjusted EBITDA does not reflect the significant non-cash stock compensation expense which should be viewed as a component of recurring operating costs; and

●

other companies in our industry may calculate EBITDA and Adjusted EBITDA differently than we do, limiting the usefulness of these measures as comparative measures.

In addition, although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and both EBITDA and Adjusted EBITDA do not reflect any expenditures for such replacements.

We compensate for these limitations by using EBITDA and Adjusted EBITDA along with other comparative tools, together with U.S. GAAP measurements, to assist in the evaluation of operating performance. Such U.S. GAAP measurements include net loss, net loss per share and other performance measures.

In evaluating these financial measures, you should be aware that in the future we may incur expenses similar to those eliminated in this presentation. Our presentation of EBITDA and Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

Consolidated Results of Operations

The results of operations for completed acquisitions have been included in our unaudited consolidated financial statements included in this Quarterly Report from the date of each acquisition. For the purpose of excluding the impact of acquisitions, operating results from acquired businesses are excluded from overall Company results for four fiscal quarters following the acquisition date where indicated in the below discussion.

Revenue. Total revenue was $521.7 million for the quarter ended September 30, 2021, compared to $288.8 million during the quarter ended September 30, 2020, an increase of $232.8 million, or 81%. Excluding the impact from acquisitions, revenue increased 32%. This increase in revenue was driven primarily by the generation of additional access fees by our membership base, most significantly among behavorial health specialities. Revenue from U.S. subscription access fees was $413.6 million for the quarter ended September 30, 2021 compared to $194.6 million for the quarter ended September 30, 2020, an increase of $219.0 million, or 113%. In addition, revenue from international access fees was $38.0 million for the quarter ended September 30, 2021 compared to $32.0 million for the quarter ended September 30, 2020, an increase of $6.0 million, or 19%.

Total revenue was $1,478.5 million for the nine months ended September 30, 2021, compared to $710.6 million for the nine months ended September 30, 2020, an increase of $767.8 million, or 108%. Excluding the impact from acquisitions, revenue increased 44%. Similar to the quarterly results, these increases were driven primarily by the generation of additional access fees by our membership base, most significantly among behavorial health specialities. Revenue from U.S. access fees was $1,161.1 million for the nine months ended September 30, 2021 compared to $454.6 million for the nine months ended September 30, 2020, an increase of $706.5 million, or 155%. In addition, international access fees, visit fees and other revenues increased by $21.4 million, $20.1 million and $19.8 million, respectively, on a year-to-date basis.

Cost of Revenue (exclusive of depreciation and amortization, which is shown separately below). Cost of revenue (exclusive of depreciation and amortization, which is shown separately below) was $169.0 million for the quarter ended September 30, 2021 compared to $104.7 million for the quarter ended September 30, 2020, an increase of $64.3 million, or 61%. Cost of revenue increased by $207.4 million, or 77%, on a year-to-date basis. The increase for both the quarter and year-to-date periods were primarily due to the impact of acquisitions, growth in visits associated with higher revenue which resulted in increased provider fees, and increased physician network operation center costs.

Table of Contents

Advertising and Marketing Expenses. Advertising and marketing expenses were $111.1 million for the quarter ended September 30, 2021 compared to $52.3 million for the quarter ended September 30, 2020, an increase of $58.8 million, or 112%. The increase was driven by a $44.2 million increase in Member engagement initiatives, digital and media advertising, sponsorship of professional organizations and trade shows; the impact from acquisitions; and a $2.6 million impact driven by the hiring of additional personnel.

On a year-to-date basis, advertising and marketing expenses increased by $171.3 million, or 129%, driven by a $123.1 million increase in Member engagement initiatives, digital and media advertising, sponsorship of professional organizations and trade shows, the impact of acquisitions, and a $6.1 million impact driven by the hiring of additional personnel.

Sales Expenses. Sales expenses were $62.6 million for the quarter ended September 30, 2021 compared to $23.5 million for the quarter ended September 30, 2020, an increase of $39.1 million, or 167%. On a year-to-date basis, sales expense increased $131.1 million, or 218%. The increases for both the quarter and year-to-date periods substantially reflect the impact from acquisitions.

Technology and Development Expenses. Technology and development expenses were $80.3 million for the quarter ended September 30, 2021 compared to $30.0 million for the quarter ended September 30, 2020, an increase of $50.3 million, or 168%. On a year-to-date basis, technology and development expenses increased by $166.8 million, or 231%. In addition to substantially reflecting the impact of acquisitions, the increases for the quarter and year-to-date periods were driven by increases of $3.0 million and $12.0 million, respectively, due to the hiring of additional personnel and increases of $0.9 million and $10.3 million, respectively, due to ongoing projects to continuously improve our technology portfolio and other similar items.

Acquisition, Integration and Transformation Costs. Acquisition, integration and transformation costs include investment banking, financing, legal, accounting, consultancy, integration, fair value changes related to contingent consideration and certain other transaction costs related to mergers and acquisitions. It also includes costs related to certain internal business transformation initiatives focused on integrating and optimizing various operations and systems, including upgrading our customer relationship management (CRM) and enterprise resource planning (ERP) systems.

Acquisition, integration and transformation costs were $4.3 million for the quarter ended September 30, 2021 compared to $25.4 million for the quarter ended September 30, 2020, a decrease of $21.1 million, primarily driven by expenses incurred for the Livongo merger in the prior year. These costs also decreased by $8.6 million on a year-to-date basis due to the timing of expenditures to drive integration and transformation activities resulting from the InTouch, Livongo and Consultant Connect acquisitions.

General and Administrative Expenses. General and administrative expenses were $103.0 million for the quarter ended September 30, 2021 compared to $59.7 million for the quarter ended September 30, 2020, an increase of $43.3 million, or 72%. The increase primarily reflects the impact of acquisitions. Other expenses, including office-related charges, bank charges, therapist recruiting, liability insurance, legal fees and related contingencies and bad debt expenses, increased a combined total of $16.6 million, reflecting the overall impact of growth on the business.

On a year-to-date basis, general and administrative expenses increased by $156.7 million, or 96%. The increase primarily reflects the impact of acquisitions and a $12.6 million increase in employee-related expenses reflecting the acceleration of the adoption of virtual care stemming from the COVID-19 pandemic. Other expenses, including office-related charges, bank charges, therapist recruiting, liability insurance, legal fees and related contingencies and bad debt expenses, increased a combined total of $50.0 million, reflecting the overall impact of growth on the business.

Depreciation and Amortization. Depreciation and amortization was $51.9 million for the quarter ended September 30, 2021 compared to $12.9 million for the quarter ended September 30, 2020, an increase of $39.0 million. Depreciation and amortization was $151.9 million for the nine months ended September 30, 2021 compared to $32.5 million, an increase of $119.4 million on a year-to-date basis. This increase was due to additional amortization and depreciation expense substantially related to intangible assets and fixed assets acquired from recent acquisitions.

Loss on Extinguishment of Debt. Loss on extinguishment of debt was $0.8 million for the quarter ended September 30, 2021 compared to $1.2 million for the quarter ended September 30, 2020, a decrease of $0.4 million. On a year-to-date basis, loss on extinguishment of debt increased by $34.8 million. This increase was primarily due to the exchanges and conversions of the 2025 Notes.

Table of Contents

Other Expense (Income), Net. Other expense (income), net was $0.4 million for the quarter ended September 30, 2021 compared to $0.3 million for the quarter ended September 30, 2020 and consisted primarily of foreign exchange remeasurements. Other expense (income), net was $(5.5) million for the nine months ended September 30, 2021, compared to $0.8 million for the nine months ended September 30, 2020. The year-to-date change consisted primarily of a $5.9 million gain on sale of a non-marketable equity security.

Interest Expense, Net. Interest expense, net consists of interest costs and amortization of debt discount associated with advances from financing companies, our convertible senior notes, interest income from cash and cash equivalents and short-term investments in marketable securities. Interest expense, net was $18.9 million and $17.0 million for the quarters ended September 30, 2021 and 2020, respectively. Interest expense, net was $61.5 million for the nine months ended September 30, 2021 compared to $38.8 million for the nine months ended September 30, 2020. The increase in interest expense primarily is associated with the 2027 Notes issued in May 2020 and Livongo Notes that the Company agreed to guarantee in October 2020.

Income tax expense (benefit). Income tax expense was $3.6 million for the quarter ended September 30, 2021 compared to $(2.3) million benefit for the quarter ended September 30, 2020. Income tax expense was $93.9 million for the nine months ended September 30, 2021 compared to $(5.4) million benefit for the nine months ended September 30, 2020. In the first quarter 2021, we recognized a non-cash income tax expense of $87.0 million, substantially reflecting the discrete charge for additional valuation allowance on excess stock compensation benefits associated with the Livongo merger.

Liquidity and Capital Resources

The following table presents a summary of our cash flow activity for the periods set forth below (in thousands):


	Nine Months Ended
	September 30,
	2021		2020
Consolidated Statements of Cash Flows Data
Net cash provided by operating activities	$	110,782	$	61,425
Net cash used in investing activities		(52,906)		(177,050)
Net cash provided by financing activities		34,322		788,700
Total	$	92,198	$	673,075

Our principal sources of liquidity were cash and cash equivalents, comprised of money market funds and marketable securities, totaling $823.8 million, including restricted cash of $3.8 million as of September 30, 2021. Additionally, we had short-term marketable securities of $2.5 million as of September 30, 2021.

We believe that our existing cash and cash equivalents and short-term marketable securities will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. Our future capital requirements will depend on many factors including our growth rate, contract renewal activity, number of visits, the timing and extent of spending to support product development efforts, our expansion of sales and marketing activities, the introduction of new and enhanced services offerings and the continuing market acceptance of telehealth. We may in the future enter into arrangements to acquire or invest in complementary businesses, services and technologies and intellectual property rights. We may be required to seek additional equity or debt financing. In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all. If we are unable to raise additional capital when desired, our business, financial condition and results of operations would be adversely affected.

Historically, we have raised additional financing primarily through sales of equity securities, convertible debt issuance and bank borrowings. See Note 11, “Convertible Senior Notes” of the Notes to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q for additional information on the Notes.

Cash Provided by Operating Activities

For the nine months ended September 30, 2021 cash flows provided by operating activities consisted of net loss adjusted for certain non-cash items and changes in assets and liabilities. Cash provided by operating activities was $110.8 million for the nine months ended September 30, 2021 compared to cash provided by operating activities of $61.4 million for the prior year period. The year-over-year increase was primarily driven by higher revenues; offset by

Table of Contents

increased payments for bonuses and payroll taxes; an increase in prepaid expenses substantially related to deferred device costs; and other net working capital movements.

Our primary uses of cash from operating activities are for the payment of cash compensation expenses, provider fees, inventory, insurance, office expenses, technology costs, market data costs, legal and professional fees, interest expense and acquisition, integration and transformation costs. Historically, the payment of cash for compensation and benefits is at its highest level in the first quarter when we pay discretionary employee compensation related to the previous fiscal year.

Cash Used in Investing Activities

Cash used in investing activities was $52.9 million for the nine months ended September 30, 2021. Cash used in investing activities consisted of acquisition of businesses of $75.9 million, net of cash acquired; investment in capital expenditures totaling $5.6 million; investments in capitalized software development costs of $35.4 million; partially offset by proceeds from short-term marketable securities of $50.0 million and sale of investment of $10.9 million.

Cash used in investing activities was $177.1 million for the nine months ended September 30, 2020. Cash used in investing activities consisted of the InTouch acquisiton of $159.7 million, purchases of property and equipment totaling $2.9 million and investments in internally developed capitalized software of $14.5 million.

Cash Provided by Financing Activities

Cash provided by financing activities for the nine months ended September 30, 2021 was $34.3 million. Cash provided by financing activities primarily consisted of $23.0 million of proceeds from the exercise of employee stock options, $14.0 million of proceeds withheld from participants in the employee stock purchase plan, $10.7 million of proceeds from advances from financing companies, offset by $12.1 million from a net change in payments against advances from financing companies.

Cash provided by financing activities for the nine months ended September 30, 2020 was $788.7 million. Cash provided by financing activities consisted of $975.9 million of net cash proceeds from the issuance of the 2027 Notes, $40.6 million of proceeds from the exercise of employee stock options, $2.5 million of proceeds from employee stock purchase plan and $1.9 million of proceeds from advances from financing companies, offset by $228.2 million of cash used in the repurchase of 2022 Notes and $4.4 million from a net change in payments against advances from financing companies.

Contractual Obligations and Commitments

The following summarizes our contractual obligations as of September 30, 2021 (in thousands):


	Payment Due by Period
			Less than		1 to 3		4 to 5		More than
	Total		1 Year		Years		Years		5 Years
Operating leases	$	67,650	$	14,594	$	25,799	$	13,260	$	13,997
Non-cancelable purchase commitments		6,366		4,040		2,326		0		0
Debt obligations under the Convertible Notes		1,550,882		0		0		550,882		1,000,000
Interest associated with the Convertible Notes		88,790		17,325		34,916		28,216		8,333
Total	$	1,713,688	$	35,959	$	63,041	$	592,358	$	1,022,330

Our existing office and hosting co-location facilities lease agreements provide us with the option to renew and generally provide for rental payments on a graduated basis. Our future operating lease obligations would change if we entered into additional operating lease agreements as we expand our operations and if we exercised the office and hosting co-location facilities lease options. The contractual commitment amounts in the table above are associated with agreements that are enforceable and legally binding and that specify all significant terms, including fixed or minimum services to be used, fixed, minimum or variable price provisions and the approximate timing of the transaction. Non-cancelable purchase commitments include inventory purchases, cloud-based software contracts and other goods and services. Obligations under contracts that we can cancel without a significant penalty are not included in the table above.

Table of Contents

Off-Balance Sheet Arrangements

During the periods presented, we did not have, nor do we currently have, any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. We are therefore not exposed to the financing, liquidity, market, or credit risk that could arise if we had engaged in those types of relationships.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk and Foreign Exchange Risk

Cash equivalents that are subject to interest rate volatility represent our principal market risk. We do not expect cash flows to be affected to any significant degree by a sudden change in market interest rates. We do not enter into investments for trading or speculative purposes.

We operate our business primarily within the United States and currently execute approximately 93% of our transactions in U.S. dollars. We have not utilized hedging strategies with respect to any foreign exchange exposure. This limited foreign currency translation risk is not expected to have a material impact on our consolidated financial statements.

Concentrations of Risk and Significant Clients

Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments and accounts receivable. Although we deposit our cash with multiple financial institutions in the U.S. and in foreign countries, our deposits, at times, may exceed federally insured limits. Our short-term investments are comprised of a portfolio of diverse high credit rating instruments with maturity durations of one year or less.

No Client represented over 10% of revenues for the quarters or nine months ended September 30, 2021 or 2020.

No Client represented over 10% of accounts receivable at September 30, 2021 or December 31, 2020.

Revenues are reported by location of the client for our business to business activities and by location of where our operations are primarily located for direct to consumer activities. Revenue from Clients located in the United States for the quarters ended September 30, 2021 and 2020 were $483.0 million and $255.9 million, respectively. Revenue from Clients located outside the United States for the quarters ended September 30, 2021 and 2020 were $38.6 million and $32.9 million, respectively. Revenue from Clients located in the United States for the nine months ended September 30, 2021 and 2020 were $1,363.9 million and $617.8 million, respectively. Revenue from Clients located outside the United States for the nine months ended September 30, 2021 and 2020 were $114.5 million and $92.8 million, respectively.

Item 4. Controls and Procedures

Management’s Report on Internal Control over Financial Reporting

In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of September 30, 2021, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and to provide

Table of Contents

reasonable assurance that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

No changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended September 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

We are subject to legal proceedings, claims and litigation arising in the ordinary course of our business. Descriptions of certain legal proceedings to which we are a party are contained in Note 13, “Legal Matters”, to our consolidated financial statements included in this Quarterly Report on Form 10-Q and are incorporated by reference herein.

Item 1A. Risk Factors

For a discussion of potential risks and uncertainties related to our Company see the information in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020.

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in the “Special Note Regarding Forward-Looking Statements” section in Part I, Item 2, of this Quarterly Report on Form 10-Q.

Table of Contents

Item 6. Exhibits

Exhibit

Index

Incorporated by Reference

Exhibit
Number

Exhibit Description

Form

File No.

Exhibit

Filing
Date

Filed
Herewith

3.1

Sixth Amended and Restated Certificate of Incorporation of Teladoc Health, Inc.

8-K

001-37477

3.1

5/31/17

3.2

Certificate of Amendment of Sixth Amended and Restated Certificate of Incorporation of Teladoc, Inc.

8-K

001-37477

3.1

6/01/18

3.3

Second Certificate of Amendment of Sixth Amended and Restated Certificate of Incorporation of Teladoc Health, Inc.

8-K

001-37477

3.1

8/10/18

3.4

Certificate of Amendment of the Sixth Amended and Restated Certificate of Incorporation of Teladoc Health, Inc.

8-K

001-37477

3.1

10/30/20

3.5

Fifth Amended and Restated Bylaws of Teladoc Health, Inc.

8-K

001-37477

3.1

2/19/21

10.1

Teladoc Health, Inc. Senior Leader Severance Plan.

31.1

Chief Executive Officer—Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Chief Financial Officer—Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Chief Executive Officer—Certification pursuant to Rule13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

Chief Financial Officer—Certification pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the

Inline XBRL document.

101.SCH

XBRL Taxonomy Extension Schema Document.

Table of Contents

101.CAL

XBRL Taxonomy Calculation Linkbase Document.

101.DEF

XBRL Definition Linkbase Document.

101.LAB

XBRL Taxonomy Label Linkbase Document.

101.PRE

XBRL Taxonomy Presentation Linkbase Document.

104

Cover Page Interactive Data File – The Cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

* Filed herewith.

** Furnished herewith.

Table of Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TELADOC HEALTH, INC.

Date: November 1, 2021	By:	/s/ JASON GOREVIC
	Name:	Jason Gorevic
	Title:	Chief Executive Officer

Date: November 1, 2021	By:	/s/ MALA MURTHY
	Name:	Mala Murthy
	Title:	Chief Financial Officer

EX-10.1 2 tdoc-20210930xex10d1.htm EX-10.1

Exhibit 10.1

TELADOC HEALTH, INC. SENIOR LEADER SEVERANCE PLAN

The Company has adopted this Severance Plan (the “Plan”) for the benefit of certain employees of the Company and its subsidiaries, on the terms and conditions hereinafter stated. All capitalized terms used herein are defined in Section 1 hereof. The Plan, as set forth herein, is intended to help retain qualified employees, maintain a stable work environment and provide economic security to eligible employees in the event of certain terminations of employment.

SECTION 1.

DEFINITIONS. As hereinafter used:

1.1“Affiliate” means, with respect to any individual or entity, any other individual or entity who, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with, such individual or entity. For purposes of this definition, “control,” when used with respect to any person or entity, means the power to direct the management and policies of such person or entity, directly or indirectly, whether through ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing.

1.2“Base Salary” means an Eligible Employee’s base salary at the rate in effect on the Severance Date (disregarding any decrease in such base salary that constitutes a Good Reason event).

1.3 “Board” means the Board of Directors of the Company.

1.4“Cause” shall mean: (A) the willful and continued failure by an Eligible Employee to substantially perform his or her duties to the Company (other than any such failure resulting from the Eligible Employee’s incapacity due to physical or mental illness), after written demand for substantial performance is delivered by the Company that identifies with reasonable specificity the manner in which the Company believes the Eligible Employee has not substantially performed his or her duties, which is not cured within thirty (30) days after notice of such failure has been given to the Eligible Employee by the Company; (B) the willful engaging by an Eligible Employee in misconduct (including any conduct that is in violation of the written employee workplace policies of the Company) that is materially injurious to the Company, monetarily, in reputation or otherwise, including any conduct that is in violation of the written employee workplace policies of the Company; or (C) an Eligible Employee’s commission of any felony, or any crime involving dishonesty in respect of the business or affairs of the Company or any of its subsidiaries. No act, or failure to act, on an Eligible Employee’s part shall be considered “willful” unless done, or omitted to be done by him or her not in good faith and without reasonable belief that his or her action or omission was in the best interest of the Company.

1.5“Change in Control” shall mean (i) any transaction or series of related transactions resulting in the consummation of merger, combination, consolidation or other reorganization of the Company with or into any third party, other than any such merger, combination, consolidation or reorganization following which the holders of

Page 1 of 10

capital stock of the Company immediately prior to such merger, combination, consolidation or reorganization continue to hold, solely in respect of their interests in the Company’s capital stock immediately prior to such merger, combination, consolidation or reorganization, at least fifty-five percent (55%) of the voting power of the outstanding capital stock of the Company or the surviving or acquiring entity; (ii) any transaction or series of related transactions resulting in the consummation of the sale, lease, exclusive or irrevocable licensing or other transfer of all or substantially all of the assets of the Company to a third party, other than any such sale, lease, exclusive or irrevocable licensing or transfer following which the holders of capital stock of the Company immediately prior to such sale, lease, exclusive or irrevocable licensing or transfer continue to hold, solely in respect of their interests in the Company’s capital stock immediately prior to such sale, lease, exclusive or irrevocable licensing or transfer, at least fifty-five percent (55%) of the voting power of the outstanding capital stock of the acquiring entity; or (iii) any transaction or series of related transactions resulting in the transfer or issuance, whether by merger, combination, consolidation or otherwise, of Company securities to a person or group if, after such transfer or issuance, such person or group would hold fifty-five percent (55%) of the voting power of the outstanding capital stock of the Company; provided that, with respect to any payments or benefits payable to an Eligible Employee pursuant to this Plan that may be considered deferred compensation under Section 409A of the Code (“Section 409A”), the transaction or event described in clause (i), (ii) or (iii) shall only constitute a Change in Control for purposes of this Plan if such transaction or event also constitutes a “change in control event,” as defined in Treasury Regulation Section 1.409A-3(i)(5).

1.6“CIC Qualifying Termination” means (i) a termination by an Eligible Employee of the Eligible Employee’s employment with the Company for Good Reason or (ii) a termination by the Company of an Eligible Employee’s employment with the Company other than for death, Disability or Cause, in either case, that occurs on or within twelve (12) months following a Change in Control.

1.7 “Code” means the Internal Revenue Code of 1986, as amended.

1.8“Committee” means the Compensation Committee of the Board.

1.9“Company” means Teladoc Health, Inc. and any successors thereto and, where the context requires, its subsidiaries.

1.10“Disability” means a physical or mental condition entitling an Eligible Employee to benefits under the applicable long-term disability plan of the Company or any its subsidiaries, or if no such plan exists, a “permanent and total disability” (within the meaning of Section 22(e)(3) of the Code).

1.11“Effective Date” shall mean May 1, 2020.

1.12“Eligible Employee” means any full-time employee of the Company or any Affiliate at the employment level of thirteen (13) or above, as designated by the Company’s Human Resources department, who is not otherwise entitled to any severance

Page 2 of 10

pay or benefits or prior notice of employment termination (or pay in lieu of such prior notice) under any binding contract or agreement with the Company or its Affiliate (except as otherwise expressly provided therein).

1.13“ERISA” means the Employee Retirement Income Security Act of 1974, as amended.

1.14“Good Reason” means the occurrence of any of the following events without an Eligible Employee’s written consent: (a) a reduction by the Company or its successor in an Eligible Employee’s annual base salary; (b) a material reduction in an Eligible Employee’s overall responsibilities or authority, or scope of duties below those existing immediately prior to such reduction; or (c) a change in the geographic location of an Eligible Employee’s principal place of employment to any location more than thirty-five (35) miles from the Eligible Employee’s principal place of employment immediately prior to such change, provided that the Eligible Employee must deliver written notice to the Company setting forth with specificity any circumstance he or she believes in good faith constitutes Good Reason within ninety (90) days after initial occurrence of such circumstance or be foreclosed from raising such circumstance thereafter. The Company shall have an opportunity to cure any claimed event of Good Reason (if capable of cure) within thirty (30) days of notice from the Eligible Employee before the Eligible Employee may terminate for Good Reason. Any voluntary termination for “Good Reason” following such 30-day cure period must occur no later than the date that is 30 days following the expiration of the Company’s cure period.

1.15“Non-CIC Qualifying Termination” means (i) a termination by an Eligible Employee of the Eligible Employee’s employment with the Company for Good Reason or (ii) a termination by the Company of an Eligible Employee’s employment with the Company due to the elimination by the Company of the Eligible Employee’s job position (and excluding, for the avoidance of doubt, a termination by the Company of an Eligible Employee’s employment with the Company due to death or Disability or for Cause), in any case, that does not occur on or within twelve (12) months following a Change in Control.

1.16 “Plan” means the Teladoc Health, Inc. Senior Leader Severance Plan, as set forth herein, as it may be amended from time to time.

1.17“Plan Administrator” means the Committee or such other person or persons appointed from time to time by the Committee to administer the Plan.

1.18“Qualifying Termination” means either (i) a CIC Qualifying Termination or (ii) a Non-CIC Qualifying Termination.

1.19 “Severance Date” means the date on which an Eligible Employee’s Qualifying Termination is effective.

1.20“Standard Severance Period” means the number of weeks following the Severance Date equal to the sum of (i) sixteen (16) weeks plus (ii) two (2) additional weeks for each completed year of service with the Company and its subsidiaries,

Page 3 of 10

provided that the Standard Severance Period shall not be greater than twenty-six (26) weeks.

SECTION 2.

SEVERANCE BENEFITS

2.1Severance Upon a CIC Qualifying Termination. Subject to the terms of the Plan, if an Eligible Employee experiences a CIC Qualifying Termination, the Eligible Employee shall be entitled to receive the following payments and benefits:

(a) The Company shall continue paying the Eligible Employee’s Base Salary for a period of six (6) months following the Severance Date in accordance with the Company’s ordinary payroll practices;

(b) The Company shall pay the Eligible Employee a cash amount equal to fifty percent (50%) of the Eligible Employee’s target annual bonus for the year in which the Severance Date occurs (disregarding any decrease in the Eligible Employee’s target annual bonus that provides a basis for Good Reason), payable in a lump sum within seventy-three (73) days following the Severance Date in accordance with the Company’s ordinary payroll practices;

(c) The Company will pay the Eligible Employee any earned and unpaid annual bonus for the calendar year immediately prior to the year in which the Severance Date occurs, as determined by the Board (or an authorized committee) in its good faith discretion, payable in a lump sum at the same time annual bonuses are paid to other Company employees generally but in no event later than June 30 of the year in which the Severance Date occurs;

(d) If the Eligible Employee timely elects continued coverage pursuant to COBRA for the Eligible Employee and the Eligible Employee’s covered dependents under the Company’s group health (medical, dental or vision) plans following such CIC Qualifying Termination, then the Company shall pay the COBRA premiums necessary to continue the Eligible Employee’s and his or her covered dependents’ health insurance coverage in effect on the Severance Date until the earliest of (x) six (6) months following the Severance Date (the “CIC COBRA Severance Period”), (y) the date when the Eligible Employee becomes eligible for substantially equivalent health insurance coverage in connection with new employment and (z) the date the Eligible Employee ceases to be eligible for COBRA continuation coverage for any reason, including plan termination (such period from the Severance Date through the earlier of (x)-(z), the “CIC COBRA Payment Period”). Notwithstanding the foregoing, if at any time the Company determines that its payment of COBRA premiums on the Eligible Employee’s behalf would result in a violation of applicable law (including but not limited to the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act) or an excise tax, then in lieu of paying COBRA premiums pursuant to this Section 2.1(d), the Company shall pay the Eligible Employee on the last day of each remaining month of the CIC COBRA Payment Period, a fully taxable cash payment equal to the COBRA premium for such month, subject to applicable tax withholding,

Page 4 of 10

such payment to be made without regard to the Eligible Employee’s payment of COBRA premiums; and

(e) All unvested equity or equity-based awards granted to the Eligible Employee under any equity compensation plans of the Company that have not vested as of the Severance Date shall become immediately vested as to time, with any such awards that are subject to performance-based vesting conditions remaining eligible to vest to the extent the performance conditions are satisfied.

2.2Severance Upon a Non-CIC Qualifying Termination. Subject to the terms of the Plan, if an Eligible Employee experiences a Non-CIC Qualifying Termination, the Eligible Employee shall be entitled to receive the following payments and benefits:

(a) The Company shall continue paying the Eligible Employee’s Base Salary during the Standard Severance Period in accordance with the Company’s ordinary payroll practices;

(b) The Company will pay the Eligible Employee any earned and unpaid annual bonus for the calendar year immediately prior to the year in which the Severance Date occurs, as determined by the Board (or an authorized committee) in its good faith discretion, payable in a lump sum at the same time annual bonuses are paid to other Company employees generally but in no event later than June 30 of the year in which the Severance Date occurs; and

(c) If the Eligible Employee timely elects continued coverage pursuant to COBRA for the Eligible Employee and the Eligible Employee’s covered dependents under the Company’s group health (medical, dental or vision) plans following such Non-CIC Qualifying Termination, then the Company shall pay the COBRA premiums necessary to continue the Eligible Employee’s and his or her covered dependents’ health insurance coverage in effect on the Severance Date until the earliest of (x) the last day of the Standard Severance Period, (y) the date when the Eligible Employee becomes eligible for substantially equivalent health insurance coverage in connection with new employment and (z) the date the Eligible Employee ceases to be eligible for COBRA continuation coverage for any reason, including plan termination (such period from the Severance Date through the earlier of (x)-(z), the “Standard COBRA Payment Period”). Notwithstanding the foregoing, if at any time the Company determines that its payment of COBRA premiums on the Eligible Employee’s behalf would result in a violation of applicable law (including but not limited to the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act) or an excise tax, then in lieu of paying COBRA premiums pursuant to this Section 2.2(c), the Company shall pay the Eligible Employee on the last day of each remaining month of the Standard COBRA Payment Period, a fully taxable cash payment equal to the COBRA premium that the Eligible Employee would be required to pay to continue the Eligible Employee’s and the Eligible Employee’s covered dependent’s group health coverage in effect on the Separation Date for such month,

Page 5 of 10

subject to applicable tax withholding, such payment to be made without regard to the Eligible Employee’s payment of COBRA premiums.

2.3Release. As a condition to an Eligible Employee’s receipt of any amounts set forth in Section 2.1 or Section 2.2, the Eligible Employee shall, within the 60-day period following the Severance Date, deliver (without revoking) prior to receipt of such severance benefits, an effective, release of claims in favor of the Company or its successor, its subsidiaries and their respective directors, officers and stockholders in a customary form reasonably acceptable to the Company or its successor. The form of the release will be provided to the Eligible Employee not later than five (5) days following the Severance Date.

2.4Accrued Rights.Upon termination of an Eligible Employee’s employment with the Company for any reason, the Eligible Employee will be entitled to receive payment of any earned but unpaid Base Salary and any other amounts or benefits, including accrued paid time off to the extent payable upon termination pursuant to the Company’s policies, under the Company’s employee benefit plans, programs or arrangements to which the Eligible Employee is entitled pursuant to the terms of such plans, programs or arrangements or applicable law, payable in accordance with the terms of such plans, programs or arrangements or as otherwise required by applicable law.

SECTION 3.

PLAN ADMINISTRATION.

3.1The Plan Administrator shall administer the Plan and may interpret the Plan, prescribe, amend and rescind rules and regulations under the Plan and make all other determinations necessary or advisable for the administration of the Plan, subject to all of the provisions of the Plan.

3.2The Plan Administrator may delegate any of its duties hereunder to such person or persons from time to time as it may designate.

3.3The Plan Administrator is empowered to engage accountants, legal counsel and such other personnel as it deems necessary or advisable to assist it in the performance of its duties under the Plan. The functions of any such persons engaged by the Plan Administrator shall be limited to the specified services and duties for which they are engaged, and such persons shall have no other duties, obligations or responsibilities under the Plan. Such persons shall exercise no discretionary authority or discretionary control respecting the management of the Plan. All reasonable expenses thereof shall be borne by the Company.

SECTION 4.

PLAN MODIFICATION OR TERMINATION.

The Plan may be terminated or amended by the Board at any time; provided, however, that during the one year period following a Change in Control, (a) the Plan may not be terminated and (b) the Plan may not be amended if such amendment would in any manner be adverse to the interests of any Eligible Employee. For the avoidance of doubt, (a) any action taken by the Company or the Plan Administrator to cause an Eligible Employee to no longer be designated as an Eligible Employee or to

Page 6 of 10

decrease the benefits under the Plan for which an Eligible Employee is eligible, and (b) any amendment to this Section 4 following the occurrence of a Change in Control shall be treated as an amendment to the Plan which is adverse to the interests of any Eligible Employee.

SECTION 5.

GENERAL PROVISIONS.

5.1Except as otherwise provided herein or by law, no right or interest of any Eligible Employee under the Plan shall be assignable or transferable, in whole or in part, either directly or by operation of law or otherwise, including without limitation by execution, levy, garnishment, attachment, pledge or in any manner; no attempted assignment or transfer thereof shall be effective; and no right or interest of any Eligible Employee under the Plan shall be liable for, or subject to, any obligation or liability of such Eligible Employee. When a payment is due under this Plan to a severed employee who is unable to care for his or her affairs, payment may be made directly to his or her legal guardian or personal representative.

5.2If the Company or any subsidiary thereof is obligated by law to pay severance pay, a termination indemnity, notice pay, or the like, or if the Company or any subsidiary thereof is obligated by law to provide advance notice of separation (“Notice Period”), then any severance pay hereunder shall be reduced (including to zero) by the amount of any such severance pay, termination indemnity, notice pay or the like, as applicable, and by the amount of any compensation received during any Notice Period. For the avoidance of doubt, the severance pay hereunder shall not be duplicative of severance pay, termination indemnity, notice pay, compensation received during any Notice Period or the like, as applicable, payable under applicable law.

5.3Neither the establishment of the Plan, nor any modification thereof, nor the creation of any fund, trust or account, nor the payment of any benefits shall be construed as giving any Eligible Employee, or any person whomsoever, the right to be retained in the service of the Company or any subsidiary thereof, and all Eligible Employees shall remain subject to discharge to the same extent as if the Plan had never been adopted. Nothing in this Plan will prevent or limit an Eligible Employee’s continuing or future participation in any plan, contract, agreement, practice, policy or program provided by the Company or any Affiliate thereof for which the Eligible Employee may qualify (an “Other Arrangement”), nor will anything in this Plan limit or otherwise affect any rights the Eligible Employee may have under any Other Arrangement with the Company or any Affiliate thereof, provided that the benefits received under this Plan and an Other Arrangement shall not be duplicative.

5.4If any provision of this Plan shall be held invalid or unenforceable, such invalidity or unenforceability shall not affect any other provisions hereof, and this Plan shall be construed and enforced as if such provisions had not been included.

5.5This Plan shall inure to the benefit of and be binding upon the heirs, executors, administrators, successors and assigns of the parties, including each Eligible Employee, present and future, and any successor to the Company. If a severed employee

Page 7 of 10

shall die while any amount would still be payable to such severed employee hereunder if the severed employee had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Plan to the executor, personal representative or administrators of the severed employee’s estate.

5.6The headings and captions herein are provided for reference and convenience only, shall not be considered part of the Plan, and shall not be employed in the construction of the Plan.

5.7The Plan shall not be required to be funded unless such funding is authorized by the Board. Regardless of whether the Plan is funded, no Eligible Employee shall have any right to, or interest in, any assets of any Company which may be applied by the Company to the payment of benefits or other rights under this Plan.

5.8Any notice or other communication required or permitted pursuant to the terms hereof shall be provided in writing and shall have been duly given when delivered or mailed by United States Mail, first class, postage prepaid, addressed to the intended recipient at his, her or its last known address.

5.9This Plan shall be construed and enforced according to the laws of the State of Delaware to the extent not preempted by federal law, which shall otherwise control.

5.10The Company and any of its Affiliates may deduct and withhold from any amounts payable under this Plan such federal, state, local, foreign or other taxes as are required to be withheld pursuant to any applicable law or regulation. All benefits hereunder shall be reduced by applicable withholding and shall be subject to applicable tax reporting, as determined by the Plan Administrator.

5.11 The Plan, as a “severance pay arrangement” within the meaning of Section 3(2)(B)(i) of ERISA, is intended to be excepted from the definitions of “employee pension benefit plan” and “pension plan” set forth under section 3(2) of ERISA, and is intended to meet the descriptive requirements of a plan constituting a “severance pay plan” within the meaning of regulations published by the Secretary of Labor at Title 29, Code of Federal Regulations §2510.3-2(b).

5.12The provisions of the Plan shall apply to Eligible Employees outside the United States, provided, however, that the Plan Administrator may make such changes to the terms of the Plan (A) to the extent necessary to comply with applicable local law and (B) to reduce the amounts payable hereunder to the extent of any statutory or other severance due to the Eligible Employee in the applicable jurisdiction.

5.13Section 409A.

(a) The payments and benefits under this Plan are intended to comply with or be exempt from Section 409A and, accordingly, to the maximum extent permitted, this Plan shall be interpreted to be in compliance therewith. Notwithstanding any provision of this Plan to the contrary, in the event that the Plan Administrator

Page 8 of 10

determines that any amounts payable hereunder will be immediately taxable to any Eligible Employee under Section 409A, the Plan Administrator may (without any obligation to do so or to indemnify the Eligible Employee for failure to do so) (A) adopt such amendments to this Plan or adopt such other policies and procedures (including amendments, policies and procedures with retroactive effect) that it determines to be necessary or appropriate to preserve the intended tax treatment of the benefits provided by this Plan or the economic benefits of this Plan and (B) take such other actions it determines to be necessary or appropriate to exempt the amounts payable hereunder from Section 409A or to comply with the requirements of Section 409A and thereby avoid the application of penalty taxes thereunder.

(b) Notwithstanding anything in this Plan to the contrary, any compensation or benefits payable under this Plan upon an Eligible Employee’s termination of employment shall be payable only upon the Eligible Employee’s “separation from service” with the Company within the meaning of Section 409A (a “Separation from Service”) and, except as provided below, any such compensation or benefits shall not be paid, or, in the case of installments, shall not commence payment, until the 60th day following the Eligible Employee’s Separation from Service (the “First Payment Date”). Any installment payments that would have been made to an Eligible Employee during the 60 day period immediately following the Eligible Employee’s Separation from Service but for the preceding sentence shall be paid to the Eligible Employee on the First Payment Date and the remaining payments shall be made as provided in this Plan.

(c) Notwithstanding any provision of this Plan to the contrary, if an Eligible Employee is deemed by the Company at the time of the Eligible Employee’s Separation from Service to be a “specified employee” for purposes of Section 409A, to the extent delayed commencement of any portion of the benefits to which the Eligible Employee is entitled under this Plan is required in order to avoid a prohibited distribution under Section 409A, such portion of the Eligible Employee’s benefits will not be provided to the Eligible Employee prior to the earlier of (i) the expiration of the six-month period measured from the date of the Eligible Employee’s Separation from Service or (ii) the date of the Eligible Employee’s death. As promptly as possible following the expiration of the applicable Section 409A period, all payments and benefits deferred pursuant to the preceding sentence will be paid in a lump sum to an Eligible Employee (or the Eligible Employee’s estate), and any remaining payments due to the Eligible Employee under this Plan will be paid as otherwise provided herein.

(d) An Eligible Employee’s right to receive any installment payments under this Plan shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment as permitted under Section 409A.

5.14Section 280G

(a) Notwithstanding any other provisions of this Plan, in the event that any payment or benefit by the Company or otherwise to or for the benefit of an

Page 9 of 10

Eligible Employee, whether paid or payable or distributed or distributable pursuant to the terms of this Plan (all such payments and benefits, including the payments and benefits under Section 2.1 or Section 2.2 of the Plan, being hereinafter referred to as the “Total Payments”), would be subject (in whole or in part) to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the Total Payments shall be reduced (in the order provided in subsection (b) below) to the minimum extent necessary to avoid the imposition of the Excise Tax on the Total Payments, but only if (i) the net amount of such Total Payments, as so reduced (and after subtracting the net amount of federal, state and local income and employment taxes on such reduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such reduced Total Payments), is greater than or equal to (ii) the net amount of such Total Payments without such reduction (but after subtracting the net amount of federal, state and local income and employment taxes on such Total Payments and the amount of the Excise Tax to which the Eligible Employee would be subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such unreduced Total Payments).

(b) The Total Payments shall be reduced in the following order: (i) reduction on a pro-rata basis of any cash severance payments that are exempt from Section 409A, (ii) reduction on a pro-rata basis of any non-cash severance payments or benefits that are exempt from Section 409A, and (iii) reduction of any payments or benefits otherwise payable to the Eligible Employee on a pro-rata basis or such other manner that complies with Section 409A; provided, in case of clauses (ii) and (iii), that reduction of any payments attributable to the acceleration of vesting of Company equity awards shall be first applied to Company equity awards that would otherwise vest last in time.

(c) All determinations regarding the application of this Section 5.13 shall be made by an accounting firm or consulting group with experience in performing calculations regarding the applicability of Section 280G of the Code and the Excise Tax selected by the Company (the “Independent Advisors”). For purposes of determinations, no portion of the Total Payments shall be taken into account which, in the opinion of the Independent Advisors, (i) does not constitute a “parachute payment” within the meaning of Section 280G(b)(2) of the Code (including by reason of Section 280G(b)(4)(A) of the Code) or (ii) constitutes reasonable compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of the Code, in excess of the “base amount” (as defined in Section 280G(b)(3) of the Code) allocable to such reasonable compensation. The costs of obtaining such determination and all related fees and expenses (including related fees and expenses incurred in any later audit) shall be borne by the Company.

(d) In the event it is later determined that a greater reduction in the Total Payments should have been made to implement the objective and intent of this Section 5.13, the excess amount shall be returned promptly by the Eligible Employee to the Company.

Page 10 of 10

EX-31.1 3 tdoc-20210930xex31d1.htm EX-31.1

Exhibit 31.1

Certification

I, Jason Gorevic, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Teladoc Health, Inc. (the “registrant”) for the period ended September 30, 2021;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 1, 2021


/s/ JASON GOREVIC
Jason Gorevic
Chief Executive Officer

EX-31.2 4 tdoc-20210930xex31d2.htm EX-31.2

Exhibit 31.2

Certification

I, Mala Murthy, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Teladoc Health, Inc. (the “registrant”) for the period ended September 30, 2021;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(a)

(b)

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 1, 2021


/s/ MALA MURTHY
Mala Murthy
Chief Financial Officer

EX-32.1 5 tdoc-20210930xex32d1.htm EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Teladoc Health, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jason Gorevic, Chief Executive Officer of the Company, certify, to my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2021


/s/ JASON GOREVIC
Jason Gorevic
Chief Executive Officer

EX-32.2 6 tdoc-20210930xex32d2.htm EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Teladoc Health, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mala Murthy, Chief Financial Officer of the Company, certify, to my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2021


/s/ MALA MURTHY
Mala Murthy
Chief Financial Officer

EX-101.SCH 7 tdoc-20210930.xsd EX-101.SCH 00100 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40304 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Deferred Cost and Other (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Intangible Assets, Net - Summary (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Leasing Operations - Future Minimum Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 41104 - Disclosure - Convertible Senior Notes - Outstanding Convertible Senior Notes - Summary (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Advances from Financing Companies (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Organization and Description of Business link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Basis of Presentation and Principles of Consolidation link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Business Acquisitions link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Intangible Assets, Net link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Convertible Senior Notes link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Legal Matters link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - Common Stock and Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 11501 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Basis of Presentation and Principles of Consolidations (Policies) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Business Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Leasing Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - Convertible Senior Notes (Tables) link:presentationLink link:calculationLink link:definitionLink 31403 - Disclosure - Common Stock and Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Basis of Presentation and Principles of Consolidation - VIE (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Other Disclosures (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Disaggregation and Other (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Revenue Remaining Performance Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Revenue Remaining Performance Obligation Default (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Business Acquisitions - Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Business Acquisitions - Assets Acquired, Liabilities Assumed, Pro forma (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Fair Value Measurements - Recurring (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - Fair Value Measurements - Level 3 (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Leasing Operations - Other (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Convertible Senior Notes - Outstanding Convertible Senior Notes - Issuances (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - Convertible Senior Notes - Certain terms of the Notes (Details) link:presentationLink link:calculationLink link:definitionLink 41103 - Disclosure - Convertible Senior Notes - Terms (Details) link:presentationLink link:calculationLink link:definitionLink 41105 - Disclosure - Convertible Senior Notes - Exchange/Redemption of Convertible Senior Notes Due (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - Common Stock and Stockholders' Equity - Capitalization (Details) link:presentationLink link:calculationLink link:definitionLink 41402 - Disclosure - Common Stock and Stockholders' Equity - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 41403 - Disclosure - Common Stock and Stockholders' Equity - Stock Plan and Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 41404 - Disclosure - Common Stock and Stockholders' Equity - Fair Value Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 41405 - Disclosure - Common Stock and Stockholders' Equity - Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 41406 - Disclosure - Common Stock and Stockholders' Equity - Performance Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 41407 - Disclosure - Common Stock and Stockholders' Equity - Employee Stock Purchase Plan (Details) link:presentationLink link:calculationLink link:definitionLink 41408 - Disclosure - Common Stock and Stockholders' Equity - Compensation Costs (Details) link:presentationLink link:calculationLink link:definitionLink 41501 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Leasing Operations link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Advances from Financing Companies link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 31203 - Disclosure - Advances from Financing Companies (Tables) link:presentationLink link:calculationLink link:definitionLink 40305 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Deferred Cost and Other Activity (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Fair Value Measurements - Equity Securities (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 tdoc-20210930_cal.xml EX-101.CAL EX-101.DEF 9 tdoc-20210930_def.xml EX-101.DEF EX-101.LAB 10 tdoc-20210930_lab.xml EX-101.LAB Document and Entity Information Statement [Table] Statement [Line Items] Disclosures: Document Type Document Quarterly Report Document Transition Report Document Period End Date Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Consolidated Balance Sheets Assets. Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Debt Securities, Available-for-sale, Current Short-term investments Accounts Receivable, Net, Current Accounts receivable, net of allowance for doubtful accounts Accounts receivable, net of allowance of $11,277 and $6,412, respectively Inventory, Net Inventories Total inventories Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Goodwill. Goodwill Beginning balance Goodwill Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Operating Lease, Right-of-Use Asset Operating lease - right-of-use assets Other Assets, Noncurrent Other assets Assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Represents carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered, excluding accrued compensation. Also includes aggregate carrying amount of liabilities not separately disclosed in the balance sheet. Used to reflect the current portion of liabilities (due within one year or within the normal operating cycle if longer). Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current Accrued expenses and other current liabilities Employee-related Liabilities, Current Accrued compensation Deferred Revenue, Current Deferred revenue-current The current portion of advances from third-party financing companies in which the Company utilizes this financing to provide its customers with a rental option. Advances from Financing Companies, Current Advances from financing companies Long-term Debt, Current Maturities Current portion of long-term debt Liabilities, Current Total current liabilities Other Liabilities, Noncurrent Other liabilities Operating Lease, Liability, Noncurrent Operating lease liabilities, net of current portion Deferred Revenue, Noncurrent Deferred revenue, net of current portion Amount of advances from third-party financing companies, net of current portion, in which the Company utilizes this financing to provide its customers with a rental option. Advances from Financing Companies, Noncurrent Advances from financing companies, net of current portion Deferred Income Tax Liabilities, Net Deferred taxes Convertible Debt, Noncurrent Convertible senior notes, net Commitments and Contingencies. Commitments and contingencies Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Common Stock, Value, Issued Common stock, $0.001 par value; 300,000,000 shares authorized as of September 30, 2021 and December 31, 2020; 160,013,624 shares and 150,281,099 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively Additional Paid in Capital, Common Stock Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive gain Stockholders' Equity Attributable to Parent (Equity) deficit Balance as of end of the period Balance as of beginning of the period Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Allowance for Doubtful Accounts Receivable, Current Allowance of Accounts receivable Common Stock, Par or Stated Value Per Share Common stock par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Number of common stock shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Consolidated Statements of Operations and Comprehensive Loss Revenue from Contract with Customer, Excluding Assessed Tax Revenue Revenue Costs and Expenses [Abstract] Expenses: Cost of Revenue Cost of revenue (exclusive of depreciation and amortization, which is shown separately below) Operating Expenses [Abstract] Operating expenses: Marketing and Advertising Expense Advertising and marketing Selling Expense Sales Research and Development Expense Technology and development Business Combination, Acquisition Related Costs Acquisition, integration and transformation costs General and Administrative Expense General and administrative Depreciation, Depletion and Amortization, Nonproduction Depreciation and amortization Costs and Expenses Total expenses Operating Income (Loss) Loss from operations Gain (Loss) on Extinguishment of Debt Loss on extinguishment of debt Other Nonoperating Income (Expense) Other expense (income), net Interest Income (Expense), Net Interest expense, net Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Net loss before taxes Income Tax Expense (Benefit) Income tax expense (benefit) Net Income (Loss) Attributable to Parent Net loss Net loss Net (loss) income Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Other comprehensive (loss) gain, net of tax: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Cumulative translation adjustment Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Earnings Per Share, Basic and Diluted Net loss per share, basic and diluted Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted-average shares used to compute basic and diluted net loss per share Consolidated Statement of Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Stockholders' Equity (Deficit) Shares, Outstanding Balance as of end of the period (in shares) Balance as of beginning of the period (in shares) Stock Issued During Period, Value, Stock Options Exercised Exercise of stock options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Stock option exercised (in shares) Exercise of stock options (in shares) Aggregate value of stock issued during the period upon the vesting of restricted stock units. Stock Issued During Period, Value, Vesting of Restricted Stock Units Issuance of common stock upon vesting of restricted stock units Number of shares issued during the period upon the vesting of restricted stock units. Stock Issued During Period, Shares, Vesting of Restricted Stock Units Issuance of common stock upon vesting of restricted stock units (in shares) Stock Issued During Period, Value, Conversion of Convertible Securities Issuance of common stock for Notes Stock Issued During Period, Shares, Conversion of Convertible Securities Issuance of common stock for Notes (in shares) Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of stock under employee stock purchase plan Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of stock under employee stock purchase plan (in shares) The equity impact of the recovered excess common stock shares issued for acquisition. Recovered Excess Common Stock Issued for Acquisition, Equity Impact Recovery of excess common stock issued for acquisition The number of recovered excess common stock shares issued for acquisition. Recovered Excess Common Stock Issued for Acquisition, Shares Recovery of excess common stock issued for acquisition (in shares) Adjustment to additional paid in capital resulting from the equity component of convertible debt that was extinguished during the period. Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Extinguishment Equity portion of extinguishment of Notes Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt Equity component of Notes, net of issuance costs Stock Issued During Period, Value, Acquisitions Issuance of stock in acquisition Stock Issued During Period, Shares, Acquisitions Issuance of stock in acquisition (in shares) Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock-based compensation Other Comprehensive Income (Loss), Net of Tax Other comprehensive gain (loss), net of tax Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Cash flows provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash provided by operating activities: Depreciation, Depletion and Amortization Depreciation and amortization The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives for rental equipments. Depreciation of Rental Equipment Depreciation of rental equipment Amount of amortization of right-of-use assets and depreciation of rental equipment. Amortization of Right-of-Use Assets and Depreciation of Rental Equipment Amortization of right-of-use assets and depreciation of rental equipment Provision for Doubtful Accounts Allowance for doubtful accounts Share-based Compensation Stock-based compensation The noncash component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations. Deferred Income Tax Noncash Expense Benefit Deferred income taxes The accretion of interest. Accretion of Interest Accretion of interest The cash flow impact of the difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Gain (Loss) on Extinguishment of Debt, Cash Flow Impact Loss on extinguishment of debt Realized Investment Gains (Losses) Gain on sale of investment Other Noncash Income (Expense) Other, net Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Inventories Inventory Increase (Decrease) in Other Operating Assets Other assets Increase (Decrease) in Accounts Payable Accounts payable The increase (decrease) during the reporting period in the aggregate amount of of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered, excluding accrued compensation. Also includes the increase (decrease) during the reported period in the aggregate carrying amount of liabilities not separately disclosed in the balance sheet. Used to reflect the current portion of liabilities (due within one year or within the normal operating cycle if longer). Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation Accrued expenses and other current liabilities Increase (Decrease) in Employee Related Liabilities Accrued compensation Increase (Decrease) in Deferred Revenue Deferred revenue The increase (decrease) during the reporting period, in operating lease liabilities arising from obtaining right-of-use assets. Increase (Decrease) in Operating Lease Liabilities Operating lease liabilities Increase (Decrease) in Other Noncurrent Liabilities Other liabilities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash provided by operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash flows used in investing activities: Payments to Acquire Property, Plant, and Equipment Capital expenditures Payments to Acquire Software Capitalized software development costs Proceeds from Sale and Maturity of Available-for-sale Securities Proceeds from marketable securities Proceeds from Sale and Maturity of Other Investments Proceeds from the sale of investment Payments to Acquire Businesses, Net of Cash Acquired Acquisitions of business, net of cash acquired Cash paid for acquisition, net Payments for (Proceeds from) Other Investing Activities Other, net Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash flows provided by financing activities: Proceeds from Stock Options Exercised Net proceeds from the exercise of stock options Proceeds from Convertible Debt Proceeds from issuance of Notes Net proceeds from issuance of Notes Payments of Debt Issuance Costs Payment of issuance costs of Notes Offering costs The cash outflow for the repurchase of convertible debt. Payments for Repurchase of Convertible Debt Repurchase of 2022 Notes The cash inflow from advances from financing companies. Proceeds from Advances from Financing Companies Proceeds from advances from financing companies The cash outflow which represents the payment from customers against advances from financing companies. Payments from Customers Against Advances from Financing Companies Payment against advances from financing companies Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Excluding Stock Options Proceeds from employee stock purchase plan Net cash for withholding taxes on stock-based awards. Cash Related to Tax Withholding for Share-based Compensation, Net Cash received for withholding taxes on stock-based compensation, net Proceeds from (Payments for) Other Financing Activities Other, net Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by financing activities Net Cash Provided by (Used in) Continuing Operations Net increase in cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Foreign exchange difference Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents at end of the period Cash and cash equivalents at beginning of the period Income Taxes Paid, Net Income taxes paid Interest Paid Interest paid N/A. Organization and Description of Business Nature of Operations [Text Block] Organization and Description of Business N/A. Basis Of Presentation And Principles Of Consolidation Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation and Principles of Consolidation Revenue, Deferred Revenue, Deferred Costs and Other Revenue from Contract with Customer [Text Block] Revenue, Deferred Revenue, Deferred Costs and Other Business Acquisitions Business Combination Disclosure [Text Block] Business Acquisitions Inventories Inventory Disclosure [Text Block] Inventories Intangible Assets, Net Intangible Assets Disclosure [Text Block] Intangible Assets, Net No definitions available. Goodwill Goodwill Disclosure [Text Block] Goodwill No definition available. Accrued Expenses and Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Expenses and Other Current Liabilities Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Leasing Operations The entire disclosure for leasing operations. Leasing Operations [Text Block] Leasing Operations Convertible Debt [Abstract] Convertible Senior Notes The entire disclosure for borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Convertible Debt [Text Block] Convertible Senior Notes Advances from Financing Companies [Abstract] Advances from Financing Companies The entire disclosure for advances from financing companies. Advance from Financing Companies [Text Block] Advances from Financing Companies No Definition available. Legal Matters Legal Matters and Contingencies [Text Block] Legal Matters EX-101.PRE 11 tdoc-20210930_pre.xml EX-101.PRE XML 12 tdoc-20210930x10q_htm.xml IDEA: XBRL DOCUMENT 0001477449 us-gaap:RetainedEarningsMember 2021-09-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001477449 us-gaap:RetainedEarningsMember 2021-06-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001477449 2021-06-30 0001477449 us-gaap:RetainedEarningsMember 2020-12-31 0001477449 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001477449 us-gaap:RetainedEarningsMember 2020-09-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001477449 us-gaap:RetainedEarningsMember 2020-06-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001477449 2020-06-30 0001477449 us-gaap:RetainedEarningsMember 2019-12-31 0001477449 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001477449 us-gaap:CommonStockMember 2021-09-30 0001477449 us-gaap:CommonStockMember 2021-06-30 0001477449 us-gaap:CommonStockMember 2020-12-31 0001477449 us-gaap:CommonStockMember 2020-09-30 0001477449 us-gaap:CommonStockMember 2020-06-30 0001477449 us-gaap:CommonStockMember 2019-12-31 0001477449 tdoc:IncentiveAwardPlan2015Member 2020-01-01 2020-12-31 0001477449 tdoc:IncentiveAwardPlan2015Member 2020-12-31 0001477449 tdoc:IncentiveAwardPlan2015Member 2021-01-01 2021-09-30 0001477449 tdoc:IncentiveAwardPlan2015Member 2021-09-30 0001477449 srt:MaximumMember tdoc:EmployeeAndNonEmployeeStockOptionMember 2021-01-01 2021-09-30 0001477449 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001477449 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001477449

2022-01-01

2021-09-30 0001477449

2021-10-01

2021-09-30 0001477449 tdoc:VisitFeeRevenueMember us-gaap:NonUsMember 2021-07-01 2021-09-30 0001477449 tdoc:SubscriptionAccessFeesMember us-gaap:NonUsMember 2021-07-01 2021-09-30 0001477449 tdoc:SubscriptionAccessFeesMember country:US 2021-07-01 2021-09-30 0001477449 tdoc:PaidVisitsRevenueMember country:US 2021-07-01 2021-09-30 0001477449 tdoc:OtherRevenueMember us-gaap:NonUsMember 2021-07-01 2021-09-30 0001477449 tdoc:OtherRevenueMember country:US 2021-07-01 2021-09-30 0001477449 tdoc:VisitFeeRevenueMember 2021-07-01 2021-09-30 0001477449 tdoc:SubscriptionAccessFeesMember 2021-07-01 2021-09-30 0001477449 tdoc:OtherRevenueMember 2021-07-01 2021-09-30 0001477449 tdoc:VisitFeeRevenueMember us-gaap:NonUsMember 2021-01-01 2021-09-30 0001477449 tdoc:SubscriptionAccessFeesMember us-gaap:NonUsMember 2021-01-01 2021-09-30 0001477449 tdoc:SubscriptionAccessFeesMember country:US 2021-01-01 2021-09-30 0001477449 tdoc:PaidVisitsRevenueMember country:US 2021-01-01 2021-09-30 0001477449 tdoc:OtherRevenueMember us-gaap:NonUsMember 2021-01-01 2021-09-30 0001477449 tdoc:OtherRevenueMember country:US 2021-01-01 2021-09-30 0001477449 tdoc:VisitFeeRevenueMember 2021-01-01 2021-09-30 0001477449 tdoc:SubscriptionAccessFeesMember 2021-01-01 2021-09-30 0001477449 tdoc:OtherRevenueMember 2021-01-01 2021-09-30 0001477449 tdoc:VisitFeeRevenueMember us-gaap:NonUsMember 2020-07-01 2020-09-30 0001477449 tdoc:SubscriptionAccessFeesMember us-gaap:NonUsMember 2020-07-01 2020-09-30 0001477449 tdoc:SubscriptionAccessFeesMember country:US 2020-07-01 2020-09-30 0001477449 tdoc:PaidVisitsRevenueMember country:US 2020-07-01 2020-09-30 0001477449 tdoc:OtherRevenueMember us-gaap:NonUsMember 2020-07-01 2020-09-30 0001477449 tdoc:OtherRevenueMember country:US 2020-07-01 2020-09-30 0001477449 tdoc:VisitFeeRevenueMember 2020-07-01 2020-09-30 0001477449 tdoc:SubscriptionAccessFeesMember 2020-07-01 2020-09-30 0001477449 tdoc:OtherRevenueMember 2020-07-01 2020-09-30 0001477449 tdoc:VisitFeeRevenueMember us-gaap:NonUsMember 2020-01-01 2020-09-30 0001477449 tdoc:SubscriptionAccessFeesMember us-gaap:NonUsMember 2020-01-01 2020-09-30 0001477449 tdoc:SubscriptionAccessFeesMember country:US 2020-01-01 2020-09-30 0001477449 tdoc:PaidVisitsRevenueMember country:US 2020-01-01 2020-09-30 0001477449 tdoc:OtherRevenueMember us-gaap:NonUsMember 2020-01-01 2020-09-30 0001477449 tdoc:OtherRevenueMember country:US 2020-01-01 2020-09-30 0001477449 tdoc:VisitFeeRevenueMember 2020-01-01 2020-09-30 0001477449 tdoc:SubscriptionAccessFeesMember 2020-01-01 2020-09-30 0001477449 tdoc:OtherRevenueMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2027Member 2020-05-19 2020-05-19 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member 2018-05-08 2018-05-08 0001477449 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-07-01 2021-09-30 0001477449 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-01-01 2021-09-30 0001477449 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-07-01 2020-09-30 0001477449 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-01-01 2020-09-30 0001477449 tdoc:ConsultantConnectLimitedMember 2021-01-04 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member 2021-01-01 2021-03-31 0001477449 srt:MinimumMember us-gaap:TrademarksMember 2021-01-01 2021-09-30 0001477449 srt:MinimumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-01-01 2021-09-30 0001477449 srt:MinimumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-01-01 2021-09-30 0001477449 srt:MinimumMember us-gaap:NoncompeteAgreementsMember 2021-01-01 2021-09-30 0001477449 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2021-01-01 2021-09-30 0001477449 srt:MaximumMember us-gaap:TrademarksMember 2021-01-01 2021-09-30 0001477449 srt:MaximumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-01-01 2021-09-30 0001477449 srt:MaximumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-01-01 2021-09-30 0001477449 srt:MaximumMember us-gaap:NoncompeteAgreementsMember 2021-01-01 2021-09-30 0001477449 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2021-01-01 2021-09-30 0001477449 us-gaap:PatentsMember 2021-01-01 2021-09-30 0001477449 srt:MinimumMember us-gaap:TrademarksMember 2020-01-01 2020-12-31 0001477449 srt:MinimumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-01-01 2020-12-31 0001477449 srt:MinimumMember us-gaap:NoncompeteAgreementsMember 2020-01-01 2020-12-31 0001477449 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2020-01-01 2020-12-31 0001477449 srt:MaximumMember us-gaap:TrademarksMember 2020-01-01 2020-12-31 0001477449 srt:MaximumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-01-01 2020-12-31 0001477449 srt:MaximumMember us-gaap:NoncompeteAgreementsMember 2020-01-01 2020-12-31 0001477449 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2020-01-01 2020-12-31 0001477449 us-gaap:PatentsMember 2020-01-01 2020-12-31 0001477449 srt:WeightedAverageMember us-gaap:TrademarksMember 2021-01-01 2021-09-30 0001477449 srt:WeightedAverageMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-01-01 2021-09-30 0001477449 srt:WeightedAverageMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-01-01 2021-09-30 0001477449 srt:WeightedAverageMember us-gaap:CustomerRelationshipsMember 2021-01-01 2021-09-30 0001477449 srt:WeightedAverageMember 2021-01-01 2021-09-30 0001477449 srt:WeightedAverageMember us-gaap:TrademarksMember 2020-01-01 2020-12-31 0001477449 srt:WeightedAverageMember us-gaap:TechnologyBasedIntangibleAssetsMember 2020-01-01 2020-12-31 0001477449 srt:WeightedAverageMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-01-01 2020-12-31 0001477449 srt:WeightedAverageMember us-gaap:NoncompeteAgreementsMember 2020-01-01 2020-12-31 0001477449 srt:WeightedAverageMember us-gaap:CustomerRelationshipsMember 2020-01-01 2020-12-31 0001477449 srt:WeightedAverageMember 2020-01-01 2020-12-31 0001477449 us-gaap:TrademarksMember 2021-09-30 0001477449 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-09-30 0001477449 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-09-30 0001477449 us-gaap:PatentsMember 2021-09-30 0001477449 us-gaap:NoncompeteAgreementsMember 2021-09-30 0001477449 us-gaap:CustomerRelationshipsMember 2021-09-30 0001477449 us-gaap:TrademarksMember 2020-12-31 0001477449 us-gaap:TechnologyBasedIntangibleAssetsMember 2020-12-31 0001477449 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-12-31 0001477449 us-gaap:PatentsMember 2020-12-31 0001477449 us-gaap:NoncompeteAgreementsMember 2020-12-31 0001477449 us-gaap:CustomerRelationshipsMember 2020-12-31 0001477449 tdoc:ContingentLiabilityMember 2021-09-30 0001477449 tdoc:ContingentLiabilityMember 2020-12-31 0001477449 tdoc:ContingentLiabilityMember 2021-01-01 2021-09-30 0001477449 tdoc:EmployeeAndNonEmployeeStockOptionMember 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDueJune2025Member 2020-10-31 0001477449 tdoc:ConvertibleSeniorNotesDue2027Member 2020-05-19 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member 2018-05-08 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member 2017-06-27 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member 2021-08-01 2021-08-31 0001477449 tdoc:ConvertibleSeniorNotesDueJune2025Member 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2027Member 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDueJune2025Member 2020-12-31 0001477449 tdoc:ConvertibleSeniorNotesDue2027Member 2020-12-31 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member 2020-12-31 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member 2020-12-31 0001477449 tdoc:SubscriptionAccessFeesMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember 2021-07-01 2021-09-30 0001477449 tdoc:SubscriptionAccessFeesMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember 2021-01-01 2021-09-30 0001477449 tdoc:SubscriptionAccessFeesMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember 2020-07-01 2020-09-30 0001477449 tdoc:SubscriptionAccessFeesMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember 2020-01-01 2020-09-30 0001477449 2020-10-30 0001477449 2020-10-29 0001477449 tdoc:CommonStockWarrantMember 2021-09-30 0001477449 tdoc:CommonStockWarrantMember 2020-12-31 0001477449 2020-09-30 0001477449 2019-12-31 0001477449 tdoc:ConsultantConnectLimitedMember us-gaap:TradeNamesMember 2021-01-04 0001477449 tdoc:ConsultantConnectLimitedMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-01-04 0001477449 tdoc:ConsultantConnectLimitedMember us-gaap:CustomerRelationshipsMember 2021-01-04 0001477449 tdoc:LivongoHealthIncMember us-gaap:TrademarksMember 2020-10-30 0001477449 tdoc:LivongoHealthIncMember us-gaap:TechnologyBasedIntangibleAssetsMember 2020-10-30 0001477449 tdoc:LivongoHealthIncMember us-gaap:CustomerRelationshipsMember 2020-10-30 0001477449 tdoc:InTouchTechnologiesIncMember us-gaap:TrademarksMember 2020-07-01 0001477449 tdoc:InTouchTechnologiesIncMember us-gaap:TechnologyBasedIntangibleAssetsMember 2020-07-01 0001477449 tdoc:InTouchTechnologiesIncMember us-gaap:CustomerRelationshipsMember 2020-07-01 0001477449 tdoc:ConsultantConnectLimitedMember 2021-01-04 2021-01-04 0001477449 tdoc:InTouchTechnologiesIncMember 2020-07-01 2020-09-30 0001477449 tdoc:InTouchTechnologiesIncMember 2020-01-01 2020-09-30 0001477449 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001477449 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001477449 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001477449 us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001477449 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-09-30 0001477449 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-12-31 0001477449 tdoc:ConvertibleSeniorNotesDueJune2025Member 2021-07-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2027Member 2021-07-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2027Member 2020-07-01 2020-09-30 0001477449 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2021-09-30 0001477449 us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0001477449 tdoc:TechnologyAndDevelopmentMember 2021-07-01 2021-09-30 0001477449 tdoc:SalesExpenseMember 2021-07-01 2021-09-30 0001477449 tdoc:EmployeeStockPurchasePlan2015Member 2021-07-01 2021-09-30 0001477449 tdoc:EmployeeAndNonEmployeeStockOptionMember 2021-07-01 2021-09-30 0001477449 tdoc:AdministrativeAndMarketingMember 2021-07-01 2021-09-30 0001477449 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-09-30 0001477449 us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0001477449 tdoc:TechnologyAndDevelopmentMember 2021-01-01 2021-09-30 0001477449 tdoc:SalesExpenseMember 2021-01-01 2021-09-30 0001477449 tdoc:EmployeeStockPurchasePlan2015Member 2021-01-01 2021-09-30 0001477449 tdoc:AdministrativeAndMarketingMember 2021-01-01 2021-09-30 0001477449 us-gaap:PerformanceSharesMember 2020-07-01 2020-09-30 0001477449 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2020-09-30 0001477449 us-gaap:CostOfSalesMember 2020-07-01 2020-09-30 0001477449 tdoc:TechnologyAndDevelopmentMember 2020-07-01 2020-09-30 0001477449 tdoc:SalesExpenseMember 2020-07-01 2020-09-30 0001477449 tdoc:EmployeeStockPurchasePlan2015Member 2020-07-01 2020-09-30 0001477449 tdoc:EmployeeAndNonEmployeeStockOptionMember 2020-07-01 2020-09-30 0001477449 tdoc:AdministrativeAndMarketingMember 2020-07-01 2020-09-30 0001477449 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001477449 us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0001477449 tdoc:TechnologyAndDevelopmentMember 2020-01-01 2020-09-30 0001477449 tdoc:SalesExpenseMember 2020-01-01 2020-09-30 0001477449 tdoc:EmployeeStockPurchasePlan2015Member 2020-01-01 2020-09-30 0001477449 tdoc:AdministrativeAndMarketingMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2027Member us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2027Member us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2027Member us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2027Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2027Member 2020-01-01 2020-09-30 0001477449 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001477449 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001477449 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001477449 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001477449 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001477449 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001477449 tdoc:EmployeeAndNonEmployeeStockOptionMember 2021-01-01 2021-09-30 0001477449 tdoc:EmployeeAndNonEmployeeStockOptionMember 2020-01-01 2020-09-30 0001477449 2021-07-01 2021-09-30 0001477449 2020-07-01 2020-09-30 0001477449 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001477449 us-gaap:PerformanceSharesMember 2020-12-31 0001477449 us-gaap:RestrictedStockUnitsRSUMember 2021-07-01 2021-09-30 0001477449 us-gaap:PerformanceSharesMember 2021-07-01 2021-09-30 0001477449 us-gaap:RestrictedStockUnitsRSUMember 2020-07-01 2020-09-30 0001477449 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0001477449 us-gaap:PerformanceSharesMember 2020-01-01 2020-09-30 0001477449 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001477449 us-gaap:PerformanceSharesMember 2021-01-01 2021-09-30 0001477449 us-gaap:RestrictedStockUnitsRSUMember 2021-09-30 0001477449 us-gaap:PerformanceSharesMember 2021-09-30 0001477449 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001477449 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001477449 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001477449 tdoc:EmployeeStockPurchasePlan2015Member 2015-07-01 2015-07-31 0001477449 2020-01-01 2020-12-31 0001477449 2020-12-29 2020-12-29 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member 2021-03-01 2021-03-31 0001477449 us-gaap:ConvertibleNotesPayableMember 2021-09-30 0001477449 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesPayableExcludingLivongoNotesMember 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDueJune2025Member 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2027Member 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member 2021-08-31 0001477449 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001477449 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001477449 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001477449 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001477449 tdoc:EmployeeStockPurchasePlan2015Member 2021-09-30 0001477449 tdoc:LivongoHealthIncMember 2020-10-30 0001477449 tdoc:InTouchTechnologiesIncMember 2020-07-01 0001477449 tdoc:LivongoHealthIncMember 2020-10-30 2020-10-30 0001477449 tdoc:InTouchTechnologiesIncMember 2020-07-01 2020-07-01 0001477449 tdoc:LivongoHealthIncMember 2021-07-01 2021-09-30 0001477449 tdoc:LivongoHealthIncMember 2021-01-01 2021-03-31 0001477449 srt:MinimumMember 2021-09-30 0001477449 srt:MaximumMember 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member 2021-07-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member 2021-01-01 2021-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member 2020-07-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member 2020-07-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2025Member 2020-01-01 2020-09-30 0001477449 tdoc:ConvertibleSeniorNotesDue2022Member 2020-01-01 2020-09-30 0001477449 srt:MinimumMember us-gaap:PerformanceSharesMember 2021-01-01 2021-09-30 0001477449 srt:MaximumMember us-gaap:PerformanceSharesMember 2021-01-01 2021-09-30 0001477449 2021-09-30 0001477449 2020-12-31 0001477449 2020-01-01 2020-09-30 0001477449 2021-10-27 0001477449 2021-01-01 2021-09-30 shares iso4217:USD pure tdoc:D iso4217:USD shares tdoc:item

150281099

160013751

P3M

P1Y

P2Y

0.00413

0.01866

0.01394

P5Y6M

P4D P4D

P1Y

0001477449 --12-31 2021 Q3 false 10-Q true 2021-09-30 false 001-37477 TELADOC HEALTH, INC. DE 04-3705970 2 Manhattanville Road Suite 203 Purchase NY 10577 203 635-2002 Common Stock, par value $0.001 per share TDOC NYSE Yes Yes Large Accelerated Filer false false false 160086661

823828000

733324000

2538000

53245000

11277000

6412000

178072000

169281000

56937000

56498000

95941000

47259000

1157316000

1059607000

27027000

28551000

14470399000

14581255000

1932012000

2020864000

47935000

46647000

17890000

18357000

17652579000

17755281000

34655000

46030000

106252000 83657000

75891000

94593000

72865000

52356000

12442000 13453000

42560000

302105000

332649000

1328000

1616000

42729000

43142000

4075000

2449000

9561000 9926000

93824000

102103000

1211375000

1379592000

0.001

300000000

160013751

150281099

160000

150000

17399023000

16857797000

-1410469000

-992661000

-1132000

18518000

15987582000

15883804000

17652579000

17755281000

521658000

288812000

1478472000

710641000

169041000

104725000

475273000

267887000

111078000

52302000

303738000

132395000

62602000

23483000

191251000

60110000

80250000

29958000

239017000

72244000

4340000

25395000

22084000

30686000

103016000

59742000

319404000

162699000

51907000

12932000

151907000

32535000

582234000

308537000

1702674000

758556000

-60576000

-19725000

-224202000

-47915000

-850000

-1227000

-43728000

-8978000

-376000

-252000

5493000

-827000

-18895000

-16970000

-61493000

-38849000

-80697000

-38174000

-323930000

-96569000

3643000

-2290000

93878000

-5400000

-84340000

-35884000

-417808000

-91169000

-13423000

16285000

-19650000

11610000

-97763000

-19599000

-437458000

-79559000

-0.53

-0.43

-2.68

-1.17

159435165

83607902

155926680

77821073

159462978

159000

17314749000

-1326129000

12291000

16001070000

216882

1000

5174000

5175000

235674 0 0 0 0 0

98217

14868000

0 0 10079000 0 0 10079000

74311000

-13423000

-84340000

160013751

160000

17399023000

-1410469000

-1132000

15987582000

150281099

150000

16857797000

-992661000

18518000

15883804000

2123935

3000

22953000

22956000

1490879 1000 -1000 0 0 0

82088

10539000

1058373

1000

270111000

270112000

5182656

5000

920514000

920519000

205279 0 40329000 0 0 40329000 0 0 668507000 0 0 668507000 0 0 224081000 0 0 224081000

250027000

-19650000

-417808000

160013751

160000

17399023000

-1410469000

-1132000

15987582000

79099433

79000

1879573000

-562810000

-21913000

1294929000

400555

7113000

49396 0 0 0 0 0

950

187000

0 0 44000 0 0 44000

187346

37780000

0 0 29326000 0 0 29326000

4620665

5000

918813000

918818000

21178000

16285000

-35884000

84358345

84000

2835274000

-598694000

-5628000

2231036000

72761941

73000

1538716000

-507525000

-17239000

1014025000

1999518

1000

40625000

40626000

801575 1000 -1000 0 0 0

35901

2473000

3951399

4000

694047000

694051000

187346

37780000

4620665

5000

918813000

918818000

0 0 715195000 0 0 715195000 0 0 29326000 0 0 29326000

285601000

61741000

11611000

-91169000

84358345

84000

2835274000

-598694000

-5628000

2231036000

-417808000

-91169000

151907000

32535000

2500000 851000 8185000 4643000

11353000

2320000

240971000

61151000

91414000 -4096000 46843000 29459000 -40631000 -8978000

5901000

-38000

-216000

19407000

16450000

34566000

5906000

2661000

2392000

3432000

-140000

-11115000

6584000

15880000 17269000

-17352000

9329000

20002000

15348000

-8202000 -4360000

1502000

-3025000

110782000

61425000

5611000

2872000

35402000

14515000

50000000

10901000

75944000

159663000

-3150000

-52906000

-177050000

22956000

40627000

1000000000

24070000

139000 228153000 10677000 1924000 12053000 4427000

13996000

2473000

3109000 326000

-4224000

34322000

788700000

92198000

673075000

-1694000

-129000

733324000

514353000

823828000

1187299000

3114000

786000

7973000

5612000

Note 1. Organization and Description of BusinessTeladoc, Inc. was incorporated in the State of Texas in June 2002 and changed its state of incorporation to the State of Delaware in October 2008. Effective August 10, 2018, Teladoc, Inc. changed its corporate name to Teladoc Health, Inc. Unless the context otherwise requires, Teladoc Health, Inc., together with its subsidiaries, is referred to herein as “Teladoc Health” or the “Company”. The Company’s principal executive office is located in Purchase, New York. Teladoc Health is a global leader in providing virtual healthcare services with a focus on high quality, lower costs, and improved outcomes around the world.On January 4, 2021, the Company completed the acquisition of the UK-based telemedicine provider Consultant Connect Limited (“Consultant Connect”). Consultant Connect provides a platform that specializes in facilitating healthcare professional-to-professional advice and guidance in the United Kingdom.On October 30, 2020, the Company completed the merger with Livongo Health, Inc. (“Livongo”), a transformational opportunity to improve the delivery, access and experience of healthcare for consumers around the world. Livongo is pioneering a new category in healthcare, called Applied Health Signals, which is transforming the management of chronic conditions.On July 1, 2020, the Company completed the acquisition of InTouch Technologies, Inc. (“InTouch”), a leading provider of enterprise telehealth solutions for hospitals and health systems.

Note 2. Basis of Presentation and Principles of ConsolidationThe accompanying unaudited consolidated financial statements for the three and nine months ended September 30, 2021 and 2020, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of Teladoc Health for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended December 31, 2020, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.These financial statements include the results of Teladoc Health, as well as three professional associations and thirteen professional corporations (collectively, the “Association”). All intercompany transactions and balances have been eliminated. Certain prior year amounts have been reclassified to conform to the current year presentation. Teladoc Health Medical Group, P.A., formerly Teladoc Physicians, P.A. is party to several Services Agreements by and among it and the professional associations and professional corporations pursuant to which each professional association and professional corporation provides services to Teladoc Health Medical Group, P.A. Each professional association and professional corporation is established pursuant to the requirements of its respective domestic jurisdiction governing the corporate practice of medicine.The Company holds a variable interest in the Association which contracts with physicians and other health professionals in order to provide services to the Company. The Association is considered a variable interest entity (“VIE”) since it does not have sufficient equity to finance its activities without additional subordinated financial support. An enterprise having a controlling financial interest in a VIE must consolidate the VIE if it has both power and benefits—that is, it has (1) the power to direct the activities of a VIE that most significantly impacts the VIE’s economic performance (power) and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE (benefits). The Company has the power and rights to control all activities of the Association and funds and absorbs all losses of the VIE and appropriately consolidates the Association. Total revenue and net income (loss) for the VIE were $56.2 million and $0.1 million, and $48.9 million and $(0.7) million, for the quarters ended September 30, 2021 and 2020, respectively. Total revenue and net income (loss) for the VIE were $161.9 million and $(3.0) million, and $149.1 million and $0.1 million, for the nine months ended September 30, 2021 and 2020, respectively. The VIE’s total assets, all of which were current, were $31.0 million and $28.7 million at September 30, 2021 and December 31, 2020, respectively. Total liabilities, all of which were current for the VIE, were $71.0 million and $65.8 million at September 30, 2021 and December 31, 2020, respectively. The VIE’s total stockholders’ deficit was $40.1 million and $37.1 million at September 30, 2021 and December 31, 2020, respectively. Business CombinationsThe Company accounts for its business combinations using the acquisition method of accounting. The purchase price is attributed to the fair value of the assets acquired and liabilities assumed. Transaction costs directly attributable to the acquisition are expensed as incurred. Identifiable assets and liabilities acquired or assumed are measured separately at their fair values as of the acquisition date. The excess of the purchase price of acquisition over the fair value of the identifiable net assets of the acquiree is recorded as goodwill. The results of businesses acquired in a business combination are included in the Company’s consolidated financial statements from the date of acquisition.When the Company issues stock-based or cash awards to an acquired company’s stockholders, the Company evaluates whether the awards are consideration or compensation for post-acquisition services. The evaluation includes, among other things, whether the vesting of the awards is contingent on the continued employment of the acquired company’s stockholders beyond the acquisition date. If continued employment is required for vesting, the awards are treated as compensation for post-acquisition services and recognized as expense over the requisite service period.Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates, including the selection of valuation methodologies, estimates of future revenue and cash flows, discount rates and selection of comparable companies. The estimates and assumptions used to determine the fair values and useful lives of identified intangible assets could change due to numerous factors, including market conditions, technological developments, economic conditions and competition. In connection with determination of fair values, the Company may engage a third-party valuation specialist to assist with the valuation of intangible and certain tangible assets acquired and certain assumed obligations. Acquisition-related transaction costs incurred by the Company are not included as a component of consideration transferred but are accounted for as an operating expense in the period in which the costs are incurred.Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates on historical experience, current business factors, and various other assumptions that the Company believes are necessary to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment evolves. The Company believes that estimates used in the preparation of these consolidated financial statements are reasonable; however, actual results could differ materially from these estimates.Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements. Significant estimates and assumptions by management affect areas including the allowance for doubtful accounts, the carrying value of long-lived assets (including goodwill and intangible assets), capitalization and amortization of software development costs, the finalization of purchase accounting adjustments, Client performance guarantees, the calculation of a contingent liability in connection with an acquisition earn-out, the provision for income taxes and related deferred tax accounts, revenue recognition, contingencies, and other items as described in the Summary of Significant Accounting policies in this Quarterly Report and in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Form 10-K”).Recently Issued Accounting PronouncementsIn August 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-06—"Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.” ASU 2020-06 simplifies the accounting for convertible instruments by eliminating the conversion option separation model for convertible debt that can be settled in cash and by eliminating the measurement model for beneficial conversion features. Convertible instruments that continue to be subject to separation models are (1) those with conversion options that are required to be accounted for as bifurcated derivatives and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. This ASU also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. This standard becomes effective for the Company on January 1, 2022 and may be early adopted during an interim period of 2021. The Company will adopt the standard on January 1, 2022 and is currently evaluating the impact of ASU 2020-06 on its consolidated financial statements.Summary of Significant Accounting PoliciesThe following sections reflect updates to the summary of significant accounting policies described in the 2020 Form 10-K. In addition, on an ongoing basis, the Company will continue to closely monitor for any significant impact to its estimates and assumptions as a result of the COVID-19 pandemic, especially on the allowance for doubtful accounts. Acquisition, Integration and Transformation Costs Acquisition, integration and transformation costs include investment banking, financing, legal, accounting, consultancy, integration, fair value changes related to contingent consideration and certain other transaction costs related to mergers and acquisitions. It also includes costs related to certain business transformation initiatives focused on integrating and optimizing various operations and systems, including enhancing our customer relationship management (CRM) and enterprise resource planning (ERP) systems, incurred in connection with our acquisition and integration activities. General and Administrative Costs General and Administrative costs consist of all operating expenses not included in the other operating expense categories and now include legal and regulatory costs for all current and historical periods presented.Other Expense (Income), Net Other expense (income), net includes the impact of foreign currency remeasurement, realized and unrealized gains on investment securities and all other non-operating items not included in other financial statement lines.

The accompanying unaudited consolidated financial statements for the three and nine months ended September 30, 2021 and 2020, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of Teladoc Health for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended December 31, 2020, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies.These financial statements include the results of Teladoc Health, as well as three professional associations and thirteen professional corporations (collectively, the “Association”). All intercompany transactions and balances have been eliminated. Certain prior year amounts have been reclassified to conform to the current year presentation. Teladoc Health Medical Group, P.A., formerly Teladoc Physicians, P.A. is party to several Services Agreements by and among it and the professional associations and professional corporations pursuant to which each professional association and professional corporation provides services to Teladoc Health Medical Group, P.A. Each professional association and professional corporation is established pursuant to the requirements of its respective domestic jurisdiction governing the corporate practice of medicine.The Company holds a variable interest in the Association which contracts with physicians and other health professionals in order to provide services to the Company. The Association is considered a variable interest entity (“VIE”) since it does not have sufficient equity to finance its activities without additional subordinated financial support. An enterprise having a controlling financial interest in a VIE must consolidate the VIE if it has both power and benefits—that is, it has (1) the power to direct the activities of a VIE that most significantly impacts the VIE’s economic performance (power) and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE (benefits). The Company has the power and rights to control all activities of the Association and funds and absorbs all losses of the VIE and appropriately consolidates the Association. Total revenue and net income (loss) for the VIE were $56.2 million and $0.1 million, and $48.9 million and $(0.7) million, for the quarters ended September 30, 2021 and 2020, respectively. Total revenue and net income (loss) for the VIE were $161.9 million and $(3.0) million, and $149.1 million and $0.1 million, for the nine months ended September 30, 2021 and 2020, respectively. The VIE’s total assets, all of which were current, were $31.0 million and $28.7 million at September 30, 2021 and December 31, 2020, respectively. Total liabilities, all of which were current for the VIE, were $71.0 million and $65.8 million at September 30, 2021 and December 31, 2020, respectively. The VIE’s total stockholders’ deficit was $40.1 million and $37.1 million at September 30, 2021 and December 31, 2020, respectively. 3 13

56200000

100000

48900000

-700000

161900000

-3000000.0

149100000

100000

31000000.0

28700000

71000000.0

65800000

-40100000

-37100000

Business CombinationsThe Company accounts for its business combinations using the acquisition method of accounting. The purchase price is attributed to the fair value of the assets acquired and liabilities assumed. Transaction costs directly attributable to the acquisition are expensed as incurred. Identifiable assets and liabilities acquired or assumed are measured separately at their fair values as of the acquisition date. The excess of the purchase price of acquisition over the fair value of the identifiable net assets of the acquiree is recorded as goodwill. The results of businesses acquired in a business combination are included in the Company’s consolidated financial statements from the date of acquisition.When the Company issues stock-based or cash awards to an acquired company’s stockholders, the Company evaluates whether the awards are consideration or compensation for post-acquisition services. The evaluation includes, among other things, whether the vesting of the awards is contingent on the continued employment of the acquired company’s stockholders beyond the acquisition date. If continued employment is required for vesting, the awards are treated as compensation for post-acquisition services and recognized as expense over the requisite service period.Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates, including the selection of valuation methodologies, estimates of future revenue and cash flows, discount rates and selection of comparable companies. The estimates and assumptions used to determine the fair values and useful lives of identified intangible assets could change due to numerous factors, including market conditions, technological developments, economic conditions and competition. In connection with determination of fair values, the Company may engage a third-party valuation specialist to assist with the valuation of intangible and certain tangible assets acquired and certain assumed obligations. Acquisition-related transaction costs incurred by the Company are not included as a component of consideration transferred but are accounted for as an operating expense in the period in which the costs are incurred.

Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates on historical experience, current business factors, and various other assumptions that the Company believes are necessary to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment evolves. The Company believes that estimates used in the preparation of these consolidated financial statements are reasonable; however, actual results could differ materially from these estimates.Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements. Significant estimates and assumptions by management affect areas including the allowance for doubtful accounts, the carrying value of long-lived assets (including goodwill and intangible assets), capitalization and amortization of software development costs, the finalization of purchase accounting adjustments, Client performance guarantees, the calculation of a contingent liability in connection with an acquisition earn-out, the provision for income taxes and related deferred tax accounts, revenue recognition, contingencies, and other items as described in the Summary of Significant Accounting policies in this Quarterly Report and in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Form 10-K”).

Recently Issued Accounting PronouncementsIn August 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-06—"Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.” ASU 2020-06 simplifies the accounting for convertible instruments by eliminating the conversion option separation model for convertible debt that can be settled in cash and by eliminating the measurement model for beneficial conversion features. Convertible instruments that continue to be subject to separation models are (1) those with conversion options that are required to be accounted for as bifurcated derivatives and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. This ASU also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. This standard becomes effective for the Company on January 1, 2022 and may be early adopted during an interim period of 2021. The Company will adopt the standard on January 1, 2022 and is currently evaluating the impact of ASU 2020-06 on its consolidated financial statements.

Acquisition, Integration and Transformation Costs Acquisition, integration and transformation costs include investment banking, financing, legal, accounting, consultancy, integration, fair value changes related to contingent consideration and certain other transaction costs related to mergers and acquisitions. It also includes costs related to certain business transformation initiatives focused on integrating and optimizing various operations and systems, including enhancing our customer relationship management (CRM) and enterprise resource planning (ERP) systems, incurred in connection with our acquisition and integration activities.

General and Administrative Costs General and Administrative costs consist of all operating expenses not included in the other operating expense categories and now include legal and regulatory costs for all current and historical periods presented.

Other Expense (Income), Net Other expense (income), net includes the impact of foreign currency remeasurement, realized and unrealized gains on investment securities and all other non-operating items not included in other financial statement lines.

Note 3. Revenue, Deferred Revenue, Deferred Costs and OtherThe Company generates access fees from Clients accessing its professional provider network, hosted virtual healthcare platform and chronic care management platforms. Visit fee revenue is generated for general medical, expert medical service and other specialty visits. In addition, other revenue is primarily associated with virtual healthcare device equipment included with its hosted virtual healthcare platform. Access revenue accounted for 87% and 78% of our revenue for the quarters ended September 30, 2021 and 2020. Access revenue accounted for 86% and 77% of our revenue for the nine months ended September 30, 2021 and 2020, respectively.The following table presents the Company’s revenues disaggregated by revenue source (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20%;margin:0pt;padding:0pt;">Quarter Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.55%;margin:0pt;padding:0pt;">Nine Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Access Fees Revenue</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">U.S. </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 413,594</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 194,622</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,161,084</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 454,582</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">International</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 37,989</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 31,997</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 112,699</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 91,261</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 451,583</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 226,619</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,273,783</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 545,843</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Visit Fee Revenue</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">U.S. </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 59,863</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 50,948</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 173,399</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 152,944</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">International</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 116</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 96</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 368</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 705</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Total</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 59,979</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 51,044</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 173,767</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 153,649</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Other</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">U.S. </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 9,583</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 10,299</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 29,617</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 10,299</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">International</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 513</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 850</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,305</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 850</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 10,096</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 11,149</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 30,922</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 11,149</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Total Revenues</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 521,658</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 288,812</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,478,472</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 710,641</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr></table>International revenues primarily reflect the location of the customer, except for direct to consumer activities which primarily reflect the location of operations to service customers.Deferred RevenueDeferred revenue represents billed, but unrecognized revenue, and is comprised of fees received in advance of the delivery or completion of the services and amounts received in instances when revenue recognition criteria have not been met. Deferred revenue associated with upfront payments for a device is amortized ratably over the expected Member enrollment period. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as current deferred revenue and the remaining portion is recorded as noncurrent deferred revenue.For certain services, payment is required for future months before the service is delivered to the Member. The Company records deferred revenue when cash payments are received in advance of the Company’s performance obligation to provide services. Deferred revenue, current plus long-term, was $76.9 million at September 30, 2021 and $51.6 million at September 30, 2020. The net increase of $21.8 million and $36.8 million in the deferred revenue balance for the nine months ended September 30, 2021 and 2020, respectively, is primarily driven by InTouch and Livongo as well as the direct-to-consumer behavioral health product and cash payments received or due in advance of satisfying the Company’s performance obligations, offset by revenue recognized that were included in the deferred revenue balance at the beginning of the period. The Company anticipates that it will satisfy most of its performance obligation associated with the deferred revenue within the prospective fiscal year. Revenue recognized during the quarters ended September 30, 2021 and 2020 that was included in deferred revenue at the beginning of the periods was $47.2 million and $18.9 million, respectively. Revenue recognized during the nine months ended September 30, 2021 and 2020 that was included in deferred revenue at the beginning of the periods was $48.5 million and $10.6 million, respectively.We expect to recognize $48.5 million and $15.4 million of revenue in 2021 and 2022, respectively, related to future performance obligations that are unsatisfied or partially unsatisfied as of September 30, 2021.Deferred Costs and OtherDeferred costs and other, consist of deferred device cost and deferred contract cost, which are classified as a component of Prepaid expenses and other current assets or Other assets depending on term, consist of the following as of September 30, 2021 (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.39%;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.37%;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">December 31,</td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;">Deferred costs and other, current</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"> 20,243</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"> 3,468</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;">Deferred costs and other, noncurrent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,788</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,179</td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;">Total deferred costs and other</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.66%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,031</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,647</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"></td></tr></table>Deferred costs and other activity are as follows (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;width:13.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Deferred Costs and Other</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.44%;margin:0pt;padding:0pt;">Beginning balance as of December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 5,647</td></tr><tr><td style="vertical-align:bottom;width:83.44%;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 34,554</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.44%;margin:0pt;padding:0pt;">Cost of revenue recognized</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (12,170)</td></tr><tr><td style="vertical-align:bottom;width:83.44%;margin:0pt;padding:0pt;">Ending balance as of September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,031</td></tr></table>

0.87

0.78

0.86

0.77

The following table presents the Company’s revenues disaggregated by revenue source (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20%;margin:0pt;padding:0pt;">Quarter Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.55%;margin:0pt;padding:0pt;">Nine Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:21.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Access Fees Revenue</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">U.S. </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 413,594</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 194,622</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,161,084</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 454,582</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">International</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 37,989</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 31,997</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 112,699</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 91,261</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 451,583</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 226,619</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,273,783</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 545,843</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Visit Fee Revenue</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">U.S. </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 59,863</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 50,948</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 173,399</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 152,944</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">International</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 116</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 96</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 368</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 705</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Total</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 59,979</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 51,044</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 173,767</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 153,649</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Other</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">U.S. </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 9,583</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 10,299</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 29,617</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 10,299</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">International</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 513</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 850</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,305</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 850</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 10,096</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 11,149</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 30,922</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 11,149</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:53.49%;margin:0pt;padding:0pt;">Total Revenues</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 521,658</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 288,812</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,478,472</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 710,641</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr></table>International revenues primarily reflect the location of the customer, except for direct to consumer activities which primarily reflect the location of operations to service customers.

413594000

194622000

1161084000

454582000

37989000

31997000

112699000

91261000

451583000

226619000

1273783000

545843000

59863000

50948000

173399000

152944000

116000

96000

368000

705000

59979000

51044000

173767000

153649000

9583000

10299000

29617000

10299000

513000

850000

1305000

850000

10096000

11149000

30922000

11149000

521658000

288812000

1478472000

710641000

76900000

51600000

21800000

36800000

47200000

18900000

48500000

10600000

48500000

15400000

Deferred costs and other, consist of deferred device cost and deferred contract cost, which are classified as a component of Prepaid expenses and other current assets or Other assets depending on term, consist of the following as of September 30, 2021 (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.39%;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.37%;margin:0pt;padding:0pt;">As of </td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">December 31,</td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.39%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;">Deferred costs and other, current</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"> 20,243</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.71%;margin:0pt;padding:0pt;"> 3,468</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;">Deferred costs and other, noncurrent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,788</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,179</td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.4%;margin:0pt;padding:0pt;">Total deferred costs and other</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.66%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,031</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.71%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,647</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"></td></tr></table>Deferred costs and other activity are as follows (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;width:13.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Deferred Costs and Other</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.44%;margin:0pt;padding:0pt;">Beginning balance as of December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 5,647</td></tr><tr><td style="vertical-align:bottom;width:83.44%;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 34,554</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.44%;margin:0pt;padding:0pt;">Cost of revenue recognized</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (12,170)</td></tr><tr><td style="vertical-align:bottom;width:83.44%;margin:0pt;padding:0pt;">Ending balance as of September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,031</td></tr></table> 20243000 3468000 7788000 2179000 28031000 5647000 5647000 34554000 -12170000 28031000

Note 4. Business AcquisitionsOn January 4, 2021, the Company completed the acquisition of the UK-based telemedicine provider Consultant Connect for cash consideration of $56.3 million, net of cash acquired. Consultant Connect provides a platform that specializes in facilitating healthcare professional-to-professional advice and guidance in the United Kingdom. As part of purchase accounting, the Company recognized intangibles related to customer relationships, technology and the brand of $9.8 million, $1.9 million, and $0.6 million, respectively; and goodwill of $47.3 million. The acquisition was considered a stock acquisition for tax purposes and accordingly, the goodwill resulting from this acquisition is not tax deductible.On October 30, 2020, the Company completed the acquisition of Livongo through a merger in which Livongo became a wholly-owned subsidiary of the Company. Upon completion of the merger, each share of Livongo’s common stock converted into the right to receive 0.5920 shares of Teladoc Health’s common stock and $4.24 in cash, without interest. In addition, in connection with the closing of the merger, Livongo paid a special cash dividend equal to $7.09 per share of Livongo’s common stock to shareholders of Livongo as of a record date of October 29, 2020. The total initial consideration calculated on upon deal closing was $13,938.0 million, consisting of $401.0 million of net cash, $555.4 million related to the conversion feature of the Livongo Notes guaranteed by the Company and 60.4 million shares of Teladoc Health’s common stock valued at approximately $12,981.6 million on October 30, 2020. The acquisition was considered a stock acquisition for tax purposes and accordingly, the goodwill resulting from this acquisition is not tax deductible. The total acquisition related costs were $59.0 million and included transaction costs for investment bankers, other professional fees and income taxes for accelerated grants and were recognized in the Company’s consolidated statement of operations in acquisition, integration and transformation costs.In the first quarter of 2021, the Company identified 205,279 of additional shares of Teladoc Health common stock that were included as part of the merger consideration (“Excess Shares”) and 85,481 of additional shares of Teladoc Health common stock that were not withheld from the merger consideration for withholding tax purposes (“Withholding Shares”). In addition, the Company identified $5.6 million of merger-related cash payments related to the Excess Shares (“Cash Overpayments”). The Company has recovered and cancelled all 205,279 of the Excess Shares and expects to recover the Cash Overpayments in the form of cash. The Company expects to apply the cash value of the Withholding Shares to offset future employment tax obligations of the Company. As a result, the total adjusted consideration was $13,876.9 million, consisting of $380.2 million of net cash, $555.4 million related to the conversion feature of the Livongo Notes guaranteed by the Company and 60.2 million shares of Teladoc Health’s common stock valued at approximately $12,941.3 million. The Company does not expect to incur any material charges or expenses related to the recovery of the Withholding Shares and the Cash Overpayments. Accordingly, the Company recorded, in the first quarter of fiscal year 2021, an increase to receivables in current other assets of $20.8 million, a decrease to consolidated stockholders’ equity of $40.3 million and a decrease to goodwill of $61.1 million. In the first quarter of 2021, the Company recognized a discrete non-cash income tax charge substantially reflecting an additional valuation allowance on excess stock compensation benefits and other state deferred tax assets associated with the Livongo merger which resulted in a $106.5 million measurement period reduction to goodwill.In the third quarter of 2021, the Company recorded a $5.0 million increase to goodwill reflecting a final adjustment to its measurement date tax valuation allowances and a $6.3 million increase to goodwill to reflect the cost to replace certain devices becoming obsolete due to provider upgrades to telecommunications networks known at the date of the Livongo merger. On July 1, 2020, the Company completed the acquisition of InTouch through a merger in which InTouch became a wholly-owned subsidiary of the Company. The aggregate merger consideration paid was $1,078.5 million, net of cash acquired of $1.1 million, which was comprised of 4.6 million shares of Teladoc’s common stock valued at $918.8 million on July 1, 2020, and $160.7 million of cash. InTouch is a leading provider of enterprise telehealth solutions for hospitals and health systems. The acquisition was considered a stock acquisition for tax purposes and accordingly, the goodwill resulting from this acquisition is not tax deductible. The total acquisition related costs were $12.5 million and included transaction costs for investment bankers and other professional fees and were recognized in the Company’s consolidated statement of operations in acquisition, integration and transformation costs.The acquisitions described above were accounted for using the acquisition method of accounting, which requires, among other things, the assets acquired and the liabilities assumed be recognized at their fair values as of the acquisition date. The results of the acquisitions were included within the consolidated financial statements commencing on the aforementioned acquisition dates. The following table summarizes the fair value estimates of the assets acquired and liabilities assumed for the Livongo and InTouch acquisitions. The Company, with the assistance of a third-party valuation expert, estimated the fair value of the acquired tangible and intangible assets with significant estimates such as revenue projections. The allocation of the consideration transferred to the assets acquired and the liabilities assumed for the Livongo merger remains preliminary and therefore can be revised as a result of additional information obtained due to the finalization of the valuation inputs and assumptions as well as completing the assessment of the tax attributes of the business combination. As discussed further in Note 15, the Company recognized a non-cash income tax charge during the nine months ended September 30, 2021, substantially reflecting the recording of a valuation allowance on stock compensation benefits associated with the Livongo merger. Additional adjustments that could have a material impact on the Company’s results of operations and financial position may be recorded within the measurement period, which will not exceed one year from the acquisition date.Identifiable assets acquired and liabilities assumed (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Livongo</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">InTouch</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Purchase price, net of cash acquired</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 13,876,931</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 1,069,759</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Less:</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Accounts receivable</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 80,084</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 16,986</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Short term investment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 52,500</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Inventory</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 24,299</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 8,492</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Property and equipment, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 8,952</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 11,366</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Right of use assets</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 15,056</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 4,965</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Other assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 17,337</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 2,541</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Client relationships</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 1,050,000</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 164,580</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Technology</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 300,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 29,190</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Trademarks</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 250,000</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 32,630</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Advances from financing companies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> (26,012)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Accounts payable</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> (119,302)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> (5,589)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Deferred revenue</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> (997)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> (20,729)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Convertible notes</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> (453,417)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Deferred taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> (37,980)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> (30,102)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Lease liabilities</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> (18,834)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> (5,495)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Other liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (46,606)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (13,042)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Goodwill</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,755,839</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 899,978</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr></table>The amount allocated to goodwill reflects the benefits Teladoc Health expects to realize from the growth of the respective acquisitions’ operations, cost savings, and various synergies.The Company’s pro forma revenue and net loss for the quarters and nine months ended September 30, 2020 below have been prepared as if Livongo and InTouch had been purchased on January 1, 2020. As such, the Company made pro-forma adjustments related to deferred revenue, deferred costs, amortization of intangible assets, interest expense, stock-based compensation, acquisition costs and transaction expenses for the purpose of this presentation.<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.74%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Unaudited Pro Forma</td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:66.74%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.83%;margin:0pt;padding:0pt;">Quarter Ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.95%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.63%;margin:0pt;padding:0pt;">Nine Months Ended</td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:66.74%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.83%;margin:0pt;padding:0pt;">September 30,</td><td style="vertical-align:bottom;white-space:nowrap;width:2.95%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.63%;margin:0pt;padding:0pt;">September 30,</td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:66.74%;margin:0pt;padding:0pt;">(in thousands)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.95%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.63%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.74%;margin:0pt;padding:0pt;">Revenue</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.45%;margin:0pt;padding:0pt;"> 395,519</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.95%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"> 1,026,957</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.94%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:66.74%;margin:0pt;padding:0pt;">Net loss</td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:11.45%;margin:0pt;padding:0pt;"> (93,149)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.95%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.77%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.86%;margin:0pt;padding:0pt;"> (778,287)</td><td style="vertical-align:bottom;white-space:nowrap;width:0.94%;margin:0pt;padding:0pt;"></td></tr></table>The unaudited pro forma financial information above is not necessarily indicative of what the Company’s consolidated results actually would have been if the acquisitions had been completed at the beginning of the respective periods. In addition, the unaudited pro forma information above does not attempt to project the Company’s future results.

56300000

9800000

1900000

600000

47300000

0.5920 4.24 7.09 13938000000.0 401000000.0 555400000 60400000 12981600000

59000000.0

205279 85481 5600000 205279

13876900000

380200000

555400000

60200000

12941300000

20800000 -40300000 -61100000 -106500000 5000000.0 6300000 1078500000

1100000

4600000 918800000 160700000

12500000

Identifiable assets acquired and liabilities assumed (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Livongo</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">InTouch</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Purchase price, net of cash acquired</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 13,876,931</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 1,069,759</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Less:</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Accounts receivable</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 80,084</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 16,986</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Short term investment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 52,500</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Inventory</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 24,299</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 8,492</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Property and equipment, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 8,952</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 11,366</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Right of use assets</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 15,056</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 4,965</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Other assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 17,337</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 2,541</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Client relationships</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 1,050,000</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 164,580</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Technology</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 300,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 29,190</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Trademarks</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 250,000</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 32,630</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Advances from financing companies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> (26,012)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Accounts payable</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> (119,302)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> (5,589)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Deferred revenue</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> (997)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> (20,729)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Convertible notes</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> (453,417)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Deferred taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> (37,980)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> (30,102)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Lease liabilities</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;margin:0pt;padding:0pt;"> (18,834)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;margin:0pt;padding:0pt;"> (5,495)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Other liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (46,606)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (13,042)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.06%;margin:0pt;padding:0pt;">Goodwill</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,755,839</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.02%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 899,978</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.04%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.26%;margin:0pt;padding:0pt;"></td></tr></table>

13876931000 1069759000

80084000

16986000

52500000 0

24299000

8492000

8952000

11366000

15056000 4965000

17337000

2541000

1050000000

164580000

300000000

29190000

250000000

32630000

0 26012000

119302000

5589000

997000

20729000

453417000 0

37980000

30102000

18834000

5495000

46606000

13042000

12755839000

899978000

395519000

1026957000

-93149000

-778287000

Note 5. InventoriesInventories consisted of the following (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.1%;margin:0pt;padding:0pt;">As of September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.69%;margin:0pt;padding:0pt;">As of December 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.71%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:13.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:66.71%;margin:0pt;padding:0pt;">Raw materials and purchased parts</td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;margin:0pt;padding:0pt;"> 21,836</td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"> 19,591</td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.71%;margin:0pt;padding:0pt;">Work in process</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.4%;margin:0pt;padding:0pt;"> 501</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"> 1,431</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.71%;margin:0pt;padding:0pt;">Finished goods</td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 34,600</td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 35,476</td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.71%;margin:0pt;padding:0pt;">Total inventories</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 56,937</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 56,498</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"></td></tr></table>

Inventories consisted of the following (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.1%;margin:0pt;padding:0pt;">As of September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.69%;margin:0pt;padding:0pt;">As of December 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.71%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:13.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:66.71%;margin:0pt;padding:0pt;">Raw materials and purchased parts</td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;margin:0pt;padding:0pt;"> 21,836</td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"> 19,591</td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.71%;margin:0pt;padding:0pt;">Work in process</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.4%;margin:0pt;padding:0pt;"> 501</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"> 1,431</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:66.71%;margin:0pt;padding:0pt;">Finished goods</td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 34,600</td><td style="vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 35,476</td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66.71%;margin:0pt;padding:0pt;">Total inventories</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 56,937</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.15%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 56,498</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"></td></tr></table>

21836000

19591000

501000

1431000

34600000

35476000

56937000

56498000

Note 6. Intangible Assets, NetIntangible assets, net consist of the following (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;">Weighted</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;">Average</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;">Remaining</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">Useful</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;">Net Carrying</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;">Useful Life</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Life</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross Value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortization</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">(Years)</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Client relationships</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">2 to 20 years </td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,467,396</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (174,523)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,292,873</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 14.8</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Non-compete agreements</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">1.5 to 5 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 5,008</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (5,008)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Trademarks</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">3 to 15 years </td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 326,594</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (38,075)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 288,519</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 9.7</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Patents</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">3 years </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 200</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (200)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Capitalized software development costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">3 to 5 years </td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 97,779</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (35,717)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 62,062</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 2.7</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Technology</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">5 to 7 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 342,039</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (53,481)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 288,558</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 5.9</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Intangible assets, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,239,016</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (307,004)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,932,012</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 12.3</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Client relationships</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">2 to 20 years </td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,460,648</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (100,844)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,359,804</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;">`</td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 15.4</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Non-compete agreements</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">1.5 to 5 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 5,097</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (4,872)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 225</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 0.4</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Trademarks</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">3 to 15 years </td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 326,786</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (15,576)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 311,210</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 10.5</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Patents</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">3 years </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 200</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (200)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Capitalized software development costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">3 to 5 years</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 52,518</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (24,771)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 27,747</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 2.8</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Technology</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">5 to 7 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 338,150</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (16,272)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 321,878</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 6.6</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Intangible assets, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,183,399</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (162,535)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,020,864</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 13.1</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr></table>Amortization expense for intangible assets net of foreign currency remeasurement for intangible assets was $49.6 million and $11.7 million for the quarters ended September 30, 2021 and 2020, respectively. Amortization expense, net of foreign currency remeasurement for intangible assets was $145.3 million and $29.6 million for the nine months ended September 30, 2021 and 2020, respectively.

Intangible assets, net consist of the following (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;">Weighted</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;">Average</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;">Remaining</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">Useful</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.93%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;">Net Carrying</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;">Useful Life</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Life</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross Value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortization</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">(Years)</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Client relationships</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">2 to 20 years </td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,467,396</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (174,523)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,292,873</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 14.8</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Non-compete agreements</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">1.5 to 5 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 5,008</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (5,008)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Trademarks</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">3 to 15 years </td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 326,594</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (38,075)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 288,519</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 9.7</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Patents</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">3 years </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 200</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (200)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Capitalized software development costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">3 to 5 years </td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 97,779</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (35,717)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 62,062</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 2.7</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Technology</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">5 to 7 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 342,039</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (53,481)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 288,558</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 5.9</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Intangible assets, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,239,016</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (307,004)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,932,012</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 12.3</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Client relationships</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">2 to 20 years </td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,460,648</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (100,844)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,359,804</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;">`</td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 15.4</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Non-compete agreements</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">1.5 to 5 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 5,097</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (4,872)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 225</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 0.4</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Trademarks</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">3 to 15 years </td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 326,786</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (15,576)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 311,210</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 10.5</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Patents</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">3 years </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 200</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (200)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Capitalized software development costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">3 to 5 years</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 52,518</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;margin:0pt;padding:0pt;"> (24,771)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 27,747</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 2.8</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Technology</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;">5 to 7 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 338,150</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (16,272)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 321,878</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 6.6</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:38.53%;margin:0pt;padding:0pt;">Intangible assets, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,183,399</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (162,535)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,020,864</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.74%;margin:0pt;padding:0pt;"> 13.1</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr></table>

P2Y

P20Y

1467396000

174523000

1292873000

P14Y9M18D

P1Y6M

P5Y

5008000

P3Y

P15Y

326594000

38075000

288519000

P9Y8M12D

P3Y

200000

P3Y

P5Y

97779000

35717000

62062000

P2Y8M12D

P5Y

P7Y

342039000

53481000

288558000

P5Y10M24D

2239016000

307004000

1932012000

P12Y3M18D

P2Y

P20Y

1460648000

100844000

1359804000

P15Y4M24D

P1Y6M

P5Y

5097000

4872000

225000

P0Y4M24D

P3Y

P15Y

326786000

15576000

311210000

P10Y6M

P3Y

200000

P3Y

P5Y

52518000

24771000

27747000

P2Y9M18D

P5Y

P7Y

338150000

16272000

321878000

P6Y7M6D

2183399000

162535000

2020864000

P13Y1M6D

49600000

11700000

145300000

29600000

Note 7. GoodwillGoodwill consists of the following (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.6%;margin:0pt;padding:0pt;">As of September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.12%;margin:0pt;padding:0pt;">As of December 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.78%;margin:0pt;padding:0pt;">Beginning balance as of December 31, 2020 and 2019, respectively</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"> 14,581,255</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"> 746,079</td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.78%;margin:0pt;padding:0pt;">Additions associated with acquisitions</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"> 61,157</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"> 13,812,198</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.78%;margin:0pt;padding:0pt;">Purchase consideration adjustments (see Note 4)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"> (55,801)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:67.78%;margin:0pt;padding:0pt;">Deferred tax adjustments (see Note 4)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"> (101,536)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.78%;margin:0pt;padding:0pt;">Cumulative translation adjustment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (14,676)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 22,978</td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:67.78%;margin:0pt;padding:0pt;">Ending balance as of September 30, 2021 and December 31, 2020, respectively</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 14,470,399</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 14,581,255</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr></table>

Goodwill consists of the following (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.6%;margin:0pt;padding:0pt;">As of September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.12%;margin:0pt;padding:0pt;">As of December 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.78%;margin:0pt;padding:0pt;">Beginning balance as of December 31, 2020 and 2019, respectively</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"> 14,581,255</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"> 746,079</td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.78%;margin:0pt;padding:0pt;">Additions associated with acquisitions</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"> 61,157</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"> 13,812,198</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.78%;margin:0pt;padding:0pt;">Purchase consideration adjustments (see Note 4)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"> (55,801)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:67.78%;margin:0pt;padding:0pt;">Deferred tax adjustments (see Note 4)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"> (101,536)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.97%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.78%;margin:0pt;padding:0pt;">Cumulative translation adjustment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (14,676)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 22,978</td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:67.78%;margin:0pt;padding:0pt;">Ending balance as of September 30, 2021 and December 31, 2020, respectively</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 14,470,399</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.97%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 14,581,255</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td></tr></table>

14581255000

746079000

61157000

13812198000

-55801000

-101536000 0

-14676000

22978000

14470399000

14581255000

Note 8. Accrued Expenses and Other Current LiabilitiesAccrued expenses and other current liabilities consist of the following (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;">As of September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.64%;margin:0pt;padding:0pt;">As of December 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Professional fees</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 2,726</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 4,717</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Consulting fees/provider fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 16,253</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 23,167</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Client performance guarantees</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 8,817</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 7,215</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Interest payable</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 5,811</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 2,049</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Income tax payable</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 1,385</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 1,627</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 6,272</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 3,139</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Marketing</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 5,733</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 2,815</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Operating lease liabilities - current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 13,148</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 11,438</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Earnout</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 4,514</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Acquisition & Integration</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 4,212</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 1,036</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Franchise and Sales Taxes</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 5,802</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 2,099</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Device Replacement Cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 6,263</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Other</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 29,831</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 19,841</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 106,252</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 83,657</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr></table>

Accrued expenses and other current liabilities consist of the following (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.11%;margin:0pt;padding:0pt;">As of September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.64%;margin:0pt;padding:0pt;">As of December 31, </td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Professional fees</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 2,726</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 4,717</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Consulting fees/provider fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 16,253</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 23,167</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Client performance guarantees</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 8,817</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 7,215</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Interest payable</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 5,811</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 2,049</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Income tax payable</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 1,385</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 1,627</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 6,272</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 3,139</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Marketing</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 5,733</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 2,815</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Operating lease liabilities - current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 13,148</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 11,438</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Earnout</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 4,514</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Acquisition & Integration</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 4,212</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 1,036</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Franchise and Sales Taxes</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 5,802</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 2,099</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Device Replacement Cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;margin:0pt;padding:0pt;"> 6,263</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Other</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 29,831</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 19,841</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.71%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 106,252</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:11.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 83,657</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr></table>

2726000

4717000

16253000 23167000 8817000 7215000

5811000

2049000

1385000

1627000

6272000

3139000

5733000

2815000

13148000

11438000

0 4514000 4212000 1036000

5802000

2099000

6263000 0

29831000

19841000

106252000 83657000

Note 9. Fair Value Measurements The carrying value of the Company’s cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued liabilities approximates fair value due to their short-term nature.The Company measures its financial assets and liabilities at fair value at each reporting period using a fair value hierarchy that requires it to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value:Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.Level 2—Include other inputs that are directly or indirectly observable in the marketplace.Level 3—Unobservable inputs that are supported by little or no market activity.The Company measures its cash equivalents at fair value on a recurring basis. The Company classifies its cash equivalents within Level 1 because they are valued using observable inputs that reflect quoted prices for identical assets in active markets and quoted prices directly in active markets.The Company’s investments in equity securities without readily determinable fair values are accounted for under the measurement alternative of the FASB ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities, with any changes to fair value recognized within other expense (income), net each reporting period. Under the measurement alternative, equity investments without readily determinable fair values are carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar securities of the same issuer; value is generally determined based on a market approach as of the transaction date.The Company measures its short-term investments at fair value on a recurring basis and classifies such as Level 2. They are valued using observable inputs that reflect quoted prices directly or indirectly in active markets. The short-term investments amortized cost approximates fair value.The Company measured its contingent consideration at fair value on a recurring basis and classifies such as Level 3. The Company estimates the fair value of contingent consideration as the present value of the expected contingent payments, determined using the weighted probability of the possible payments.The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis using the above input categories (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:47.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, 2021</td></tr><tr><td style="vertical-align:bottom;width:50.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.22%;margin:0pt;padding:0pt;">Cash and cash equivalents</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 823,828</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 823,828</td></tr><tr><td style="vertical-align:bottom;width:50.22%;margin:0pt;padding:0pt;">Short-term investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,538</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,538</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:47.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">December 31, 2020</td></tr><tr><td style="vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;">Cash and cash equivalents</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 733,324</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 733,324</td></tr><tr><td style="vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;">Short-term investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 53,245</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 53,245</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;">Equity securities without readily determinable fair values</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,000</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,000</td></tr><tr><td style="vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;">Contingent liability </td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,514</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,514</td></tr></table>There were no transfers between fair value measurement levels during the quarters or nine months ended September 30, 2021 and 2020.The change in fair value of the Company’s equity securities without readily determinable fair values was as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Fair value and historical cost basis at December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 5,000</td></tr><tr><td style="vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Upward adjustment due to observable price change in identical securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 5,901</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Sale of investment</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (10,901)</td></tr><tr><td style="vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Fair value at September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td></tr></table>The change in fair value of the Company’s contingent liability is recorded in acquisition, integration and transformation costs in the consolidated statements of operations. The contingent liability is based on future revenue and profitability expectations. The following table reconciles the beginning and ending balance of the Company’s Level 3 contingent liability (in thousands): <table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Fair value at December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 4,514</td></tr><tr><td style="vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Payments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> (4,367)</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Change in fair value </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 0</td></tr><tr><td style="vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Currency translation adjustment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (147)</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Fair value at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td></tr></table>

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis using the above input categories (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:47.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, 2021</td></tr><tr><td style="vertical-align:bottom;width:50.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.22%;margin:0pt;padding:0pt;">Cash and cash equivalents</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 823,828</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 823,828</td></tr><tr><td style="vertical-align:bottom;width:50.22%;margin:0pt;padding:0pt;">Short-term investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,538</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,538</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:47.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">December 31, 2020</td></tr><tr><td style="vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;">Cash and cash equivalents</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 733,324</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 733,324</td></tr><tr><td style="vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;">Short-term investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 53,245</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 53,245</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;">Equity securities without readily determinable fair values</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,000</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,000</td></tr><tr><td style="vertical-align:bottom;width:50.15%;margin:0pt;padding:0pt;">Contingent liability </td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.83%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,514</td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,514</td></tr></table>

823828000

2538000

733324000

53245000

5000000

0 0 4514000 4514000

The change in fair value of the Company’s equity securities without readily determinable fair values was as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Fair value and historical cost basis at December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 5,000</td></tr><tr><td style="vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Upward adjustment due to observable price change in identical securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 5,901</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Sale of investment</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (10,901)</td></tr><tr><td style="vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Fair value at September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td></tr></table>

5000000

5901000

10901000

<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Fair value at December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 4,514</td></tr><tr><td style="vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Payments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> (4,367)</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Change in fair value </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"> 0</td></tr><tr><td style="vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Currency translation adjustment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (147)</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:85.1%;margin:0pt;padding:0pt;">Fair value at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td></tr></table>

4514000

4367000

-147000

Note 10. Leasing Operations The Company has operating leases for facilities, hosting co-location facilities and certain equipment under non-cancelable leases in the United States and various international locations. The leases have remaining lease terms of 1 to 7 years, with options to extend the lease term from 1 to 5 years. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the arrangement covering the right to use property, plant or equipment for a stated period of time. For new and amended leases beginning in 2020 and after, the Company will separately allocate the lease (e.g., fixed lease payments for right-to-use land, building, etc.) and non-lease components (e.g., common area maintenance) for its leases. Operating LeasesThe Company leases office space under non-cancelable operating leases in the United States and various international locations. As of September 30, 2021, the future minimum lease payments under non-cancelable operating leases were as follows (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;">As of</td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">Operating Leases:</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"> 14,594</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"> 14,872</td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">2023</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"> 10,927</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">2024</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"> 7,233</td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">2025</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"> 6,028</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">2026 and thereafter</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,997</td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">Total future minimum payments</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 67,651</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr></table>The Company rents its systems to certain qualified customers under arrangements that qualify as either sales-type lease or operating lease arrangements. Leases have terms that generally range from two to five years.

P1Y

P7Y

true

P1Y

P5Y

<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;margin:0pt;padding:0pt;">As of</td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">Operating Leases:</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"> 14,594</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"> 14,872</td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">2023</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"> 10,927</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">2024</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"> 7,233</td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">2025</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;margin:0pt;padding:0pt;"> 6,028</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">2026 and thereafter</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,997</td><td style="vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.07%;margin:0pt;padding:0pt;">Total future minimum payments</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.13%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 67,651</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.49%;margin:0pt;padding:0pt;"></td></tr></table>

14594000

14872000

10927000

7233000

6028000

13997000

67651000

P5Y

Note 11. Convertible Senior NotesOutstanding Convertible Senior NotesAs of September 30, 2021, the Company had three series of convertible senior notes outstanding. The issuances of such notes originally consisted of (i) $1 billion aggregate principal amount of 1.25% convertible senior notes due 2027 (the “2027 Notes”), issued on May 19, 2020 for net proceeds to the Company of $975.9 million after deducting offering costs of approximately $24.1 million, (ii) $287.5 million aggregate principal amount of 1.375% convertible senior notes due 2025 (the “2025 Notes”), issued on May 8, 2018 for net proceeds to the Company of $279.1 million after deducting offering costs of approximately $8.4 million, and (iii) $550.0 million aggregate principal amount of 0.875% convertible senior notes due 2025 that were issued by Livongo on June 4, 2020 for which the Company has agreed to guarantee Livongo’s obligations (the “Livongo Notes;” and together with the 2027 Notes, the 2025 Notes and the 2022 Notes (as defined below), the “Notes”). On June 27, 2017, the Company issued, at par value, $275 million aggregate principal amount of 3% convertible senior notes due 2022 (the “2022 Notes”), which were redeemed during the quarter ended March 31, 2021 as described below.The following table presents certain terms of the Notes that were outstanding as of September 30, 2021:<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.19%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2027 Notes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2025 Notes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Livongo Notes</td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Interest Rate Per Year</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;"> 1.25</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;">% </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;"> 1.375</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;">% </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"> 0.875</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Fair Value as of September 30, 2021 (in millions)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;"> 970.5</td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;"> 2.1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"> 710.6</td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Maturity Date</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;">June 1, 2027</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;">May 15, 2025</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;">June 1, 2025</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Optional Redemption Date</td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;">June 5, 2024</td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;">May 22, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;">June 5, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Conversion Date</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;">December 1, 2026</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;">November 15, 2024</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;">March 1, 2025</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Conversion Rate Per $1,000 Principal Amount as of September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;"> 4.1258</td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;"> 18.6621</td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"> 13.94</td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Remaining Contractual Life as of September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;">5.7 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;">3.6 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;">3.7 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr></table>All of the Notes are unsecured obligations of the Company and rank senior in right of payment to the Company’s indebtedness that is expressly subordinated in right of payment to such Notes; equal in right of payment to the Company’s liabilities that are not so subordinated; effectively junior in right of payment to any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities incurred by the Company’s subsidiaries.Holders may convert all or any portion of their Notes in integral multiples of $1,000 principal amount, at their option, at any time prior to the close of business on the business day immediately preceding the applicable conversion date only under the following circumstances:<div style="margin-top:10pt;"/><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">during any quarter (and only during such quarter), if the last reported sale price of the shares of Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding quarter is greater than or equal to 130% of the conversion price for the applicable Notes on each applicable trading day; </td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:10pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">during the five business day period after any ten consecutive trading day period (or five consecutive trading day period in the case of the Livongo Notes) in which the trading price was less than 98% of the product of the last reported sale price of Company’s common stock and the conversion rate for the applicable Notes on each such trading day; </td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:10pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">upon the occurrence of specified corporate events described under the applicable indenture; or</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:10pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">if the Company calls the applicable Notes for redemption, at any time until the close of business on the second business day immediately preceding the redemption date.</td></tr></table>On or after the applicable conversion date, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of such Notes, regardless of the foregoing circumstances.The 2027 Notes and the 2025 Notes are convertible into shares of the Company’s common stock at the applicable conversion rate shown in the table above. The Livongo Notes are convertible at the applicable conversion rate shown in the table above into “units of reference property,” each of which is comprised of 0.5920 of a share of the Company’s common stock and $4.24 in cash, without interest. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s common stock (or units of reference property, in the case of the Livongo Notes) or a combination thereof, at the Company’s election. If the Company elects to satisfy the conversion obligation solely in cash or through payment and delivery, as the case may be, of a combination of cash and shares of the Company’s common stock or units of reference property, the amount of cash and shares of the Company’s common stock or units of reference property, if any, due upon conversion will be based on a daily conversion value calculated on a proportionate basis for each trading day in a 25 consecutive trading days observation period (or 40 days in the case of the Livongo Notes).The Company may redeem for cash all or part of the Notes, at its option, on or after the applicable optional redemption date shown in the table above (and prior to the 41st scheduled trading day immediately preceding the maturity date in the case of the Livongo Notes) if the last reported sale price of its common stock exceeds 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading days ending on, and including, the trading day immediately preceding the date on which the Company provides notice of the redemption. The redemption price will be the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any. In addition, calling any 2027 Note or 2025 Note for redemption on or after the applicable optional redemption date will constitute a make-whole fundamental change with respect to that Note, in which case the conversion rate applicable to the conversion of that Note, if it is converted in connection with the redemption, will be increased in certain circumstances as described in the applicable indenture. If Livongo undergoes a fundamental change (as defined in the applicable indenture) at any time prior to the maturity date, holders will have the right, at their option, to require Livongo to repurchase for cash all or any portion of their Livongo Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Livongo Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.In accounting for the issuance of the 2027 Notes, 2025 Notes and the 2022 Notes, the Company separated the Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of a similar liability that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the applicable Notes as a whole. The excess of the principal amount of the liability component over its carrying amount, referred to as the debt discount, is amortized to interest expense from the issuance date to the applicable maturity date. The equity component is not re-measured as long as it continues to meet the conditions for equity classification. The equity component related to the 2027 Notes, 2025 Notes and 2022 Notes was $286 million, $91.4 million and $62.4 million, respectively, net of issuance costs which were recorded in additional paid-in capital on the accompanying condensed consolidated balance sheet. The Company carries the liability component of the Livongo Notes at face value less unamortized debt discount on its condensed consolidated balance sheets and provides the fair value for disclosure purposes only. The Company has reserved an aggregate of 8.7 million shares of common stock for the Notes.In accounting for the transaction costs related to the issuance of the 2027 Notes, 2025 Notes and 2022 Notes, the Company allocated the total costs incurred to the liability and equity components of the Notes based on their relative values. Transaction costs attributable to the liability component are being amortized to interest expense over the seven-year term of the Notes (or five-and-a-half year term in the case of the 2022 Notes), and transaction costs attributable to the equity component are netted with the equity components in stockholders’ equity.The liability components of the Notes consist of the following (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.62%;margin:0pt;padding:0pt;">As of September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.14%;margin:0pt;padding:0pt;">As of December 31, </td></tr><tr><td style="vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">2027 Notes</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Principal</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.87%;margin:0pt;padding:0pt;"> 1,000,000</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.44%;margin:0pt;padding:0pt;"> 1,000,000</td></tr><tr><td style="vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Less: Debt discount, net (1)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (260,324)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (287,916)</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Net carrying amount</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 739,676</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 712,084</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">2025 Notes </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.87%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Principal</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.87%;margin:0pt;padding:0pt;"> 882</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.44%;margin:0pt;padding:0pt;"> 276,788</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Less: Debt discount, net (1)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (215)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (65,923)</td></tr><tr><td style="vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Net carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 667</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 210,865</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:67.8%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.87%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Livongo Notes </td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Principal</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.87%;margin:0pt;padding:0pt;"> 550,000</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.44%;margin:0pt;padding:0pt;"> 550,000</td></tr><tr><td style="vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Less: Debt discount, net (1)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (78,968)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (93,357)</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Net carrying amount</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 471,032</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 456,643</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.8%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">2022 Notes</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.87%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Principal</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.87%;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.44%;margin:0pt;padding:0pt;"> 46,762</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Less: Debt discount, net (1)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (4,202)</td></tr><tr><td style="vertical-align:bottom;width:67.8%;margin:0pt;padding:0pt;">Net carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.87%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.69%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 42,560</td></tr></table><div style="margin-top:10pt;"/><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;">Included in the accompanying consolidated balance sheet within convertible senior notes and amortized to interest expense over the expected life of the Notes using the effective interest rate method.</td></tr></table>The Company estimates the fair value of its Notes utilizing market quotations for debt that have quoted prices in active markets. Since the Notes do not trade on a daily basis in an active market, the fair value estimates are based on market observable inputs based on borrowing rates currently available for debt with similar terms and average maturities. The following table sets forth total interest expense recognized related to the Notes (and in the case of the Livongo Notes, subsequent to the acquisition of Livongo) (in thousands): <table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:96.6%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.08%;margin:0pt;padding:0pt;">Quarters Ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:21.95%;margin:0pt;padding:0pt;">Nine Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:21.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">2027 Notes:</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Contractual interest expense</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 3,125</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 3,125</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 9,375</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 4,618</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Amortization of debt discount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 9,370</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,989</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 27,592</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 12,911</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Total</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,495</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,114</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 36,967</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 17,529</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Effective interest rate of the liability component</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 3.4</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 3.4</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 3.4</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 3.4</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.08%;margin:0pt;padding:0pt;">Quarters Ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.59%;margin:0pt;padding:0pt;">Nine Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">2025 Notes:</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Contractual interest expense</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 10</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 971</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 1,080</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 2,947</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Amortization of debt discount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 48</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,170</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,546</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 9,379</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Total</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 58</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,141</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,626</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,326</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Effective interest rate of the liability component</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 4.7</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 7.9</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 4.7</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 7.9</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.8%;margin:0pt;padding:0pt;">Quarters Ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.16%;margin:0pt;padding:0pt;">Nine Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Livongo Notes:</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021 </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Contractual interest expense</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 1,203</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 3,609</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Amortization of debt discount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,858</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 14,389</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Total</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,061</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 17,998</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Effective interest rate of the liability component</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 5.2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 5.2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.08%;margin:0pt;padding:0pt;">Quarters Ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.59%;margin:0pt;padding:0pt;">Nine Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">2022 Notes:</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Contractual interest expense</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 351</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 116</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 3,696</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Amortization of debt discount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 650</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 316</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,940</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Total</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,001</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 432</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 10,636</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Effective interest rate of the liability component</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 10.0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 3.0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 10.0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td></tr></table>Exchanges and Conversions of Convertible Senior Notes Due 2025In August 2021, the Company entered into privately negotiated agreements with certain holders of the 2025 Notes to exchange approximately $5.1 million aggregate principal amount of 2025 Notes for an aggregate of 95,347 shares of the Company’s common stock in private placement transactions pursuant to Section 4(a)(2) of the Securities Act. In addition, certain holders of the 2025 Notes converted their 2025 Notes in exchange for approximately 5.2 million shares of the Company’s common stock during the nine months ended September 30, 2021. As a result of the exchanges and conversions, the Company recorded a charge associated with the loss on extinguishment of debt net of transaction fees of $0.8 million and $40.3 million during the quarter and nine months ended September 30, 2021, respectively.Redemption and Conversions of Convertible Senior Notes Due 2022In March 2021, the Company completed a redemption of all of the then outstanding 2022 Notes in exchange for approximately $0.1 million in cash (including accrued and unpaid interest). Prior to that redemption, certain holders of the 2022 Notes converted their 2022 Notes in exchange for 1.1 million shares of the Company’s common stock during the quarter ended March 31, 2021. As a result of the redemption and conversions, the Company recorded a charge associated with the loss on extinguishment of debt of $3.4 million during the quarter ended March 31, 2021.

1000000000

0.0125

975900000

24100000

287500000

0.01375

279100000

8400000

550000000.0

0.00875

275000000

0.03

<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:42.19%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2027 Notes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:18.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2025 Notes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Livongo Notes</td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Interest Rate Per Year</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;"> 1.25</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;">% </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;"> 1.375</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;">% </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"> 0.875</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;">%</td></tr><tr><td style="vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Fair Value as of September 30, 2021 (in millions)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;"> 970.5</td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;"> 2.1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"> 710.6</td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Maturity Date</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;">June 1, 2027</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;">May 15, 2025</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;">June 1, 2025</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Optional Redemption Date</td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;">June 5, 2024</td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;">May 22, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;">June 5, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Conversion Date</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;">December 1, 2026</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;">November 15, 2024</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;">March 1, 2025</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Conversion Rate Per $1,000 Principal Amount as of September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;"> 4.1258</td><td style="vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;"> 18.6621</td><td style="vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;"> 13.94</td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:42.19%;margin:0pt;padding:0pt;">Remaining Contractual Life as of September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:16.36%;margin:0pt;padding:0pt;">5.7 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.75%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:17.68%;margin:0pt;padding:0pt;">3.6 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.85%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:13.16%;margin:0pt;padding:0pt;">3.7 years</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"></td></tr></table>The liability components of the Notes consist of the following (in thousands):

0.0125

0.01375

0.00875

970500000

2100000

710600000

1000 P5Y8M12D P3Y7M6D P3Y8M12D 1000

1.30

5 10 5 0.98 0.5920 4.24 25 40

1.30

100

286000000

91400000

62400000

8700000

P7Y

1000000000

260324000

287916000

739676000

712084000

882000

276788000

215000

65923000

667000

210865000

550000000

78968000

93357000

471032000

456643000

46762000

4202000

42560000

The following table sets forth total interest expense recognized related to the Notes (and in the case of the Livongo Notes, subsequent to the acquisition of Livongo) (in thousands): <table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:96.6%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.08%;margin:0pt;padding:0pt;">Quarters Ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:21.95%;margin:0pt;padding:0pt;">Nine Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:21.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">2027 Notes:</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Contractual interest expense</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 3,125</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 3,125</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 9,375</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 4,618</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Amortization of debt discount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 9,370</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,989</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 27,592</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 12,911</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Total</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,495</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,114</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 36,967</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 17,529</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Effective interest rate of the liability component</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 3.4</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 3.4</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 3.4</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 3.4</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.08%;margin:0pt;padding:0pt;">Quarters Ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.59%;margin:0pt;padding:0pt;">Nine Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">2025 Notes:</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Contractual interest expense</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 10</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 971</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 1,080</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 2,947</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Amortization of debt discount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 48</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,170</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,546</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 9,379</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Total</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 58</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,141</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,626</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,326</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Effective interest rate of the liability component</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 4.7</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 7.9</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 4.7</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 7.9</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.8%;margin:0pt;padding:0pt;">Quarters Ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:15.16%;margin:0pt;padding:0pt;">Nine Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Livongo Notes:</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021 </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Contractual interest expense</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 1,203</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 3,609</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Amortization of debt discount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,858</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 14,389</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Total</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,061</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 17,998</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Effective interest rate of the liability component</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 5.2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 5.2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.08%;margin:0pt;padding:0pt;">Quarters Ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.59%;margin:0pt;padding:0pt;">Nine Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:45.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.08%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:23.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">2022 Notes:</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Contractual interest expense</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 351</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 116</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 3,696</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Amortization of debt discount</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 650</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 316</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,940</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Total</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.59%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.2%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,001</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 432</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 10,636</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:45.84%;margin:0pt;padding:0pt;">Effective interest rate of the liability component</td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.2%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 10.0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.67%;margin:0pt;padding:0pt;"> 3.0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.36%;margin:0pt;padding:0pt;"> 10.0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;">% </td></tr></table>

3125000

9375000

4618000

9370000

8989000

27592000

12911000

12495000

12114000

36967000

17529000

0.034

10000

971000

1080000

2947000

48000

3170000

4546000

9379000

58000

4141000

5626000

12326000

0.047

0.079

0.047

0.079

1203000

3609000

4858000

14389000

6061000

17998000

0.052

351000 116000 3696000

650000

316000

6940000

1001000

432000

10636000

0.100

0.030

0.100

5100000

95347

5200000

-800000

-40300000

100000

1100000

-3400000

Note 12. Advances from Financing CompaniesThe Company utilizes a third-party financing company to provide certain Clients with a rental option. The principal portion of these up-front payments are reported as advances from financing companies in the accompanying consolidated balance sheet. Interest rates applicable to the outstanding advances as of September 30, 2021 ranged from 3.35% to 9.89%. Client lease payments to third party financing companies will reduce the advances from financing companies as of September 30, 2021 by year as follows (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.75%;margin:0pt;padding:0pt;">As of September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;">$ </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> 3,763</td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;">2022</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> 11,718</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> 5,491</td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;">2024</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,031</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 22,003</td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr></table> 0.0335 0.0989 Client lease payments to third party financing companies will reduce the advances from financing companies as of September 30, 2021 by year as follows (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.75%;margin:0pt;padding:0pt;">As of September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:16.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;">$ </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> 3,763</td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;">2022</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> 11,718</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;">2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> 5,491</td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;">2024</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,031</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:78.71%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.95%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 22,003</td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"></td></tr></table> 3763000 11718000 5491000 1031000 22003000

Note 13. Legal MattersFrom time to time, Teladoc Health is involved in various litigation matters arising in the normal course of business, including the matters described below. The Company consults with legal counsel on those issues related to litigation and seeks input from other experts and advisors with respect to such matters. Estimating the probable losses or a range of probable losses resulting from litigation, government actions and other legal proceedings is inherently difficult and requires an extensive degree of judgment, particularly where the matters involve indeterminate claims for monetary damages, may involve discretionary amounts, present novel legal theories, are in the early stages of the proceedings, or are subject to appeal. Whether any losses, damages or remedies ultimately resulting from such matters could reasonably have a material effect on our business, financial condition, results of operations, or cash flows will depend on a number of variables, including, for example, the timing and amount of such losses or damages (if any) and the structure and type of any such remedies. As of the date of these financial statements, Teladoc Health’s management does not expect any litigation matter to have a material adverse impact on its business, financial condition, results of operations or cash flows.On May 14, 2018, a purported class action complaint (Thomas v. Best Doctors, Inc.) was filed in the United States District Court for the District of Massachusetts against the Company’s wholly owned subsidiary, Best Doctors, Inc. The complaint alleges that on or about May 16, 2017, Best Doctors violated the U.S. Telephone Consumer Protection Act (the “TCPA”) by sending unsolicited facsimiles to plaintiff and certain other recipients without the recipients’ prior express invitation or permission. The lawsuit seeks statutory damages for each violation, subject to trebling under the TCPA, and injunctive relief. The Company will vigorously defend the lawsuit and any potential loss is currently deemed to be immaterial.On December 12, 2018, a purported securities class action complaint (Reiner v. Teladoc Health, Inc., et.al.) was filed in the United States District Court for the Southern District of New York (the “SDNY”) against the Company and certain of the Company’s officers and a former officer. The complaint is brought on behalf of a purported class consisting of all persons or entities who purchased or otherwise acquired shares of the Company’s common stock during the period March 3, 2016 through December 5, 2018. The complaint asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegedly false or misleading statements and omissions with respect to, among other things, the alleged misconduct of one of the Company’s previous executive officers. The complaint seeks certification as a class action and unspecified compensatory damages plus interest and attorneys’ fees. On November 30, 2020, the SDNY granted the Company’s motion to dismiss the complaint, but granted the plaintiff the opportunity to refile, which refiling was made on December 30, 2020. The Company subsequently filed a motion to dismiss the lawsuit, which was granted with prejudice by the SDNY on September 29, 2021.In addition, on June 21, 2019, a stockholder derivative lawsuit (Kreutter v. Gorevic, et al.) was filed in the SDNY against certain current and former directors and officers of the Company. The derivative lawsuit alleges that the named directors and officers breached their fiduciary duties to the Company in connection with factual assertions substantially similar to those in the purported securities class action complaint described above. On September 17, 2021, the Company’s motion to dismiss the lawsuit was granted with prejudice by the SDNY.On August 27, 2021, a purported securities class action complaint (City of Hialeah Employees’ Retirement System v. Teladoc Health, Inc., et.al.) was filed in the Circuit Court of Cook County, Illinois against the Company and certain of the Company’s current and former officers and directors. The complaint is brought on behalf of a purported class consisting of all persons who acquired shares of Teladoc Health common stock issued in the Livongo merger. The complaint asserts violations of Sections 11, 12(a)(2) and 15 of the Securities Act of 1933 based on allegedly false or misleading statements and omissions with respect to the registration statement and prospectus filed in connection with the Livongo merger. The complaint seeks certification as a class action, unspecified compensatory damages plus interest and attorneys’ fees, rescission or a rescissory measure of damages and equitable or other relief. The Company believes that these claims are without merit, and the Company and its named current and former officers and directors intend to defend the Company vigorously.

Note 14. Common Stock and Stockholders’ Equity CapitalizationEffective October 30, 2020, the authorized number of shares of the Company’s common stock was increased from 150,000,000 to 300,000,000 shares.WarrantsThe Company had no warrants outstanding as of September 30, 2021 or December 31, 2020. Stock PlansThe Company’s 2015 Incentive Award Plan, 2017 Employment Inducement Incentive Award Plan and Livongo Acquisition Incentive Award Plan (collectively, the “Plans”) provide for the issuance of incentive and non-statutory options and other equity-based awards to its employees and non-employee service providers.In connection with the closing of the Livongo merger, the Company assumed the Livongo Health, Inc. 2019 Equity Incentive Plan, the Livongo Health, Inc. Amended and Restated 2014 Stock Incentive Plan and the Livongo Health, Inc. Amended and Restated 2008 Stock Incentive Plan (collectively, the “Assumed Plans”). At the effective time of the Livongo merger on October 30, 2020, each outstanding Livongo equity award issued under the Assumed Plans was converted into a corresponding award with respect to the Company’s common stock, with the number of shares underlying such award adjusted based on the “Equity Award Adjustment Ratio” (as defined below), and remained outstanding in accordance with the terms that were applicable to such award prior to the Livongo merger. The exercise price of each outstanding Livongo stock option was also adjusted based on the Equity Award Adjustment Ratio. The “Equity Award Adjustment Ratio” means the quotient determined by dividing (i) the volume weighted average closing price of Livongo common stock on the four trading days ending on October 29, 2020, by (ii) the volume weighted average closing price of the Company’s common stock on the New York Stock Exchange on the four trading days beginning on October 29, 2020.All stock-based awards to employees are measured based on the grant-date fair value or replacement grant date fair value in relation to the Livongo transaction, and are generally recognized on a straight line basis in the Company’s consolidated statement of operations over the period during which the employee is required to perform services in exchange for the award (generally requiring a four-year vesting period for each stock option and a three-year vesting period for each restricted stock unit (“RSU”)).Stock OptionsOptions issued under the Plans are exercisable for periods not to exceed ten years, and vest and contain such other terms and conditions as specified in the applicable award document. Options to buy common stock are issued under the Plans, with exercise prices equal to the closing price of shares of the Company’s common stock on the New York Stock Exchange on the date of award. The Company had 12,574,026 shares available for grant at September 30, 2021.Activity under the Plans was as follows (in thousands, except share and per share amounts and years):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">Weighted-</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;">Weighted-</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">Average</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;">Number of</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;">Average</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">Remaining</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;">Aggregate</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;">Shares</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;">Exercise</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">Contractual</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;">Intrinsic</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Outstanding</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Price</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Life in Years</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Value</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Balance at December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"> 5,826,685</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 17.19</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> 5.31</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,064,944</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Stock option grants</td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"> 35,740</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 162.38</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Stock options exercised</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"> (2,120,943)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 10.79</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">N/A</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> (409,182)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Stock options forfeited</td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (90,583)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 30.03</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Balance at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,650,899</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 21.96</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> 5.57</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 386,390</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Vested or expected to vest at September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,650,899</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 21.96</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> 7.10</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 35,607</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Exercisable at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,243,849</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 18.84</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> 5.37</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 350,848</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr></table>The total grant-date fair value of stock options granted during the quarters ended September 30, 2021 and 2020 were $3.0 million and $10.7 million, respectively. The total grant-date fair value of stock options granted during the nine months ended September 30, 2021 and 2020 were $5.8 million and $11.2 million, respectively.The Company estimates the fair value of stock options granted using the Black Scholes option pricing model.The assumptions used in the Black-Scholes option-pricing model are determined as follows:Volatility. The expected volatility was derived from the historical stock volatilities of the Company’s stock volatility over a period equivalent to the expected term of the stock option grants.Expected Term. The expected term represents the period that the stock-based awards are expected to be outstanding. When establishing the expected term assumption, the Company utilizes historical data.Risk-Free Interest Rate. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with terms similar to the expected term on the options.Dividend Yield. The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, it used an expected dividend yield of zero.Forfeiture rate. The Company recognizes forfeitures as they occur.The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions and fair value per share:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Nine Months Ended September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;">Volatility</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;">56.52% - 58.14%</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;">46.1% - 56.0%</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;">Expected term (in years)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;">4.1</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;">4.1</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;">Risk-free interest rate</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;">0.31% - 0.70%</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;">0.27%-1.64%</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;">Dividend yield</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;">0</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;">0</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;">Weighted-average fair value of underlying stock options</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;">72.46</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;">49.21</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr></table>The Company determined that a Monte Carlo valuation model is most suitable for valuation of options for the replaced and replacement awards from the Livongo merger, for the following reasons: <table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Options are deeply in-the-money, as such don’t qualify as “plain-vanilla” options.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">With the merger, the exercise pattern of the replaced and replacement options might be different from a regular “plain-vanilla” option that assumes the exercise of the option at the end of the option expiration time. A lattice approach can be used to directly model the effect of different expected periods before exercise on the fair-value-based measure of the option, whereas it is assumed under the Black-Scholes-Merton model that exercise occurs at the end of the option’s expected term.</td></tr></table><div style="margin-top:8pt;"/>For the quarters ended September 30, 2021 and 2020, the Company recorded compensation expense related to stock options of $23.3 million and $3.4 million, respectively. For the nine months ended September 30, 2021 and 2020, the Company recorded compensation expense related to stock options granted of $77.1 million and $11.5 million, respectively.As of September 30, 2021, the Company had $40.4 million in unrecognized compensation cost related to non-vested stock options, which is expected to be recognized over a weighted-average period of approximately 0.9 years.Restricted Stock UnitsThe fair value of RSUs is determined on the date of grant. The Company records compensation expense in the consolidated statement of operations on a straight-line basis over the vesting period for RSUs. The vesting period for employees and members of the Board of Directors ranges from one to four years.Activity under RSUs was as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.16%;margin:0pt;padding:0pt;">Weighted-Average</td></tr><tr><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.16%;margin:0pt;padding:0pt;">Grant Date</td></tr><tr><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">RSUs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Fair Value Per RSU</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Balance at December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.49%;margin:0pt;padding:0pt;"> 3,550,595</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 162.11</td></tr><tr><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Granted</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;margin:0pt;padding:0pt;"> 650,335</td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 192.86</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Vested and issued</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.49%;margin:0pt;padding:0pt;"> (1,222,550)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 131.65</td></tr><tr><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Forfeited</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (681,510)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 183.98</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Balance at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,296,870</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 175.60</td></tr><tr><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Vested and unissued at September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 13,755</td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 50.90</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Non-vested at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,283,115</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 175.60</td></tr></table>The total grant-date fair value of RSUs granted during the quarters ended September 30, 2021 and 2020 were $23.1 million and $11.9 million, respectively. The total grant-date fair value of RSUs granted during the nine months ended September 30, 2021 and 2020 were $125.0 million and $54.9 million, respectively.For the quarters ended September 30, 2021 and 2020, the Company recorded stock-based compensation expense related to RSUs of $42.8 million and $11.3 million, respectively. For the nine months ended September 30, 2021 and 2020, the Company recorded stock-based compensation expense related to RSUs of $142.6 million and $32.0 million, respectively.As of September 30, 2021, the Company had $343.6 million in unrecognized compensation cost related to non-vested RSUs, which is expected to be recognized over a weighted-average period of approximately 2.2 years.Performance Stock UnitsStock-based compensation costs associated with our performance stock units (“PSUs”) are initially determined using the fair market value of the Company's common stock on the date the awards are approved by the Compensation Committee of the Board of Directors (service inception date). The vesting of these PSUs is subject to certain performance conditions and a service requirement ranging from 1-3 years. Until the performance conditions are met, stock compensation costs associated with these PSUs are re-assessed each reporting period based upon the estimated performance attainment on the reporting date. The ultimate number of PSUs that are issued to an employee is the result of the actual performance of the Company at the end of the performance period compared to the performance conditions and can range from 50% to 225% of the initial grant. Stock compensation expense for PSUs is recognized on an accelerated tranche by tranche basis for performance-based awards. Forfeitures are accounted for at the time they occur consistent with Company policy. Activity under PSUs was as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.97%;margin:0pt;padding:0pt;">Weighted-Average</td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.97%;margin:0pt;padding:0pt;">Grant Date</td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Shares</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Fair Value Per PSU</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Balance at December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 429,319</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 76.60</td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Granted</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 531,309</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 132.66</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Vested and issued</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> (268,201)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 74.33</td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Forfeited</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (26,730)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 153.05</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Balance at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 665,697</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 119.07</td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Vested and unissued at September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 0</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Non-vested at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 665,697</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 119.07</td></tr></table>The total grant-date fair value of PSUs granted during the quarter ended September 30, 2021 was $2.5 million and no PSUs were granted during the quarter ended September 30, 2020. The total grant-date fair value of PSUs granted during the nine months ended September 30, 2021 and 2020 were $70.4 million and $13.1 million, respectively.For the quarters ended September 30, 2021 and 2020, the Company recorded stock-based compensation expense related to PSUs of $4.2 million and $5.9 million, respectively. For the nine months ended September 30, 2021 and 2020, the Company recorded stock-based compensation expense related to PSUs of $16.7 million and $16.8 million, respectively.As of September 30, 2021, the Company had $22.5 million in unrecognized compensation cost related to non-vested PSUs, which is expected to be recognized over a weighted-average period of approximately 2.4 years.Employee Stock Purchase PlanIn July 2015, the Company adopted the 2015 Employee Stock Purchase Plan (“ESPP”) in connection with its initial public offering. A total of 926,109 shares of common stock were reserved for issuance under this plan as of September 30, 2021. The Company’s ESPP permits eligible employees to purchase common stock at a discount through payroll deductions during defined offering periods. Under the ESPP, the Company may specify offerings with durations of not more than 27 months and may specify shorter purchase periods within each offering. Each offering will have one or more purchase dates on which shares of its common stock will be purchased for employees participating in the offering. An offering may be terminated under certain circumstances. The price at which the stock is purchased is equal to the lower of 85% of the fair market value of the common stock at the beginning of an offering period or on the date of purchase.During the quarters ended September 30, 2021 and 2020, the Company did not issue any shares under the ESPP. During the nine months ended September 30, 2021 and 2020, the Company issued 82,088 shares and 35,901 shares, respectively under the ESPP. As of September 30, 2021, 517,015 shares remained available for issuance.For the quarters ended September 30, 2021 and 2020, the Company recorded stock-based compensation expense related to the ESPP of $1.4 million and $0.6 million, respectively. For the nine months ended September 30, 2021 and 2020, the Company recorded stock-based compensation expense related to the ESPP of $4.6 million and $1.4 million, respectively.As of September 30, 2021, the Company had $0.6 million in unrecognized compensation cost related to the ESPP, which is expected to be recognized over a weighted-average period of approximately 0.1 year.Total compensation costs for stock-based awards were recorded as follows (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;">Quarter Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:19.42%;margin:0pt;padding:0pt;">Nine Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:19.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:19.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;">Cost of revenue (exclusive of depreciation and amortization, which is shown separately)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.76%;margin:0pt;padding:0pt;"> 2,162</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"> 128</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 6,310</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 128</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;">Advertising and marketing</td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.76%;margin:0pt;padding:0pt;"> 5,244</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"> 1,644</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 15,141</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 4,447</td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;">Sales</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.76%;margin:0pt;padding:0pt;"> 17,518</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"> 3,275</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 57,638</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 9,465</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;">Technology and development</td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.76%;margin:0pt;padding:0pt;"> 22,910</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"> 2,622</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 77,335</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 7,285</td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;">General and administrative</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 23,867</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,239</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 84,547</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 39,826</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;">Total stock-based compensation expense (1)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 71,701</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 20,908</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 240,971</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 61,151</td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;">Excluding the amount capitalized related to internal software development projects.</td></tr></table>

150000000

300000000

P4Y

P3Y

P10Y

12574026

Activity under the Plans was as follows (in thousands, except share and per share amounts and years):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">Weighted-</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;">Weighted-</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">Average</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;">Number of</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;">Average</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">Remaining</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;">Aggregate</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;">Shares</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;">Exercise</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">Contractual</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;">Intrinsic</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Outstanding</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Price</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Life in Years</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Value</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Balance at December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"> 5,826,685</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 17.19</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> 5.31</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 1,064,944</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Stock option grants</td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"> 35,740</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 162.38</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Stock options exercised</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"> (2,120,943)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 10.79</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">N/A</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> (409,182)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Stock options forfeited</td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (90,583)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 30.03</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">N/A</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Balance at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,650,899</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 21.96</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> 5.57</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 386,390</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Vested or expected to vest at September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,650,899</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 21.96</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> 7.10</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 35,607</td><td style="vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.07%;margin:0pt;padding:0pt;">Exercisable at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.08%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,243,849</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 18.84</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> 5.37</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.69%;margin:0pt;padding:0pt;"> 350,848</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.41%;margin:0pt;padding:0pt;"></td></tr></table>

5826685

17.19

P5Y3M21D

1064944000

35740

162.38

2120943

10.79

409182000

90583

30.03

3650899

21.96

P5Y6M25D

386390000

3650899

21.96

P7Y1M6D

35607000

3243849

18.84

P5Y4M13D

350848000

3000000.0 10700000 5800000 11200000

<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Nine Months Ended September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:15.45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;">Volatility</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;">56.52% - 58.14%</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;">46.1% - 56.0%</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;">Expected term (in years)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;">4.1</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;">4.1</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;">Risk-free interest rate</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;">0.31% - 0.70%</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;">0.27%-1.64%</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;">Dividend yield</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;">0</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;">0</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:65.84%;margin:0pt;padding:0pt;">Weighted-average fair value of underlying stock options</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:14.42%;margin:0pt;padding:0pt;">72.46</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.03%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;">49.21</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td></tr></table>

0.5652

0.5814

0.461

0.560

P4Y1M6D

0.0031

0.0070

0.0027

0.0164

72.46 49.21

23300000

3400000

77100000

11500000

40400000

P0Y10M24D

P4Y

Activity under RSUs was as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.16%;margin:0pt;padding:0pt;">Weighted-Average</td></tr><tr><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.16%;margin:0pt;padding:0pt;">Grant Date</td></tr><tr><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">RSUs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Fair Value Per RSU</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Balance at December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.49%;margin:0pt;padding:0pt;"> 3,550,595</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 162.11</td></tr><tr><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Granted</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;margin:0pt;padding:0pt;"> 650,335</td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 192.86</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Vested and issued</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.49%;margin:0pt;padding:0pt;"> (1,222,550)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 131.65</td></tr><tr><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Forfeited</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (681,510)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 183.98</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Balance at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,296,870</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 175.60</td></tr><tr><td style="vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Vested and unissued at September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 13,755</td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 50.90</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:68.88%;margin:0pt;padding:0pt;">Non-vested at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.49%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,283,115</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.72%;margin:0pt;padding:0pt;"> 175.60</td></tr></table>

3550595

162.11

650335

192.86 1222550 131.65

681510

183.98

2296870

175.60 13755 50.90

2283115

175.60

23100000 11900000 125000000.0 54900000

42800000

11300000

142600000

32000000.0

343600000

P2Y2M12D

P1Y

P3Y

0.50 2.25 Activity under PSUs was as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.97%;margin:0pt;padding:0pt;">Weighted-Average</td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.97%;margin:0pt;padding:0pt;">Grant Date</td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Shares</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Fair Value Per PSU</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Balance at December 31, 2020</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 429,319</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 76.60</td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Granted</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 531,309</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 132.66</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Vested and issued</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> (268,201)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 74.33</td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Forfeited</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (26,730)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 153.05</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Balance at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 665,697</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 119.07</td></tr><tr><td style="vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Vested and unissued at September 30, 2021</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 0</td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 0</td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:69.01%;margin:0pt;padding:0pt;">Non-vested at September 30, 2021</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 665,697</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.52%;margin:0pt;padding:0pt;"> 119.07</td></tr></table>

429319

76.60

531309

132.66 268201 74.33

26730

153.05

665697

119.07 0 0

665697

119.07

2500000

70400000 13100000

4200000

5900000

16700000

16800000

22500000

P2Y4M24D

926109

P27M

0.85

82088

35901

517015

1400000

600000

4600000

1400000

600000

P0Y1M6D

Total compensation costs for stock-based awards were recorded as follows (in thousands):<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:19.65%;margin:0pt;padding:0pt;">Quarter Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:19.42%;margin:0pt;padding:0pt;">Nine Months Ended </td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:19.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:19.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">September 30, </td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2021</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"> </td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">2020</td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;">Cost of revenue (exclusive of depreciation and amortization, which is shown separately)</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.76%;margin:0pt;padding:0pt;"> 2,162</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"> 128</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 6,310</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;">$</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 128</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;">Advertising and marketing</td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.76%;margin:0pt;padding:0pt;"> 5,244</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"> 1,644</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 15,141</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 4,447</td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;">Sales</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.76%;margin:0pt;padding:0pt;"> 17,518</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"> 3,275</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 57,638</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 9,465</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;">Technology and development</td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.76%;margin:0pt;padding:0pt;"> 22,910</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"> 2,622</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;margin:0pt;padding:0pt;"> 77,335</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;margin:0pt;padding:0pt;"> 7,285</td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;">General and administrative</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 23,867</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,239</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 84,547</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> </td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 39,826</td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:55.11%;margin:0pt;padding:0pt;">Total stock-based compensation expense (1)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.76%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 71,701</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 20,908</td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:8.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 240,971</td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.23%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">$</td><td style="vertical-align:bottom;white-space:nowrap;width:7.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 61,151</td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;">Excluding the amount capitalized related to internal software development projects.</td></tr></table>

2162000

128000

6310000

128000

5244000

1644000

15141000

4447000

17518000

3275000

57638000

9465000

22910000

2622000

77335000

7285000

23867000

13239000

84547000

39826000

71701000

20908000

240971000

61151000

Note 15. Income TaxesAs a result of the Company’s history of net operating losses (“NOL”), the Company had historically provided for a full valuation allowance against its deferred tax assets for assets that are not more-likely-than-not to be realized, which was partially released in the quarter ended December 31, 2020. The Company’s income tax expense for the quarter and nine months ended September 30, 2021 was $3.6 million and $93.9 million, respectively. For the quarter ended September 30, 2021, the Company recognized an additional discrete non-cash income tax charge reflecting an additional valuation allowance on excess stock compensation and other state deferred tax assets associated with the Livongo merger. For the nine months ended September 30, 2021, the Company recognized a discrete non-cash income tax charge substantially reflecting an additional valuation allowance on excess stock compensation benefits and other state deferred tax assets associated with the Livongo merger. This was recorded in the first quarter, and was partially offset by tax benefits on current period losses. The Company’s income tax benefit for the quarter and nine months ended September 30, 2020 of $(2.3) million and $(5.4) million, respectively, was primarily related to the release of an uncertain tax provision, amortization of acquired intangibles, and stock compensation deductions.

3600000

93900000

-2300000

-5400000

XML 13 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2021	Oct. 27, 2021
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Entity File Number	001-37477
Entity Registrant Name	TELADOC HEALTH, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	04-3705970
Entity Address, Address Line One	2 Manhattanville Road
Entity Address, Address Line Two	Suite 203
Entity Address, City or Town	Purchase
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10577
City Area Code	203
Local Phone Number	635-2002
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	TDOC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Central Index Key	0001477449
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		160,086,661

XML 14 R2.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 823,828	$ 733,324
Short-term investments	2,538	53,245
Accounts receivable, net of allowance of $11,277 and $6,412, respectively	178,072	169,281
Inventories	56,937	56,498
Prepaid expenses and other current assets	95,941	47,259
Total current assets	1,157,316	1,059,607
Property and equipment, net	27,027	28,551
Goodwill	14,470,399	14,581,255
Intangible assets, net	1,932,012	2,020,864
Operating lease - right-of-use assets	47,935	46,647
Other assets	17,890	18,357
Total assets	17,652,579	17,755,281
Current liabilities:
Accounts payable	34,655	46,030
Accrued expenses and other current liabilities	106,252	83,657
Accrued compensation	75,891	94,593
Deferred revenue-current	72,865	52,356
Advances from financing companies	12,442	13,453
Current portion of long-term debt	0	42,560
Total current liabilities	302,105	332,649
Other liabilities	1,328	1,616
Operating lease liabilities, net of current portion	42,729	43,142
Deferred revenue, net of current portion	4,075	2,449
Advances from financing companies, net of current portion	9,561	9,926
Deferred taxes	93,824	102,103
Convertible senior notes, net	1,211,375	1,379,592
Commitments and contingencies
Stockholders' equity:
Common stock, $0.001 par value; 300,000,000 shares authorized as of September 30, 2021 and December 31, 2020; 160,013,624 shares and 150,281,099 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	160	150
Additional paid-in capital	17,399,023	16,857,797
Accumulated deficit	(1,410,469)	(992,661)
Accumulated other comprehensive gain	(1,132)	18,518
Total stockholders' equity	15,987,582	15,883,804
Total liabilities and stockholders' equity	$ 17,652,579	$ 17,755,281

XML 15 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Consolidated Balance Sheets
Allowance of Accounts receivable	$ 11,277	$ 6,412
Common stock par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	160,013,751	150,281,099
Common stock, shares outstanding	160,013,751	150,281,099

XML 16 R4.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Consolidated Statements of Operations and Comprehensive Loss
Revenue	$ 521,658	$ 288,812	$ 1,478,472	$ 710,641
Expenses:
Cost of revenue (exclusive of depreciation and amortization, which is shown separately below)	169,041	104,725	475,273	267,887
Operating expenses:
Advertising and marketing	111,078	52,302	303,738	132,395
Sales	62,602	23,483	191,251	60,110
Technology and development	80,250	29,958	239,017	72,244
Acquisition, integration and transformation costs	4,340	25,395	22,084	30,686
General and administrative	103,016	59,742	319,404	162,699
Depreciation and amortization	51,907	12,932	151,907	32,535
Total expenses	582,234	308,537	1,702,674	758,556
Loss from operations	(60,576)	(19,725)	(224,202)	(47,915)
Loss on extinguishment of debt	850	1,227	43,728	8,978
Other expense (income), net	376	252	(5,493)	827
Interest expense, net	18,895	16,970	61,493	38,849
Net loss before taxes	(80,697)	(38,174)	(323,930)	(96,569)
Income tax expense (benefit)	3,643	(2,290)	93,878	(5,400)
Net loss	(84,340)	(35,884)	(417,808)	(91,169)
Other comprehensive (loss) gain, net of tax:
Cumulative translation adjustment	(13,423)	16,285	(19,650)	11,610
Comprehensive loss	$ (97,763)	$ (19,599)	$ (437,458)	$ (79,559)
Net loss per share, basic and diluted	$ (0.53)	$ (0.43)	$ (2.68)	$ (1.17)
Weighted-average shares used to compute basic and diluted net loss per share	159,435,165	83,607,902	155,926,680	77,821,073

XML 17 R5.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Common Stock 2022 Notes	Common Stock 2025 Notes	Common Stock 2027 Notes	Common Stock	Additional Paid-In Capital 2022 Notes	Additional Paid-In Capital 2025 Notes	Additional Paid-In Capital 2027 Notes	Additional Paid-In Capital	Accumulated Deficit 2022 Notes	Accumulated Deficit 2025 Notes	Accumulated Deficit 2027 Notes	Accumulated Deficit	Accumulated Other Comprehensive Loss 2022 Notes	Accumulated Other Comprehensive Loss 2025 Notes	Accumulated Other Comprehensive Loss 2027 Notes	Accumulated Other Comprehensive Loss	2022 Notes	2025 Notes	2027 Notes	Total
Balance as of beginning of the period at Dec. 31, 2019				$ 73,000				$ 1,538,716,000				$ (507,525,000)				$ (17,239,000)				$ 1,014,025,000
Balance as of beginning of the period (in shares) at Dec. 31, 2019				72,761,941
Stockholders' Equity (Deficit)
Exercise of stock options				$ 1,000				40,625,000				0				0				40,626,000
Exercise of stock options (in shares)				1,999,518
Issuance of common stock upon vesting of restricted stock units				$ 1,000				(1,000)				0				0				0
Issuance of common stock upon vesting of restricted stock units (in shares)				801,575
Issuance of common stock for Notes	$ 4,000	$ 0			$ 694,047,000	$ 37,780,000			$ 0	$ 0			$ 0	$ 0			$ 694,051,000	$ 37,780,000
Issuance of common stock for Notes (in shares)	3,951,399	187,346
Issuance of stock under employee stock purchase plan				$ 0				2,473,000				0				0				2,473,000
Issuance of stock under employee stock purchase plan (in shares)				35,901
Equity portion of extinguishment of Notes	$ 0	$ 0			(715,195,000)	(29,326,000)			0	0			0	0			(715,195,000)	(29,326,000)
Equity component of Notes, net of issuance costs			$ 0				$ 285,601,000				$ 0				$ 0				$ 285,601,000
Issuance of stock in acquisition				$ 5,000				918,813,000				0				0				918,818,000
Issuance of stock in acquisition (in shares)				4,620,665
Stock-based compensation				$ 0				61,741,000				0				0				61,741,000
Other comprehensive gain (loss), net of tax				0				0				0				11,611,000				11,611,000
Net loss				0				0				(91,169,000)				0				(91,169,000)
Balance as of end of the period at Sep. 30, 2020				$ 84,000				2,835,274,000				(598,694,000)				(5,628,000)				2,231,036,000
Balance as of end of the period (in shares) at Sep. 30, 2020				84,358,345
Balance as of beginning of the period at Jun. 30, 2020				$ 79,000				1,879,573,000				(562,810,000)				(21,913,000)				1,294,929,000
Balance as of beginning of the period (in shares) at Jun. 30, 2020				79,099,433
Stockholders' Equity (Deficit)
Exercise of stock options				$ 0				7,113,000				0				0				7,113,000
Exercise of stock options (in shares)				400,555
Issuance of common stock upon vesting of restricted stock units				$ 0				0				0				0				0
Issuance of common stock upon vesting of restricted stock units (in shares)				49,396
Issuance of common stock for Notes	$ 0	$ 0			187,000	37,780,000			0	0			0	0			187,000	37,780,000
Issuance of common stock for Notes (in shares)	950	187,346
Equity portion of extinguishment of Notes	$ 0	$ 0			(44,000)	(29,326,000)			0	0			0	0			(44,000)	(29,326,000)
Issuance of stock in acquisition				$ 5,000				918,813,000				0				0				918,818,000
Issuance of stock in acquisition (in shares)				4,620,665
Stock-based compensation				$ 0				21,178,000				0				0				21,178,000
Other comprehensive gain (loss), net of tax				0				0				0				16,285,000				16,285,000
Net loss				0				0				(35,884,000)				0				(35,884,000)
Balance as of end of the period at Sep. 30, 2020				$ 84,000				2,835,274,000				(598,694,000)				(5,628,000)				2,231,036,000
Balance as of end of the period (in shares) at Sep. 30, 2020				84,358,345
Balance as of beginning of the period at Dec. 31, 2020				$ 150,000				16,857,797,000				(992,661,000)				18,518,000				15,883,804,000
Balance as of beginning of the period (in shares) at Dec. 31, 2020				150,281,099
Stockholders' Equity (Deficit)
Exercise of stock options				$ 3,000				22,953,000				0				0				22,956,000
Exercise of stock options (in shares)				2,123,935
Issuance of common stock upon vesting of restricted stock units				$ 1,000				(1,000)				0				0				0
Issuance of common stock upon vesting of restricted stock units (in shares)				1,490,879
Issuance of common stock for Notes	$ 1,000	$ 5,000			270,111,000	920,514,000			0	0			0	0			270,112,000	920,519,000
Issuance of common stock for Notes (in shares)	1,058,373	5,182,656
Issuance of stock under employee stock purchase plan				$ 0				10,539,000				0				0				10,539,000
Issuance of stock under employee stock purchase plan (in shares)				82,088
Recovery of excess common stock issued for acquisition				$ 0				(40,329,000)				0				0				(40,329,000)
Recovery of excess common stock issued for acquisition (in shares)				(205,279)
Equity portion of extinguishment of Notes	$ 0	$ 0			$ (224,081,000)	(668,507,000)			$ 0	0			$ 0	0			$ (224,081,000)	(668,507,000)
Stock-based compensation				$ 0				250,027,000				0				0				250,027,000
Other comprehensive gain (loss), net of tax				0				0				0				(19,650,000)				(19,650,000)
Net loss				0				0				(417,808,000)				0				(417,808,000)
Balance as of end of the period at Sep. 30, 2021				$ 160,000				17,399,023,000				(1,410,469,000)				(1,132,000)				15,987,582,000
Balance as of end of the period (in shares) at Sep. 30, 2021				160,013,751
Balance as of beginning of the period at Jun. 30, 2021				$ 159,000				17,314,749,000				(1,326,129,000)				12,291,000				16,001,070,000
Balance as of beginning of the period (in shares) at Jun. 30, 2021				159,462,978
Stockholders' Equity (Deficit)
Exercise of stock options				$ 1,000				5,174,000				0				0				5,175,000
Exercise of stock options (in shares)				216,882
Issuance of common stock upon vesting of restricted stock units				$ 0				0				0				0				0
Issuance of common stock upon vesting of restricted stock units (in shares)				235,674
Issuance of common stock for Notes		$ 0				14,868,000				0				0				14,868,000
Issuance of common stock for Notes (in shares)		98,217
Equity portion of extinguishment of Notes		$ 0				$ (10,079,000)				$ 0				$ 0				$ (10,079,000)
Stock-based compensation				$ 0				74,311,000				0				0				74,311,000
Other comprehensive gain (loss), net of tax				0				0				0				(13,423,000)				(13,423,000)
Net loss				0				0				(84,340,000)				0				(84,340,000)
Balance as of end of the period at Sep. 30, 2021				$ 160,000				$ 17,399,023,000				$ (1,410,469,000)				$ (1,132,000)				$ 15,987,582,000
Balance as of end of the period (in shares) at Sep. 30, 2021				160,013,751

XML 18 R6.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows provided by operating activities:
Net loss	$ (417,808)	$ (91,169)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	151,907	32,535
Depreciation of rental equipment	2,500	851
Amortization of right-of-use assets and depreciation of rental equipment	8,185	4,643
Allowance for doubtful accounts	11,353	2,320
Stock-based compensation	240,971	61,151
Deferred income taxes	91,414	(4,096)
Accretion of interest	46,843	29,459
Loss on extinguishment of debt	40,631	8,978
Gain on sale of investment	(5,901)	0
Other, net	38	216
Changes in operating assets and liabilities:
Accounts receivable	(19,407)	(16,450)
Prepaid expenses and other current assets	(34,566)	(5,906)
Inventory	(2,661)	(2,392)
Other assets	(3,432)	140
Accounts payable	(11,115)	6,584
Accrued expenses and other current liabilities	15,880	17,269
Accrued compensation	(17,352)	9,329
Deferred revenue	20,002	15,348
Operating lease liabilities	(8,202)	(4,360)
Other liabilities	1,502	(3,025)
Net cash provided by operating activities	110,782	61,425
Cash flows used in investing activities:
Capital expenditures	(5,611)	(2,872)
Capitalized software development costs	(35,402)	(14,515)
Proceeds from marketable securities	50,000	0
Proceeds from the sale of investment	10,901	0
Acquisitions of business, net of cash acquired	(75,944)	(159,663)
Other, net	3,150	0
Net cash used in investing activities	(52,906)	(177,050)
Cash flows provided by financing activities:
Net proceeds from the exercise of stock options	22,956	40,627
Proceeds from advances from financing companies	10,677	1,924
Payment against advances from financing companies	(12,053)	(4,427)
Proceeds from employee stock purchase plan	13,996	2,473
Cash received for withholding taxes on stock-based compensation, net	3,109	326
Other, net	(4,224)	0
Net cash provided by financing activities	34,322	788,700
Net increase in cash and cash equivalents	92,198	673,075
Foreign exchange difference	(1,694)	(129)
Cash and cash equivalents at beginning of the period	733,324	514,353
Cash and cash equivalents at end of the period	823,828	1,187,299
Income taxes paid	3,114	786
Interest paid	7,973	5,612
2027 Notes
Cash flows provided by financing activities:
Proceeds from issuance of Notes	0	1,000,000
Payment of issuance costs of Notes	0	(24,070)
2022 Notes
Cash flows provided by financing activities:
Repurchase of 2022 Notes	$ (139)	$ (228,153)

XML 19 R7.htm IDEA: XBRL DOCUMENT

Organization and Description of Business

9 Months Ended

Sep. 30, 2021

Organization and Description of Business

Organization and Description of Business

Note 1. Organization and Description of Business

On July 1, 2020, the Company completed the acquisition of InTouch Technologies, Inc. (“InTouch”), a leading provider of enterprise telehealth solutions for hospitals and health systems.

XML 20 R8.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Principles of Consolidation

9 Months Ended

Sep. 30, 2021

Basis Of Presentation And Principles Of Consolidation

Basis of Presentation and Principles of Consolidation

Note 2. Basis of Presentation and Principles of Consolidation

Business Combinations

Use of Estimates

Recently Issued Accounting Pronouncements

Summary of Significant Accounting Policies

Acquisition, Integration and Transformation Costs

General and Administrative Costs

Other Expense (Income), Net

XML 21 R9.htm IDEA: XBRL DOCUMENT

Revenue, Deferred Revenue, Deferred Costs and Other

9 Months Ended

Sep. 30, 2021

Revenue, Deferred Revenue, Deferred Costs and Other

Revenue, Deferred Revenue, Deferred Costs and Other

Note 3. Revenue, Deferred Revenue, Deferred Costs and Other

The following table presents the Company’s revenues disaggregated by revenue source (in thousands):


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Access Fees Revenue
U.S.	$	413,594	$	194,622	$	1,161,084	$	454,582
International		37,989		31,997		112,699		91,261
Total		451,583		226,619		1,273,783		545,843

Visit Fee Revenue
U.S.		59,863		50,948		173,399		152,944
International		116		96		368		705
Total		59,979		51,044		173,767		153,649

Other
U.S.		9,583		10,299		29,617		10,299
International		513		850		1,305		850
Total		10,096		11,149		30,922		11,149

Total Revenues	$	521,658	$	288,812	$	1,478,472	$	710,641

International revenues primarily reflect the location of the customer, except for direct to consumer activities which primarily reflect the location of operations to service customers.

Deferred Revenue

Deferred Costs and Other


	As of		As of
	September 30,		December 31,
	2021		2020
Deferred costs and other, current	$	20,243	$	3,468
Deferred costs and other, noncurrent		7,788		2,179
Total deferred costs and other	$	28,031	$	5,647

Deferred costs and other activity are as follows (in thousands):


	Deferred Costs and Other
Beginning balance as of December 31, 2020	$	5,647
Additions		34,554
Cost of revenue recognized		(12,170)
Ending balance as of September 30, 2021	$	28,031

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

+ Details

XML 22 R10.htm IDEA: XBRL DOCUMENT

Business Acquisitions

9 Months Ended

Sep. 30, 2021

Business Acquisitions

Business Acquisitions

Note 4. Business Acquisitions

Identifiable assets acquired and liabilities assumed (in thousands):


	Livongo		InTouch
Purchase price, net of cash acquired	$	13,876,931	$	1,069,759
Less:
Accounts receivable		80,084		16,986
Short term investment		52,500		0
Inventory		24,299		8,492
Property and equipment, net		8,952		11,366
Right of use assets		15,056		4,965
Other assets		17,337		2,541
Client relationships		1,050,000		164,580
Technology		300,000		29,190
Trademarks		250,000		32,630
Advances from financing companies		0		(26,012)
Accounts payable		(119,302)		(5,589)
Deferred revenue		(997)		(20,729)
Convertible notes		(453,417)		0
Deferred taxes		(37,980)		(30,102)
Lease liabilities		(18,834)		(5,495)
Other liabilities		(46,606)		(13,042)
Goodwill	$	12,755,839	$	899,978

The amount allocated to goodwill reflects the benefits Teladoc Health expects to realize from the growth of the respective acquisitions’ operations, cost savings, and various synergies.


	Unaudited Pro Forma
	Quarter Ended		Nine Months Ended
	September 30,		September 30,
(in thousands)	2020		2020
Revenue	$	395,519	$	1,026,957
Net loss	$	(93,149)	$	(778,287)

XML 23 R11.htm IDEA: XBRL DOCUMENT

Inventories

9 Months Ended

Sep. 30, 2021

Inventories

Inventories

Note 5. Inventories

Inventories consisted of the following (in thousands):


	As of September 30,		As of December 31,
	2021		2020
Raw materials and purchased parts	$	21,836	$	19,591
Work in process		501		1,431
Finished goods		34,600		35,476
Total inventories	$	56,937	$	56,498

XML 24 R12.htm IDEA: XBRL DOCUMENT

Intangible Assets, Net

9 Months Ended

Sep. 30, 2021

Intangible Assets, Net

Intangible Assets, Net

Note 6. Intangible Assets, Net

Intangible assets, net consist of the following (in thousands):


									Weighted
									Average
									Remaining
	Useful			Accumulated		Net Carrying			Useful Life
	Life	Gross Value		Amortization		Value			(Years)
September 30, 2021
Client relationships	2 to 20 years	$	1,467,396	$	(174,523)	$	1,292,873		14.8
Non-compete agreements	1.5 to 5 years		5,008		(5,008)		0
Trademarks	3 to 15 years		326,594		(38,075)		288,519		9.7
Patents	3 years		200		(200)		0
Capitalized software development costs	3 to 5 years		97,779		(35,717)		62,062		2.7
Technology	5 to 7 years		342,039		(53,481)		288,558		5.9
Intangible assets, net		$	2,239,016	$	(307,004)	$	1,932,012		12.3
December 31, 2020
Client relationships	2 to 20 years	$	1,460,648	$	(100,844)	$	1,359,804	`	15.4
Non-compete agreements	1.5 to 5 years		5,097		(4,872)		225		0.4
Trademarks	3 to 15 years		326,786		(15,576)		311,210		10.5
Patents	3 years		200		(200)		0
Capitalized software development costs	3 to 5 years		52,518		(24,771)		27,747		2.8
Technology	5 to 7 years		338,150		(16,272)		321,878		6.6
Intangible assets, net		$	2,183,399	$	(162,535)	$	2,020,864		13.1

XML 25 R13.htm IDEA: XBRL DOCUMENT

Goodwill

9 Months Ended

Sep. 30, 2021

Goodwill

Goodwill

Note 7. Goodwill

Goodwill consists of the following (in thousands):


	As of September 30,		As of December 31,
	2021		2020
Beginning balance as of December 31, 2020 and 2019, respectively	$	14,581,255	$	746,079
Additions associated with acquisitions		61,157		13,812,198
Purchase consideration adjustments (see Note 4)		(55,801)		0
Deferred tax adjustments (see Note 4)		(101,536)		0
Cumulative translation adjustment		(14,676)		22,978
Ending balance as of September 30, 2021 and December 31, 2020, respectively	$	14,470,399	$	14,581,255

XML 26 R14.htm IDEA: XBRL DOCUMENT

Accrued Expenses and Other Current Liabilities

9 Months Ended

Sep. 30, 2021

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Note 8. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):


	As of September 30,		As of December 31,
	2021		2020
Professional fees	$	2,726	$	4,717
Consulting fees/provider fees		16,253		23,167
Client performance guarantees		8,817		7,215
Interest payable		5,811		2,049
Income tax payable		1,385		1,627
Insurance		6,272		3,139
Marketing		5,733		2,815
Operating lease liabilities - current		13,148		11,438
Earnout		0		4,514
Acquisition & Integration		4,212		1,036
Franchise and Sales Taxes		5,802		2,099
Device Replacement Cost		6,263		0
Other		29,831		19,841
Total	$	106,252	$	83,657

XML 27 R15.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

9 Months Ended

Sep. 30, 2021

Fair Value Measurements

Fair Value Measurements

Note 9. Fair Value Measurements

The carrying value of the Company’s cash equivalents, short-term investments, accounts receivable, accounts payable, and accrued liabilities approximates fair value due to their short-term nature.

Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active

markets.

Level 2—Include other inputs that are directly or indirectly observable in the marketplace.

Level 3—Unobservable inputs that are supported by little or no market activity.

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis using the above input categories (in thousands):


	September 30, 2021
	Level 1		Level 2		Level 3		Total
Cash and cash equivalents	$	823,828	$	0	$	0	$	823,828
Short-term investments	$	0	$	2,538	$	0	$	2,538


	December 31, 2020
	Level 1		Level 2		Level 3		Total
Cash and cash equivalents	$	733,324	$	0	$	0	$	733,324
Short-term investments	$	0	$	53,245	$	0	$	53,245
Equity securities without readily determinable fair values	$	0	$	5,000	$	0	$	5,000
Contingent liability	$	0	$	0	$	4,514	$	4,514

There were no transfers between fair value measurement levels during the quarters or nine months ended September 30, 2021 and 2020.

The change in fair value of the Company’s equity securities without readily determinable fair values was as follows:


Fair value and historical cost basis at December 31, 2020	$	5,000
Upward adjustment due to observable price change in identical securities		5,901
Sale of investment		(10,901)
Fair value at September 30, 2021	$	0


Fair value at December 31, 2020	$	4,514
Payments		(4,367)
Change in fair value		0
Currency translation adjustment		(147)
Fair value at September 30, 2021	$	0

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 28 R16.htm IDEA: XBRL DOCUMENT

Leasing Operations

9 Months Ended

Sep. 30, 2021

Leasing Operations

Leasing Operations

Note 10. Leasing Operations

Operating Leases


	As of
Operating Leases:	September 30, 2021
2021	$	14,594
2022		14,872
2023		10,927
2024		7,233
2025		6,028
2026 and thereafter		13,997
Total future minimum payments	$	67,651

XML 29 R17.htm IDEA: XBRL DOCUMENT

Convertible Senior Notes

9 Months Ended

Sep. 30, 2021

Convertible Senior Notes

Convertible Senior Notes

Note 11. Convertible Senior Notes

Outstanding Convertible Senior Notes

The following table presents certain terms of the Notes that were outstanding as of September 30, 2021:



	2027 Notes			2025 Notes			Livongo Notes
Interest Rate Per Year		1.25	%		1.375	%		0.875	%
Fair Value as of September 30, 2021 (in millions)	$	970.5		$	2.1		$	710.6
Maturity Date		June 1, 2027			May 15, 2025			June 1, 2025
Optional Redemption Date		June 5, 2024			May 22, 2022			June 5, 2023
Conversion Date		December 1, 2026			November 15, 2024			March 1, 2025
Conversion Rate Per $1,000 Principal Amount as of September 30, 2021		4.1258			18.6621			13.94
Remaining Contractual Life as of September 30, 2021		5.7 years			3.6 years			3.7 years

●

upon the occurrence of specified corporate events described under the applicable indenture; or

●

if the Company calls the applicable Notes for redemption, at any time until the close of business on the second business day immediately preceding the redemption date.

The liability components of the Notes consist of the following (in thousands):


	As of September 30,		As of December 31,
2027 Notes	2021		2020
Principal	$	1,000,000	$	1,000,000
Less: Debt discount, net (1)		(260,324)		(287,916)
Net carrying amount	$	739,676	$	712,084

2025 Notes
Principal	$	882	$	276,788
Less: Debt discount, net (1)		(215)		(65,923)
Net carrying amount	$	667	$	210,865

Livongo Notes
Principal	$	550,000	$	550,000
Less: Debt discount, net (1)		(78,968)		(93,357)
Net carrying amount	$	471,032	$	456,643

2022 Notes
Principal	$	0	$	46,762
Less: Debt discount, net (1)		0		(4,202)
Net carrying amount	$	0	$	42,560

(1)

Included in the accompanying consolidated balance sheet within convertible senior notes and amortized to interest expense over the expected life of the Notes using the effective interest rate method.

The following table sets forth total interest expense recognized related to the Notes (and in the case of the Livongo Notes, subsequent to the acquisition of Livongo) (in thousands):


	Quarters Ended							Nine Months Ended
	September 30,							September 30,
2027 Notes:		2021			2020			2021		2020
Contractual interest expense	$	3,125		$	3,125		$	9,375		$	4,618
Amortization of debt discount		9,370			8,989			27,592			12,911
Total	$	12,495		$	12,114		$	36,967		$	17,529
Effective interest rate of the liability component		3.4	%		3.4	%		3.4	%		3.4	%

	Quarters Ended						Nine Months Ended
	September 30,						September 30,
2025 Notes:		2021			2020			2021		2020
Contractual interest expense	$	10		$	971		$	1,080		$	2,947
Amortization of debt discount		48			3,170			4,546			9,379
Total	$	58		$	4,141		$	5,626		$	12,326
Effective interest rate of the liability component		4.7	%		7.9	%		4.7	%		7.9	%

	Quarters Ended						Nine Months Ended
	September 30,						September 30,
Livongo Notes:	2021							2021
Contractual interest expense	$	1,203					$	3,609
Amortization of debt discount		4,858						14,389
Total	$	6,061					$	17,998
Effective interest rate of the liability component		5.2	%					5.2	%

	Quarters Ended						Nine Months Ended
	September 30,						September 30,
2022 Notes:		2021			2020			2021		2020
Contractual interest expense	$	0		$	351		$	116		$	3,696
Amortization of debt discount		0			650			316			6,940
Total	$	0		$	1,001		$	432		$	10,636
Effective interest rate of the liability component					10.0	%		3.0	%		10.0	%

Exchanges and Conversions of Convertible Senior Notes Due 2025

Redemption and Conversions of Convertible Senior Notes Due 2022

XML 30 R18.htm IDEA: XBRL DOCUMENT

Advances from Financing Companies

9 Months Ended

Sep. 30, 2021

Advances from Financing Companies

Advances from Financing Companies

Note 12. Advances from Financing Companies

Client lease payments to third party financing companies will reduce the advances from financing companies as of September 30, 2021 by year as follows (in thousands):


	As of September 30,
	2021
2021	$	3,763
2022		11,718
2023		5,491
2024		1,031
	$	22,003

XML 31 R19.htm IDEA: XBRL DOCUMENT

Legal Matters

9 Months Ended

Sep. 30, 2021

Legal Matters

Legal Matters

Note 13. Legal Matters

XML 32 R20.htm IDEA: XBRL DOCUMENT

Common Stock and Stockholders' Equity

9 Months Ended

Sep. 30, 2021

Common Stock and Stockholders'Equity

Common Stock and Stockholders' Equity

Note 14. Common Stock and Stockholders’ Equity

Capitalization

Effective October 30, 2020, the authorized number of shares of the Company’s common stock was increased from 150,000,000 to 300,000,000 shares.

Warrants

The Company had no warrants outstanding as of September 30, 2021 or December 31, 2020.

Stock Plans

Stock Options

Activity under the Plans was as follows (in thousands, except share and per share amounts and years):


				Weighted-
		Weighted-		Average
	Number of	Average		Remaining	Aggregate
	Shares	Exercise		Contractual	Intrinsic
	Outstanding	Price		Life in Years	Value
Balance at December 31, 2020	5,826,685	$	17.19	5.31	$	1,064,944
Stock option grants	35,740	$	162.38	N/A
Stock options exercised	(2,120,943)	$	10.79	N/A	$	(409,182)
Stock options forfeited	(90,583)	$	30.03	N/A
Balance at September 30, 2021	3,650,899	$	21.96	5.57	$	386,390
Vested or expected to vest at September 30, 2021	3,650,899	$	21.96	7.10	$	35,607
Exercisable at September 30, 2021	3,243,849	$	18.84	5.37	$	350,848

The Company estimates the fair value of stock options granted using the Black Scholes option pricing model.

The assumptions used in the Black-Scholes option-pricing model are determined as follows:

Volatility. The expected volatility was derived from the historical stock volatilities of the Company’s stock volatility over a period equivalent to the expected term of the stock option grants.

Risk-Free Interest Rate. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with terms similar to the expected term on the options.

Dividend Yield. The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, it used an expected dividend yield of zero.

Forfeiture rate. The Company recognizes forfeitures as they occur.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions and fair value per share:


	Nine Months Ended September 30,
	2021		2020
Volatility		56.52% - 58.14%		46.1% - 56.0%
Expected term (in years)		4.1		4.1
Risk-free interest rate		0.31% - 0.70%		0.27%-1.64%
Dividend yield		0		0
Weighted-average fair value of underlying stock options	$	72.46	$	49.21

The Company determined that a Monte Carlo valuation model is most suitable for valuation of options for the replaced and replacement awards from the Livongo merger, for the following reasons:

●

Options are deeply in-the-money, as such don’t qualify as “plain-vanilla” options.

●

the Company recorded compensation expense related to stock options granted of $77.1 million and $11.5 million, respectively.

Restricted Stock Units

Activity under RSUs was as follows:


		Weighted-Average
		Grant Date
	RSUs	Fair Value Per RSU
Balance at December 31, 2020	3,550,595	$	162.11
Granted	650,335	$	192.86
Vested and issued	(1,222,550)	$	131.65
Forfeited	(681,510)	$	183.98
Balance at September 30, 2021	2,296,870	$	175.60
Vested and unissued at September 30, 2021	13,755	$	50.90
Non-vested at September 30, 2021	2,283,115	$	175.60

Performance Stock Units

Activity under PSUs was as follows:


		Weighted-Average
		Grant Date
	Shares	Fair Value Per PSU
Balance at December 31, 2020	429,319	$	76.60
Granted	531,309	$	132.66
Vested and issued	(268,201)	$	74.33
Forfeited	(26,730)	$	153.05
Balance at September 30, 2021	665,697	$	119.07
Vested and unissued at September 30, 2021	0	$	0
Non-vested at September 30, 2021	665,697	$	119.07

Employee Stock Purchase Plan

Total compensation costs for stock-based awards were recorded as follows (in thousands):


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Cost of revenue (exclusive of depreciation and amortization, which is shown separately)	$	2,162	$	128	$	6,310	$	128
Advertising and marketing		5,244		1,644		15,141		4,447
Sales		17,518		3,275		57,638		9,465
Technology and development		22,910		2,622		77,335		7,285
General and administrative		23,867		13,239		84,547		39,826
Total stock-based compensation expense (1)	$	71,701	$	20,908	$	240,971	$	61,151

(1)	Excluding the amount capitalized related to internal software development projects.

XML 33 R21.htm IDEA: XBRL DOCUMENT

Income Taxes

9 Months Ended

Sep. 30, 2021

Income Taxes

Income Taxes

Note 15. Income Taxes

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

XML 34 R22.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Principles of Consolidations (Policies)	9 Months Ended
	Sep. 30, 2021
Basis Of Presentation And Principles Of Consolidation
Basis of Presentation and Principles of Consolidation	The accompanying unaudited consolidated financial statements for the three and nine months ended September 30, 2021 and 2020, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of Teladoc Health for the periods presented. However, the financial results for interim periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) have been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended December 31, 2020, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies. These financial statements include the results of Teladoc Health, as well as three professional associations and thirteen professional corporations (collectively, the “Association”). All intercompany transactions and balances have been eliminated. Certain prior year amounts have been reclassified to conform to the current year presentation. Teladoc Health Medical Group, P.A., formerly Teladoc Physicians, P.A. is party to several Services Agreements by and among it and the professional associations and professional corporations pursuant to which each professional association and professional corporation provides services to Teladoc Health Medical Group, P.A. Each professional association and professional corporation is established pursuant to the requirements of its respective domestic jurisdiction governing the corporate practice of medicine. The Company holds a variable interest in the Association which contracts with physicians and other health professionals in order to provide services to the Company. The Association is considered a variable interest entity (“VIE”) since it does not have sufficient equity to finance its activities without additional subordinated financial support. An enterprise having a controlling financial interest in a VIE must consolidate the VIE if it has both power and benefits—that is, it has (1) the power to direct the activities of a VIE that most significantly impacts the VIE’s economic performance (power) and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE (benefits). The Company has the power and rights to control all activities of the Association and funds and absorbs all losses of the VIE and appropriately consolidates the Association. Total revenue and net income (loss) for the VIE were $56.2 million and $0.1 million, and $48.9 million and $(0.7) million, for the quarters ended September 30, 2021 and 2020, respectively. Total revenue and net income (loss) for the VIE were $161.9 million and $(3.0) million, and $149.1 million and $0.1 million, for the nine months ended September 30, 2021 and 2020, respectively. The VIE’s total assets, all of which were current, were $31.0 million and $28.7 million at September 30, 2021 and December 31, 2020, respectively. Total liabilities, all of which were current for the VIE, were $71.0 million and $65.8 million at September 30, 2021 and December 31, 2020, respectively. The VIE’s total stockholders’ deficit was $40.1 million and $37.1 million at September 30, 2021 and December 31, 2020, respectively.
Business Combinations	Business Combinations The Company accounts for its business combinations using the acquisition method of accounting. The purchase price is attributed to the fair value of the assets acquired and liabilities assumed. Transaction costs directly attributable to the acquisition are expensed as incurred. Identifiable assets and liabilities acquired or assumed are measured separately at their fair values as of the acquisition date. The excess of the purchase price of acquisition over the fair value of the identifiable net assets of the acquiree is recorded as goodwill. The results of businesses acquired in a business combination are included in the Company’s consolidated financial statements from the date of acquisition. When the Company issues stock-based or cash awards to an acquired company’s stockholders, the Company evaluates whether the awards are consideration or compensation for post-acquisition services. The evaluation includes, among other things, whether the vesting of the awards is contingent on the continued employment of the acquired company’s stockholders beyond the acquisition date. If continued employment is required for vesting, the awards are treated as compensation for post-acquisition services and recognized as expense over the requisite service period. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates, including the selection of valuation methodologies, estimates of future revenue and cash flows, discount rates and selection of comparable companies. The estimates and assumptions used to determine the fair values and useful lives of identified intangible assets could change due to numerous factors, including market conditions, technological developments, economic conditions and competition. In connection with determination of fair values, the Company may engage a third-party valuation specialist to assist with the valuation of intangible and certain tangible assets acquired and certain assumed obligations. Acquisition-related transaction costs incurred by the Company are not included as a component of consideration transferred but are accounted for as an operating expense in the period in which the costs are incurred.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates on historical experience, current business factors, and various other assumptions that the Company believes are necessary to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment evolves. The Company believes that estimates used in the preparation of these consolidated financial statements are reasonable; however, actual results could differ materially from these estimates. Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements. Significant estimates and assumptions by management affect areas including the allowance for doubtful accounts, the carrying value of long-lived assets (including goodwill and intangible assets), capitalization and amortization of software development costs, the finalization of purchase accounting adjustments, Client performance guarantees, the calculation of a contingent liability in connection with an acquisition earn-out, the provision for income taxes and related deferred tax accounts, revenue recognition, contingencies, and other items as described in the Summary of Significant Accounting policies in this Quarterly Report and in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Form 10-K”).
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-06—"Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.” ASU 2020-06 simplifies the accounting for convertible instruments by eliminating the conversion option separation model for convertible debt that can be settled in cash and by eliminating the measurement model for beneficial conversion features. Convertible instruments that continue to be subject to separation models are (1) those with conversion options that are required to be accounted for as bifurcated derivatives and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. This ASU also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. This standard becomes effective for the Company on January 1, 2022 and may be early adopted during an interim period of 2021. The Company will adopt the standard on January 1, 2022 and is currently evaluating the impact of ASU 2020-06 on its consolidated financial statements.
Acquisition, Integration and Transformation Costs	Acquisition, Integration and Transformation Costs Acquisition, integration and transformation costs include investment banking, financing, legal, accounting, consultancy, integration, fair value changes related to contingent consideration and certain other transaction costs related to mergers and acquisitions. It also includes costs related to certain business transformation initiatives focused on integrating and optimizing various operations and systems, including enhancing our customer relationship management (CRM) and enterprise resource planning (ERP) systems, incurred in connection with our acquisition and integration activities.
General and Administrative Costs	General and Administrative Costs General and Administrative costs consist of all operating expenses not included in the other operating expense categories and now include legal and regulatory costs for all current and historical periods presented.
Other Expense (Income), Net	Other Expense (Income), Net Other expense (income), net includes the impact of foreign currency remeasurement, realized and unrealized gains on investment securities and all other non-operating items not included in other financial statement lines.

XML 35 R23.htm IDEA: XBRL DOCUMENT

Revenue, Deferred Revenue, Deferred Costs and Other (Tables)

9 Months Ended

Sep. 30, 2021

Revenue, Deferred Revenue, Deferred Costs and Other

Schedule of disaggregation of revenue

The following table presents the Company’s revenues disaggregated by revenue source (in thousands):


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Access Fees Revenue
U.S.	$	413,594	$	194,622	$	1,161,084	$	454,582
International		37,989		31,997		112,699		91,261
Total		451,583		226,619		1,273,783		545,843

Visit Fee Revenue
U.S.		59,863		50,948		173,399		152,944
International		116		96		368		705
Total		59,979		51,044		173,767		153,649

Other
U.S.		9,583		10,299		29,617		10,299
International		513		850		1,305		850
Total		10,096		11,149		30,922		11,149

Total Revenues	$	521,658	$	288,812	$	1,478,472	$	710,641

International revenues primarily reflect the location of the customer, except for direct to consumer activities which primarily reflect the location of operations to service customers.

Schedule of deferred costs and other


	As of		As of
	September 30,		December 31,
	2021		2020
Deferred costs and other, current	$	20,243	$	3,468
Deferred costs and other, noncurrent		7,788		2,179
Total deferred costs and other	$	28,031	$	5,647

Deferred costs and other activity are as follows (in thousands):


	Deferred Costs and Other
Beginning balance as of December 31, 2020	$	5,647
Additions		34,554
Cost of revenue recognized		(12,170)
Ending balance as of September 30, 2021	$	28,031

XML 36 R24.htm IDEA: XBRL DOCUMENT

Business Acquisitions (Tables)

9 Months Ended

Sep. 30, 2021

Business Acquisitions

Summary of identifiable assets acquired and liabilities assumed

Identifiable assets acquired and liabilities assumed (in thousands):


	Livongo		InTouch
Purchase price, net of cash acquired	$	13,876,931	$	1,069,759
Less:
Accounts receivable		80,084		16,986
Short term investment		52,500		0
Inventory		24,299		8,492
Property and equipment, net		8,952		11,366
Right of use assets		15,056		4,965
Other assets		17,337		2,541
Client relationships		1,050,000		164,580
Technology		300,000		29,190
Trademarks		250,000		32,630
Advances from financing companies		0		(26,012)
Accounts payable		(119,302)		(5,589)
Deferred revenue		(997)		(20,729)
Convertible notes		(453,417)		0
Deferred taxes		(37,980)		(30,102)
Lease liabilities		(18,834)		(5,495)
Other liabilities		(46,606)		(13,042)
Goodwill	$	12,755,839	$	899,978

Schedule of unaudited pro forma revenue and net loss


	Unaudited Pro Forma
	Quarter Ended		Nine Months Ended
	September 30,		September 30,
(in thousands)	2020		2020
Revenue	$	395,519	$	1,026,957
Net loss	$	(93,149)	$	(778,287)

XML 37 R25.htm IDEA: XBRL DOCUMENT

Inventories (Tables)

9 Months Ended

Sep. 30, 2021

Inventories

Schedule of inventories

Inventories consisted of the following (in thousands):


	As of September 30,		As of December 31,
	2021		2020
Raw materials and purchased parts	$	21,836	$	19,591
Work in process		501		1,431
Finished goods		34,600		35,476
Total inventories	$	56,937	$	56,498

XML 38 R26.htm IDEA: XBRL DOCUMENT

Intangible Assets, Net (Tables)

9 Months Ended

Sep. 30, 2021

Intangible Assets, Net

Schedule of finite lived intangible assets

Intangible assets, net consist of the following (in thousands):


									Weighted
									Average
									Remaining
	Useful			Accumulated		Net Carrying			Useful Life
	Life	Gross Value		Amortization		Value			(Years)
September 30, 2021
Client relationships	2 to 20 years	$	1,467,396	$	(174,523)	$	1,292,873		14.8
Non-compete agreements	1.5 to 5 years		5,008		(5,008)		0
Trademarks	3 to 15 years		326,594		(38,075)		288,519		9.7
Patents	3 years		200		(200)		0
Capitalized software development costs	3 to 5 years		97,779		(35,717)		62,062		2.7
Technology	5 to 7 years		342,039		(53,481)		288,558		5.9
Intangible assets, net		$	2,239,016	$	(307,004)	$	1,932,012		12.3
December 31, 2020
Client relationships	2 to 20 years	$	1,460,648	$	(100,844)	$	1,359,804	`	15.4
Non-compete agreements	1.5 to 5 years		5,097		(4,872)		225		0.4
Trademarks	3 to 15 years		326,786		(15,576)		311,210		10.5
Patents	3 years		200		(200)		0
Capitalized software development costs	3 to 5 years		52,518		(24,771)		27,747		2.8
Technology	5 to 7 years		338,150		(16,272)		321,878		6.6
Intangible assets, net		$	2,183,399	$	(162,535)	$	2,020,864		13.1

XML 39 R27.htm IDEA: XBRL DOCUMENT

Goodwill (Tables)

9 Months Ended

Sep. 30, 2021

Goodwill

Summary of goodwill

Goodwill consists of the following (in thousands):


	As of September 30,		As of December 31,
	2021		2020
Beginning balance as of December 31, 2020 and 2019, respectively	$	14,581,255	$	746,079
Additions associated with acquisitions		61,157		13,812,198
Purchase consideration adjustments (see Note 4)		(55,801)		0
Deferred tax adjustments (see Note 4)		(101,536)		0
Cumulative translation adjustment		(14,676)		22,978
Ending balance as of September 30, 2021 and December 31, 2020, respectively	$	14,470,399	$	14,581,255

XML 40 R28.htm IDEA: XBRL DOCUMENT

Accrued Expenses and Other Current Liabilities (Tables)

9 Months Ended

Sep. 30, 2021

Accrued Expenses and Other Current Liabilities

Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):


	As of September 30,		As of December 31,
	2021		2020
Professional fees	$	2,726	$	4,717
Consulting fees/provider fees		16,253		23,167
Client performance guarantees		8,817		7,215
Interest payable		5,811		2,049
Income tax payable		1,385		1,627
Insurance		6,272		3,139
Marketing		5,733		2,815
Operating lease liabilities - current		13,148		11,438
Earnout		0		4,514
Acquisition & Integration		4,212		1,036
Franchise and Sales Taxes		5,802		2,099
Device Replacement Cost		6,263		0
Other		29,831		19,841
Total	$	106,252	$	83,657

XML 41 R29.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2021

Fair Value Measurements

Schedule assets and liabilities measured at fair value on a recurring basis

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis using the above input categories (in thousands):


	September 30, 2021
	Level 1		Level 2		Level 3		Total
Cash and cash equivalents	$	823,828	$	0	$	0	$	823,828
Short-term investments	$	0	$	2,538	$	0	$	2,538


	December 31, 2020
	Level 1		Level 2		Level 3		Total
Cash and cash equivalents	$	733,324	$	0	$	0	$	733,324
Short-term investments	$	0	$	53,245	$	0	$	53,245
Equity securities without readily determinable fair values	$	0	$	5,000	$	0	$	5,000
Contingent liability	$	0	$	0	$	4,514	$	4,514

Schedule of change in fair value of the Company's equity securities without readily determinable fair values:

The change in fair value of the Company’s equity securities without readily determinable fair values was as follows:


Fair value and historical cost basis at December 31, 2020	$	5,000
Upward adjustment due to observable price change in identical securities		5,901
Sale of investment		(10,901)
Fair value at September 30, 2021	$	0

Schedule of reconciliation of company's Level 3 liabilities


Fair value at December 31, 2020	$	4,514
Payments		(4,367)
Change in fair value		0
Currency translation adjustment		(147)
Fair value at September 30, 2021	$	0

XML 42 R30.htm IDEA: XBRL DOCUMENT

Leasing Operations (Tables)

9 Months Ended

Sep. 30, 2021

Leasing Operations

Schedule of future minimum lease payments


	As of
Operating Leases:	September 30, 2021
2021	$	14,594
2022		14,872
2023		10,927
2024		7,233
2025		6,028
2026 and thereafter		13,997
Total future minimum payments	$	67,651

XML 43 R31.htm IDEA: XBRL DOCUMENT

Convertible Senior Notes (Tables)

9 Months Ended

Sep. 30, 2021

Convertible Senior Notes

Summary of the Notes



	2027 Notes			2025 Notes			Livongo Notes
Interest Rate Per Year		1.25	%		1.375	%		0.875	%
Fair Value as of September 30, 2021 (in millions)	$	970.5		$	2.1		$	710.6
Maturity Date		June 1, 2027			May 15, 2025			June 1, 2025
Optional Redemption Date		June 5, 2024			May 22, 2022			June 5, 2023
Conversion Date		December 1, 2026			November 15, 2024			March 1, 2025
Conversion Rate Per $1,000 Principal Amount as of September 30, 2021		4.1258			18.6621			13.94
Remaining Contractual Life as of September 30, 2021		5.7 years			3.6 years			3.7 years

The liability components of the Notes consist of the following (in thousands):

Schedule of total interest expense recognized related to the Notes

The following table sets forth total interest expense recognized related to the Notes (and in the case of the Livongo Notes, subsequent to the acquisition of Livongo) (in thousands):


	Quarters Ended							Nine Months Ended
	September 30,							September 30,
2027 Notes:		2021			2020			2021		2020
Contractual interest expense	$	3,125		$	3,125		$	9,375		$	4,618
Amortization of debt discount		9,370			8,989			27,592			12,911
Total	$	12,495		$	12,114		$	36,967		$	17,529
Effective interest rate of the liability component		3.4	%		3.4	%		3.4	%		3.4	%

	Quarters Ended						Nine Months Ended
	September 30,						September 30,
2025 Notes:		2021			2020			2021		2020
Contractual interest expense	$	10		$	971		$	1,080		$	2,947
Amortization of debt discount		48			3,170			4,546			9,379
Total	$	58		$	4,141		$	5,626		$	12,326
Effective interest rate of the liability component		4.7	%		7.9	%		4.7	%		7.9	%

	Quarters Ended						Nine Months Ended
	September 30,						September 30,
Livongo Notes:	2021							2021
Contractual interest expense	$	1,203					$	3,609
Amortization of debt discount		4,858						14,389
Total	$	6,061					$	17,998
Effective interest rate of the liability component		5.2	%					5.2	%

	Quarters Ended						Nine Months Ended
	September 30,						September 30,
2022 Notes:		2021			2020			2021		2020
Contractual interest expense	$	0		$	351		$	116		$	3,696
Amortization of debt discount		0			650			316			6,940
Total	$	0		$	1,001		$	432		$	10,636
Effective interest rate of the liability component					10.0	%		3.0	%		10.0	%

XML 44 R32.htm IDEA: XBRL DOCUMENT

Advances from Financing Companies (Tables)

9 Months Ended

Sep. 30, 2021

Advances from Financing Companies

Schedule of client lease payments to third party financing companies

Client lease payments to third party financing companies will reduce the advances from financing companies as of September 30, 2021 by year as follows (in thousands):


	As of September 30,
	2021
2021	$	3,763
2022		11,718
2023		5,491
2024		1,031
	$	22,003

XML 45 R33.htm IDEA: XBRL DOCUMENT

Common Stock and Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2021

Common Stock and Stockholders'Equity

Summary of stock option activity under the Plan

Activity under the Plans was as follows (in thousands, except share and per share amounts and years):


				Weighted-
		Weighted-		Average
	Number of	Average		Remaining	Aggregate
	Shares	Exercise		Contractual	Intrinsic
	Outstanding	Price		Life in Years	Value
Balance at December 31, 2020	5,826,685	$	17.19	5.31	$	1,064,944
Stock option grants	35,740	$	162.38	N/A
Stock options exercised	(2,120,943)	$	10.79	N/A	$	(409,182)
Stock options forfeited	(90,583)	$	30.03	N/A
Balance at September 30, 2021	3,650,899	$	21.96	5.57	$	386,390
Vested or expected to vest at September 30, 2021	3,650,899	$	21.96	7.10	$	35,607
Exercisable at September 30, 2021	3,243,849	$	18.84	5.37	$	350,848

Assumptions used for estimate of fair value of options


	Nine Months Ended September 30,
	2021		2020
Volatility		56.52% - 58.14%		46.1% - 56.0%
Expected term (in years)		4.1		4.1
Risk-free interest rate		0.31% - 0.70%		0.27%-1.64%
Dividend yield		0		0
Weighted-average fair value of underlying stock options	$	72.46	$	49.21

Schedule of activity under the RSUs

Activity under RSUs was as follows:


		Weighted-Average
		Grant Date
	RSUs	Fair Value Per RSU
Balance at December 31, 2020	3,550,595	$	162.11
Granted	650,335	$	192.86
Vested and issued	(1,222,550)	$	131.65
Forfeited	(681,510)	$	183.98
Balance at September 30, 2021	2,296,870	$	175.60
Vested and unissued at September 30, 2021	13,755	$	50.90
Non-vested at September 30, 2021	2,283,115	$	175.60

Schedule of activity under the PSUs

Activity under PSUs was as follows:


		Weighted-Average
		Grant Date
	Shares	Fair Value Per PSU
Balance at December 31, 2020	429,319	$	76.60
Granted	531,309	$	132.66
Vested and issued	(268,201)	$	74.33
Forfeited	(26,730)	$	153.05
Balance at September 30, 2021	665,697	$	119.07
Vested and unissued at September 30, 2021	0	$	0
Non-vested at September 30, 2021	665,697	$	119.07

Components of operating expense charged for compensation cost expense

Total compensation costs for stock-based awards were recorded as follows (in thousands):


	Quarter Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Cost of revenue (exclusive of depreciation and amortization, which is shown separately)	$	2,162	$	128	$	6,310	$	128
Advertising and marketing		5,244		1,644		15,141		4,447
Sales		17,518		3,275		57,638		9,465
Technology and development		22,910		2,622		77,335		7,285
General and administrative		23,867		13,239		84,547		39,826
Total stock-based compensation expense (1)	$	71,701	$	20,908	$	240,971	$	61,151

(1)	Excluding the amount capitalized related to internal software development projects.

XML 46 R34.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Principles of Consolidation - VIE (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) item	Sep. 30, 2020 USD ($)	Jun. 30, 2021 USD ($)	Dec. 31, 2020 USD ($)	Jun. 30, 2020 USD ($)	Dec. 31, 2019 USD ($)
Variable interest entity
Number of professional associations consolidated as VIEs \| item			3
Number of professional corporations consolidated as VIEs \| item			13
Revenue	$ 521,658	$ 288,812	$ 1,478,472	$ 710,641
Net (loss) income	(84,340)	(35,884)	(417,808)	(91,169)
Assets	17,652,579		17,652,579			$ 17,755,281
(Equity) deficit	(15,987,582)	(2,231,036)	(15,987,582)	(2,231,036)	$ (16,001,070)	(15,883,804)	$ (1,294,929)	$ (1,014,025)
Primary beneficiary
Variable interest entity
Revenue	56,200	48,900	161,900	149,100
Net (loss) income	100	$ (700)	(3,000)	$ 100
Assets	31,000		31,000			28,700
Liabilities	71,000		71,000			65,800
(Equity) deficit	$ 40,100		$ 40,100			$ 37,100

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

- Definition

Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

- Definition

Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References + Details

XML 47 R35.htm IDEA: XBRL DOCUMENT

Revenue, Deferred Revenue, Deferred Costs and Other - Other Disclosures (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Product and Service Concentration Risk \| Revenue from Contract with Customer \| Access Fees Revenue
Revenue, Deferred Revenue, Deferred Costs and Other
Concentration risk (as a percent)	87.00%	78.00%	86.00%	77.00%

XML 48 R36.htm IDEA: XBRL DOCUMENT

Revenue, Deferred Revenue, Deferred Costs and Other - Disaggregation and Other (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Revenue
Revenue	$ 521,658	$ 288,812	$ 1,478,472	$ 710,641
Accounts receivable, net of allowance for doubtful accounts	178,072		178,072		$ 169,281
Deferred revenue	76,900		76,900		$ 51,600
Net increase in deferred revenue			21,800	36,800
Revenue recognized, included in deferred revenue balance at beginning of period	47,200	18,900	48,500	10,600
Access Fees Revenue
Revenue
Revenue	451,583	226,619	1,273,783	545,843
Access Fees Revenue \| United States
Revenue
Revenue	413,594	194,622	1,161,084	454,582
Access Fees Revenue \| Foreign.
Revenue
Revenue	37,989	31,997	112,699	91,261
Visit Fee Revenue
Revenue
Revenue	59,979	51,044	173,767	153,649
Visit Fee Revenue \| Foreign.
Revenue
Revenue	116	96	368	705
Other
Revenue
Revenue	10,096	11,149	30,922	11,149
Other \| United States
Revenue
Revenue	9,583	10,299	29,617	10,299
Other \| Foreign.
Revenue
Revenue	513	850	1,305	850
Paid Visits \| United States
Revenue
Revenue	$ 59,863	$ 50,948	$ 173,399	$ 152,944

XML 49 R37.htm IDEA: XBRL DOCUMENT

Revenue, Deferred Revenue, Deferred Costs and Other - Revenue Remaining Performance Obligation (Details) $ in Millions	Sep. 30, 2021 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01
Future Performance Obligations
Revenue recognized, performance obligation	$ 48.5
Period of performance obligation	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01
Future Performance Obligations
Revenue recognized, performance obligation	$ 15.4
Period of performance obligation	1 year

XML 50 R38.htm IDEA: XBRL DOCUMENT

Revenue, Deferred Revenue, Deferred Costs and Other - Deferred Cost and Other (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Deferred Device Cost And Other
Deferred costs and other, current	$ 20,243	$ 3,468
Deferred costs and other, noncurrent	7,788	2,179
Total Deferred cost and other	$ 28,031	$ 5,647

XML 51 R39.htm IDEA: XBRL DOCUMENT

Revenue, Deferred Revenue, Deferred Costs and Other - Deferred Cost and Other Activity (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021 USD ($)
Change in Deferred Device Cost And Other
Beginning balance	$ 5,647
Additions	34,554
Cost of revenue recognized	(12,170)
Ending Balance	$ 28,031

XML 52 R40.htm IDEA: XBRL DOCUMENT

Business Acquisitions - Transactions (Details) $ / shares in Units, $ in Thousands				3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 04, 2021 USD ($)	Oct. 30, 2020 USD ($) $ / shares shares	Jul. 01, 2020 USD ($) shares	Sep. 30, 2021 USD ($)	Mar. 31, 2021 USD ($) shares	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Business acquisition
Goodwill				$ 14,470,399		$ 14,470,399		$ 14,581,255	$ 746,079
Cash paid for acquisition, net						75,944	$ 159,663
Measurement period increase (reduction) to goodwill						$ (101,536)		$ 0
Consultant Connect
Business acquisition
Total consideration	$ 56,300
Goodwill	47,300
Consultant Connect \| Client relationships
Business acquisition
Finite-lived intangibles	9,800
Consultant Connect \| Technology
Business acquisition
Finite-lived intangibles	1,900
Consultant Connect \| Brand
Business acquisition
Finite-lived intangibles	$ 600
Livongo Health
Business acquisition
Total consideration					$ 13,876,900
Merger, conversion of common shares ratio		0.5920
Merger, conversion price (in dollars per share) \| $ / shares		$ 4.24
Merger, special cash dividend \| $ / shares		$ 7.09
Goodwill		$ 12,755,839
Initial consideration		13,938,000
Initial cash consideration		401,000
Cash paid for acquisition, net					380,200
Debt incurred upon acquisition					$ 555,400
Amount related to conversion feature of the Livongo Notes guaranteed by the Company		$ 555,400
Initial equity consideration (in shares) \| shares		60,400,000
Initial equity consideration		$ 12,981,600
Equity consideration (in shares) \| shares					60,200,000
Equity consideration					$ 12,941,300
Acquisition related costs		59,000
Excess shares identified \| shares					205,279
Excess shares not withheld \| shares					85,481
Merger-related cash payments identified as cash overpayments					$ 5,600
Excess shares cancelled \| shares					205,279
Increase to receivables					$ 20,800
Decrease to stockholders' equity					(40,300)
Measurement period increase (reduction) to goodwill				5,000	(106,500)
Increase (decrease) to goodwill				$ 6,300	$ (61,100)
Livongo Health \| Client relationships
Business acquisition
Finite-lived intangibles		1,050,000
Livongo Health \| Technology
Business acquisition
Finite-lived intangibles		$ 300,000
InTouch
Business acquisition
Goodwill			$ 899,978
Initial consideration			1,078,500
Initial cash consideration			160,700
Cash acquired			$ 1,100
Initial equity consideration (in shares) \| shares			4,600,000
Initial equity consideration			$ 918,800
Acquisition related costs			12,500
InTouch \| Client relationships
Business acquisition
Finite-lived intangibles			164,580
InTouch \| Technology
Business acquisition
Finite-lived intangibles			$ 29,190

XML 53 R41.htm IDEA: XBRL DOCUMENT

Business Acquisitions - Assets Acquired, Liabilities Assumed, Pro forma (Details) - USD ($) $ in Thousands			3 Months Ended	9 Months Ended
	Oct. 30, 2020	Jul. 01, 2020	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Less:
Goodwill					$ 14,470,399	$ 14,581,255	$ 746,079
Livongo Health
Identifiable assets acquired and liabilities assumed:
Purchase price, net of cash acquired	$ 13,876,931
Less:
Accounts receivable	80,084
Short term investment	52,500
Inventory	24,299
Property and equipment, net	8,952
Right of use assets	15,056
Other assets	17,337
Advances from financing companies	0
Accounts payable	(119,302)
Deferred revenue	(997)
Convertible notes	(453,417)
Deferred taxes	(37,980)
Lease liabilities	(18,834)
Other liabilities	(46,606)
Goodwill	12,755,839
Livongo Health \| Client relationships
Less:
Finite-lived intangibles	1,050,000
Livongo Health \| Technology
Less:
Finite-lived intangibles	300,000
Livongo Health \| Trademarks
Less:
Finite-lived intangibles	$ 250,000
InTouch
Identifiable assets acquired and liabilities assumed:
Purchase price, net of cash acquired		$ 1,069,759
Less:
Accounts receivable		16,986
Short term investment		0
Inventory		8,492
Property and equipment, net		11,366
Right of use assets		4,965
Other assets		2,541
Advances from financing companies		(26,012)
Accounts payable		(5,589)
Deferred revenue		(20,729)
Convertible notes		0
Deferred taxes		(30,102)
Lease liabilities		(5,495)
Other liabilities		(13,042)
Goodwill		899,978
Pro forma information
Revenue			$ 395,519	$ 1,026,957
Net loss			$ (93,149)	$ (778,287)
InTouch \| Client relationships
Less:
Finite-lived intangibles		164,580
InTouch \| Technology
Less:
Finite-lived intangibles		29,190
InTouch \| Trademarks
Less:
Finite-lived intangibles		$ 32,630

XML 54 R42.htm IDEA: XBRL DOCUMENT

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Inventories
Raw materials and purchased parts	$ 21,836	$ 19,591
Work in process	501	1,431
Finished goods	34,600	35,476
Total inventories	$ 56,937	$ 56,498

XML 55 R43.htm IDEA: XBRL DOCUMENT

Intangible Assets, Net - Summary (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Intangible assets
Gross Value	$ 2,239,016		$ 2,239,016		$ 2,183,399
Accumulated Amortization	(307,004)		(307,004)		(162,535)
Net Carrying Value	1,932,012		1,932,012		$ 2,020,864
Amortization expense for intangible assets	49,600	$ 11,700	$ 145,300	$ 29,600
Weighted Average
Intangible assets
Weighted Average Remaining Useful Life			12 years 3 months 18 days		13 years 1 month 6 days
Client relationships
Intangible assets
Gross Value	1,467,396		$ 1,467,396		$ 1,460,648
Accumulated Amortization	(174,523)		(174,523)		(100,844)
Net Carrying Value	1,292,873		$ 1,292,873		$ 1,359,804
Client relationships \| Minimum
Intangible assets
Useful life			2 years		2 years
Client relationships \| Maximum
Intangible assets
Useful life			20 years		20 years
Client relationships \| Weighted Average
Intangible assets
Weighted Average Remaining Useful Life			14 years 9 months 18 days		15 years 4 months 24 days
Non-compete agreements
Intangible assets
Gross Value	5,008		$ 5,008		$ 5,097
Accumulated Amortization	(5,008)		(5,008)		(4,872)
Net Carrying Value	0		$ 0		$ 225
Non-compete agreements \| Minimum
Intangible assets
Useful life			1 year 6 months		1 year 6 months
Non-compete agreements \| Maximum
Intangible assets
Useful life			5 years		5 years
Non-compete agreements \| Weighted Average
Intangible assets
Weighted Average Remaining Useful Life					4 months 24 days
Trademarks
Intangible assets
Gross Value	326,594		$ 326,594		$ 326,786
Accumulated Amortization	(38,075)		(38,075)		(15,576)
Net Carrying Value	288,519		$ 288,519		$ 311,210
Trademarks \| Minimum
Intangible assets
Useful life			3 years		3 years
Trademarks \| Maximum
Intangible assets
Useful life			15 years		15 years
Trademarks \| Weighted Average
Intangible assets
Weighted Average Remaining Useful Life			9 years 8 months 12 days		10 years 6 months
Patents
Intangible assets
Gross Value	200		$ 200		$ 200
Accumulated Amortization	(200)		$ (200)		(200)
Net Carrying Value					$ 0
Useful life			3 years		3 years
Capitalized software development costs
Intangible assets
Gross Value	97,779		$ 97,779		$ 52,518
Accumulated Amortization	(35,717)		(35,717)		(24,771)
Net Carrying Value	62,062		$ 62,062		$ 27,747
Capitalized software development costs \| Minimum
Intangible assets
Useful life			3 years		3 years
Capitalized software development costs \| Maximum
Intangible assets
Useful life			5 years		5 years
Capitalized software development costs \| Weighted Average
Intangible assets
Weighted Average Remaining Useful Life			2 years 8 months 12 days		2 years 9 months 18 days
Technology
Intangible assets
Gross Value	342,039		$ 342,039		$ 338,150
Accumulated Amortization	(53,481)		(53,481)		(16,272)
Net Carrying Value	$ 288,558		$ 288,558		$ 321,878
Technology \| Minimum
Intangible assets
Useful life			5 years
Technology \| Maximum
Intangible assets
Useful life			7 years
Technology \| Weighted Average
Intangible assets
Weighted Average Remaining Useful Life			5 years 10 months 24 days		6 years 7 months 6 days

XML 56 R44.htm IDEA: XBRL DOCUMENT

Goodwill (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
Goodwill (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Goodwill
Beginning balance	$ 14,581,255	$ 746,079
Additions associated with acquisitions	61,157	13,812,198
Purchase consideration adjustments	(55,801)	0
Deferred tax adjustments	(101,536)	0
Cumulative translation adjustment	(14,676)	22,978
Goodwill	$ 14,470,399	$ 14,581,255

XML 57 R45.htm IDEA: XBRL DOCUMENT

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Accrued Expenses and Other Current Liabilities
Professional fees	$ 2,726	$ 4,717
Consulting fees/provider fees	16,253	23,167
Client performance guarantees	8,817	7,215
Interest payable	5,811	2,049
Income tax payable	1,385	1,627
Insurance	6,272	3,139
Marketing	5,733	2,815
Operating lease liabilities - current	13,148	11,438
Earnout	0	4,514
Acquisition & Integration	4,212	1,036
Franchise and Sales Taxes	5,802	2,099
Device Replacement Cost	6,263	0
Other	29,831	19,841
Total	$ 106,252	$ 83,657

XML 58 R46.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Recurring (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Fair Value
Short-term investments	$ 2,538		$ 2,538		$ 53,245
Equity securities without readily determinable fair values	0		0		5,000
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	0	$ 0	0	$ 0
Fair Value, Assets, Level 2 to Level 1 Transfers, Amount	0	0	0	0
Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount	0	0	0	0
Fair value assets level 3 net transfers	0	0	0	0
Fair value liabilities level 3 net transfers	0	$ 0	0	$ 0
Recurring
Fair Value
Cash and cash equivalents	823,828		823,828		733,324
Short-term investments	2,538		2,538		53,245
Equity securities without readily determinable fair values					5,000
Contingent liability					4,514
Level 1 \| Recurring
Fair Value
Cash and cash equivalents	823,828		823,828		733,324
Short-term investments	0		0		0
Equity securities without readily determinable fair values					0
Contingent liability					0
Level 2 \| Recurring
Fair Value
Cash and cash equivalents	0		0		0
Short-term investments	2,538		2,538		53,245
Equity securities without readily determinable fair values					5,000
Contingent liability					0
Level 3 \| Recurring
Fair Value
Cash and cash equivalents	0		0		0
Short-term investments	$ 0		$ 0		0
Equity securities without readily determinable fair values					0
Contingent liability					$ 4,514

XML 59 R47.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Equity Securities (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2021 USD ($)
Change in fair value of the Company's equity securities without readily determinable fair values:
Fair value and historical cost basis at December 31, 2020	$ 5,000
Upward adjustment due to observable price change in identical securities	5,901
Sale of investment	(10,901)
Fair value at September 30, 2021	$ 0

XML 60 R48.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Level 3 (Details) - Contingent Liability $ in Thousands	9 Months Ended
	Sep. 30, 2021 USD ($)
Reconciliation of Level 3 liabilities
Fair value at beginning of period	$ 4,514
Payments	(4,367)
Change in fair value	0
Currency translation adjustment	(147)
Fair value at end of period	$ 0

XML 61 R49.htm IDEA: XBRL DOCUMENT

Leasing Operations - Other (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Leases and Contractual Obligations
Operating lease - right-of-use assets	$ 47,935	$ 46,647
Options to extend	true
Minimum
Leases and Contractual Obligations
Remaining lease terms	1 year
Options to extend lease terms	1 year
Lessor lease term	2 years
Maximum
Leases and Contractual Obligations
Remaining lease terms	7 years
Options to extend lease terms	5 years
Lessor lease term	5 years

XML 62 R50.htm IDEA: XBRL DOCUMENT

Leasing Operations - Future Minimum Lease Payments (Details) $ in Thousands	Sep. 30, 2021 USD ($)
Future minimum lease payments under non cancelable operating leases:
2021	$ 14,594
2022	14,872
2023	10,927
2024	7,233
2025	6,028
2026	13,997
Total future minimum payments	$ 67,651

XML 63 R51.htm IDEA: XBRL DOCUMENT

Convertible Senior Notes - Outstanding Convertible Senior Notes - Issuances (Details) - USD ($) $ in Thousands			9 Months Ended
	May 19, 2020	May 08, 2018	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Oct. 31, 2020	Jun. 27, 2017
2027 Notes
Convertible Senior Notes
Face amount	$ 1,000,000		$ 1,000,000		$ 1,000,000
Interest rate (as a percent)	1.25%
Net proceeds from issuance of Notes	$ 975,900		0	$ 1,000,000
Offering costs	$ 24,100		0	$ 24,070
2025 Notes
Convertible Senior Notes
Face amount		$ 287,500	882		276,788
Interest rate (as a percent)		1.375%
Net proceeds from issuance of Notes		$ 279,100
Offering costs		$ 8,400
Livongo Notes
Convertible Senior Notes
Face amount			550,000		550,000	$ 550,000
Interest rate (as a percent)						0.875%
2022 Notes
Convertible Senior Notes
Face amount			$ 0		$ 46,762		$ 275,000
Interest rate (as a percent)							3.00%

XML 64 R52.htm IDEA: XBRL DOCUMENT

Convertible Senior Notes - Certain terms of the Notes (Details)	9 Months Ended
	Sep. 30, 2021 USD ($) $ / shares
2027 Notes
Convertible Senior Notes
Interest Rate Per Year	1.25%
Fair value	$ 970,500,000
Conversion Rate Per $1,000 Principal Amount \| $ / shares	$ 0.00413
Remaining contractual life	5 years 8 months 12 days
2025 Notes
Convertible Senior Notes
Interest Rate Per Year	1.375%
Fair value	$ 2,100,000
Conversion Rate Per $1,000 Principal Amount \| $ / shares	$ 0.01866
Remaining contractual life	3 years 7 months 6 days
Livongo Notes
Convertible Senior Notes
Interest Rate Per Year	0.875%
Fair value	$ 710,600,000
Conversion Rate Per $1,000 Principal Amount \| $ / shares	$ 0.01394
Remaining contractual life	3 years 8 months 12 days
Notes
Convertible Senior Notes
Principal multiple amount used in the conversion of the debt instrument	$ 1,000

XML 65 R53.htm IDEA: XBRL DOCUMENT

Convertible Senior Notes - Terms (Details) $ / shares in Units, shares in Millions	9 Months Ended
	Sep. 30, 2021 USD ($) D $ / shares shares
2027 Notes
Convertible Senior Notes
Convertible debt, conversion price (in dollars per share) \| $ / shares	$ 0.00413
Convertible debt, equity component \| $	$ 286,000,000
2025 Notes
Convertible Senior Notes
Convertible debt, conversion price (in dollars per share) \| $ / shares	$ 0.01866
Convertible debt, equity component \| $	$ 91,400,000
Livongo Notes
Convertible Senior Notes
Convertible debt, number of consecutive trading days, measurement period	5
Convertible debt, conversion price (in dollars per share) \| $ / shares	$ 0.01394
Convertible debt, Reference property rate	0.5920
Convertible debt, Reference property , conversion price (in dollars per share) \| $ / shares	$ 4.24
Trading day observation period used to determine the amount of cash and shares, if any, that are due upon conversion	40
Percentage of principal for repurchase price (as percent)	100
2022 Notes
Convertible Senior Notes
Convertible debt, equity component \| $	$ 62,400,000
Debt term	5 years 6 months
Notes
Convertible Senior Notes
Principal multiple amount used in the conversion of the debt instrument \| $	$ 1,000
Convertible debt, threshold, trading days	20
Convertible debt, threshold, consecutive trading days	30
Minimum percentage of common stock price as a percentage of the conversion price	130.00%
Convertible debt, number of business days, measurement period	5
Convertible debt, number of consecutive trading days, measurement period	10
Trading price expressed as a percentage of the last reported sales price and conversion rate after the specified consecutive trading day period	98.00%
Shares reserved for issuance (in shares) \| shares	8.7
Debt term	7 years
2027 Notes, 2025 Notes and the 2022 Notes
Convertible Senior Notes
Trading day observation period used to determine the amount of cash and shares, if any, that are due upon conversion	25

XML 66 R54.htm IDEA: XBRL DOCUMENT

Convertible Senior Notes - Outstanding Convertible Senior Notes - Summary (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Oct. 31, 2020	May 19, 2020	May 08, 2018	Jun. 27, 2017
2027 Notes
Convertible Senior Notes
Principal	$ 1,000,000		$ 1,000,000		$ 1,000,000		$ 1,000,000
Less: Debt discount, net	(260,324)		(260,324)		(287,916)
Net carrying amount	739,676		739,676		712,084
Interest Expense
Contractual interest expense	3,125	$ 3,125	9,375	$ 4,618
Amortization of debt discount	9,370	8,989	27,592	12,911
Total	$ 12,495	$ 12,114	$ 36,967	$ 17,529
Effective interest rate of the liability component (as a percent)	3.40%	3.40%	3.40%	3.40%
2025 Notes
Convertible Senior Notes
Principal	$ 882		$ 882		276,788			$ 287,500
Less: Debt discount, net	(215)		(215)		(65,923)
Net carrying amount	667		667		210,865
Interest Expense
Contractual interest expense	10	$ 971	1,080	$ 2,947
Amortization of debt discount	48	3,170	4,546	9,379
Total	$ 58	$ 4,141	$ 5,626	$ 12,326
Effective interest rate of the liability component (as a percent)	4.70%	7.90%	4.70%	7.90%
Livongo Notes
Convertible Senior Notes
Principal	$ 550,000		$ 550,000		550,000	$ 550,000
Less: Debt discount, net	(78,968)		(78,968)		(93,357)
Net carrying amount	471,032		471,032		456,643
Interest Expense
Contractual interest expense	1,203		3,609
Amortization of debt discount	4,858		14,389
Total	$ 6,061		$ 17,998
Effective interest rate of the liability component (as a percent)	5.20%		5.20%
2022 Notes
Convertible Senior Notes
Principal	$ 0		$ 0		46,762				$ 275,000
Less: Debt discount, net	0		0		(4,202)
Net carrying amount	$ 0		0		$ 42,560
Interest Expense
Contractual interest expense		$ 351	116	$ 3,696
Amortization of debt discount		650	316	6,940
Total		$ 1,001	$ 432	$ 10,636
Effective interest rate of the liability component (as a percent)		10.00%	3.00%	10.00%

XML 67 R55.htm IDEA: XBRL DOCUMENT

Convertible Senior Notes - Exchange/Redemption of Convertible Senior Notes Due (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended			9 Months Ended
	Aug. 31, 2021	Mar. 31, 2021	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Convertible Senior Notes
Loss on extinguishment of debt			$ 850		$ 1,227	$ 43,728	$ 8,978
2025 Notes
Convertible Senior Notes
Shares issued for conversion/exchange of debt	95,347					5,200,000
Principal amount of debt exchanged for shares of the Company's common stock in private placement transactions	$ 5,100
Loss on extinguishment of debt			$ 800			$ 40,300
2022 Notes
Convertible Senior Notes
Shares issued for conversion/exchange of debt		1,100,000
Cash exchanged, redemption of convertible notes		$ 100
Loss on extinguishment of debt				$ 3,400

XML 68 R56.htm IDEA: XBRL DOCUMENT

Advances from Financing Companies (Details) $ in Thousands	Sep. 30, 2021 USD ($)
2021	$ 3,763
2022	11,718
2023	5,491
2024	1,031
Total	$ 22,003
Minimum
Advances from financing companies, interest rate (as a percent)	3.35%
Maximum
Advances from financing companies, interest rate (as a percent)	9.89%

XML 69 R57.htm IDEA: XBRL DOCUMENT

Common Stock and Stockholders' Equity - Capitalization (Details) - shares	Sep. 30, 2021	Dec. 31, 2020	Oct. 30, 2020	Oct. 29, 2020
Common Stock and Stockholders'Equity
Number of common stock shares authorized	300,000,000	300,000,000	300,000,000	150,000,000

XML 70 R58.htm IDEA: XBRL DOCUMENT

Common Stock and Stockholders' Equity - Warrants (Details) - shares	Sep. 30, 2021	Dec. 31, 2020
Common stock warrants
Warrants
Warrants outstanding (in shares)	0	0

XML 71 R59.htm IDEA: XBRL DOCUMENT

Common Stock and Stockholders' Equity - Stock Plan and Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 29, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Common Stock and Stockholders' Equity
Trading days	4 days
Shares available for grant		12,574,026		12,574,026
Aggregate Intrinsic Value
Grant-date fair value of stock options granted during the period		$ 3,000	$ 10,700	$ 5,800	$ 11,200
Stock options
Common Stock and Stockholders' Equity
Vesting period				4 years
Stock options \| Maximum
Common Stock and Stockholders' Equity
Exercisable period (in years)				10 years
RSUs
Common Stock and Stockholders' Equity
Vesting period				3 years
RSUs \| Maximum
Common Stock and Stockholders' Equity
Vesting period				4 years
2015 Incentive Award Plan
Number of Shares Outstanding
Balance, beginning of period (in shares)				5,826,685
Stock option grants and assumed awards (in shares)				35,740
Stock option exercised (in shares)				(2,120,943)
Stock options forfeited (in shares)				(90,583)
Balance, end of period (in shares)		3,650,899		3,650,899		5,826,685
Vested or expected to vest at end of period (in shares)		3,650,899		3,650,899
Exercisable as of end of period (in shares)		3,243,849		3,243,849
Weighted-Average Exercise Price
Balance, beginning of period (in dollars per share)				$ 17.19
Stock option grants and assumed awards (in dollars per share)				162.38
Stock option exercised (in dollars per share)				10.79
Stock options forfeited (in dollars per share)				30.03
Balance, end of period (in dollars per share)		$ 21.96		21.96		$ 17.19
Vested or expected to vest at end of period (in dollars per share)		21.96		21.96
Exercisable as of end of period (in dollars per share)		$ 18.84		$ 18.84
Weighted-average remaining contractual life in Years
Weighted-average remaining contractual life (in years)				5 years 6 months 25 days		5 years 3 months 21 days
Vested or expected to vest at end of period (in years)				7 years 1 month 6 days
Exercisable as of end of period (in years)				5 years 4 months 13 days
Aggregate Intrinsic Value
Aggregate Intrinsic Value		$ 386,390		$ 386,390		$ 1,064,944
Stock options exercised				(409,182)
Vested or expected to vest at end of period		35,607		35,607
Exercisable as of end of period		$ 350,848		$ 350,848

XML 72 R60.htm IDEA: XBRL DOCUMENT

Common Stock and Stockholders' Equity - Fair Value Assumptions (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Fair value assumptions
Risk-free interest rate, maximum			0.70%
Other disclosures
Compensation expense	$ 71,701	$ 20,908	$ 240,971	$ 61,151
Stock options
Fair value assumptions
Volatility, minimum (as a percent)			56.52%	46.10%
Volatility, maximum (as a percent)			58.14%	56.00%
Expected life (in years)			4 years 1 month 6 days	4 years 1 month 6 days
Risk-free interest rate, minimum			0.31%	0.27%
Risk-free interest rate, maximum				1.64%
Dividend yield (as a percent)			0.00%	0.00%
Weighted-average fair value of the underlying stock options			$ 72.46	$ 49.21
Other disclosures
Compensation expense	23,300	$ 3,400	$ 77,100	$ 11,500
Unrecognized compensation cost	$ 40,400		$ 40,400
Period over which unrecognized compensation cost is expected to be recognized			10 months 24 days

XML 73 R61.htm IDEA: XBRL DOCUMENT

Common Stock and Stockholders' Equity - Restricted Stock Units (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Other disclosures
Stock-based compensation	$ 71,701	$ 20,908	$ 240,971	$ 61,151
RSUs
Common Stock and Stockholders' Equity
Vesting period			3 years
Shares
Outstanding at beginning of period (in shares)			3,550,595
Granted including replacement awards for merger (in shares)			650,335
Vested and issued (in shares)			(1,222,550)
Forfeited (in shares)			(681,510)
Outstanding at end of period (in shares)	2,296,870		2,296,870
Vested and unissued (in shares)	13,755		13,755
Nonvested (in shares)	2,283,115		2,283,115
Weighted-Average Grant Date Fair Value Per Share
Outstanding at beginning of period (in dollars per share)			$ 162.11
Granted including replacement awards for merger (in dollars per share)			192.86
Vested and issued (in dollars per share)			131.65
Forfeited (in dollars per share)			183.98
Outstanding at end of period (in dollars per share)	$ 175.60		175.60
Vested and unissued (in dollars per share)	50.90		50.90
Non-vested (in dollars per share)	$ 175.60		$ 175.60
Other disclosures
Grant date fair value of RSUs granted	$ 23,100	11,900	$ 125,000	54,900
Stock-based compensation	42,800	$ 11,300	142,600	$ 32,000
Unrecognized compensation cost related to non vested awards	$ 343,600		$ 343,600
Period over which unrecognized compensation cost is expected to be recognized			2 years 2 months 12 days
Minimum \| RSUs
Common Stock and Stockholders' Equity
Vesting period			1 year
Maximum \| RSUs
Common Stock and Stockholders' Equity
Vesting period			4 years

XML 74 R62.htm IDEA: XBRL DOCUMENT

Common Stock and Stockholders' Equity - Performance Stock Units (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Other disclosures
Stock-based compensation	$ 71,701	$ 20,908	$ 240,971	$ 61,151
PSUs
Shares
Outstanding at beginning of period (in shares)			429,319
Granted		0	531,309
Vested and issued (in shares)			(268,201)
Forfeited (in shares)			(26,730)
Outstanding at end of period (in shares)	665,697		665,697
Vested and unissued (in shares)	0		0
Nonvested (in shares)	665,697		665,697
Weighted-Average Grant Date Fair Value Per Share
Outstanding at beginning of period (in dollars per share)			$ 76.60
Granted (in dollars per share)			132.66
Vested and issued (in dollars per share)			74.33
Forfeited (in dollars per share)			153.05
Outstanding at end of period (in dollars per share)	$ 119.07		119.07
Vested and unissued (in dollars per share)	0		0
Non-vested (in dollars per share)	$ 119.07		$ 119.07
Other disclosures
Grant date fair value of PSUs granted	$ 2,500		$ 70,400	13,100
Stock-based compensation	4,200	$ 5,900	16,700	$ 16,800
Unrecognized compensation cost related to non vested awards	$ 22,500		$ 22,500
Period over which unrecognized compensation cost is expected to be recognized			2 years 4 months 24 days
PSUs \| Minimum
Common Stock and Stockholders' Equity
Vesting period			1 year
Actual performance compared to performance conditions percentage			50.00%
PSUs \| Maximum
Common Stock and Stockholders' Equity
Vesting period			3 years
Actual performance compared to performance conditions percentage			225.00%

XML 75 R63.htm IDEA: XBRL DOCUMENT

Common Stock and Stockholders' Equity - Employee Stock Purchase Plan (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Jul. 31, 2015	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Employee Stock Purchase Plan
Stock-based compensation		$ 71,701	$ 20,908	$ 240,971	$ 61,151
ESPP
Employee Stock Purchase Plan
Shares reserved for issuance under the plan (in shares)		926,109		926,109
Maximum offering period	27 months
Stock purchase price as a percentage of fair value (as a percent)	85.00%
Issuance of stock under employee stock purchase plan (in shares)				82,088	35,901
Remaining shares available for issuance under the plan (in shares)		517,015		517,015
Stock-based compensation		$ 1,400	$ 600	$ 4,600	$ 1,400
Unrecognized compensation cost		$ 600		$ 600
Period over which unrecognized compensation cost is expected to be recognized				1 month 6 days

XML 76 R64.htm IDEA: XBRL DOCUMENT

Common Stock and Stockholders' Equity - Compensation Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Compensation costs charged as an expense
Stock-based compensation	$ 71,701	$ 20,908	$ 240,971	$ 61,151
Cost of revenue (exclusive of depreciation and amortization, which is shown separately)
Compensation costs charged as an expense
Stock-based compensation	2,162	128	6,310	128
Advertising and marketing
Compensation costs charged as an expense
Stock-based compensation	5,244	1,644	15,141	4,447
Sales
Compensation costs charged as an expense
Stock-based compensation	17,518	3,275	57,638	9,465
Technology and development
Compensation costs charged as an expense
Stock-based compensation	22,910	2,622	77,335	7,285
General and administrative expenses
Compensation costs charged as an expense
Stock-based compensation	$ 23,867	$ 13,239	$ 84,547	$ 39,826

XML 77 R65.htm IDEA: XBRL DOCUMENT

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Income Taxes
Income tax expense (benefit)	$ 3,643	$ (2,290)	$ 93,878	$ (5,400)
Deferred tax adjustments			$ (101,536)		$ 0

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

EXCEL 78 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 80 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 81 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 298 448 1 false 49 0 false 6 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.teladoc.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.teladoc.com/role/StatementConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.teladoc.com/role/StatementConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 00300 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 10101 - Disclosure - Organization and Description of Business Sheet http://www.teladoc.com/role/DisclosureOrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 7 false false R8.htm 10201 - Disclosure - Basis of Presentation and Principles of Consolidation Sheet http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidation Basis of Presentation and Principles of Consolidation Notes 8 false false R9.htm 10301 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other Sheet http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOther Revenue, Deferred Revenue, Deferred Costs and Other Notes 9 false false R10.htm 10401 - Disclosure - Business Acquisitions Sheet http://www.teladoc.com/role/DisclosureBusinessAcquisitions Business Acquisitions Notes 10 false false R11.htm 10501 - Disclosure - Inventories Sheet http://www.teladoc.com/role/DisclosureInventories Inventories Notes 11 false false R12.htm 10601 - Disclosure - Intangible Assets, Net Sheet http://www.teladoc.com/role/DisclosureIntangibleAssetsNet Intangible Assets, Net Notes 12 false false R13.htm 10701 - Disclosure - Goodwill Sheet http://www.teladoc.com/role/DisclosureGoodwill Goodwill Notes 13 false false R14.htm 10801 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 14 false false R15.htm 10901 - Disclosure - Fair Value Measurements Sheet http://www.teladoc.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 11001 - Disclosure - Leasing Operations Sheet http://www.teladoc.com/role/DisclosureLeasingOperations Leasing Operations Notes 16 false false R17.htm 11101 - Disclosure - Convertible Senior Notes Notes http://www.teladoc.com/role/DisclosureConvertibleSeniorNotes Convertible Senior Notes Notes 17 false false R18.htm 11201 - Disclosure - Advances from Financing Companies Sheet http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompanies Advances from Financing Companies Notes 18 false false R19.htm 11301 - Disclosure - Legal Matters Sheet http://www.teladoc.com/role/DisclosureLegalMatters Legal Matters Notes 19 false false R20.htm 11401 - Disclosure - Common Stock and Stockholders' Equity Sheet http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquity Common Stock and Stockholders' Equity Notes 20 false false R21.htm 11501 - Disclosure - Income Taxes Sheet http://www.teladoc.com/role/DisclosureIncomeTaxes Income Taxes Notes 21 false false R22.htm 20202 - Disclosure - Basis of Presentation and Principles of Consolidations (Policies) Sheet http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationsPolicies Basis of Presentation and Principles of Consolidations (Policies) Policies 22 false false R23.htm 30303 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other (Tables) Sheet http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherTables Revenue, Deferred Revenue, Deferred Costs and Other (Tables) Tables http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOther 23 false false R24.htm 30403 - Disclosure - Business Acquisitions (Tables) Sheet http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTables Business Acquisitions (Tables) Tables http://www.teladoc.com/role/DisclosureBusinessAcquisitions 24 false false R25.htm 30503 - Disclosure - Inventories (Tables) Sheet http://www.teladoc.com/role/DisclosureInventoriesTables Inventories (Tables) Tables http://www.teladoc.com/role/DisclosureInventories 25 false false R26.htm 30603 - Disclosure - Intangible Assets, Net (Tables) Sheet http://www.teladoc.com/role/DisclosureIntangibleAssetsNetTables Intangible Assets, Net (Tables) Tables http://www.teladoc.com/role/DisclosureIntangibleAssetsNet 26 false false R27.htm 30703 - Disclosure - Goodwill (Tables) Sheet http://www.teladoc.com/role/DisclosureGoodwillTables Goodwill (Tables) Tables http://www.teladoc.com/role/DisclosureGoodwill 27 false false R28.htm 30803 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities 28 false false R29.htm 30903 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.teladoc.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.teladoc.com/role/DisclosureFairValueMeasurements 29 false false R30.htm 31003 - Disclosure - Leasing Operations (Tables) Sheet http://www.teladoc.com/role/DisclosureLeasingOperationsTables Leasing Operations (Tables) Tables http://www.teladoc.com/role/DisclosureLeasingOperations 30 false false R31.htm 31103 - Disclosure - Convertible Senior Notes (Tables) Notes http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTables Convertible Senior Notes (Tables) Tables http://www.teladoc.com/role/DisclosureConvertibleSeniorNotes 31 false false R32.htm 31203 - Disclosure - Advances from Financing Companies (Tables) Sheet http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesTables Advances from Financing Companies (Tables) Tables http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompanies 32 false false R33.htm 31403 - Disclosure - Common Stock and Stockholders' Equity (Tables) Sheet http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityTables Common Stock and Stockholders' Equity (Tables) Tables http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquity 33 false false R34.htm 40201 - Disclosure - Basis of Presentation and Principles of Consolidation - VIE (Details) Sheet http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails Basis of Presentation and Principles of Consolidation - VIE (Details) Details http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationsPolicies 34 false false R35.htm 40301 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Other Disclosures (Details) Sheet http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails Revenue, Deferred Revenue, Deferred Costs and Other - Other Disclosures (Details) Details 35 false false R36.htm 40302 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Disaggregation and Other (Details) Sheet http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails Revenue, Deferred Revenue, Deferred Costs and Other - Disaggregation and Other (Details) Details 36 false false R37.htm 40303 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Revenue Remaining Performance Obligation (Details) Sheet http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherRevenueRemainingPerformanceObligationDetails Revenue, Deferred Revenue, Deferred Costs and Other - Revenue Remaining Performance Obligation (Details) Details 37 false false R38.htm 40304 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Deferred Cost and Other (Details) Sheet http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherDetails Revenue, Deferred Revenue, Deferred Costs and Other - Deferred Cost and Other (Details) Details 38 false false R39.htm 40305 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Deferred Cost and Other Activity (Details) Sheet http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherActivityDetails Revenue, Deferred Revenue, Deferred Costs and Other - Deferred Cost and Other Activity (Details) Details 39 false false R40.htm 40401 - Disclosure - Business Acquisitions - Transactions (Details) Sheet http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails Business Acquisitions - Transactions (Details) Details 40 false false R41.htm 40402 - Disclosure - Business Acquisitions - Assets Acquired, Liabilities Assumed, Pro forma (Details) Sheet http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails Business Acquisitions - Assets Acquired, Liabilities Assumed, Pro forma (Details) Details 41 false false R42.htm 40501 - Disclosure - Inventories (Details) Sheet http://www.teladoc.com/role/DisclosureInventoriesDetails Inventories (Details) Details http://www.teladoc.com/role/DisclosureInventoriesTables 42 false false R43.htm 40601 - Disclosure - Intangible Assets, Net - Summary (Details) Sheet http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails Intangible Assets, Net - Summary (Details) Details 43 false false R44.htm 40701 - Disclosure - Goodwill (Details) Sheet http://www.teladoc.com/role/DisclosureGoodwillDetails Goodwill (Details) Details http://www.teladoc.com/role/DisclosureGoodwillTables 44 false false R45.htm 40801 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities (Details) Details http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables 45 false false R46.htm 40901 - Disclosure - Fair Value Measurements - Recurring (Details) Sheet http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails Fair Value Measurements - Recurring (Details) Details 46 false false R47.htm 40902 - Disclosure - Fair Value Measurements - Equity Securities (Details) Sheet http://www.teladoc.com/role/DisclosureFairValueMeasurementsEquitySecuritiesDetails Fair Value Measurements - Equity Securities (Details) Details 47 false false R48.htm 40903 - Disclosure - Fair Value Measurements - Level 3 (Details) Sheet http://www.teladoc.com/role/DisclosureFairValueMeasurementsLevel3Details Fair Value Measurements - Level 3 (Details) Details 48 false false R49.htm 41001 - Disclosure - Leasing Operations - Other (Details) Sheet http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails Leasing Operations - Other (Details) Details 49 false false R50.htm 41002 - Disclosure - Leasing Operations - Future Minimum Lease Payments (Details) Sheet http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails Leasing Operations - Future Minimum Lease Payments (Details) Details 50 false false R51.htm 41101 - Disclosure - Convertible Senior Notes - Outstanding Convertible Senior Notes - Issuances (Details) Notes http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails Convertible Senior Notes - Outstanding Convertible Senior Notes - Issuances (Details) Details 51 false false R52.htm 41102 - Disclosure - Convertible Senior Notes - Certain terms of the Notes (Details) Notes http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails Convertible Senior Notes - Certain terms of the Notes (Details) Details 52 false false R53.htm 41103 - Disclosure - Convertible Senior Notes - Terms (Details) Notes http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails Convertible Senior Notes - Terms (Details) Details 53 false false R54.htm 41104 - Disclosure - Convertible Senior Notes - Outstanding Convertible Senior Notes - Summary (Details) Notes http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails Convertible Senior Notes - Outstanding Convertible Senior Notes - Summary (Details) Details 54 false false R55.htm 41105 - Disclosure - Convertible Senior Notes - Exchange/Redemption of Convertible Senior Notes Due (Details) Notes http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesExchangeRedemptionOfConvertibleSeniorNotesDueDetails Convertible Senior Notes - Exchange/Redemption of Convertible Senior Notes Due (Details) Details 55 false false R56.htm 41201 - Disclosure - Advances from Financing Companies (Details) Sheet http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails Advances from Financing Companies (Details) Details http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesTables 56 false false R57.htm 41401 - Disclosure - Common Stock and Stockholders' Equity - Capitalization (Details) Sheet http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCapitalizationDetails Common Stock and Stockholders' Equity - Capitalization (Details) Details 57 false false R58.htm 41402 - Disclosure - Common Stock and Stockholders' Equity - Warrants (Details) Sheet http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityWarrantsDetails Common Stock and Stockholders' Equity - Warrants (Details) Details 58 false false R59.htm 41403 - Disclosure - Common Stock and Stockholders' Equity - Stock Plan and Stock Options (Details) Sheet http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails Common Stock and Stockholders' Equity - Stock Plan and Stock Options (Details) Details 59 false false R60.htm 41404 - Disclosure - Common Stock and Stockholders' Equity - Fair Value Assumptions (Details) Sheet http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails Common Stock and Stockholders' Equity - Fair Value Assumptions (Details) Details 60 false false R61.htm 41405 - Disclosure - Common Stock and Stockholders' Equity - Restricted Stock Units (Details) Sheet http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails Common Stock and Stockholders' Equity - Restricted Stock Units (Details) Details 61 false false R62.htm 41406 - Disclosure - Common Stock and Stockholders' Equity - Performance Stock Units (Details) Sheet http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails Common Stock and Stockholders' Equity - Performance Stock Units (Details) Details 62 false false R63.htm 41407 - Disclosure - Common Stock and Stockholders' Equity - Employee Stock Purchase Plan (Details) Sheet http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails Common Stock and Stockholders' Equity - Employee Stock Purchase Plan (Details) Details 63 false false R64.htm 41408 - Disclosure - Common Stock and Stockholders' Equity - Compensation Costs (Details) Sheet http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCompensationCostsDetails Common Stock and Stockholders' Equity - Compensation Costs (Details) Details 64 false false R65.htm 41501 - Disclosure - Income Taxes (Details) Sheet http://www.teladoc.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.teladoc.com/role/DisclosureIncomeTaxes 65 false false All Reports Book All Reports tdoc-20210930x10q.htm tdoc-20210930.xsd tdoc-20210930_cal.xml tdoc-20210930_def.xml tdoc-20210930_lab.xml tdoc-20210930_pre.xml tdoc-20210930xex10d1.htm tdoc-20210930xex31d1.htm tdoc-20210930xex31d2.htm tdoc-20210930xex32d1.htm tdoc-20210930xex32d2.htm http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true JSON 84 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tdoc-20210930x10q.htm": { "axisCustom": 0, "axisStandard": 19, "contextCount": 298, "dts": { "calculationLink": { "local": [ "tdoc-20210930_cal.xml" ] }, "definitionLink": { "local": [ "tdoc-20210930_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "tdoc-20210930x10q.htm" ] }, "labelLink": { "local": [ "tdoc-20210930_lab.xml" ] }, "presentationLink": { "local": [ "tdoc-20210930_pre.xml" ] }, "schema": { "local": [ "tdoc-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 548, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 32, "http://www.teladoc.com/20210930": 2, "http://xbrl.sec.gov/dei/2020-01-31": 5, "total": 39 }, "keyCustom": 98, "keyStandard": 350, "memberCustom": 20, "memberStandard": 29, "nsprefix": "tdoc", "nsuri": "http://www.teladoc.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "role": "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - Business Acquisitions", "role": "http://www.teladoc.com/role/DisclosureBusinessAcquisitions", "shortName": "Business Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - Inventories", "role": "http://www.teladoc.com/role/DisclosureInventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - Intangible Assets, Net", "role": "http://www.teladoc.com/role/DisclosureIntangibleAssetsNet", "shortName": "Intangible Assets, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - Goodwill", "role": "http://www.teladoc.com/role/DisclosureGoodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - Accrued Expenses and Other Current Liabilities", "role": "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities", "shortName": "Accrued Expenses and Other Current Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - Fair Value Measurements", "role": "http://www.teladoc.com/role/DisclosureFairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "tdoc:LeasingOperationsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11001 - Disclosure - Leasing Operations", "role": "http://www.teladoc.com/role/DisclosureLeasingOperations", "shortName": "Leasing Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "tdoc:LeasingOperationsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "tdoc:ConvertibleDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11101 - Disclosure - Convertible Senior Notes", "role": "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotes", "shortName": "Convertible Senior Notes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "tdoc:ConvertibleDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "tdoc:AdvanceFromFinancingCompaniesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11201 - Disclosure - Advances from Financing Companies", "role": "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompanies", "shortName": "Advances from Financing Companies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "tdoc:AdvanceFromFinancingCompaniesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11301 - Disclosure - Legal Matters", "role": "http://www.teladoc.com/role/DisclosureLegalMatters", "shortName": "Legal Matters", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11401 - Disclosure - Common Stock and Stockholders' Equity", "role": "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquity", "shortName": "Common Stock and Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11501 - Disclosure - Income Taxes", "role": "http://www.teladoc.com/role/DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "tdoc:BasisOfAccountingAndConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - Basis of Presentation and Principles of Consolidations (Policies)", "role": "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationsPolicies", "shortName": "Basis of Presentation and Principles of Consolidations (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "tdoc:BasisOfAccountingAndConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other (Tables)", "role": "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherTables", "shortName": "Revenue, Deferred Revenue, Deferred Costs and Other (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30403 - Disclosure - Business Acquisitions (Tables)", "role": "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTables", "shortName": "Business Acquisitions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30503 - Disclosure - Inventories (Tables)", "role": "http://www.teladoc.com/role/DisclosureInventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30603 - Disclosure - Intangible Assets, Net (Tables)", "role": "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetTables", "shortName": "Intangible Assets, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30703 - Disclosure - Goodwill (Tables)", "role": "http://www.teladoc.com/role/DisclosureGoodwillTables", "shortName": "Goodwill (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "tdoc:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30803 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)", "role": "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables", "shortName": "Accrued Expenses and Other Current Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "tdoc:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30903 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.teladoc.com/role/DisclosureFairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.teladoc.com/role/StatementConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31003 - Disclosure - Leasing Operations (Tables)", "role": "http://www.teladoc.com/role/DisclosureLeasingOperationsTables", "shortName": "Leasing Operations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "tdoc:ConvertibleDebtTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31103 - Disclosure - Convertible Senior Notes (Tables)", "role": "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTables", "shortName": "Convertible Senior Notes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "tdoc:ConvertibleDebtTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "tdoc:AdvanceFromFinancingCompaniesTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "tdoc:AdvancesFromFinancingCompaniesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31203 - Disclosure - Advances from Financing Companies (Tables)", "role": "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesTables", "shortName": "Advances from Financing Companies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "tdoc:AdvanceFromFinancingCompaniesTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "tdoc:AdvancesFromFinancingCompaniesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31403 - Disclosure - Common Stock and Stockholders' Equity (Tables)", "role": "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityTables", "shortName": "Common Stock and Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "tdoc:BasisOfAccountingAndConsolidationPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": "0", "first": true, "lang": null, "name": "tdoc:NumberOfProfessionalAssociationsConsolidatedAsVariableInterestEntities", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_IUcSgM2Nq0WFQu0iECutNA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - Basis of Presentation and Principles of Consolidation - VIE (Details)", "role": "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails", "shortName": "Basis of Presentation and Principles of Consolidation - VIE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "tdoc:BasisOfAccountingAndConsolidationPolicyTextBlock", "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": "0", "first": true, "lang": null, "name": "tdoc:NumberOfProfessionalAssociationsConsolidatedAsVariableInterestEntities", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_IUcSgM2Nq0WFQu0iECutNA", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_srt_ProductOrServiceAxis_tdoc_SubscriptionAccessFeesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember_2xJNmQva_UiLF9LPAu7JMg", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_eFZbs_W-skGBsPD0zEHPPA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Other Disclosures (Details)", "role": "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails", "shortName": "Revenue, Deferred Revenue, Deferred Costs and Other - Other Disclosures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_srt_ProductOrServiceAxis_tdoc_SubscriptionAccessFeesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember_2xJNmQva_UiLF9LPAu7JMg", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_eFZbs_W-skGBsPD0zEHPPA", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_OUUMTjc7tEaJA5ApO6Yn2A", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40302 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Disaggregation and Other (Details)", "role": "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails", "shortName": "Revenue, Deferred Revenue, Deferred Costs and Other - Disaggregation and Other (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_TiklnpLehUuLZNvHX-qg7A", "decimals": "-5", "lang": null, "name": "us-gaap:DeferredRevenue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_tdoc_cnst_2021-10-01_GcMDotMVN0CvhwzllGN7_Q", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40303 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Revenue Remaining Performance Obligation (Details)", "role": "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherRevenueRemainingPerformanceObligationDetails", "shortName": "Revenue, Deferred Revenue, Deferred Costs and Other - Revenue Remaining Performance Obligation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_tdoc_cnst_2021-10-01_GcMDotMVN0CvhwzllGN7_Q", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "tdoc:ScheduleOfDeferredCostAndOtherTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "tdoc:DeferredDeviceCostAndOtherCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40304 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Deferred Cost and Other (Details)", "role": "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherDetails", "shortName": "Revenue, Deferred Revenue, Deferred Costs and Other - Deferred Cost and Other (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "tdoc:ScheduleOfDeferredCostAndOtherTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "tdoc:DeferredDeviceCostAndOtherCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "tdoc:ScheduleOfDeferredCostAndOtherTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_TiklnpLehUuLZNvHX-qg7A", "decimals": "-3", "first": true, "lang": null, "name": "tdoc:DeferredDeviceCostAndOther", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40305 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other - Deferred Cost and Other Activity (Details)", "role": "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherActivityDetails", "shortName": "Revenue, Deferred Revenue, Deferred Costs and Other - Deferred Cost and Other Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "tdoc:ScheduleOfDeferredCostAndOtherTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": "-3", "lang": null, "name": "tdoc:DeferredDeviceCostAndOtherAdditions", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_OUUMTjc7tEaJA5ApO6Yn2A", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS", "role": "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_OUUMTjc7tEaJA5ApO6Yn2A", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - Business Acquisitions - Transactions (Details)", "role": "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails", "shortName": "Business Acquisitions - Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_4_2021_To_1_4_2021_us-gaap_BusinessAcquisitionAxis_tdoc_ConsultantConnectLimitedMember_TKNc8fc76EeZPG1flYQqCg", "decimals": "-5", "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40402 - Disclosure - Business Acquisitions - Assets Acquired, Liabilities Assumed, Pro forma (Details)", "role": "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "shortName": "Business Acquisitions - Assets Acquired, Liabilities Assumed, Pro forma (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_10_30_2020_To_10_30_2020_us-gaap_BusinessAcquisitionAxis_tdoc_LivongoHealthIncMember_HOkaDHBsSka7bP6UyoryDw", "decimals": "-3", "lang": null, "name": "tdoc:BusinessCombinationConsiderationTransferredNetOfCashAcquired", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - Inventories (Details)", "role": "http://www.teladoc.com/role/DisclosureInventoriesDetails", "shortName": "Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - Intangible Assets, Net - Summary (Details)", "role": "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails", "shortName": "Intangible Assets, Net - Summary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_TiklnpLehUuLZNvHX-qg7A", "decimals": "-3", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_TiklnpLehUuLZNvHX-qg7A", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - Goodwill (Details)", "role": "http://www.teladoc.com/role/DisclosureGoodwillDetails", "shortName": "Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": "-3", "lang": null, "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "tdoc:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedProfessionalFeesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)", "role": "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails", "shortName": "Accrued Expenses and Other Current Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "tdoc:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedProfessionalFeesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40901 - Disclosure - Fair Value Measurements - Recurring (Details)", "role": "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails", "shortName": "Fair Value Measurements - Recurring (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_aAQxKvOKLEqjuVO5XYIVTw", "decimals": "-3", "lang": null, "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_TiklnpLehUuLZNvHX-qg7A", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40902 - Disclosure - Fair Value Measurements - Equity Securities (Details)", "role": "http://www.teladoc.com/role/DisclosureFairValueMeasurementsEquitySecuritiesDetails", "shortName": "Fair Value Measurements - Equity Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": "-3", "lang": null, "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_us-gaap_FairValueByLiabilityClassAxis_tdoc_ContingentLiabilityMember_V6s7l1jqeUy2VRPJJxv5Iw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40903 - Disclosure - Fair Value Measurements - Level 3 (Details)", "role": "http://www.teladoc.com/role/DisclosureFairValueMeasurementsLevel3Details", "shortName": "Fair Value Measurements - Level 3 (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_us-gaap_FairValueByLiabilityClassAxis_tdoc_ContingentLiabilityMember_V6s7l1jqeUy2VRPJJxv5Iw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41001 - Disclosure - Leasing Operations - Other (Details)", "role": "http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails", "shortName": "Leasing Operations - Other (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "tdoc:LeasingOperationsTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HznlVy4QXEWoIl6_s9cR2w", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "role": "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_HznlVy4QXEWoIl6_s9cR2w", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41002 - Disclosure - Leasing Operations - Future Minimum Lease Payments (Details)", "role": "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails", "shortName": "Leasing Operations - Future Minimum Lease Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "tdoc:ConvertibleDebtTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_5_19_2020_us-gaap_DebtInstrumentAxis_tdoc_ConvertibleSeniorNotesDue2027Member_7hqaTZik-UGJS7oDQUV5ow", "decimals": "-9", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41101 - Disclosure - Convertible Senior Notes - Outstanding Convertible Senior Notes - Issuances (Details)", "role": "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails", "shortName": "Convertible Senior Notes - Outstanding Convertible Senior Notes - Issuances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "tdoc:ConvertibleDebtTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_5_19_2020_us-gaap_DebtInstrumentAxis_tdoc_ConvertibleSeniorNotesDue2027Member_7hqaTZik-UGJS7oDQUV5ow", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_eFZbs_W-skGBsPD0zEHPPA", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "tdoc:ConvertibleDebtTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_us-gaap_DebtInstrumentAxis_tdoc_ConvertibleSeniorNotesDue2027Member_0xOw2g6Zz0CEzGrVQPiQZw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtConversionOriginalDebtInterestRateOfDebt", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_eFZbs_W-skGBsPD0zEHPPA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41102 - Disclosure - Convertible Senior Notes - Certain terms of the Notes (Details)", "role": "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "shortName": "Convertible Senior Notes - Certain terms of the Notes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "tdoc:ConvertibleDebtTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_us-gaap_DebtInstrumentAxis_tdoc_ConvertibleSeniorNotesDue2027Member_0xOw2g6Zz0CEzGrVQPiQZw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtConversionOriginalDebtInterestRateOfDebt", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_eFZbs_W-skGBsPD0zEHPPA", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_tdoc_ConvertibleSeniorNotesDue2027Member_V5Ut73lmVkWIZFNzosOaaw", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41103 - Disclosure - Convertible Senior Notes - Terms (Details)", "role": "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails", "shortName": "Convertible Senior Notes - Terms (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_tdoc_ConvertibleSeniorNotesDue2027Member_V5Ut73lmVkWIZFNzosOaaw", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_DebtInstrumentAxis_tdoc_ConvertibleSeniorNotesDue2027Member_V5Ut73lmVkWIZFNzosOaaw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41104 - Disclosure - Convertible Senior Notes - Outstanding Convertible Senior Notes - Summary (Details)", "role": "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails", "shortName": "Convertible Senior Notes - Outstanding Convertible Senior Notes - Summary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_us-gaap_DebtInstrumentAxis_tdoc_ConvertibleSeniorNotesDue2027Member_AQg3S-7uNEW610fyCSp3DA", "decimals": "-3", "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_OUUMTjc7tEaJA5ApO6Yn2A", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41105 - Disclosure - Convertible Senior Notes - Exchange/Redemption of Convertible Senior Notes Due (Details)", "role": "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesExchangeRedemptionOfConvertibleSeniorNotesDueDetails", "shortName": "Convertible Senior Notes - Exchange/Redemption of Convertible Senior Notes Due (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_8_1_2021_To_8_31_2021_us-gaap_DebtInstrumentAxis_tdoc_ConvertibleSeniorNotesDue2025Member_WNnEKLsKJ0iOpnX4EQEWaA", "decimals": "INF", "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentSharesIssued1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_5cbdNghFA0mW_5C9dJVXIQ", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "tdoc:AdvancesFromFinancingCompaniesTableTextBlock", "tdoc:AdvanceFromFinancingCompaniesTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "tdoc:AdvancesFromFinancingCompaniesCustomerPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41201 - Disclosure - Advances from Financing Companies (Details)", "role": "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails", "shortName": "Advances from Financing Companies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "tdoc:AdvancesFromFinancingCompaniesTableTextBlock", "tdoc:AdvanceFromFinancingCompaniesTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "-3", "first": true, "lang": null, "name": "tdoc:AdvancesFromFinancingCompaniesCustomerPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_Standard_shares_5cbdNghFA0mW_5C9dJVXIQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41401 - Disclosure - Common Stock and Stockholders' Equity - Capitalization (Details)", "role": "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCapitalizationDetails", "shortName": "Common Stock and Stockholders' Equity - Capitalization (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_10_30_2020_HZmHqKnlske-dDG9woJ-WQ", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_5cbdNghFA0mW_5C9dJVXIQ", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_tdoc_CommonStockWarrantMember_RXrsIhSAxUGn4XqQ6o1utg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_5cbdNghFA0mW_5C9dJVXIQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41402 - Disclosure - Common Stock and Stockholders' Equity - Warrants (Details)", "role": "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityWarrantsDetails", "shortName": "Common Stock and Stockholders' Equity - Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_ClassOfWarrantOrRightAxis_tdoc_CommonStockWarrantMember_RXrsIhSAxUGn4XqQ6o1utg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_5cbdNghFA0mW_5C9dJVXIQ", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_wDZw9BF69E-cBWJBtiXhoA", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "reportCount": 1, "unitRef": "Unit_Standard_shares_5cbdNghFA0mW_5C9dJVXIQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41403 - Disclosure - Common Stock and Stockholders' Equity - Stock Plan and Stock Options (Details)", "role": "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails", "shortName": "Common Stock and Stockholders' Equity - Stock Plan and Stock Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_OUUMTjc7tEaJA5ApO6Yn2A", "decimals": "-5", "lang": null, "name": "tdoc:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_eFZbs_W-skGBsPD0zEHPPA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41404 - Disclosure - Common Stock and Stockholders' Equity - Fair Value Assumptions (Details)", "role": "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails", "shortName": "Common Stock and Stockholders' Equity - Fair Value Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_eFZbs_W-skGBsPD0zEHPPA", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_OUUMTjc7tEaJA5ApO6Yn2A", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41405 - Disclosure - Common Stock and Stockholders' Equity - Restricted Stock Units (Details)", "role": "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails", "shortName": "Common Stock and Stockholders' Equity - Restricted Stock Units (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_JXLN-939m0mbOQ2ihB3JqQ", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_5cbdNghFA0mW_5C9dJVXIQ", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_OUUMTjc7tEaJA5ApO6Yn2A", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41406 - Disclosure - Common Stock and Stockholders' Equity - Performance Stock Units (Details)", "role": "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "shortName": "Common Stock and Stockholders' Equity - Performance Stock Units (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "tdoc:ScheduleOfPerformanceBasedUnitsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_R4JlY-jtJE6S3qTTHOrq-w", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_5cbdNghFA0mW_5C9dJVXIQ", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_OUUMTjc7tEaJA5ApO6Yn2A", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41407 - Disclosure - Common Stock and Stockholders' Equity - Employee Stock Purchase Plan (Details)", "role": "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails", "shortName": "Common Stock and Stockholders' Equity - Employee Stock Purchase Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2015_To_7_31_2015_us-gaap_PlanNameAxis_tdoc_EmployeeStockPurchasePlan2015Member_OAVM_iLhi0SxjGggX0mEow", "decimals": null, "lang": "en-US", "name": "tdoc:MaximumOfferingPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_OUUMTjc7tEaJA5ApO6Yn2A", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41408 - Disclosure - Common Stock and Stockholders' Equity - Compensation Costs (Details)", "role": "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCompensationCostsDetails", "shortName": "Common Stock and Stockholders' Equity - Compensation Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_yQf2wXpDJkGApuaAib4iJw", "decimals": "-3", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_OUUMTjc7tEaJA5ApO6Yn2A", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "Unit_Standard_USD_V_ur0eMEO0an4dvFXJMocA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41501 - Disclosure - Income Taxes (Details)", "role": "http://www.teladoc.com/role/DisclosureIncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - Organization and Description of Business", "role": "http://www.teladoc.com/role/DisclosureOrganizationAndDescriptionOfBusiness", "shortName": "Organization and Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - Basis of Presentation and Principles of Consolidation", "role": "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidation", "shortName": "Basis of Presentation and Principles of Consolidation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - Revenue, Deferred Revenue, Deferred Costs and Other", "role": "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOther", "shortName": "Revenue, Deferred Revenue, Deferred Costs and Other", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "tdoc-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_9rvKDv3f3EuN7D8SZTJs5g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 49, "tag": { "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "U [S]", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r316", "r317", "r320", "r321", "r427" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r316", "r317", "r320", "r321" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r233", "r235", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r405", "r408" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails", "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails", "http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r233", "r235", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r405", "r408" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails", "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails", "http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r144", "r212", "r215", "r371", "r404", "r406" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails", "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r144", "r212", "r215", "r371", "r404", "r406" ], "lang": { "en-us": { "role": { "label": "Products And Services [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails", "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r223", "r233", "r235", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r405", "r408" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails", "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails", "http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r223", "r233", "r235", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r405", "r408" ], "lang": { "en-us": { "role": { "label": "Range [Member]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails", "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails", "http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r145", "r146", "r212", "r216", "r407", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425" ], "lang": { "en-us": { "role": { "label": "Segment Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r145", "r146", "r212", "r216", "r407", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "stringItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r364", "r366", "r369" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]", "terseLabel": "Weighted Average" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "domainItemType" }, "tdoc_AccretionOfInterest": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The accretion of interest.", "label": "Accretion of Interest", "terseLabel": "Accretion of interest" } } }, "localname": "AccretionOfInterest", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "tdoc_AccruedConsultingAndCustomerServiceFeesCurrent": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for consulting and customer service fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Consulting And Customer Service Fees Current", "terseLabel": "Consulting fees/provider fees" } } }, "localname": "AccruedConsultingAndCustomerServiceFeesCurrent", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_AccruedEarnOutCurrent": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 9.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of earn out obligations. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Earn-Out, Current", "terseLabel": "Earnout" } } }, "localname": "AccruedEarnOutCurrent", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_AccruedExpensesAndOtherCurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Accrued Expenses and Other Current Liabilities" } } }, "localname": "AccruedExpensesAndOtherCurrentLiabilitiesAbstract", "nsuri": "http://www.teladoc.com/20210930", "xbrltype": "stringItemType" }, "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Also includes aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet.", "label": "Accrued Liabilities And Other Liabilities Current", "totalLabel": "Total" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilitiesCurrent", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered, excluding accrued compensation. Also includes aggregate carrying amount of liabilities not separately disclosed in the balance sheet. Used to reflect the current portion of liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "tdoc_AcquisitionIntegrationAndTransformationRelatedCostsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for acquisition, integration and transformation related costs.", "label": "Acquisition, Integration and Transformation Related Costs Policy [Policy Text Block]", "terseLabel": "Acquisition, Integration and Transformation Costs" } } }, "localname": "AcquisitionIntegrationAndTransformationRelatedCostsPolicyPolicyTextBlock", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationsPolicies" ], "xbrltype": "textBlockItemType" }, "tdoc_ActualPerformanceComparedToPerformanceConditionsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of actual performance of the Company at the end of the performance period compared to the performance conditions.", "label": "Actual performance Compared To Performance Conditions Percentage", "terseLabel": "Actual performance compared to performance conditions percentage" } } }, "localname": "ActualPerformanceComparedToPerformanceConditionsPercentage", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails" ], "xbrltype": "percentItemType" }, "tdoc_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtExtinguishment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustment to additional paid in capital resulting from the equity component of convertible debt that was extinguished during the period.", "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Extinguishment", "negatedLabel": "Equity portion of extinguishment of Notes" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtExtinguishment", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "tdoc_AdministrativeAndMarketingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing administrative and marketing expense.", "label": "Administrative And Marketing [Member]", "terseLabel": "Advertising and marketing" } } }, "localname": "AdministrativeAndMarketingMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "tdoc_AdvanceFromFinancingCompaniesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for advances from financing companies.", "label": "Advance from Financing Companies [Text Block]", "terseLabel": "Advances from Financing Companies" } } }, "localname": "AdvanceFromFinancingCompaniesTextBlock", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompanies" ], "xbrltype": "textBlockItemType" }, "tdoc_AdvancesFromFinancingCompaniesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advances from Financing Companies [Abstract]", "label": "Advances from Financing Companies" } } }, "localname": "AdvancesFromFinancingCompaniesAbstract", "nsuri": "http://www.teladoc.com/20210930", "xbrltype": "stringItemType" }, "tdoc_AdvancesFromFinancingCompaniesCurrent": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The current portion of advances from third-party financing companies in which the Company utilizes this financing to provide its customers with a rental option.", "label": "Advances from Financing Companies, Current", "terseLabel": "Advances from financing companies" } } }, "localname": "AdvancesFromFinancingCompaniesCurrent", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "tdoc_AdvancesFromFinancingCompaniesCustomerPaymentsDue": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "In aggregate, the amount of customer lease payments due, reducing the Company's outstanding advances from financing companies balance.", "label": "Advances from Financing Companies, Customer Payments Due", "totalLabel": "Total" } } }, "localname": "AdvancesFromFinancingCompaniesCustomerPaymentsDue", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_AdvancesFromFinancingCompaniesCustomerPaymentsDueCurrent": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails": { "order": 2.0, "parentTag": "tdoc_AdvancesFromFinancingCompaniesCustomerPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of customer lease payments due in current fiscal year, reducing the Company's outstanding advances from financing companies balance.", "label": "Advances from Financing Companies, Customer Payments, Due Current", "terseLabel": "2021" } } }, "localname": "AdvancesFromFinancingCompaniesCustomerPaymentsDueCurrent", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_AdvancesFromFinancingCompaniesCustomerPaymentsDueYearOne": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails": { "order": 4.0, "parentTag": "tdoc_AdvancesFromFinancingCompaniesCustomerPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of customer lease payments due in next fiscal year following current fiscal year, reducing the Company's outstanding advances from financing companies balance.", "label": "Advances from Financing Companies, Customer Payments, Due Year One", "terseLabel": "2022" } } }, "localname": "AdvancesFromFinancingCompaniesCustomerPaymentsDueYearOne", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_AdvancesFromFinancingCompaniesCustomerPaymentsDueYearThree": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails": { "order": 1.0, "parentTag": "tdoc_AdvancesFromFinancingCompaniesCustomerPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of customer lease payments due in third fiscal year following current fiscal year, reducing the Company's outstanding advances from financing companies balance.", "label": "Advances from Financing Companies Customer Payments Due Year Three", "terseLabel": "2024" } } }, "localname": "AdvancesFromFinancingCompaniesCustomerPaymentsDueYearThree", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_AdvancesFromFinancingCompaniesCustomerPaymentsDueYearTwo": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails": { "order": 3.0, "parentTag": "tdoc_AdvancesFromFinancingCompaniesCustomerPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of customer lease payments due in second fiscal year following current fiscal year, reducing the Company's outstanding advances from financing companies balance.", "label": "Advances from Financing Companies Customer Payments Due Year Two", "terseLabel": "2023" } } }, "localname": "AdvancesFromFinancingCompaniesCustomerPaymentsDueYearTwo", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_AdvancesFromFinancingCompaniesInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The interest rate applicable to the outstanding advances from financing companies as of the end of the reporting period.", "label": "Advances from Financing Companies, Interest Rate", "terseLabel": "Advances from financing companies, interest rate (as a percent)" } } }, "localname": "AdvancesFromFinancingCompaniesInterestRate", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails" ], "xbrltype": "percentItemType" }, "tdoc_AdvancesFromFinancingCompaniesNoncurrent": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of advances from third-party financing companies, net of current portion, in which the Company utilizes this financing to provide its customers with a rental option.", "label": "Advances from Financing Companies, Noncurrent", "terseLabel": "Advances from financing companies, net of current portion" } } }, "localname": "AdvancesFromFinancingCompaniesNoncurrent", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "tdoc_AdvancesFromFinancingCompaniesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of customer lease payments due to third party financing companies reducing the Company's outstanding advances from financing companies balance.", "label": "Advances from Financing Companies [Table Text Block]", "terseLabel": "Schedule of client lease payments to third party financing companies" } } }, "localname": "AdvancesFromFinancingCompaniesTableTextBlock", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesTables" ], "xbrltype": "textBlockItemType" }, "tdoc_AmortizationOfRightOfUseAssetsAndDepreciationOfRentalEquipment": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization of right-of-use assets and depreciation of rental equipment.", "label": "Amortization of Right-of-Use Assets and Depreciation of Rental Equipment", "terseLabel": "Amortization of right-of-use assets and depreciation of rental equipment" } } }, "localname": "AmortizationOfRightOfUseAssetsAndDepreciationOfRentalEquipment", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "tdoc_BasisOfAccountingAndConsolidationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Also, disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Basis Of Accounting And Consolidation Policy Text Block", "terseLabel": "Basis of Presentation and Principles of Consolidation" } } }, "localname": "BasisOfAccountingAndConsolidationPolicyTextBlock", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationsPolicies" ], "xbrltype": "textBlockItemType" }, "tdoc_BasisOfPresentationAndPrinciplesOfConsolidationDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "N/A.", "label": "Basis Of Presentation And Principles Of Consolidation" } } }, "localname": "BasisOfPresentationAndPrinciplesOfConsolidationDisclosureAbstract", "nsuri": "http://www.teladoc.com/20210930", "xbrltype": "stringItemType" }, "tdoc_BusinessAcquisitionAdjustmentToGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The adjustment realized during the reporting period to goodwill in connection with a business acquisition.", "label": "Business Acquisition Adjustment to Goodwill", "terseLabel": "Increase (decrease) to goodwill" } } }, "localname": "BusinessAcquisitionAdjustmentToGoodwill", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_BusinessAcquisitionAdjustmentToReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The adjustment realized during the reporting period to receivables in connection with a business acquisition.", "label": "Business Acquisition, Adjustment to Receivables", "terseLabel": "Increase to receivables" } } }, "localname": "BusinessAcquisitionAdjustmentToReceivables", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_BusinessAcquisitionAdjustmentToStockholdersEquity": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The adjustment realized during the reporting period to stockholders' equity in connection with a business acquisition.", "label": "Business Acquisition Adjustment to Stockholders' Equity", "terseLabel": "Decrease to stockholders' equity" } } }, "localname": "BusinessAcquisitionAdjustmentToStockholdersEquity", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_BusinessAcquisitionExcessShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of excess shares identified in a business acquisition.", "label": "Business Acquisition, Excess Shares", "terseLabel": "Excess shares identified" } } }, "localname": "BusinessAcquisitionExcessShares", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "sharesItemType" }, "tdoc_BusinessAcquisitionInitialCashConsideration": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The initial cash consideration in a business acquisition.", "label": "Business Acquisition, Initial Cash Consideration", "terseLabel": "Initial cash consideration" } } }, "localname": "BusinessAcquisitionInitialCashConsideration", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_BusinessAcquisitionInitialEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition Initial Equity Interests Issued or Issuable Number of Shares Issued", "terseLabel": "Initial equity consideration (in shares)" } } }, "localname": "BusinessAcquisitionInitialEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "sharesItemType" }, "tdoc_BusinessAcquisitionMergerRelatedExpensesOverpayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of merger-related cash payments in a business acquisition identified as cash overpayments.", "label": "Business Acquisition, Merger Related Expenses, Overpayment", "terseLabel": "Merger-related cash payments identified as cash overpayments" } } }, "localname": "BusinessAcquisitionMergerRelatedExpensesOverpayment", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_BusinessCombinationCancelledExcessSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares cancelled which was issued earlier excess issued under business combination.", "label": "Business Combination, Canceled Excess Shares Issued", "terseLabel": "Excess shares cancelled" } } }, "localname": "BusinessCombinationCancelledExcessSharesIssued", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "sharesItemType" }, "tdoc_BusinessCombinationConsiderationConversionFeatureOfNotesGuaranteedByCompany": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount related to the conversion feature of the Livongo Notes guaranteed by the Company.", "label": "Business Combination Consideration, Conversion Feature of Notes Guaranteed by Company", "terseLabel": "Amount related to conversion feature of the Livongo Notes guaranteed by the Company" } } }, "localname": "BusinessCombinationConsiderationConversionFeatureOfNotesGuaranteedByCompany", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_BusinessCombinationConsiderationTransferredNetOfCashAcquired": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer, net of cash acquired.", "label": "Business Combination, Consideration Transferred, Net of Cash Acquired", "terseLabel": "Purchase price, net of cash acquired" } } }, "localname": "BusinessCombinationConsiderationTransferredNetOfCashAcquired", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_BusinessCombinationExcessSharesNotWithheldForWithholdingTaxPurposes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of excess shares in a business combination that were not withheld for withholding tax purposes.", "label": "Business Combination Excess Shares Not Withheld For Withholding Tax Purposes", "terseLabel": "Excess shares not withheld" } } }, "localname": "BusinessCombinationExcessSharesNotWithheldForWithholdingTaxPurposes", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "sharesItemType" }, "tdoc_BusinessCombinationInitialConsiderationTransferred": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of initial consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Initial Consideration Transferred", "terseLabel": "Initial consideration" } } }, "localname": "BusinessCombinationInitialConsiderationTransferred", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_BusinessCombinationInitialConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Initial amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Business Combination, Initial Consideration Transferred, Equity Interests Issued and Issuable", "terseLabel": "Initial equity consideration" } } }, "localname": "BusinessCombinationInitialConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvancesFromFinancingCompanies": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of advances from financing companies recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Advances from Financing Companies", "negatedLabel": "Advances from financing companies" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvancesFromFinancingCompanies", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBusinessCombinationInvestments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term investments recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Business Combination, Investments", "terseLabel": "Short term investment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBusinessCombinationInvestments", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesConvertibleDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of convertible long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Convertible Debt", "negatedLabel": "Convertible notes" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesConvertibleDebt", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of right of use assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right Of Use Assets", "terseLabel": "Right of use assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_CashRelatedToTaxWithholdingForShareBasedCompensationNet": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net cash for withholding taxes on stock-based awards.", "label": "Cash Related to Tax Withholding for Share-based Compensation, Net", "terseLabel": "Cash received for withholding taxes on stock-based compensation, net" } } }, "localname": "CashRelatedToTaxWithholdingForShareBasedCompensationNet", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "tdoc_ChangeInDeferredDeviceCostAndOtherAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Change in Deferred Device Cost And Other [Abstract]", "terseLabel": "Change in Deferred Device Cost And Other" } } }, "localname": "ChangeInDeferredDeviceCostAndOtherAbstract", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherActivityDetails" ], "xbrltype": "stringItemType" }, "tdoc_CommonStockCapitalSharesRemainingSharesAvailableForIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares remaining that are available for issuance.", "label": "Common Stock, Capital Shares Remaining Shares Available For Issuance", "terseLabel": "Remaining shares available for issuance under the plan (in shares)" } } }, "localname": "CommonStockCapitalSharesRemainingSharesAvailableForIssuance", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails" ], "xbrltype": "sharesItemType" }, "tdoc_CommonStockWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to common stock warrants.", "label": "Common Stock Warrant [Member]", "terseLabel": "Common stock warrants" } } }, "localname": "CommonStockWarrantMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityWarrantsDetails" ], "xbrltype": "domainItemType" }, "tdoc_ConsultantConnectLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Consultant Connect Limited.", "label": "Consultant Connect Limited [Member]", "terseLabel": "Consultant Connect" } } }, "localname": "ConsultantConnectLimitedMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "domainItemType" }, "tdoc_ContingentLiabilityFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the fair value of contingent liability.", "label": "Contingent Liability Fair Value Disclosure", "terseLabel": "Contingent liability" } } }, "localname": "ContingentLiabilityFairValueDisclosure", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_ContingentLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to contingent liability.", "label": "Contingent Liability [Member]", "terseLabel": "Contingent Liability" } } }, "localname": "ContingentLiabilityMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsLevel3Details" ], "xbrltype": "domainItemType" }, "tdoc_ContractualInterestExpenseNet": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails": { "order": 3.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The contractual interest expense, net, excluding amortization of debt discount (premium).", "label": "Contractual Interest Expense, Net", "terseLabel": "Contractual interest expense" } } }, "localname": "ContractualInterestExpenseNet", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_ConvertibleDebtAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Debt [Abstract]", "label": "Convertible Senior Notes" } } }, "localname": "ConvertibleDebtAbstract", "nsuri": "http://www.teladoc.com/20210930", "xbrltype": "stringItemType" }, "tdoc_ConvertibleDebtExchangedInPrivatePlacementPrincipalAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The principal amount of debt exchanged for shares of the Company's common stock in private placement transactions.", "label": "Convertible Debt Exchanged in Private Placement, Principal Amount", "terseLabel": "Principal amount of debt exchanged for shares of the Company's common stock in private placement transactions" } } }, "localname": "ConvertibleDebtExchangedInPrivatePlacementPrincipalAmount", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesExchangeRedemptionOfConvertibleSeniorNotesDueDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_ConvertibleDebtInterestExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of interest expense on the convertible debt.", "label": "Convertible Debt Interest Expense [Table Text Block]", "terseLabel": "Schedule of total interest expense recognized related to the Notes" } } }, "localname": "ConvertibleDebtInterestExpenseTableTextBlock", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTables" ], "xbrltype": "textBlockItemType" }, "tdoc_ConvertibleDebtRemainingContractualLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The remaining contractual life of the convertible debt instrument.", "label": "Convertible Debt Remaining Contractual Life", "terseLabel": "Remaining contractual life" } } }, "localname": "ConvertibleDebtRemainingContractualLife", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails" ], "xbrltype": "durationItemType" }, "tdoc_ConvertibleDebtTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder.", "label": "Convertible Debt [Text Block]", "terseLabel": "Convertible Senior Notes" } } }, "localname": "ConvertibleDebtTextBlock", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotes" ], "xbrltype": "textBlockItemType" }, "tdoc_ConvertibleDebtTradingDayObservationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The trading day observation period used to determine the amount of cash and shares, if any, that are due upon conversion.", "label": "Convertible Debt, Trading Day Observation Period", "terseLabel": "Trading day observation period used to determine the amount of cash and shares, if any, that are due upon conversion" } } }, "localname": "ConvertibleDebtTradingDayObservationPeriod", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "integerItemType" }, "tdoc_ConvertibleSeniorNotesDue2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information relating to the convertible senior notes due 2022 (the \"2022 Notes\").", "label": "Convertible Senior Notes Due2022 [Member]", "terseLabel": "2022 Notes" } } }, "localname": "ConvertibleSeniorNotesDue2022Member", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesExchangeRedemptionOfConvertibleSeniorNotesDueDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "tdoc_ConvertibleSeniorNotesDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information relating to the convertible senior notes due 2025 (the \"2025 Notes\").", "label": "Convertible Senior Notes Due2025 [Member]", "terseLabel": "2025 Notes" } } }, "localname": "ConvertibleSeniorNotesDue2025Member", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesExchangeRedemptionOfConvertibleSeniorNotesDueDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "tdoc_ConvertibleSeniorNotesDue2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information relating to the convertible senior notes due 2027 (the \"2027 Notes\").", "label": "Convertible Senior Notes Due2027 [Member]", "terseLabel": "2027 Notes" } } }, "localname": "ConvertibleSeniorNotesDue2027Member", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "tdoc_ConvertibleSeniorNotesDueJune2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information relating to the convertible senior notes due June 2025 (the \"June 2025 Notes\"), which were assumed as part of the Livongo acquisition.", "label": "Convertible Senior Notes Due June2025 [Member]", "terseLabel": "Livongo Notes" } } }, "localname": "ConvertibleSeniorNotesDueJune2025Member", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "domainItemType" }, "tdoc_ConvertibleSeniorNotesPayableExcludingLivongoNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the 2027 Notes, 2025 Notes and the 2022 Notes.", "label": "Convertible Senior Notes Payable Excluding Livongo Notes [Member]", "terseLabel": "2027 Notes, 2025 Notes and the 2022 Notes" } } }, "localname": "ConvertibleSeniorNotesPayableExcludingLivongoNotesMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "domainItemType" }, "tdoc_DebtConvertibleRepurchasePricePercentageOfPrincipal": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represent percentage of principal for repurchase price.", "label": "Debt convertible, Repurchase Price, Percentage Of Principal", "terseLabel": "Percentage of principal for repurchase price (as percent)" } } }, "localname": "DebtConvertibleRepurchasePricePercentageOfPrincipal", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "pureItemType" }, "tdoc_DebtInstrumentConversionObligationNumberOfBusinessDaysAfterConsecutiveTradingDayPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of business days immediately after any ten consecutive trading day period during the debt instrument measurement period.", "label": "Debt Instrument Conversion Obligation Number Of Business Days After Consecutive Trading Day Period", "terseLabel": "Convertible debt, number of business days, measurement period" } } }, "localname": "DebtInstrumentConversionObligationNumberOfBusinessDaysAfterConsecutiveTradingDayPeriod", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "integerItemType" }, "tdoc_DebtInstrumentConversionObligationPeriodOfConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of consecutive trading days prior to the five business days during the debt instrument measurement period.", "label": "Debt Instrument Conversion Obligation Period Of Consecutive Trading Days", "terseLabel": "Convertible debt, number of consecutive trading days, measurement period" } } }, "localname": "DebtInstrumentConversionObligationPeriodOfConsecutiveTradingDays", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "integerItemType" }, "tdoc_DebtInstrumentConvertibleConversionReferencePropertyPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument with each unit of reference property price in cash.", "label": "Debt Instrument, Convertible, Conversion, Reference Property Price", "terseLabel": "Convertible debt, Reference property , conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionReferencePropertyPrice", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "perShareItemType" }, "tdoc_DebtInstrumentConvertibleConversionReferencePropertyRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount for each unit of reference property.", "label": "Debt Instrument, Convertible, Conversion, Reference Property Ratio", "terseLabel": "Convertible debt, Reference property rate" } } }, "localname": "DebtInstrumentConvertibleConversionReferencePropertyRatio", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "pureItemType" }, "tdoc_DebtInstrumentConvertiblePrincipalAmountMultiple": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The principal multiple amount used in the conversion of the debt instrument.", "label": "Debt Instrument, Convertible, Principal Amount Multiple", "terseLabel": "Principal multiple amount used in the conversion of the debt instrument" } } }, "localname": "DebtInstrumentConvertiblePrincipalAmountMultiple", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_DebtInstrumentTradingPriceAsPercentageOfLastReportedSalesPriceAndConversionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the trading price expressed as a percentage of the last reported sales price and conversion rate after the specified consecutive trading day period.", "label": "Debt Instrument Trading Price as a Percentage of Last Reported Sales Price and Conversion Rate", "terseLabel": "Trading price expressed as a percentage of the last reported sales price and conversion rate after the specified consecutive trading day period" } } }, "localname": "DebtInstrumentTradingPriceAsPercentageOfLastReportedSalesPriceAndConversionRate", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "percentItemType" }, "tdoc_DebtRedemptionCashExchanged": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash exchanged in the redemption of the convertible senior notes.", "label": "Debt Redemption, Cash Exchanged", "terseLabel": "Cash exchanged, redemption of convertible notes" } } }, "localname": "DebtRedemptionCashExchanged", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesExchangeRedemptionOfConvertibleSeniorNotesDueDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_DeferredDeviceCostAndOther": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred device cost and other that are deferred and amortized over the life span of the device.", "label": "Deferred Device Cost And Other", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total Deferred cost and other" } } }, "localname": "DeferredDeviceCostAndOther", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherActivityDetails", "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_DeferredDeviceCostAndOtherAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Deferred Device Cost And Other [Abstract]", "terseLabel": "Deferred Device Cost And Other" } } }, "localname": "DeferredDeviceCostAndOtherAbstract", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherDetails" ], "xbrltype": "stringItemType" }, "tdoc_DeferredDeviceCostAndOtherAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred device cost and other due to addiitons .", "label": "Deferred Device Cost And Other, Additions", "terseLabel": "Additions" } } }, "localname": "DeferredDeviceCostAndOtherAdditions", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherActivityDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_DeferredDeviceCostAndOtherCostOfRevenueRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of change in deferred device cost and other from cost of revenue recognized during the period.", "label": "Deferred Device Cost And Other, Cost Of Revenue Recognized", "terseLabel": "Cost of revenue recognized" } } }, "localname": "DeferredDeviceCostAndOtherCostOfRevenueRecognized", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherActivityDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_DeferredDeviceCostAndOtherCurrent": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherDetails": { "order": 1.0, "parentTag": "tdoc_DeferredDeviceCostAndOther", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred device cost and other that are deferred and amortized over the life span of the device , classified as current.", "label": "Deferred Device Cost And Other, Current", "verboseLabel": "Deferred costs and other, current" } } }, "localname": "DeferredDeviceCostAndOtherCurrent", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_DeferredDeviceCostAndOtherNoncurrent": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherDetails": { "order": 2.0, "parentTag": "tdoc_DeferredDeviceCostAndOther", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred device cost and other that are deferred and amortized over the life span of the device , classified as noncurrent.", "label": "Deferred Device Cost And Other Noncurrent", "terseLabel": "Deferred costs and other, noncurrent" } } }, "localname": "DeferredDeviceCostAndOtherNoncurrent", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDeferredCostAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_DeferredIncomeTaxNoncashExpenseBenefit": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The noncash component of income tax expense for the period representing the increase (decrease) in the entity's deferred tax assets and liabilities pertaining to continuing operations.", "label": "Deferred Income Tax Noncash Expense Benefit", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxNoncashExpenseBenefit", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "tdoc_DepreciationOfRentalEquipment": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives for rental equipments.", "label": "Depreciation of Rental Equipment", "terseLabel": "Depreciation of rental equipment" } } }, "localname": "DepreciationOfRentalEquipment", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "tdoc_EmployeeAndNonEmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Although there are variations, normally, after vesting, when an option is exercised, the holder pays the strike value in cash to the issuing entity and receives equity shares. The equity shares can be sold into the market for cash at the current market price without restriction. Options may be used to attract, retain and incentivize employees, in addition to their regular salary and other benefits.", "label": "Employee And Non Employee Stock Option [Member]", "terseLabel": "Stock options" } } }, "localname": "EmployeeAndNonEmployeeStockOptionMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "domainItemType" }, "tdoc_EmployeeStockPurchasePlan2015Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information relating to the 2015 Employee Stock Purchase Plan (\"ESPP\").", "label": "Employee Stock Purchase Plan2015 [Member]", "terseLabel": "ESPP" } } }, "localname": "EmployeeStockPurchasePlan2015Member", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails" ], "xbrltype": "domainItemType" }, "tdoc_EquitySecuritiesWithoutReadilyDeterminableFairValueSaleOfInvestment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in fair value from the sale of investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Sale of Investment", "negatedLabel": "Sale of investment" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueSaleOfInvestment", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsEquitySecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_ExercisePriceAdjustmentRatioClosingPriceThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of trading days for Exercise price of stock option adjusted based on the Equity Award Adjustment Ratio.", "label": "Exercise Price Adjustment Ratio, Closing Price, Threshold Trading Days", "terseLabel": "Trading days" } } }, "localname": "ExercisePriceAdjustmentRatioClosingPriceThresholdTradingDays", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "durationItemType" }, "tdoc_GainLossOnExtinguishmentOfDebtCashFlowImpact": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash flow impact of the difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt, Cash Flow Impact", "negatedLabel": "Loss on extinguishment of debt" } } }, "localname": "GainLossOnExtinguishmentOfDebtCashFlowImpact", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "tdoc_GoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definitions available.", "label": "Goodwill" } } }, "localname": "GoodwillAbstract", "nsuri": "http://www.teladoc.com/20210930", "xbrltype": "stringItemType" }, "tdoc_GoodwillMeasurementPeriodAdjustmentDeferredTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of increase (decrease) in goodwill related to deferred tax measurement period adjustment.", "label": "Goodwill Measurement Period Adjustment, Deferred Taxes", "terseLabel": "Deferred tax adjustments", "verboseLabel": "Measurement period increase (reduction) to goodwill" } } }, "localname": "GoodwillMeasurementPeriodAdjustmentDeferredTaxes", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails", "http://www.teladoc.com/role/DisclosureGoodwillDetails", "http://www.teladoc.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_InTouchTechnologiesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to InTouch Technologies, Inc.", "label": "In Touch Technologies Inc [Member]", "terseLabel": "InTouch" } } }, "localname": "InTouchTechnologiesIncMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "domainItemType" }, "tdoc_IncentiveAwardPlan2015Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information relating to the Company's 2015 Incentive Award Plan (the \"Plan\") which provides for the issuance of incentive and non-statutory options and other equity-based awards to employees and non-employees.", "label": "Incentive Award Plan2015 [Member]", "terseLabel": "2015 Incentive Award Plan" } } }, "localname": "IncentiveAwardPlan2015Member", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "domainItemType" }, "tdoc_IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered, excluding accrued compensation. Also includes the increase (decrease) during the reported period in the aggregate carrying amount of liabilities not separately disclosed in the balance sheet. Used to reflect the current portion of liabilities (due within one year or within the normal operating cycle if longer).", "label": "Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "tdoc_IncreaseDecreaseInOperatingLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period, in operating lease liabilities arising from obtaining right-of-use assets.", "label": "Increase (Decrease) in Operating Lease Liabilities", "verboseLabel": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiabilities", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "tdoc_LeasingOperationsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for leasing operations.", "label": "Leasing Operations [Text Block]", "terseLabel": "Leasing Operations" } } }, "localname": "LeasingOperationsTextBlock", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperations" ], "xbrltype": "textBlockItemType" }, "tdoc_LegalMattersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No Definition available.", "label": "Legal Matters" } } }, "localname": "LegalMattersAbstract", "nsuri": "http://www.teladoc.com/20210930", "xbrltype": "stringItemType" }, "tdoc_LivongoHealthIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to Livongo Health, Inc.", "label": "Livongo Health Inc [Member]", "terseLabel": "Livongo Health" } } }, "localname": "LivongoHealthIncMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "domainItemType" }, "tdoc_MaximumOfferingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the maximum offering period related to the employee stock purchase plan.", "label": "Maximum Offering Period", "terseLabel": "Maximum offering period" } } }, "localname": "MaximumOfferingPeriod", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails" ], "xbrltype": "durationItemType" }, "tdoc_MergerConversionOfSharesRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of common stock by party to merger into equity shares of the Company upon the completion of the merger.", "label": "Merger, Conversion of Shares, Ratio", "terseLabel": "Merger, conversion of common shares ratio" } } }, "localname": "MergerConversionOfSharesRatio", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "pureItemType" }, "tdoc_MergerConversionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion of common stock upon completion of the merger.", "label": "Merger, Conversion, Price", "terseLabel": "Merger, conversion price (in dollars per share)" } } }, "localname": "MergerConversionPrice", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "perShareItemType" }, "tdoc_MergerSpecialCashDividend": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The special cash dividend paid in connection with the closing of the merger.", "label": "Merger, Special Cash Dividend", "terseLabel": "Merger, special cash dividend" } } }, "localname": "MergerSpecialCashDividend", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "perShareItemType" }, "tdoc_NumberOfProfessionalAssociationsConsolidatedAsVariableInterestEntities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of professional associations who are consolidated into the financials as variable interest entities.", "label": "Number of Professional Associations Consolidated as Variable Interest Entities", "terseLabel": "Number of professional associations consolidated as VIEs" } } }, "localname": "NumberOfProfessionalAssociationsConsolidatedAsVariableInterestEntities", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails" ], "xbrltype": "integerItemType" }, "tdoc_NumberOfProfessionalCorporationsConsolidatedAsVariableInterestEntities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of professional corporations who are consolidated into the financials as variable interest entities.", "label": "Number Of Professional Corporations Consolidated As Variable Interest Entities", "terseLabel": "Number of professional corporations consolidated as VIEs" } } }, "localname": "NumberOfProfessionalCorporationsConsolidatedAsVariableInterestEntities", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails" ], "xbrltype": "integerItemType" }, "tdoc_OrganizationAndDescriptionOfBusinessDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "N/A.", "label": "Organization and Description of Business" } } }, "localname": "OrganizationAndDescriptionOfBusinessDisclosureAbstract", "nsuri": "http://www.teladoc.com/20210930", "xbrltype": "stringItemType" }, "tdoc_OtherCurrentLiabilitiesAcquisitionAndIntegration": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 10.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other current liabilities relating to acquisition and integration costs.", "label": "Other Current Liabilities, Acquisition and Integration", "terseLabel": "Acquisition & Integration" } } }, "localname": "OtherCurrentLiabilitiesAcquisitionAndIntegration", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_OtherCurrentLiabilitiesClientsGuarantees": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 3.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other current liabilities related to clients guarantees.", "label": "Other Current Liabilities, Clients Guarantees", "terseLabel": "Client performance guarantees" } } }, "localname": "OtherCurrentLiabilitiesClientsGuarantees", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_OtherCurrentLiabilitiesDeviceReplacementCost": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 11.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other current liabilities relating to device replacement cost.", "label": "Other Current Liabilities, Device Replacement Cost", "terseLabel": "Device Replacement Cost" } } }, "localname": "OtherCurrentLiabilitiesDeviceReplacementCost", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_OtherIncomeExpensesPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for other income (expenses).", "label": "Other Income (Expenses) Policy [Policy Text Block]", "terseLabel": "Other Expense (Income), Net" } } }, "localname": "OtherIncomeExpensesPolicyPolicyTextBlock", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationsPolicies" ], "xbrltype": "textBlockItemType" }, "tdoc_OtherRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents other revenue.", "label": "Other Revenue [Member]", "terseLabel": "Other" } } }, "localname": "OtherRevenueMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "domainItemType" }, "tdoc_PaidVisitsRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents paid visits revenue.", "label": "Paid Visits Revenue [Member]", "terseLabel": "Paid Visits" } } }, "localname": "PaidVisitsRevenueMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "domainItemType" }, "tdoc_PaymentsForRepurchaseOfConvertibleDebt": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the repurchase of convertible debt.", "label": "Payments for Repurchase of Convertible Debt", "negatedLabel": "Repurchase of 2022 Notes" } } }, "localname": "PaymentsForRepurchaseOfConvertibleDebt", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "tdoc_PaymentsFromCustomersAgainstAdvancesFromFinancingCompanies": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow which represents the payment from customers against advances from financing companies.", "label": "Payments from Customers Against Advances from Financing Companies", "negatedLabel": "Payment against advances from financing companies" } } }, "localname": "PaymentsFromCustomersAgainstAdvancesFromFinancingCompanies", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "tdoc_ProceedsFromAdvancesFromFinancingCompanies": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from advances from financing companies.", "label": "Proceeds from Advances from Financing Companies", "terseLabel": "Proceeds from advances from financing companies" } } }, "localname": "ProceedsFromAdvancesFromFinancingCompanies", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "tdoc_RecoveredExcessCommonStockIssuedForAcquisitionEquityImpact": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The equity impact of the recovered excess common stock shares issued for acquisition.", "label": "Recovered Excess Common Stock Issued for Acquisition, Equity Impact", "negatedLabel": "Recovery of excess common stock issued for acquisition" } } }, "localname": "RecoveredExcessCommonStockIssuedForAcquisitionEquityImpact", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "tdoc_RecoveredExcessCommonStockIssuedForAcquisitionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of recovered excess common stock shares issued for acquisition.", "label": "Recovered Excess Common Stock Issued for Acquisition, Shares", "negatedLabel": "Recovery of excess common stock issued for acquisition (in shares)" } } }, "localname": "RecoveredExcessCommonStockIssuedForAcquisitionShares", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "tdoc_SalesExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing sales expense.", "label": "Sales Expense [Member]", "terseLabel": "Sales" } } }, "localname": "SalesExpenseMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "tdoc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; (c) accrued liabilities; and (d) other current liabilities not separately disclosed. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Schedule Of Accrued Liabilities And Other Current Liabilities Table Text Block", "terseLabel": "Schedule of accrued expenses and other current liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "tdoc_ScheduleOfDeferredCostAndOtherTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of deferred costs and other including activity during the period.", "label": "Schedule of Deferred Cost And Other [Table Text block]", "terseLabel": "Schedule of deferred costs and other" } } }, "localname": "ScheduleOfDeferredCostAndOtherTableTextBlock", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherTables" ], "xbrltype": "textBlockItemType" }, "tdoc_ScheduleOfPerformanceBasedUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding performance-based units.", "label": "Schedule of Performance-based Units Activity [Table Text Block]", "terseLabel": "Schedule of activity under the PSUs" } } }, "localname": "ScheduleOfPerformanceBasedUnitsActivityTableTextBlock", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "tdoc_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No description available.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateIntrinsicValueAbstract", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "stringItemType" }, "tdoc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that are vested and exercisable as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Exercisable, Number", "terseLabel": "Vested and unissued (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "tdoc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date of equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) that are vested and exercisable as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested and Exercisable, Weighted Average Grant Date Fair Value", "terseLabel": "Vested and unissued (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableWeightedAverageGrantDateFairValue", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "tdoc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for equity-based awards excluding options that were either cancelled or expired during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award Non-Option Equity Instruments Forfeitures and Expirations Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsWeightedAverageGrantDateFairValue", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "tdoc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodTotalGrantDateFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total fair value of non-option equity instruments granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants In Period, Total Grant Date Fair Value", "terseLabel": "Grant date fair value of RSUs granted", "verboseLabel": "Grant date fair value of PSUs granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodTotalGrantDateFairValue", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for equity-based awards excluding options issued during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted including replacement awards for merger (in dollars per share)", "verboseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "tdoc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were vested and issued.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested and Issued", "negatedLabel": "Vested and issued (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndIssued", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "tdoc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndIssuedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for equity-based awards excluding options that were vested and issued during the period.", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award Non-Option Equity Instruments, Vested and Issued, Weighted Average Grant Date Fair Value", "terseLabel": "Vested and issued (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndIssuedWeightedAverageGrantDateFairValue", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "tdoc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of equity-based awards excluding option plans.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding at end of period (in dollars per share)", "periodStartLabel": "Outstanding at beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageGrantDateFairValue", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "tdoc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalGrantDateFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the total fair value of options granted during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total Grant Date Fair Value", "terseLabel": "Grant-date fair value of stock options granted during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalGrantDateFairValue", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "tdoc_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageFairValueOfUnderlyingStockOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted-average fair value of the underlying stock options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Weighted Average Fair Value Of Underlying Stock Options", "terseLabel": "Weighted-average fair value of the underlying stock options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageFairValueOfUnderlyingStockOptions", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "tdoc_ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageRemainingContractualTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No description available.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Weighted Average Remaining Contractual Term [Abstract]", "terseLabel": "Weighted-average remaining contractual life in Years" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageRemainingContractualTermAbstract", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "stringItemType" }, "tdoc_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period upon the vesting of restricted stock units.", "label": "Stock Issued During Period, Shares, Vesting of Restricted Stock Units", "terseLabel": "Issuance of common stock upon vesting of restricted stock units (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "tdoc_StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock issued during the period upon the vesting of restricted stock units.", "label": "Stock Issued During Period, Value, Vesting of Restricted Stock Units", "terseLabel": "Issuance of common stock upon vesting of restricted stock units" } } }, "localname": "StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "tdoc_SubscriptionAccessFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subscription access fees.", "label": "Subscription Access Fees [Member]", "terseLabel": "Access Fees Revenue" } } }, "localname": "SubscriptionAccessFeesMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails", "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails" ], "xbrltype": "domainItemType" }, "tdoc_TechnologyAndDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing technology and development expense.", "label": "Technology And Development [Member]", "terseLabel": "Technology and development" } } }, "localname": "TechnologyAndDevelopmentMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "tdoc_VisitFeeRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents visit fee revenue", "label": "Visit Fee Revenue [Member]", "terseLabel": "Visit Fee Revenue" } } }, "localname": "VisitFeeRevenueMember", "nsuri": "http://www.teladoc.com/20210930", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "Accrued Expenses and Other Current Liabilities" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r3", "r18", "r148", "r149" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts receivable, net of allowance for doubtful accounts", "verboseLabel": "Accounts receivable, net of allowance of $11,277 and $6,412, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails", "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r14", "r378", "r391" ], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 4.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income tax payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedInsuranceCurrent": { "auth_ref": [ "r7", "r8", "r39" ], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 5.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Insurance, Current", "terseLabel": "Insurance" } } }, "localname": "AccruedInsuranceCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedMarketingCostsCurrent": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 8.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Marketing Costs, Current", "terseLabel": "Marketing" } } }, "localname": "AccruedMarketingCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r7", "r8", "r39" ], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r21", "r51", "r52", "r53", "r393", "r413", "r414" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive gain" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r50", "r53", "r54", "r100", "r101", "r102", "r319", "r409", "r410" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r19" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r100", "r101", "r102", "r266", "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash provided by operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": { "auth_ref": [ "r187" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.", "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt", "terseLabel": "Equity component of Notes, net of issuance costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r236", "r238", "r272", "r273" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r238", "r262", "r271" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share-based Compensation Expense", "terseLabel": "Stock-based compensation", "verboseLabel": "Compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCompensationCostsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r25", "r150", "r158" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowance for Doubtful Accounts Receivable, Current", "terseLabel": "Allowance of Accounts receivable" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r71", "r87", "r352" ], "calculation": { "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r87", "r172", "r178" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense for intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r95", "r133", "r136", "r142", "r156", "r316", "r320", "r343", "r376", "r390" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails", "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets.", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r5", "r49", "r95", "r156", "r316", "r320", "r343" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": { "auth_ref": [ "r152", "r160" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.", "label": "Debt Securities, Available-for-sale, Current", "terseLabel": "Short-term investments" } } }, "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails", "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r239", "r264" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation and Principles of Consolidation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidation" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r232", "r234" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r232", "r234", "r297", "r298" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Business Acquisition, Transaction Costs", "verboseLabel": "Acquisition related costs" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Equity consideration (in shares)" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business acquisition" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Information [Abstract]", "terseLabel": "Pro forma information" } } }, "localname": "BusinessAcquisitionProFormaInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r295", "r296" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Schedule of unaudited pro forma revenue and net loss" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r295", "r296" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Net loss" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r295", "r296" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Revenue" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r294" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition, integration and transformation costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r308", "r309", "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "verboseLabel": "Total consideration" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r308", "r309" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable", "terseLabel": "Equity consideration" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "auth_ref": [ "r307", "r308", "r309", "r311" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.", "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "terseLabel": "Debt incurred upon acquisition" } } }, "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r313" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Acquisitions" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": { "auth_ref": [ "r300" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lease obligation assumed in business combination.", "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation", "negatedLabel": "Lease liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts receivable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r300" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "auth_ref": [ "r300" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "negatedLabel": "Deferred revenue", "terseLabel": "Deferred revenue assumed from business combinations" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r300" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "negatedLabel": "Other liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r300" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Current", "negatedLabel": "Deferred taxes" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r299", "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Finite-lived intangibles" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r299", "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventory" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]", "terseLabel": "Less:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r299", "r300" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property and equipment, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]", "terseLabel": "Identifiable assets acquired and liabilities assumed:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Acquisitions" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r94", "r292" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r74" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash Acquired from Acquisition", "terseLabel": "Cash acquired" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r1", "r34", "r89" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r84", "r89", "r93" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of the period", "periodStartLabel": "Cash and cash equivalents at beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r84", "r344" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Net Cash Provided by (Used in) Continuing Operations", "totalLabel": "Net increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r199", "r237" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class Of Warrant Or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Warrants" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrants outstanding (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r199", "r237" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r44", "r184", "r381", "r397" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies.", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Shares reserved for issuance under the plan (in shares)", "verboseLabel": "Shares reserved for issuance (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r100", "r101" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized", "verboseLabel": "Number of common stock shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCapitalizationDetails", "http://www.teladoc.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r17", "r193" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r17" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value; 300,000,000 shares authorized as of September 30, 2021 and December 31, 2020; 160,013,624 shares and 150,281,099 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r57", "r59", "r60", "r65", "r385", "r400" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive (loss) gain, net of tax:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r122", "r123", "r147", "r340", "r341" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r122", "r123", "r147", "r340", "r341", "r415" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r122", "r123", "r147", "r340", "r341", "r415" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "verboseLabel": "Revenue, Deferred Revenue, Deferred Costs and Other" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r122", "r123", "r147", "r340", "r341" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk (as a percent)" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r120", "r122", "r123", "r124", "r340", "r342" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r122", "r123", "r147", "r340", "r341" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r213" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized, included in deferred revenue balance at beginning of period" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r15", "r379", "r392" ], "calculation": { "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible Debt", "totalLabel": "Net carrying amount" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtNoncurrent": { "auth_ref": [ "r42" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.", "label": "Convertible Debt, Noncurrent", "terseLabel": "Convertible senior notes, net" } } }, "localname": "ConvertibleDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Summary of the Notes" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r13", "r377", "r389", "r416" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]", "terseLabel": "Notes" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r69", "r371" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Revenue", "verboseLabel": "Cost of revenue (exclusive of depreciation and amortization, which is shown separately below)" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost Of Sales [Member]", "terseLabel": "Cost of revenue (exclusive of depreciation and amortization, which is shown separately)" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r68" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Client relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails", "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r91", "r92" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt Conversion, Converted Instrument, Shares Issued", "verboseLabel": "Shares issued for conversion/exchange of debt" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesExchangeRedemptionOfConvertibleSeniorNotesDueDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionOriginalDebtInterestRateOfDebt": { "auth_ref": [ "r91", "r92" ], "lang": { "en-us": { "role": { "documentation": "The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Original Debt, Interest Rate of Debt", "terseLabel": "Interest Rate Per Year" } } }, "localname": "DebtConversionOriginalDebtInterestRateOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r13", "r14", "r15", "r377", "r379", "r389" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesExchangeRedemptionOfConvertibleSeniorNotesDueDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r188" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "terseLabel": "Convertible debt, equity component" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Convertible debt, conversion price (in dollars per share)", "verboseLabel": "Conversion Rate Per $1,000 Principal Amount" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Convertible debt, threshold, consecutive trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "terseLabel": "Minimum percentage of common stock price as a percentage of the conversion price" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Convertible debt, threshold, trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r353", "r354" ], "calculation": { "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_ConvertibleDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Face amount", "verboseLabel": "Principal" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r339" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Fair value" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r41", "r353" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument, Interest Rate During Period", "terseLabel": "Effective interest rate of the liability component (as a percent)" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate (as a percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "verboseLabel": "Convertible Senior Notes" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesExchangeRedemptionOfConvertibleSeniorNotesDueDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesExchangeRedemptionOfConvertibleSeniorNotesDueDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r42", "r97", "r194", "r195", "r196", "r197", "r352", "r353", "r354", "r388" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesExchangeRedemptionOfConvertibleSeniorNotesDueDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r352", "r354" ], "calculation": { "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_ConvertibleDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Less: Debt discount, net" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r277", "r278" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r26" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "verboseLabel": "Deferred revenue-current" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueNoncurrent": { "auth_ref": [ "r26" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred Revenue, Noncurrent", "terseLabel": "Deferred revenue, net of current portion" } } }, "localname": "DeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r87", "r181" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 7.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r87", "r131" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Revenue" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r212", "r215", "r216", "r217", "r218", "r219", "r220", "r221" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r212" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of disaggregation of revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Net loss per share, basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r344" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "Foreign exchange difference" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued compensation" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]", "terseLabel": "Other disclosures" } } }, "localname": "EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]", "terseLabel": "Compensation costs charged as an expense" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCompensationCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r263" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "terseLabel": "Unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition", "terseLabel": "Period over which unrecognized compensation cost is expected to be recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r263" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options", "terseLabel": "Unrecognized compensation cost related to non vested awards" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r263" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options", "terseLabel": "Unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock and Stockholders'Equity" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r100", "r101", "r102", "r104", "r109", "r111", "r114", "r157", "r193", "r198", "r266", "r267", "r268", "r283", "r284", "r345", "r346", "r347", "r348", "r349", "r351", "r409", "r410", "r411" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "auth_ref": [ "r153" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "periodEndLabel": "Fair value at September 30, 2021", "periodStartLabel": "Fair value and historical cost basis at December 31, 2020", "terseLabel": "Equity securities without readily determinable fair values" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsEquitySecuritiesDetails", "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAnnualAmountAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Securities without Readily Determinable Fair Value, Annual Amount [Abstract]", "terseLabel": "Change in fair value of the Company's equity securities without readily determinable fair values:" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAnnualAmountAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsEquitySecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value [Table Text Block]", "terseLabel": "Schedule of change in fair value of the Company's equity securities without readily determinable fair values:" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": { "auth_ref": [ "r154" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount", "terseLabel": "Upward adjustment due to observable price change in identical securities" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsEquitySecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Assets and liabilities measured at fair value on a recurring basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r327", "r328", "r329", "r337" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount": { "auth_ref": [ "r329" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.", "label": "Fair Value, Assets, Level 1 to Level 2 Transfers, Amount" } } }, "localname": "FairValueAssetsLevel1ToLevel2TransfersAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount": { "auth_ref": [ "r329" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.", "label": "Fair Value, Assets, Level 2 to Level 1 Transfers, Amount" } } }, "localname": "FairValueAssetsLevel2ToLevel1TransfersAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r328", "r361", "r362", "r363" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r336", "r337" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsLevel3Details" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r327", "r328", "r330", "r331", "r338" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r224", "r225", "r230", "r231", "r328", "r361" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value Inputs Level1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r224", "r225", "r230", "r231", "r328", "r362" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value Inputs Level2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r328", "r363" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Inputs Level3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesLevel1ToLevel2TransfersAmount": { "auth_ref": [ "r329" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of liabilities measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.", "label": "Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount" } } }, "localname": "FairValueLiabilitiesLevel1ToLevel2TransfersAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation By Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsLevel3Details" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Reconciliation of Level 3 liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsLevel3Details" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsLevel3Details" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r332", "r337" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsLevel3Details" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r332", "r337" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliation of company's Level 3 liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Fair Value Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net", "terseLabel": "Fair value assets level 3 net transfers" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Change in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome": { "auth_ref": [ "r334" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)", "terseLabel": "Currency translation adjustment" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r335" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "negatedLabel": "Payments" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "terseLabel": "Fair value liabilities level 3 net transfers" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r332" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value", "periodEndLabel": "Fair value at end of period", "periodStartLabel": "Fair value at beginning of period" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r361", "r362", "r363" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r336", "r338" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value Measurements Recurring [Member]", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetAssetLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Net Asset (Liability)", "terseLabel": "Fair Value" } } }, "localname": "FairValueNetAssetLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "verboseLabel": "Useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r177" ], "calculation": { "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r173", "r174", "r177", "r179", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails", "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r177", "r373" ], "calculation": { "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Value" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r173", "r176" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite Lived Intangible Assets Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails", "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r177", "r372" ], "calculation": { "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net Carrying Value" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Assets, Remaining Amortization Period", "terseLabel": "Weighted Average Remaining Useful Life" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "durationItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r87", "r191", "r192" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Loss on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesExchangeRedemptionOfConvertibleSeniorNotesDueDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r70" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 6.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General And Administrative Expense [Member]", "terseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r163", "r164", "r375" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill.", "periodEndLabel": "Goodwill", "periodStartLabel": "Beginning balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails", "http://www.teladoc.com/role/DisclosureGoodwillDetails", "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r165" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Additions associated with acquisitions" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureGoodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r166" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Cumulative translation adjustment" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r167", "r293" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "Purchase consideration adjustments" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r62", "r133", "r135", "r138", "r141", "r143", "r374", "r382", "r387", "r401" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest", "totalLabel": "Net loss before taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Operations and Comprehensive Loss" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCompensationCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCompensationCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r280", "r281", "r282", "r285", "r287", "r289", "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r96", "r110", "r111", "r132", "r279", "r286", "r288", "r402" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "verboseLabel": "Income tax expense (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIncomeTaxesDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r90" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r86" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r86" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r86" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Net increase in deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r86" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r86" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Increase (Decrease) in Employee Related Liabilities", "terseLabel": "Accrued compensation" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r86" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r86" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r86" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Stockholders' Equity (Deficit)" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible Assets, Net" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r171", "r175" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r71", "r190" ], "calculation": { "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "totalLabel": "Total" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest Expense, Debt [Abstract]", "terseLabel": "Interest Expense" } } }, "localname": "InterestExpenseDebtAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r73" ], "calculation": { "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Contractual interest expense" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r386" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "negatedLabel": "Interest expense, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r90" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest Paid", "terseLabel": "Interest paid" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r8", "r9", "r39" ], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 7.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventories" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureInventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r27", "r161" ], "calculation": { "http://www.teladoc.com/role/DisclosureInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r2", "r48" ], "calculation": { "http://www.teladoc.com/role/DisclosureInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureInventoriesDetails", "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves": { "auth_ref": [ "r29", "r161" ], "calculation": { "http://www.teladoc.com/role/DisclosureInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of items purchased for use as components of a finished product or pieces of machinery and equipment plus any items in their natural and unrefined state. This element may be used when the reporting entity combines raw materials and purchased parts into an aggregate amount.", "label": "Inventory, Raw Materials and Purchased Parts, Net of Reserves", "terseLabel": "Raw materials and purchased parts" } } }, "localname": "InventoryRawMaterialsAndPurchasedPartsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r28", "r161" ], "calculation": { "http://www.teladoc.com/role/DisclosureInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leasing Operations" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Matters and Contingencies [Text Block]", "terseLabel": "Legal Matters" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLegalMatters" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "verboseLabel": "Leases and Contractual Obligations" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether lessee has option to extend operating lease.", "label": "Lessee, Operating Lease, Existence of Option to Extend [true false]", "terseLabel": "Options to extend" } } }, "localname": "LesseeOperatingLeaseExistenceOfOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails" ], "xbrltype": "booleanItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r359" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of future minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r359" ], "calculation": { "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total future minimum payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r359" ], "calculation": { "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r359" ], "calculation": { "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r359" ], "calculation": { "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r359" ], "calculation": { "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r359" ], "calculation": { "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r359" ], "calculation": { "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Options to extend lease terms" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Remaining lease terms" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Term of Contract", "verboseLabel": "Lessor lease term" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r38", "r95", "r137", "r156", "r317", "r320", "r321", "r343" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "terseLabel": "Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r24", "r95", "r156", "r343", "r380", "r395" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r40", "r95", "r156", "r317", "r320", "r321", "r343" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r37" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r42", "r186" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Longterm Debt Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesCertainTermsOfNotesDetails", "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesTermsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MarketingAndAdvertisingExpense": { "auth_ref": [ "r70" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.", "label": "Marketing and Advertising Expense", "terseLabel": "Advertising and marketing" } } }, "localname": "MarketingAndAdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r115", "r128" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Organization and Description of Business" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureOrganizationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r84" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows provided by financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r84" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]", "terseLabel": "Cash flows used in investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r84", "r85", "r88" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]", "verboseLabel": "Cash flows provided by operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r0", "r55", "r58", "r63", "r88", "r95", "r103", "r105", "r106", "r107", "r108", "r110", "r111", "r112", "r133", "r135", "r138", "r141", "r143", "r156", "r343", "r383", "r398" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net (loss) income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "verboseLabel": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non Us [Member]", "terseLabel": "Foreign." } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncompeteAgreementsMember": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.", "label": "Noncompete Agreements [Member]", "terseLabel": "Non-compete agreements" } } }, "localname": "NoncompeteAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r133", "r135", "r138", "r141", "r143" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Liabilities, Payments Due [Abstract]", "verboseLabel": "Future minimum lease payments under non cancelable operating leases:" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsFutureMinimumLeasePaymentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r356" ], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 6.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities - current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r356" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "verboseLabel": "Operating lease liabilities, net of current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r355" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "verboseLabel": "Operating lease - right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureLeasingOperationsOtherDetails", "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r35" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r314", "r315", "r318" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "verboseLabel": "Cumulative translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r56", "r59", "r61", "r64", "r193", "r345", "r350", "r351", "r384", "r399" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive gain (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r6", "r7", "r39" ], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 13.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r88" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other, net" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r72" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedLabel": "Other expense (income), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]", "terseLabel": "Patents" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r75", "r78", "r98" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r82" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedLabel": "Payment of issuance costs of Notes", "terseLabel": "Offering costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r76" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisitions of business, net of cash acquired", "terseLabel": "Cash paid for acquisition, net" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r77" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireSoftware": { "auth_ref": [ "r77" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.", "label": "Payments to Acquire Software", "negatedLabel": "Capitalized software development costs" } } }, "localname": "PaymentsToAcquireSoftware", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "PSUs" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r239", "r264" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r4", "r32", "r33" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r80" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from issuance of Notes", "verboseLabel": "Net proceeds from issuance of Notes" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureConvertibleSeniorNotesOutstandingConvertibleSeniorNotesIssuancesDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": { "auth_ref": [ "r79", "r265" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.", "label": "Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Excluding Stock Options", "terseLabel": "Proceeds from employee stock purchase plan" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r81", "r83", "r98" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other, net" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Available-for-sale Securities", "terseLabel": "Proceeds from marketable securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments": { "auth_ref": [ "r75" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.", "label": "Proceeds from Sale and Maturity of Other Investments", "terseLabel": "Proceeds from the sale of investment" } } }, "localname": "ProceedsFromSaleAndMaturityOfOtherInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r79", "r265" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Net proceeds from the exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductConcentrationRiskMember": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.", "label": "Product Concentration Risk [Member]", "terseLabel": "Product and Service Concentration Risk" } } }, "localname": "ProductConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r11", "r12", "r182", "r396" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r67", "r159" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for Doubtful Accounts", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealizedInvestmentGainsLosses": { "auth_ref": [ "r403" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment.", "label": "Realized Investment Gains (Losses)", "negatedLabel": "Gain on sale of investment" } } }, "localname": "RealizedInvestmentGainsLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r276", "r428" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Technology and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units R S U [Member]", "terseLabel": "RSUs" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r20", "r198", "r269", "r394", "r412", "r414" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r100", "r101", "r102", "r104", "r109", "r111", "r157", "r266", "r267", "r268", "r283", "r284", "r409", "r411" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue, Deferred Revenue, Deferred Costs and Other" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r129", "r130", "r134", "r139", "r140", "r144", "r145", "r147", "r211", "r212", "r371" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenue", "verboseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails", "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherDisaggregationAndOtherDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r122", "r147" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue From Contract With Customer [Member]", "terseLabel": "Revenue from Contract with Customer" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherOtherDisclosuresDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r201", "r202", "r203", "r204", "r205", "r206", "r209", "r210", "r214", "r222" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue, Deferred Revenue, Deferred Costs and Other" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOther" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r207" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue recognized, performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Future Performance Obligations" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Period of performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureRevenueDeferredRevenueDeferredCostsAndOtherRevenueRemainingPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "auth_ref": [ "r8", "r36" ], "calculation": { "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 12.0, "parentTag": "tdoc_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales and Excise Tax Payable, Current", "terseLabel": "Franchise and Sales Taxes" } } }, "localname": "SalesAndExciseTaxPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r297", "r298" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r238", "r261", "r271" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityCompensationCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r238", "r261", "r271" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]", "terseLabel": "Components of operating expense charged for compensation cost expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r327", "r328" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule assets and liabilities measured at fair value on a recurring basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r173", "r176", "r372" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r173", "r176" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of finite lived intangible assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r168", "r169" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Summary of goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r10", "r29", "r30", "r31" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureInventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Schedule of activity under the RSUs" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Summary of identifiable assets acquired and liabilities assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r239", "r264" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r243", "r254", "r256" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]", "terseLabel": "Summary of stock option activity under the Plan" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Assumptions used for estimate of fair value of options" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "auth_ref": [ "r316", "r317", "r320", "r321", "r322", "r323", "r324", "r325", "r326" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "Schedule of Variable Interest Entities [Table]" } } }, "localname": "ScheduleOfVariableInterestEntitiesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingExpense": { "auth_ref": [ "r70" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized in the period that are directly related to the selling and distribution of products or services.", "label": "Selling Expense", "terseLabel": "Sales" } } }, "localname": "SellingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "auth_ref": [ "r94", "r275" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.", "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]", "terseLabel": "General and Administrative Costs" } } }, "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r86" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Compensation", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "terseLabel": "Nonvested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "terseLabel": "Non-vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted-Average Grant Date Fair Value Per Share" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]", "terseLabel": "Fair value assumptions" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "terseLabel": "Volatility, maximum (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Volatility, minimum (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Risk-free interest rate, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk-free interest rate, minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Common Stock and Stockholders' Equity", "verboseLabel": "Employee Stock Purchase Plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations", "negatedLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted", "terseLabel": "Granted including replacement awards for merger (in shares)", "verboseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r244", "r246" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Outstanding at end of period (in shares)", "periodStartLabel": "Outstanding at beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]", "terseLabel": "Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Shares available for grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Exercisable as of end of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable as of end of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r255" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value", "negatedLabel": "Stock options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Stock options forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Stock option grants and assumed awards (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r264" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r245", "r264" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Balance, end of period (in shares)", "periodStartLabel": "Balance, beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Shares Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Balance, end of period (in dollars per share)", "periodStartLabel": "Balance, beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted-Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r256" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Vested or expected to vest at end of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Vested or expected to vest at end of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Vested or expected to vest at end of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r237", "r242" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityPerformanceStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityRestrictedStockUnitsDetails", "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "verboseLabel": "Stock option exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Stock options forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "verboseLabel": "Stock option grants and assumed awards (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Exercisable period (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r259", "r270" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityFairValueAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r264" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Exercisable as of end of period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable as of end of period (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted-average remaining contractual life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Vested or expected to vest at end of period (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Stock purchase price as a percentage of fair value (as a percent)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r200", "r274" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "Shareholders' Equity and Share-based Payments [Text Block]", "terseLabel": "Common Stock and Stockholders' Equity" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance as of end of the period (in shares)", "periodStartLabel": "Balance as of beginning of the period (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.", "label": "Software And Software Development Costs [Member]", "terseLabel": "Capitalized software development costs" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r47", "r100", "r101", "r102", "r104", "r109", "r111", "r114", "r157", "r193", "r198", "r266", "r267", "r268", "r283", "r284", "r345", "r346", "r347", "r348", "r349", "r351", "r409", "r410", "r411" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Disclosures:" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statement of Stockholders' Equity" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r100", "r101", "r102", "r114", "r371" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureAdvancesFromFinancingCompaniesDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r16", "r17", "r198" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Issuance of stock in acquisition (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r46", "r193", "r194", "r198" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "verboseLabel": "Issuance of common stock for Notes (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r16", "r17", "r193", "r198" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Issuance of stock under employee stock purchase plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityEmployeeStockPurchasePlanDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r16", "r17", "r193", "r198", "r249" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Stock option exercised (in shares)", "terseLabel": "Exercise of stock options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureCommonStockAndStockholdersEquityStockPlanAndStockOptionsDetails", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r47", "r193", "r198" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Issuance of stock in acquisition" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r47", "r193", "r198" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Issuance of common stock for Notes" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r16", "r17", "r193", "r198" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Issuance of stock under employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r47", "r193", "r198" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r17", "r22", "r23", "r95", "r151", "r156", "r343" ], "calculation": { "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "negatedLabel": "(Equity) deficit", "periodEndLabel": "Balance as of end of the period", "periodStartLabel": "Balance as of beginning of the period", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails", "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets", "http://www.teladoc.com/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "verboseLabel": "Stockholders' equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "auth_ref": [ "r302" ], "lang": { "en-us": { "role": { "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.", "label": "Technology Based Intangible Assets [Member]", "terseLabel": "Technology" } } }, "localname": "TechnologyBasedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails", "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Brand" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]", "terseLabel": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBusinessAcquisitionsAssetsAcquiredLiabilitiesAssumedProFormaDetails", "http://www.teladoc.com/role/DisclosureIntangibleAssetsNetSummaryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r116", "r117", "r118", "r119", "r125", "r126", "r127" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Variable Interest Entity [Line Items]", "terseLabel": "Variable interest entity" } } }, "localname": "VariableInterestEntityLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "auth_ref": [ "r316", "r317", "r320", "r321", "r322" ], "lang": { "en-us": { "role": { "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.", "label": "Variable Interest Entity Primary Beneficiary [Member]", "terseLabel": "Primary beneficiary" } } }, "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/DisclosureBasisOfPresentationAndPrinciplesOfConsolidationVieDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Weighted-average shares used to compute basic and diluted net loss per share" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.teladoc.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r128": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r162": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/subtopic&trid=2144439" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r185": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=51819886&loc=SL6014347-161799" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r222": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r274": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r291": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r313": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6228884-111685" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919359-209981" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.3(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r429": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r431": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r432": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r433": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r434": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r99": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" } }, "version": "2.1" } ZIP 85 0001558370-21-013911-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-21-013911-xbrl.zip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�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�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end